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The call for articles on the long term health effects of the 11 September 2001 terrorist attacks
(9/11) has resulted in twenty-three papers that add a significant amount of information to the growing
body of research on the effects of the World Trade Center (WTC) disaster almost two decades later.
The attacks on 9/11 were a paradigm altering event in US history and have had major repercussions
in the political landscape and response to terrorism. The toll of 9/11 includes the continued impact
of accumulated health effects among those who were directly exposed to either the air pollution or
re-suspended material that resulted from the collapse of the two WTC towers, and physical injuries or
psychological trauma. This includes a wide range of physical and mental health disorders that continue
to plague thousands of people 18 years later as well as newly identified conditions emerging as a result
of prolonged disease latency. This was recently highlighted by the addition of “The Memorial Glade”
at the WTC site that acknowledges illnesses and deaths years after the towers collapsed [1].
The articles in this special issue also demonstrate the importance of the medical monitoring of the
wide range of populations exposed to unprecedented levels of physical and psychological insult from
the 9/11 attacks. As such, the reports in this issue represent research findings from the clinics supported
by World Trade Center Health Programs and the epidemiological follow-up by the World Trade Center
Health Registry. Although the majority of the articles represent rescue, recovery, and clean-up workers
(12), some other non-rescue recovery groups included in the special issue are residents of Chinatown,
just 10 blocks from ground zero (Kung et al. 2019 [2]), and other residents of lower Manhattan (Antao
et al. 2019 [3]).
Respiratory and lung problems are among the most prevalent and highly persistent physical health
problems arising from 9/11 exposure to dust clouds from the collapsing building and the subsequent
re-suspension of dust (Aldrich, 2010 [4]). In this issue, there are nine respiratory-related papers that
provide new insights into the long term consequences of lung damage from 9/11 exposure not reported
in previous research. These papers highlight the chronic and still emerging health sequela of 9/11
exposure. An analysis of cleaning practices by residents in lower Manhattan showed that cleaning
with dry methods was associated with more types of respiratory symptoms than other cleaning
methods (Antao, 2019 [3]). Other papers delved into the underlying physical and biological aspects of
pulmonary illness among persons exposed to 9/11 (Liu, 2019 [5]; Kwon, 2019 [6]; Pradhan, 2019 [7]).
Liu et al. (2019) used chest tomography (CT) and reported that firefighters with high intensity exposure
on 9/11 had increased risk of bronchial wall thickening, emphysema, and air trapping. They correlated
the CT-identified abnormalities with respiratory symptoms. A second paper also evaluated the role of
metabolic syndrome biomarkers (MSBs) among firefighters (e.g., elevated systolic blood pressure and
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insulin resistance) in airway hyperactivity (Kwon, 2019 [6]). They reported that given 9/11 exposure,
having three or more MSBs increased airway hyperactivity beyond that associated with 9/11 exposure.
Another paper that evaluated the bronchodilator response among community members exposed to
9/11 found that a proportion of small airway problems were irreversible, which was predicted by the
bronchodilator response at initial visits (Pradhan, 2019 [7]). Two other papers evaluated the increased
risk of asthma control issues and quality of life as a function of indoor allergens (Rojano, 2019 [8]) and
air pollution/irritants (Yung, 2019 [9]). In addition, an emerging respiratory condition, pulmonary
fibrosis (PF)—a common long term sequelae of occupational dust exposure—was documented in a
paper based on data from the World Trade Center Health Registry for which there was evidence of a
dose-response relationship with the level of exposure among rescue/recovery and other 9/11 workers
and the likelihood of PF (Li, 2019 [10]).
Three other papers reported additional findings on a condition known as sarcoidosis (Cleven,
2019 [11]; Hena, 2019 [12]) and sarcoid-like granulomatous (Sunil, 2019). Sarcoidosis is a rare
autoimmune disease that can affect any organ, but among rescue, recovery, clean-up workers, it has
been previously reported as granulomatous disease involving the thoracic organs (Izbicki, 2007 [13];
Jordan, 2011 [14]), primarily among firefighters or other rescue, recovery, or clean-up workers arriving
early at the WTC site. One paper in this issue describes sarcoidosis among community members who
were patients at the WTC Environmental Health Center (Hena, 2019 [12]). Another paper focused
on the genetic predisposition for sarcoidosis in a case control study (Cleven, 2019 [11]). Sunil (Sunil,
2019 [15]) reported a detailed pathology review of sarcoid like granulomatous disease (SGD). Out of
seven cases, five were definite SGD and had high exposure to 9/11 WTC dust.
In addition to respiratory disease, other long term adverse health outcomes of WTC-related
exposure include neurologic conditions and cancer. Papers in this issue focused on these emerging
conditions including peripheral neuropathy (Colbeth, 2019 [16]), paresthesia (Thawani, 2019 [17]),
and thyroid cancer (van Gerwen, 2019 [18]; Tuminello, 2019 [19], see Gargano, 2018 [20] for a review
of non-respiratory physical health conditions). Two studies focused on neuropathic conditions that
included peripheral neuropathy among New York City firefighters and emergency medical workers
(Colbeth, 2019 [16]) and parenthesia among community survivors who received treatment at one of
the WTC Health programs (Thawani, 2019 [17]). Potential exposures for neuropathic conditions on
9/11/2001 and afterward included heavy metals and complex hydrocarbons. Both studies used the
self-reporting of unusual and painful sensations such prickling, burning, or aching pain in the limbs.
Colbeth et al. reported a 35% increase in the likelihood of peripheral neuropathy symptoms among
those with the highest 9/11 exposure versus low/no exposure. Similarly, Thawani et al. reported a
significant hazard ratio of 1.4 for parenthesia among persons who had a job that required cleaning-up
materials resulting from building fires and buildings collapsing. The physical health outcome of
cancer was represented by two papers on thyroid cancer (Tuminello, 2019 [19]; van Gerwen, 2019 [18]).
Thyroid cancer has been identified as a cancer with a higher expected incidence among potential
WTC-exposed persons (Zeig-Owens, 2011 [21]; Li, 2016 [22]; Solan et al., 2013 [23]). Tuminello (2019)
evaluated the possibility that increased surveillance for thyroid cancer among WTC survivors could
account for the elevated thyroid cancer incidence. In another study (van Gerwin, 2019 [18]) that
evaluated thyroid cancers derived from the same population, the authors compared the pathological
characteristics of cancer tumors of WTC exposed to non-WTC cases in order to assess whether there
were more false positives among the WTC exposed that would suggest a surveillance bias.
The high prevalence of adverse mental health, especially post-traumatic stress disorder (PTSD),
has been documented among survivors of 9/11 (Brackbill, 2009 [24]; Stellman, 2008 [25]), in addition to
the persistence of PTSD (Pietrzak, 2014 [26]; Maslow, 2015 [27]; Welch, 2016 [28]). A number of papers
in this issue addressed the characteristics of those receiving or not adequately receiving mental health
treatment and some measurement of the effectiveness of treatment (Jacobson, 2019 [29]; Kung, 2019 [2];
Rosen, 2019 [30]; Bellehsen, 2019 [31]). Based on data from the World Trade Center Health Registry
(WTCHR), 38% of enrollees reported they had utilized mental health counseling or therapy sometime
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in the 15 years after 9/11, with younger persons more likely to seek counseling, but older persons
perceiving treatment to be helpful (Jacobson, 2019). Those with persistent PTSD perceived treatment to
be less helpful. Another paper also used WTCHR information to characterize unmet mental health care
needs for a specific sub-group of Asian WTCHR enrollees, who typically underutilize mental health
services (Kung, 2019 [2]). Among the 2300 Asian WTCHR enrollees included in the study, 12% said that
they had an unmet mental health care need, for whom 69% reported attitudinal barriers (e.g., I do not
need to see a doctor) to utilizing mental health care, 36% said there were cost barriers (e.g., lack of health
insurance), and 28% had access barriers (e.g., where to go for doctor, childcare, transportation issues).
Two other 9/11 mental health papers used information on patients enrolled in a community WTC
Health Program (Rosen, 2019 [30]) and rescue/recovery worker health program (Bellehsen, 2019 [31]).
Among patients who reached the criteria for PTSD at the first visit, 77% continued to meet the criteria
for PTSD 3 to 4 years later (Rosen, 2019 [30]). Further analysis indicated that some reduction in PTSD
symptoms was associated with treatment. The second paper evaluated the extent to which patients
were receiving evidence-based treatment (EBT) by community health providers. Like the Rosen et al.
paper, they employed baseline and follow-up information in addition to providers reporting their use
of EBT. However, after an independent review, 12% of the patients were likely to have received full
EBT, and another 40% received some elements of EBT.
Some papers in this issue fittingly addressed the long-term effects of 9/11 exposure on both
physical and mental functioning. For instance, Brackbill et al. (2019) [32] assessed the self-reported
physical and mental health functioning of persons who were injured on 9/11 15 years after the attack.
The severity of injury was associated with physical functioning, but not with mental health functioning;
PTSD history also had a significant additive influence on the effect of injury on physical functioning.
Using a more objective measure of functionality referred to as handgrip strength, which is a measure
of general health status and biomarker of aging, Mukherjee (2019 [33]) reported that rescue/recovery
workers with probable PTSD had significantly lower HGS than those without PTSD or depression.
Apart from functionality and physical loss, there is concern that persons exposed to 9/11 could be
at greater risk of cognitive impairment, memory loss, or confusion at a faster rate than would be
expected normally with age. Seil (2019) [34], using the WTC Health Registry data, derived levels of
protective factor or cognitive reserve (based on educational level, employed or not, social support, and
level of physical activity) for cognitive impairment and found that higher levels of cognitive reserve
were associated with less self-reported memory loss for both persons with and without a history of
PTSD. Two other aspects of quality of life are represented by papers on early retirement and post-2019
(Yu, 2019 [35]). Among the Lower Manhattan residents and area workers, a history of PTSD and the
number of 9/11 related chronic conditions were associated with early retirement (retired before 60).
In addition, income loss among those who retired was more likely among those with the highest level
of exposure. In the quality of sleep study, it was reported that 9/11 related co-morbidities including
gastroesophageal reflux disease, chronic rhinosinusitis, PTSD, anxiety, and depression were associated
with a great proportion of sleep related complaints (Ayappa, 2019 [36]). With the presence of these
co-morbidities, apnea had no significant impact on sleep quality.
The papers in this special issue clearly document the continued long term effects of the September
11, 2001 WTC disaster on a wide range of health and quality of life issues. They underscore the need
for ongoing health monitoring of these highly exposed populations while also representing the cutting
edge research on subject areas from the biological underpinnings of 9/11 related respiratory disease
to the effectiveness of treatment for mental health problems related to 9/11. This work continues to
inform the World Trade Center Health Program for those most affected by the disaster. While this is a
uniquely exposed population, this large body research will inform responses to, and the monitoring of,
populations exposed to future human caused and natural disasters.
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Abstract: Following the World Trade Center (WTC) attacks in New York City (NYC) on 11 September
2001 (9/11), thousands in NYC experienced significant stress reactions and disorders, presenting an
immediate need for counseling and treatment. While other studies documented post-9/11 mental
health treatment utilization, none have data more than two years post-disaster. We used data from
35,629 enrollees of the WTC Health Registry, a longitudinal cohort study of those exposed to the
WTC attacks, to examine predictors of counseling after 9/11, the types of practitioners seen, and
the perceived helpfulness of therapy up to 15 years post-disaster. Among enrollees, 37.7% reported
receiving counseling at some time after 9/11. Predictors of seeking counseling included race/ethnicity,
age at 9/11, education level, exposure to the WTC attacks, other traumatic experiences, mental health
symptomology, and pre-9/11 counseling. Whites and Hispanics, those who were children on 9/11,
and those with high levels of exposure to the WTC attacks sought counseling soonest after 9/11.
Among those who sought counseling, Blacks, Asians, and those with lower education and income
were less likely to see mental health specialists and more likely to see general practitioners or religious
advisors. Finally, among those who sought recent counseling, women, Blacks, those aged ≥65 years,
and those with very high WTC exposures were more likely to rate their recent counseling as very
helpful. This study used data up to 15 years post-disaster to document mental health treatment
utilization patterns, trends, and disparities that have implications for future preparedness plans and
needs assessments.
Keywords: counseling; post-disaster; psychotherapy; mental health treatment; treatment utilization
1. Introduction
The World Trade Center (WTC) terrorist attacks in New York City (NYC) on 11 September 2001
(9/11) resulted in thousands of casualties and, among the survivor population in NYC, a substantial
mental health burden [1], primarily consisting of stress disorders [2,3]. Specifically, similar to the
aftermath of other natural or human-made disasters, posttraumatic stress disorder (PTSD) was the
most common mental health condition that resulted from the attacks [4]. This mental health burden
translated into a need for crisis counseling and treatment [1]. In response, several mental health
programs in New York City were established after 9/11, such as Project Liberty [5]. Project Liberty
was a mental health screening and treatment program with a bilateral approach. The first tier was a
general outreach program to communities affected by the attacks, providing free short-term counseling
IJERPH 2019, 16, 626; doi:10.3390/ijerph16040626 www.mdpi.com/journal/ijerph7
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and education on coping methods for typical stress reactions. In addition, it included delivery of
counseling to children in schools [6]. Secondly, individuals were screened for more severe and/or
prolonged symptoms and then referred to specialized mental health treatment. Separately, mental
health treatment was also offered through a program initially designed to monitor and treat those
who participated in the rescue and recovery efforts [7]. Subsequently, treatment for mental health
conditions was also made available to community members (i.e., those who were not involved in
the rescue and recovery work) [8]. Together, these programs are collectively referred to as the WTC
Health Program. Despite these established programs, it was consistently documented that receipt
of these mental healthcare services was less than expected given the number of affected individuals
and magnitude of the situation [9,10], which is common among populations who experience different
types of mass trauma, such as natural disasters [11,12].
Several studies examined mental health treatment use after 9/11 and documented predictors of
treatment receipt [9,13–17]. These studies reported that those with the greatest levels of exposure to
the WTC attacks and those who had experienced peri-event panic attacks were the most likely to use
mental health services after 9/11. Individuals who were Black and those without a regular doctor were
less likely to use mental health services, including therapy and medication. However, these studies
were conducted between six months and up to two years after the attacks, and data on longer-term
or delayed utilization are sparse. Furthermore, studies generally lack specific details on the type of
practitioner sought and the perceived degree of benefit of counseling.
The main objective of this study was to describe post-9/11 mental health treatment utilization,
specifically counseling and therapy among individuals exposed to the WTC attacks up to 15 years
post-disaster. Firstly, we examined predictors (e.g., demographics and exposure to the WTC attacks)
of seeking counseling after 9/11, and then compared the characteristics of individuals who sought
different types of practitioners for such counseling. Secondly, we assessed determinants of perceived
benefit of recent counseling. Lastly, we evaluated the distributions of time to first counseling after 9/11
by several factors.
2. Materials and Methods
Study Population. The World Trade Center Health Registry (Registry) is a longitudinal cohort
study of persons exposed to the WTC terrorist attacks on 9/11 [18]. Those who lived, worked, went to
school, or were otherwise present in lower Manhattan on 9/11 and/or those who participated in the
rescue and recovery efforts were eligible to enroll. The Registry was established in order to track the
short and long-term potential health effects of 9/11.
The study design, eligibility, and enrollment methods of the Registry were previously
described [18]. Briefly, in 2003–2004, 71,426 individuals who were exposed to the WTC attacks
on 9/11 either as rescue and recovery workers or community members, were enrolled into the Registry
and completed a baseline questionnaire (Wave 1). This was followed in subsequent years by Wave 2
(2006–2007), Wave 3 (2011–2012), and Wave 4 (2015–2016). The Institutional Review Boards of the
Centers for Disease Control Prevention and the New York City Department of Health and Mental
Hygiene approved the Registry protocol.
For this study, enrollees had to complete the Wave 4 questionnaire (N = 36,862), which included
questions on their mental health treatment history, and were required to not be missing data on date of
birth (N = 18) or missing a response to the question about whether the enrollee had at least one session
of counseling or therapy after 9/11 (N = 1215). This yielded a final sample of 35,629.
Mental health treatment. On the Wave 4 survey, enrollees were asked about their mental
healthcare-seeking behavior ever, after 9/11, and in the last 12 months. Firstly, enrollees were asked
whether they had ever had a session of counseling or therapy lasting 30 minutes or longer and, if so,
at what age the first session of counseling occurred, and whether any counseling was sought after
9/11. Among those who reported seeking care after 9/11, questions were asked about the conditions
for which counseling was sought (e.g., depression, PTSD, anxiety, among others) and what types of
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practitioners were sought (e.g., psychologist, psychiatrist, social worker, clergy member, among others).
Lastly, among those who reported seeking counseling in the last 12 months, questions were asked
about medical indications for counseling, frequency of counseling, and perceived benefit. Whether any
counseling was sought in relation to the events of 9/11 was not explicitly asked in the questionnaire.
Explanatory variables. Questionnaire data consisted of details on demographics and social factors,
WTC-related exposures and experiences, health-related and care-seeking behaviors, and mental and
physical health symptoms and conditions over time. Demographic information included sex, age, race
and ethnicity, household income, and education. For this study focusing on mental health, exposure
to the WTC attacks was operationalized using data on several traumatic experiences on and directly
after 9/11 that were asked about on Waves 1 and 2. Based on work by Adams and Boscarino [19],
Brackbill et al. derived a composite score consisting of 11 questions about traumatic experiences such
as being in the North or South World Trade Center (WTC) towers at the time of the attack, witnessing
three or more events (seeing planes hit the buildings, people fall or jump from buildings, people injured,
or people running), being injured on 9/11; having a relative killed on 9/11, and being displaced from
home due to 9/11 [20]. These items were summed (range = 0–11) and the score was then categorized as
none/low (0–1 exposures), medium (2–3), high (4–5), and very high (≥6). In addition, another measure
of “exposure” to the WTC attacks was the Registry eligibility group. Enrollees were categorized with
regard to how they originally became eligible for the Registry: rescue and recovery workers, lower
Manhattan residents or lower Manhattan area workers, passersby, or students. Because these groups
were not mutually exclusive, those who met the criteria for more than one category were placed in
the category considered to be more highly exposed to 9/11, such that rescue and recovery workers
had greater levels of WTC exposure than residents, who had greater exposures than area workers,
passersby, and students.
Mental health measures. PTSD symptoms were assessed at each wave (Waves 1–4) using the
9/11-specific PTSD Checklist (PCL)-17 [21–23]. The PCL is a self-administered questionnaire based
on Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria [24] and its validity was
established [25]. Total scores ≥44 were considered to be indicative of probable PTSD [21]. PTSD status
was summarized across time as ever (scores ≥44 on at least one wave) or never (scores <44 on all
waves). Persistent PTSD was defined as those who had scores ≥44 at all four waves.
Depressive symptoms were assessed using the Patient Health Questionnaire (PHQ)-8 [26] at
Waves 3 and 4 only. This self-administered and validated instrument contains eight of the nine criteria
that constitute the DSM-IV diagnosis of depressive disorders [24,27]. Scores ≥10 were considered to
be indicative of moderate to severe depression [28].
Enrollees were also asked whether they had ever been diagnosed by a doctor or other medical
professional with various mental health conditions, such as depression, PTSD, or anxiety.
Statistical Analysis. Firstly, we evaluated the distribution of personal characteristics, WTC
exposures, and mental health symptomology by whether enrollees sought counseling at some time
after 9/11. In order to identify predictors of seeking counseling, we then fit multivariable log binomial
models to estimate associations between these factors and seeking counseling after 9/11. In these
models, we did not include factors that required a doctor diagnosis (e.g., doctor-diagnosed depression),
since these diagnoses could have been received through such counseling visits. Instead, we included
PTSD and depression symptoms as measured by the PCL-17 and PHQ-8, respectively. We fit these
models among everyone in the sample, and then conducted a sensitivity analysis restricting the
sample to those who had a history of PTSD (Waves 1–4) or depression (Waves 3–4) via threshold
PCL-17 and PHQ-8 scores, respectively, in order to examine those with the most theoretical clinical
need for counseling. Next, among those who sought counseling, we then examined the types of
practitioners sought, and the distributions of personal characteristics, WTC exposures, and mental
health symptomology across practitioner type. Again, we did this in the total sample, and subsequently
just among those with a history of PTSD or depression. Next, among those who had sought counseling
in the last 12 months prior to completing the Wave 4 questionnaire, we explored the determinants of
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perceived helpfulness of therapy. We fit log binomial models estimating adjusted risk ratios (aRR) and
95% confidence intervals (CI) to identify predictors of perceiving recent counseling as “very helpful”
compared with all other ratings (i.e., collapsing all other categories: somewhat, slightly, and not at all).
Demographic characteristics, WTC-related exposures, mental health symptomology, and variables
related to care-seeking were examined simultaneously in models. Finally, among those who did not
seek counseling before 9/11, we assessed the distributions of time elapsed between 9/11 and first
seeking counseling (i.e., time to first counseling after 9/11) by several covariates, such as demographics
and WTC exposures using unadjusted Kaplan–Meier curves.
3. Results
The study population was majority male (60.6%), White (70.0%), and had at least a college
education (53.2%) (Table 1). There was approximately equal representation of rescue and recovery
workers (46.3%) and community members (residents, area workers, passersby, and students; 53.7%)
in the sample. Mental health conditions were common: 27.1% screened positive for PTSD on at least
one Wave according to PCL-17 scores over time and 16.3% reported ever being diagnosed with PTSD
by a medical professional. Likewise, although only 18.5% of individuals reported seeking counseling
before 9/11, 37.7% reported counseling at some time after 9/11. Among those who sought treatment
for the first time after 9/11, counseling was sought consistently throughout the 15 years after 9/11,
with the largest increase observed in the first year after 9/11 (Figure 1).
Table 1. Distributions of personal characteristics, World Trade Center (WTC) exposures, and
mental health symptomology by seeking counseling post 11 September 2001 (9/11) and adjusted












aRR a 95% CI
N % N % N %
Sex
Men 21586 60.6 7240 33.5 14346 66.5 1.00 Reference
Women 14043 39.4 6195 44.1 7848 55.9 1.01 0.99 1.03
Race/Ethnicity
White 24939 70.0 9857 39.5 15082 60.5 1.00 Reference
Black 3416 9.6 1045 30.6 2371 69.4 0.83 0.76 0.90
Hispanic 4046 11.4 1550 38.3 2496 61.7 0.98 0.94 1.02
Asian 2002 5.6 470 23.5 1532 76.5 0.72 0.63 0.82
Other race 1226 3.4 513 41.8 713 58.2 1.00 0.99 1.02
Education at Wave 1
≤High school/GED 7857 22.2 2619 33.3 5238 66.7 0.94 0.90 0.99
Some college 8704 24.6 3138 36.1 5566 63.9 0.99 0.96 1.02
College 11423 32.3 4470 39.1 6953 60.9 0.99 0.98 1.00
Graduate degree 7376 20.9 3115 42.2 4261 57.8 1.00 Reference
Income at Wave 1
<$50,000 8876 27.6 3632 40.9 5244 59.1 1.00 0.98 1.01
≥$50,000 to <$150,000 19249 59.8 6974 36.2 12275 63.8 0.99 0.98 1.00
≥$150,000 4050 12.6 1623 40.1 2427 59.9 1.00 Reference
Age at 9/11 (years)
0–17 852 2.4 438 51.4 414 48.6 2.44 1.86 3.20
18–24 1720 4.8 845 49.1 875 50.9 2.42 1.84 3.17
25–44 18212 51.1 7442 40.9 10770 59.1 2.37 1.81 3.11
45–64 14010 39.3 4551 32.5 9459 67.5 2.08 1.58 2.73
≥65 835 2.3 159 19.0 676 81.0 1.00 Reference
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aRR a 95% CI
N % N % N %
Eligibility group
Rescue/recovery worker 16480 46.3 5732 34.8 10748 65.2 1.00 0.98 1.01
Lower Manhattan resident 5103 14.3 2266 44.4 2837 55.6 0.99 0.95 1.02
Lower Manhattan area
worker/passerby 14046 39.4 5437 38.7 8609 61.3 1.00 Reference
WTC exposure score
None/low 15620 43.8 5083 32.5 10537 67.5 1.00 Reference
Medium 11923 33.5 4518 37.9 7405 62.1 1.08 1.04 1.12
High 6203 17.4 2743 44.2 3460 55.8 1.09 1.04 1.13
Very high 1883 5.3 1091 57.9 792 42.1 1.10 1.06 1.14
Traumatic experiences after 9/11 b
No 21859 61.4 6700 30.7 15159 69.3 1.00 Reference
Yes 13770 38.6 6735 48.9 7035 51.1 1.08 1.05 1.12
Ever-PTSD c
No 17572 72.9 5156 29.3 12416 70.7 1.00 Reference
Yes 6543 27.1 3726 56.9 2817 43.1 1.27 1.20 1.33
Ever-Depression d
No 22209 77.5 6691 30.1 15518 69.9 1.00 Reference
Yes 6451 22.5 3973 61.6 2478 38.4 1.17 1.11 1.23
Counseling before 9/11
No 27971 81.5 7460 26.7 20511 73.3 1.00 Reference
Yes 6340 18.5 4810 75.9 1530 24.1 2.25 2.16 2.34
Doctor-diagnosed depression (ever)
No 28099 78.9 7366 26.2 20733 73.8 - -
Yes 7530 21.1 6069 80.6 1461 19.4 - -
Doctor-diagnosed PTSD (ever)
No 29816 83.7 8490 28.5 21326 71.5 - -
Yes 5813 16.3 4945 85.1 868 14.9 - -
Doctor-diagnosed anxiety (ever)
No 30950 86.9 9695 31.3 21255 68.7 - -
Yes 4679 13.1 3740 79.9 939 20.1 - -
a Risk ratio represents the comparison of seeking counseling vs. not seeking counseling (reference). b Traumatic
experiences were defined as one or more of the following: experiencing a serious accident (e.g., in a car or a fall),
an intentional attack with or without a weapon, forceful unwanted sexual contact, and serious family or work
problems. c As measured by a score of ≥44 on the 9/11-specific PTSD Checklist (PCL)-17 on at least one wave
(Waves 1–4). d As measured by a score of ≥10 on Patient Health Questionnaire (PHQ)-8 on at least one wave
(Waves 3–4).
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Figure 1. Unadjusted Kaplan–Meier curves and 95% confidence intervals of time to first counseling
after 11 September 2001 (9/11) among those who had not sought counseling before 9/11 (N = 27,971),
World Trade Center (WTC) Health Registry, 2003–2016: (A) by race/ethnicity; (B) by age at 9/11; (C) by
WTC exposure summary score.
Females were more likely to seek counseling compared with males (44.1% vs. 33.5%, although
in adjusted models, sex was not a predictor of counseling (aRR = 1.01, 95% CI: 0.99, 1.03). While
Blacks (aRR = 0.83, 95% CI: 0.76, 0.90) and Asians (aRR = 0.72, 95% CI: 0.63, 0.82) were less likely
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to seek counseling compared with Whites, Hispanics and those of other races were equally likely
to seek counseling compared with Whites. This was also apparent in the examination of time to
counseling (Figure 1A). Asians were the most likely to delay counseling after 9/11 (i.e., had the longest
times to counseling) compared with those of other races (i.e., who had the shortest times). Age at
9/11 was a strong predictor of counseling. Those who were younger at 9/11, especially those aged
0–17 years, were the most likely to seek counseling compared with those aged 65 years and older
(Table 1). This observation was consistent in the distributions of times to counseling (Figure 1B). Those
who were children (0–17 years) at the time of 9/11 sought counseling sooner than those who were older.
This relationship between age at 9/11 and time to counseling was monotonically positive such that,
as age increased, the delay in seeking counseling also increased (i.e., longer times). Other demographic
characteristics showed mixed associations with seeking counseling; while those with less than a high
school education were slightly less likely to seek counseling compared with those with a graduate
degree, income was not associated with seeking counseling (Table 1).
Measures of exposure to the WTC attacks, other post-9/11 traumatic experiences, and mental
health symptomology were positively associated with seeking counseling. For example, those with
very high scores of WTC exposure were more likely to seek counseling compared with those with
none or low exposure (aRR = 1.10, 95% CI: 1.06, 1.14), and again this pattern was visible when
times to counseling were considered (Figure 1C). Those who experienced the greatest number of
traumatic exposures on 9/11 sought counseling soonest, such that there was a negative dose–response
relationship between the WTC exposure summary score and time to counseling; the greater the number
of exposures, the sooner counseling was sought (i.e., shorter times). Other traumatic experiences
after 9/11 were similarly associated with an increased likelihood of seeking counseling (aRR = 1.08,
95% CI: 1.05, 1.12)
Although residents were the most likely to seek counseling (44.4%) compared with rescue and
recovery workers (34.8%) or area workers and passersby (38.7%) in bivariate analyses, all were equally
likely to seek counseling in adjusted models (Table 1). Those who had threshold PTSD symptoms at
any wave (ever-PTSD), as well as those who had threshold depressive symptoms at Waves 3 and/or 4
(ever-depression), were more likely to seek counseling after 9/11 compared with those who did not
meet symptom thresholds for each condition. Although not included in models, those who received
diagnoses of depression, PTSD, and anxiety were more much more likely to have sought counseling
compared with those without diagnoses. Finally, having sought counseling before 9/11 was a strong
predictor of seeking counseling after 9/11 (aRR = 2.25, 95% CI: 2.16, 2.34).
When this analysis was conducted among those with PTSD or depression symptoms (N = 9391),
results did not change (data not shown). Although the prevalence of having sought counseling after
9/11 was greater among those with PTSD or depression symptoms over time (57.1%) compared to
the total (37.7%), the associations between enrollee characteristics and seeking counseling did not
materially vary.
Among those who sought counseling after 9/11, psychiatrists (40.2%), psychologists (50.0%),
and/or other mental health professionals (i.e., social worker, therapist, or counselor) (47.3%) were the
most common types of practitioners sought (Table 2). Type of practitioners sought varied across most
demographic characteristics, but did not vary by sex. Whites, Hispanics, and those of other races were
more likely to see psychiatrists or psychologists compared with Blacks or Asians. However, Blacks
and those of other races were more likely to seek counseling from nurses/occupational therapists or
religious or spiritual advisors than Whites or Asians. Finally, Asians were the most likely to report
seeking general practitioners for counseling compared with other race/ethnicity groups. In addition,
although seeing a psychiatrist did not vary by education or income, these demographic characteristics
were positively associated with seeing a psychologist such that those with the highest level of education
or income were more likely to see a psychologist compared with those with lower levels. In contrast,
those with lower education or income were more likely to see a general practitioner, nurse/occupational
therapist, or religious advisor compared with those more educated and/or who earned more income.
13
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Those who were children (aged 0–17 years) at 9/11 were more likely to seek counseling from
mental health specialists (e.g., psychologists, psychiatrists, or other mental health professionals)
compared with those who were older. However, older individuals, especially those 65 years and
older, were more likely to seek general practitioners and nurses for counseling compared with
those of younger age groups, whereas middle aged individuals were the most likely to see religious
advisors. Rescue and recovery workers, residents, and area workers/passersby generally saw different
practitioners with similar frequencies, although residents were the least likely to seek counseling from
religious or spiritual advisors (9.0%) compared with rescue and recovery workers (18.5%) or area
workers/passersby (15.2%).
Those with high WTC exposures were more likely to see all types of practitioners compared
with those with lower exposures. The most common practitioners sought overall were psychologists;
56.2% of those with high WTC exposures reported seeing a psychologist for counseling. Similarly,
those with threshold PTSD or depression symptoms were more likely to seek counseling from all types
of practitioners compared with those without symptoms, although these differences were smallest
for seeking counseling from other mental health professionals. Specifically, 47.4% of those who never
had threshold PTSD symptoms reported seeking counseling from other mental health professionals
compared with 50.2% of those who did have threshold PTSD symptoms. This pattern was similar
across those who reported receiving a formal diagnosis of depression, PTSD, or anxiety compared with
those who did not. There was also little difference between the types of practitioners sought comparing
those who had sought counseling before 9/11 and those who had not. Finally, the conditions for
which individuals sought counseling affected the type of practitioner they sought. Specifically, more
of those who sought counseling for alcohol or drug problems saw all types of practitioners other
than psychiatrists or psychologists, such as general practitioners, nurses/occupational therapists, and
religious advisors, compared to those who sought counseling for other conditions. Overall, these
trends did not change when the sample was restricted to those who experienced PTSD or depression
symptoms over time (data not shown).
Lastly, among those who reported receipt of counseling within the last 12 months (N = 5429),
the vast majority (79.3%) reported that the counseling was at least somewhat helpful (Table 3). Women
(vs. men), Blacks (vs. all other race/ethnicities), and those aged ≥65 years at 9/11 (vs. all younger
age groups) were more likely to report that therapy was very helpful. In bivariate analysis, similar
distributions of perceived helpfulness were observed across eligibility groups and WTC exposure levels;
however, in adjusted models, those with very high WTC exposure scores (aRR = 1.21, 95% CI: 1.07, 1.36)
were more likely to rate their recent counseling as very helpful compared with those with none or low
levels of WTC exposures.
16
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Those with persistent PTSD were less likely to rate their recent counseling as very helpful
(aRR = 0.68, 95% CI: 0.58, 0.81), and more likely to report that it was “not at all” (5.4%) or slightly”
(21.8%) helpful compared with those who never had PTSD (2.2% and 12.3%, respectively). Those who
had non-persistent PTSD (i.e., intermittent, delayed, or recovered) were also less likely to rate their
recent counseling as very helpful compared with those who never had PTSD (aRR = 0.76, 95% CI:
0.68, 0.83). Although similar frequencies of helpfulness were observed across the conditions for which
people received counseling, in adjusted models, those who received counseling for depression (vs. all
other indications) were less likely to rate their counseling as very helpful, whereas those who received
counseling for PTSD (vs. all other indications) were more likely to rate their counseling as very helpful.
The frequency of counseling was positively associated with perceived helpfulness such that those
who sought counseling more often reported it to be “very helpful” compared with those who went
less often. Similarly, those who had received therapy prior to the last 12 months were more likely
to report that their current counseling was very helpful compared with those who had never before
received therapy (aRR = 1.34, 95% CI: 1.14, 1.57). Those who received medication for a mental health
problem in the last 12 months were slightly less likely to report that their counseling was very helpful
(aRR = 0.91, 95% CI: 0.83, 0.99) compared with those who did not receive medication, although this
difference was small (38.8% vs. 44.4%, respectively) and not consistent among those who reported that
it was somewhat helpful (39.4% vs. 36.4%, respectively). Finally, those who reported unmet mental
healthcare needs in the last 12 months and previously were less likely to report that their therapy was
very helpful compared to those who did not have unmet mental healthcare needs.
4. Discussion
In a large cohort of individuals exposed to the trauma of the WTC disaster, this study documented
mental health treatment utilization up to 15 years after 9/11. Approximately one-third of Registry
enrollees sought counseling at some time after 9/11. Counseling was sought consistently over time
after 9/11 up to 15 years after, although the largest increase was observed within the first year after the
disaster. Predictors of seeking counseling included race/ethnicity, age at 9/11, education level attained,
exposure to the WTC attacks, other post-9/11 traumatic experiences, mental health symptomology,
and pre-9/11 counseling. Whites, Hispanics, and those of other races, those who were children
at the time of 9/11, and those with high levels of exposure to the WTC attacks sought counseling
soonest after 9/11. Among those who sought counseling, several trends were identified across types of
practitioners seen. For example, Blacks, Asians, and those with lower education and income were less
likely to seek counseling from mental health specialists (e.g., psychologists) and more likely to seek
counseling from general practitioners such as family doctors or religious advisors compared with their
White and more highly educated counterparts. Finally, among those who sought recent counseling,
most enrollees perceived their counseling to have been at least somewhat helpful. Women, Blacks,
those aged ≥65 years, and those with very high WTC exposures were more likely to rate their recent
counseling as very helpful. These predictors of counseling and time to counseling after 9/11, types of
practitioners seen, and perceived helpfulness of recent counseling did not vary when the population
was restricted to those with significant PTSD or depression symptoms.
One of the strongest predictors of seeking counseling after 9/11 was having sought counseling
before 9/11. Another study among 9/11-exposed individuals reported that new uptake of mental
healthcare was rare after 9/11 among those who were not already receiving care beforehand [9].
Although this study was conducted only six months after 9/11, whereas ours was conducted 15 years
after 9/11, results were very similar. Stuber et al. reported that, among those who were already
receiving mental health services before 9/11, 82.7% sought mental healthcare after 9/11, which is
comparable to the 75.9% in our study. In addition, we found that those who sought counseling
more often, as well as those who were previously connected to care, were more likely to rate their
recent counseling as very helpful compared to those who went less frequently or had not sought care
prior. This may indicate that those with established provider–patient relationships, or those who are
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accustomed to seeking counseling fare better than those just starting out [29]. Alternatively, those
already connected to care and those who go often may be experiencing more symptom abatement
and, thus, satisfaction compared with those who may have intermittent care that may not be satisfying
their needs [30]. This correlation between symptom abatement and reports of perceived benefit is
consistent with our observation that persistent PTSD was associated with a reduced degree of perceived
helpfulness of recent therapy compared with those who never had PTSD.
Another strong predictor of seeking counseling after 9/11 was younger age at the time of the event.
Specifically, those who were children at the time of 9/11 were the most likely to seek mental health
treatment and sought treatment more quickly compared with those of older ages at 9/11. This may
reflect counseling programs that were provided in schools [31,32], as well as parents worrying about
children’s potential needs after the disaster [6,33]. Given the vulnerable life stage of children who were
exposed to 9/11 and the resulting psychological consequences that are thought to be of greater severity
in this age group [34,35], this relatively greater degree of uptake is reassuring. However, in our study,
the absolute proportions show a different perspective, with just over half of those aged 0–17 years at
9/11 having sought counseling at some time after 9/11. This represents an underutilization of the
services that were available, especially in the aftermath of the events, both in this age group and in the
overall population. In addition, we found that these young individuals were the least likely to rate
any recent counseling as very helpful compared with older age groups. However, it should be noted
that, for the majority of those who sought counseling in the 12 months before survey administration
(i.e., recent counseling), the indication was likely not related to 9/11. However, we did not explicitly
ask whether the counseling sought was to address 9/11-related trauma.
Consistent with other studies in post-disaster settings [12], this study documented an
underutilization in counseling and mental health treatment. Despite several public health programs
devoted to mental health, only about one-third of enrollees reported seeking counseling at some
time in the 15 years after 9/11. This is similar to what was observed in the aftermath of Hurricane
Katrina, although studied time frames were shorter [36]; however, even so, after initiation, drop-outs
in treatment were common. In addition, we observed significant delays in seeking counseling across
several strata. These types of delays in seeking treatment are common [37,38]. One major driver
of utilization of care and delay in seeking it that was consistently documented is stigma [39,40].
Although we did not measure this, it was shown that certain populations are differentially more
likely to be affected by stigma, including Blacks and Asians, males, and young people. Future
studies in 9/11-exposed populations should explore race/ethnicity-specific barriers to care, including
perceived stigma.
Another relevant issue for mental healthcare delivery in post-disaster settings is that natural
reactions to disasters change over time [41]. The course of reactions is generally referred to as “threat”
or “impact” (i.e., immediate), short-term, and long-term. These different phases present the need
for different types of mental healthcare support. For example, in the aftermath of the Hanshin
Awaji earthquake in 1995, depressive symptoms did not manifest in most of the affected population
until weeks to months after the event [42]. This presents a very different need than the shock- and
grief-related reactions that are more common in the “impact” phase [41]. Specifically, we reported a
racial/ethnic disparity in receipt of counseling. Blacks and particularly Asians were the least likely
to seek counseling after 9/11 compared with other racial and ethnic groups. It was repeatedly noted
in the literature that Asian Americans are less likely to seek mental health treatment compared with
other racial and ethnic groups, especially non-Hispanic Whites [43–49]. This is attributed to language
barriers, deficiencies in cultural competence in the delivery of care, general lack of awareness of such
service availability, and cultural differences in the conception of mental illness itself. These data have
implications for improving the accessibility of culturally competent mental health services for Blacks
and Asians.
This study benefited from several strengths. Firstly, this study provided long-term information
on mental health treatment utilization after 9/11. Most published studies to date reported on mental
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health treatment utilization up to a maximum of two years post-disaster [15,17], whereas this study
had data up to 15 years after 9/11. This is an important addition to the literature because we were able
to document the degree of delays in treatment in a trauma-exposed population. However, it should be
noted that, due to this long follow-up time, our examination of mental health treatment likely included
visits related to 9/11, as well as utilization unrelated to the events of 9/11, and we were unable to
discern between the two. Another attribute was that, although several studies were published on the
topic of post-9/11 mental health service utilization, to our knowledge, this is the first that collected
data on the type of practitioner sought. This type of information is important because we identified
trends and disparities in care-seeking behavior across various demographics. These findings may
inform future disaster response plans with regard to establishing more equitable care to all those
potentially affected.
However, we also note this study’s limitations. Firstly, the Wave 4 survey asked about age at
first counseling, irrespective of 9/11. Thus, our analysis of time to counseling after 9/11 was limited
to those who sought counseling for the first time after 9/11. This limited our ability to examine the
determinants of time to counseling after 9/11 among those who had sought treatment before 9/11
as well. Secondly, despite the information we had over time on several mental health conditions
and symptoms, we were not able to assess whether mental health treatment was associated with
improvement in symptoms because we did not ask detailed questions over time on treatment initiation
and continuation or types of therapy and specific medication use and duration of use. In order to
answer this question, in addition to longitudinal data on mental health symptomology, an in-depth
study would be necessary that asked about specific treatment modes, practitioner characteristics,
duration of treatments, use of medications over time, and more. Thirdly, although we asked about the
type of practitioner sought for counseling, it is possible that enrollees were not able to reliably report
the specific type, especially more subtle distinctions such as psychologists vs. psychiatrists. However,
we were able to observe differences and disparities across different providers. Fourthly, we did not
collect data on specific mental health or neurodevelopmental conditions before 9/11. Having this data
would have allowed us to explore whether these disorders conferred an additional risk of developing
PTSD after 9/11 [50], and perhaps an increased likelihood of seeking treatment. Lastly, our study was
limited to Registry enrollees who completed the Wave 4 survey, which was administered in 2015–2016.
These enrollees represented just over half (51.6%) of those originally enrolled in 2003–2004. Therefore,
selection bias is a concern due to the potential for selective participation across several strata. However,
previous investigation of this issue showed that, although those with PTSD symptoms were slightly
less likely to continue to participate in Registry surveys than those without, the degree of exposure
to the WTC attacks was not associated with participation over time [51]. Furthermore, the Registry
was not able to enroll all WTC-exposed individuals, which was estimated to be over 400,000, of which
the Registry recruited more than 71,000 (17.4% enrollment rate) [52]. The enrollment rate was highest
among rescue and recovery workers (33.5%) and lowest among passersby (12.0%). Unfortunately,
however, we do not have information on those who did not enroll.
5. Conclusions
The WTC terrorist attacks exposed thousands, if not millions, of individuals in NYC to
trauma, resulting in a significant mental health burden and subsequent need for services. Overall,
approximately one-third of WTC-exposed individuals sought counseling up to 15 years post-9/11,
which represents an underutilization that is consistent with other post-disaster literature. Those who
were White or Hispanic, children at the time of 9/11, and had high levels of exposure to the WTC
attacks were the most likely to seek counseling after 9/11 and had the shortest waiting times to seeking
counseling. Among those who sought counseling, there was heterogeneity across several demographic
strata in the types of practitioners seen, such as Blacks and Asians being less likely to seek counseling
from mental health specialists compared with Whites. These results highlight the need for tailoring
outreach to specific demographic subgroups in post-disaster settings. This study used data up to 15
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years post-disaster to document mental health treatment utilization patterns, trends, and disparities
that have implications for future preparedness plans and needs assessments.
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Abstract: A large number of World Trade Center (WTC) rescue and recovery workers are affected
by asthma. While physical and mental health comorbidities have been associated with poor asthma
control in this population, the potential role of allergen sensitization is unknown. This study
examined the association of indoor sensitization and exposure as a risk factor for increased asthma
morbidity in WTC workers. We used data from a prospective cohort of 331 WTC workers with
asthma. Sensitization to indoor allergens was assessed by measurement of antigen-specific serum
immunoglobulin E (IgE) levels. We used validated tools to evaluate the exposure to indoor allergens.
Asthma morbidity outcomes included level of control (Asthma Control Questionnaire, ACQ), quality
of life (Asthma Quality of Life Questionnaire, AQLQ) and acute resource utilization. The prevalence
of sensitization to cat, dog, mouse, dust mite, cockroach, and mold allergens were 33%, 21%, 17%, 40%,
17%, and 17%, respectively. Unadjusted and regression analyses showed no significant relationship
between sensitization and increased asthma morbidity (p > 0.05 for all comparisons), except for
sensitization to Aspergillus Fumigatus, cat and mouse epithelium, which were associated with
decreased morbidity.
Keywords: World Trade Center; indoor allergens sensitization; asthma quality of life; asthma control;
asthma outcomes; mini asthma quality of life questionnaire; asthma morbidity; WTC-related asthma;
immunoglobulin E; allergen exposure
1. Introduction
Multiple studies have documented high rates of asthma prevalence (approximately 30%
cumulative incidence, 9 years after exposure) among World Trade Center (WTC) rescue and recovery
workers [1,2]. Recent studies have also demonstrated that many WTC-exposed individuals suffer
from substantial asthma morbidity, including poor disease control and a relatively high number
of emergency room visits and hospitalizations [1]. The reasons for the poor outcomes observed
among WTC workers are likely multifactorial and partially explained by an increased prevalence of
IJERPH 2019, 16, 737; doi:10.3390/ijerph16050737 www.mdpi.com/journal/ijerph25
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comorbidities, such as gastroesophageal reflux (GERD) and chronic sinusitis, which are known to
worsen asthma [1,3]. Similarly, post-traumatic stress disorder (PTSD), which has been described in up
to 30% of WTC workers, is strongly associated with increased asthma morbidity [4].
Allergic sensitization is also associated with increased asthma morbidity, particularly in inner-city
children [5,6]. Moreover, environmental remediation strategies to reduce indoor exposures have been
shown to improve asthma control in this population [7,8]. The results of studies assessing the role of
allergic sensitization in adult asthmatics are mixed [9–11]. Nonetheless, anti-immunoglobulin E (IgE)
therapy is effective for antigen-sensitized patients and trigger avoidance is currently recommended as
a major component of asthma self-management by the most recent national asthma guidelines [12].
The role sensitization and exposure to allergens on asthma outcomes in WTC workers has not been
previously explored.
In this study, we determined the rates of sensitization to indoor allergens in a cohort of WTC
workers with asthma, and assessed the relationship to asthma control and acute resource utilization.
2. Materials and Methods
2.1. Study Population
The study was conducted using data from a cohort of WTC workers with a physician diagnosis
of asthma. Study participants were recruited between December 2012 and July 2016, from WTC
workers who were followed by the Mount Sinai Hospital, North Shore-Long Island Jewish Health
System/Queens College, and the New York University School of Medicine WTC Health Program.
Criteria for recruitment into this program have been previously published [4,13] and include
individuals who have volunteered or worked in the lower Manhattan, barge-loading piers or Staten
Island landfill, and workers from the Port Authority Trans Hudson Corporation who were engaged in
cleaning and personnel of the Office of the Chief Medical Examiner who processed human remains.
Lower Manhattan residents, schoolchildren, building occupants, and passers-by were not included in
this registry. Members of the Fire Department of the City of New York (FDNY) who are followed in a
parallel program were also not included in the present study.
The current study was limited to patients with physician-diagnosed asthma who spoke English or
Spanish and were ≥18 years of age at the time of enrollment. We excluded WTC workers with a prior
diagnosis of chronic obstructive lung disease (COPD) and those who had history of >15 pack-years of
smoking, due to the possibility of undiagnosed COPD. We also excluded workers with other chronic
respiratory illnesses. Signed consent was obtained from all participants; the Institutional Review
Boards of the Icahn School of Medicine at Mount Sinai, Queens College and New York University
School of Medicine approved this study.
2.2. Study Variables
Study participants underwent an in-person standardized interview in English or Spanish to
collect sociodemographic information and data regarding asthma history, including onset in relation
to WTC exposure and medication regimen. We obtained information about physician diagnosis of
GERD, allergic rhinitis, and chronic sinusitis, as well as other comorbidities. In order to diagnose
the presence of mental health conditions (PTSD, panic disorder and depression) patients underwent
a structured clinical psychiatric interview (SCID) [14]. According to criteria published in previous
studies, participants were assigned to one of four different groups depending on the level of WTC
exposure: Low, intermediate, high, and very high [1].
2.3. Allergic Sensitization and Exposure Assessments
Sensitization to indoor allergens was assessed using serum IgE levels in peripheral blood; a
level >0.35 kU/L was considered indicative of sensitization [12,15]. The allergens included were,
cat epithelium and dander, dog, mouse epithelium, house dust mites (Dermatophagoides Farinae and
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Dermatophagoides Pteronyssinus), cockroaches (Blatella Germanica or Periplaneta Americana), and molds
(Alternaria Alternata and Aspergillus Fumigatus). Serum IgE levels were determined using the Thermo
Fisher Scientific Analyzer Phadia™ 1000® (Phadia AB, Uppsala, Sweden). Home environmental
exposures were ascertained using survey questions previously validated against findings from home
inspections [16–18]. The survey included questions about the presence of pets at home, visible molds,
mildew, wet spots, and/or cockroaches. In addition, study participants were asked about the presence
of dust at home, home cleaning behaviors, and if the participants kept windows closed during the
allergy seasons.
2.4. Outcomes
We used the Asthma Control Questionnaire (ACQ) to assess the level of asthma control [19].
The ACQ is a validated tool available in English and Spanish and has been extensively used in clinical
practice and research [20]. Higher ACQ scores indicate worse asthma control and a change of >0.5
units is considered clinically significant [19]. The impact of allergic sensitization on quality of life
was assessed with the Mini Asthma Quality of Life Questionnaire (AQLQ) [21]. This validated tool
includes 15 questions in four domains (symptoms, environment, emotions and activities) and has
good reliability and responsiveness [21,22]. A higher score on the AQLQ indicates better quality of life
related to asthma [21]. We also collected information about asthma-related resource utilization (visits
to emergency department, hospitalizations, use of oral corticosteroids) in the previous year.
2.5. Statistical Analysis
The means with standard deviations and percentages with 95% confidence intervals (CI) were
used to describe the baseline characteristics of the study participants. We used the t-test to compare
ACQ and AQLQ scores of WTC workers sensitized versus those not sensitized to each specific indoor
allergen. The chi-square test was used to compare acute resource utilization according to sensitization
status. The adjusted association between sensitization status, ACQ, and AQLQ scores over time
was assessed using linear regression to control for sociodemographic characteristics, asthma history,
asthma onset in relation to 9/11 exposure, asthma regimen, WTC exposure level, and comorbidities.
The potential relationship of acute resource utilization with sensitization to each allergen was evaluated
using logistic regression analysis.
Power calculations showed that a total of approximately 220 patients were required for the study
to have 80% power to detect a clinically significance difference of ≥0.5 units in ACQ and AQLQ
scores among patients sensitized versus not sensitized to each indoor allergen. All statistical tests were
performed with SAS statistical software (SAS Institute, Cary, NC, USA) using 2-tailed tests.
3. Results
3.1. Participant Characteristics
Overall, 373 WTC workers with asthma were enrolled in the study; of these, 42 lacked results for
specific IgE and were excluded from these analyses. The mean (SD) age of study participants was
52.7 (8) years; 73% were male; 35% white, 13% Black, and 43% Hispanic (Table 1). Most WTC workers
(72%) reported asthma onset after WTC exposure and 66% were prescribed an asthma controller
medication. Among the cohort, the frequency of patients with well-controlled, uncontrolled, and
very poorly controlled asthma was 27%, 26%, and 47%, respectively; almost half (49%) reported poor
quality of life. In terms of resource utilization, 20% of WTC workers had a hospitalization or an ER
visit related to their asthma in the previous 12 months, and 27% had received an oral corticosteroid
burst for an exacerbation.
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Table 1. Baseline characteristics of World Trade Center rescue and recovery workers with asthma.
Characteristic Value
Age, years, mean (SD) 52.7 (8)








Did not graduate high school 30 (9)
High School or GED 52 (16)
Some College 135 (41)
College Graduate or More Advanced Degree 114 (34)
Monthly Income < $3,000, No. (%) 183 (55)
Occupation, No. (%)
Employed Full Time 141 (43)
Employed Part Time 35 (10)
Unemployed 19 (6)
On Disability 40 (12)
Retired 72 (22)
Not Working/Student/Other 24 (7)
Smoking Status No. (%)
Current/former Smoker 101 (31)
Never Smoked 220 (66)
Refused/Unknown 10 (3)




Very High 26 (8)
Asthma Onset Post 9/11, No. (%) 242 (72)
Hospitalization/Emergency Room Visit for
Asthma in the Past Year, No. (%) 64 (20)
Oral Corticosteroid Use in Past 12 Months No. (%) 88 (27)
Asthma Control Level, No. (%)
Well Controlled 91 (27)
Uncontrolled 86 (26)
Very Poorly Controlled 154 (47)
Asthma-related Quality of Life, No. (%)
Good 172 (52)
Poor 159 (48)
On Asthma Controller Medication, No. (%) 218 (66)
Comorbidities No. (%)
Gastric Esophageal Reflux Disorder 222 (67)
Sinusitis 207 (63)
Major Depression 88 (27)
Posttraumatic Stress Disorder 81 (24)
SD: standard deviation. No.: Number. WTC: World Trade Center.
Overall, 56% (95% CI: 51–62%) of WTC workers were sensitized to at least one indoor allergen
(Table 2). The frequency of sensitization to cat, dog, mouse epithelium, Dermatophagoides Farinae,
Dermatophagoides Pteronyssines, cockroach, Alternaria Tenuis, and Aspergillus Fumigatus was 33% (95% CI:
28–38%), 21% (95% CI: 17–26%), 17% (95% CI: 13–22%), 34% (95% CI: 30–40%), 32% (95% CI: 26–37%),
17% (95% CI: 13–21%), 11% (95% CI: 7–14%), and 10% (95% CI: 6–15%), respectively. Overall, 50% of
participants had cats, dogs, or birds at home, 17% reported presence of mice/rats at home, 24% had
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observed cockroaches, 20% observed wet spots, 25% had mold/mildew at their home, and only 34%
kept windows closed during the allergy season.
Table 2. Sensitization and exposure to indoor allergens among World Trade Center rescue and recovery
workers with asthma.
Allergen Number Percentage (95% CI)
At least One Indoor Allergens 186 56 (51–62)
Cat Dander 110 33 (28–38)
Dog Dander 63 21 (17–26)
Mouse Epithelium 57 17 (13–22)
Dermatophagoides Farinae 115 34 (29–40)
Dermatophagoides Pteronyssines 105 32 (26–37)
Cockroach 57 17 (13–21)
Alternaria Tenuis 35 11 (7–14)
Aspergillus Fumigatus 20 10 (6–15)
Home Exposures
Cats, dogs or birds living in home 165 50 (44–55)
Mice or rats 58 17 (13–22)
Cockroaches 79 24 (19–29)
Wet spots on walls, wallpaper, ceilings or carpets 68 20 (16–25)
Mold or mildew growing on surfaces 83 25 (20–30)
Keeps windows closed during allergen season 110 34 (29–40)
CI: confidence interval.
3.2. Unadjusted Associations between Sensitization and Asthma Morbidity
Unadjusted analyses showed no significant association between sensitization to most indoor
allergen and ACQ and AQLQ scores (p > 0.05 for all comparisons) (Table 3). Only sensitization to
Aspergillus Fumigatus (mean difference: −0.63; 95% CI: −1.17 to −0.09) was associated with a lower
ACQ score. Similarly, sensitization to at least one allergen (mean difference: 0.29; 95% CI: 0.01 to 0.56),
and sensitization to cat allergens (mean difference: 0.36; 95% CI: 0.08 to 0.65) were associated with
higher AQLQ scores. In addition, the use of oral corticosteroids and acute resource utilization were
not significantly associated with sensitization status to most allergens (p > 0.05 for all comparisons).
However, sensitization to mouse epithelium (OR: 0.39; 95% CI: 0.18–0.86) was associated with a
decreased use of oral corticoids in the year before enrollment. We also found that acute asthma-related
resource utilization was lower in patients sensitized to at least one allergen (OR: 0.54; 95% CI: 0.29–0.99).
Unadjusted analyses also showed no significant interaction between allergen sensitization and WTC
exposure category (p > 0.05 for all comparisons), suggesting the effect of sensitization was not different
according to the level of exposure at the WTC site.
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Table 3. Unadjusted associations between sensitization to indoor allergens and asthma morbidity in












Allergen −0.15 (−0.40, 0.09) 0.29 (0.01, 0.56) * 1.24 (0.75, 2.06) 0.54 (0.29, 0.99)
Cat Dander −0.14 (−0.40, 0.11) 0.36 (0.08, 0.65) * 1.51 (0.91, 2.52) 0.66 (0.33, 1.31)
Dog Dander 0.04 (−0.28, 0.35) 0.21 (−0.15, 0.56) 0.83 (0.43, 1.60) 0.58 (0.23, 1.45)
Mouse Epithelium 0.12 (−0.21, 0.44) 0.04 (−0.32, 0.40) 0.39 (0.18, 0.86) * 0.62 (0.25, 1.54)
Dermatophagoides
Farinae 0.03 (−0.23, 0.28) 0.10 (−0.18, 0.39) 1.06 (0.63, 1.77) 0.71 (0.36, 1.38)
Dermatophagoides
Pteronyssines −0.11 (−0.38, 0.15) 0.14 (−0.15, 0.44) 0.76 (0.44, 1.32) 0.75 (0.38, 1.48)
Cockroach −0.04 (−0.37, 0.29) 0.01 (−0.35, 0.37) 0.91 (0.47, 1.77) 0.50 (0.19, 1.33)
Alternaria Tenuis −0.33 (−0.73, 0.06) 0.39 (−0.06, 0.83) 0.55 (0.22, 1.38) 0.32 (0.07, 1.36)
Aspergillus
Fumigatus −0.63 (−1.17, −0.09) * 0.53 (−0.05, 1.12) 0.56 (0.18, 1.77) 0.29 (0.04, 2.25)
CI: confidence interval; OR: odds ratio; OCS: oral corticosteroids, ACQ: Asthma Control Questionnaire, AQLQ:
Asthma Quality of Life Questionnaire. * Statistically significant at a <0.05 level.
3.3. Adjusted Associations between Indoor Sensitization and Asthma Control
Adjusted analyses also showed no statistically significant association between the sensitization to
most allergens and ACQ and AQLQ scores, use of oral steroids, and previous utilization of health care
services (p > 0.05 for all comparisons) (Table 4). However, sensitization to at least one indoor allergen
(mean difference: 0.27; 95% CI: 0.03 to 0.50) or Dermatophagoides Pteronyssines (mean difference:
0.29; 95% CI: 0.03 to 0.55) were significantly associated with higher AQLQ scores. Finally, sensitization
to at least one allergen (OR: 0.41; 95% CI: 0.20–0.85), and cockroach (OR: 0.27; 95% CI: 0.08–0.91) were
significantly associated with lower rates of acute asthma-related resource utilization.
Table 4. Adjusted associations between sensitization to indoor allergens and asthma morbidity in











Allergen −0.19 (−0.43, 0.04) 0.27 (0.03, 0.50) * 1.16 (0.65, 2.07) 0.41 (0.20, 0.85) *
Cat Dander −0.09 (−0.34, 0.16) 0.17 (−0.09, 0.43) 1.46 (0.80, 2.66) 0.47 (0.21, 1.06)
Dog Dander −0.06 (−0.37, 0.24) 0.29 (−0.02, 0.61) 0.77 (0.37, 1.62) 0.45 (0.16, 1.27)
Mouse Epithelium 0.20 (−0.11, 0.50) −0.08 (−0.39, 0.24) 0.42 (0.17, 1.02) 0.41 (0.13, 1.31)
Dermatophagoides
Farinae 0.02 (−0.23, 0.27) 0.06 (−0.19, 0.31) 1.10 (0.60, 2.00) 0.48 (0.21, 1.08)
Dermatophagoides
Pteronyssines −0.24 (−0.49, 0.01) 0.29 (0.03, 0.55) * 0.77 (0.40, 1.46) 0.56 (0.24, 1.31)
Cockroach −0.29 (−0.61, 0.03) 0.30 (−0.03, 0.63) 0.81 (0.36, 1.80) 0.27 (0.08, 0.91) *
Alternaria Tenuis −0.10 (−0.48, 0.28) 0.09 (−0.30, 0.48) 0.49 (0.17, 1.38) 0.31 (0.06, 1.60)
Aspergillus
Fumigatus −0.42 (−0.94, 0.10) 0.46 (−0.08, 0.99) 0.42 (0.10, 1.69) 0.44 (0.05, 4.14)
CI: confidence interval; OR: odds ratio; OCS: oral corticosteroids, ACQ: Asthma Control Questionnaire, AQLQ:
Asthma Quality of Life Questionnaire. * Statistically significant at a <0.05 level.
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4. Discussion
Asthma is a common WTC-related condition that is frequently poorly controlled and associated
with substantial healthcare resource utilization [1]. In this study, we found that a large percentage
of WTC workers are sensitized to common indoor allergens, similarly to the general population [23].
However, sensitization to most of the indoor allergens evaluated was not significantly associated with
increased asthma morbidity or acute resource utilization, even among WTC workers exposed to these
allergens. These results suggest that efforts to better control WTC-related asthma should focus on other
established risk factors, such as other medical co-morbidities, PTSD, or low adherence to controller
medication, and other effective self-management behaviors [1,2,4].
There is strong epidemiologic evidence linking allergen sensitization to increased asthma
morbidity in inner-city children [5,6,24,25]. Moreover, the effectiveness of home-based environmental
remediation and multi-trigger interventions in decreasing allergen exposure and reducing asthma
morbidity is well-established [26,27]. Several studies have also evaluated the potential impact of
allergic sensitization on asthma outcomes in adults. Specific allergens, in particular cockroach [5] and
Alternaria [28], have been associated with more severe asthma; asthma deaths have been linked to high
fungal spore counts in the environment [29]. Similarly, a study of 140 inner-city women with asthma
showed a statistically significant association between increased asthma morbidity and exposure to cats
among sensitized patients [30]. A study of elderly inner-city asthmatics showed that patients with high
levels of cockroach-specific IgE had worse disease control and more severe airflow obstruction [10].
Similarly, a study of 5845 adults with asthma showed higher exacerbation rates in those sensitized
to cat or dogs that had these pets at home [31]. Conversely, a study of 245 inner-city adults with
persistent asthma showed no significant relationship between indoor allergen sensitization and asthma
outcomes [9]. The European Respiratory Health Survey showed no association between the levels of
cat allergen and/or sensitization status with asthma symptoms [32]. Our study extends these findings
by showing a lack of association between sensitization and asthma morbidity in WTC workers.
Several factors may explain our findings. WTC-related asthma may be associated with a
higher prevalence of airway neutrophilia [33]. Asthma is characterized by airway inflammation [34],
characterized by an eosinophil-dominated pattern, especially in patients who have allergen-induced
symptoms and an underlying T2 inflammatory profile. However, asthma is a heterogeneous disease
and there is increased evidence that other mechanisms, such as a neutrophil-mediated inflammation,
less often associated with atopy, could lead to enhanced bronchial reactivity and airflow obstruction in
some patients [35]. Th-17 cells appear to play a key role in the pathophysiology of neutrophilic asthma,
a disease often associated with worse control and resistance to inhaled corticosteroids [34,36–43].
Thus, if a larger proportion of WTC workers have neutrophil predominant asthma, it is expected that
sensitization plays a decreased role in the underlying pathophysiology of this asthma phenotype, and
hence its control. Further understanding about the most common patterns of airway inflammation in
WTC workers with asthma is important for personalizing their management.
Many WTC workers have physical and/or mental health comorbidities known to increase
asthma morbidity. These include GERD, chronic sinusitis, and rhinitis, as well as, PTSD, and major
depression [1,3,4]. Thus, these conditions may be more important determinants of the level of asthma
control in WTC workers, rather than the potential impact of allergic sensitization. While prior studies
have showed that there is a strong negative impact of allergic sensitization among inner-city children
with asthma, our cohort was limited to adults, who spent less time at home and therefore are less
exposed to the home indoor environment [44].
Given the relatively high rate of allergen sensitization in our population of WTC workers with
asthma, avoidance of environmental triggers could still contribute to improved control in some of
these patients, particularly those with features of eosinophilic disease. However, our findings suggest
that healthcare providers should also focus on other important asthma triggers in this population,
such as other medical comorbidities and occupational exposures.
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Our study has some limitations that should be mentioned. Our data were collected between
11 and 15 years of the WTC exposure, and therefore our findings represent a narrow window in
time. Despite enrolling a relatively large number of WTC workers, our cohort did not represent all
populations exposed to WTC disaster, such as firefighters, local residents, and passersby. Thus, our
results may not be generalizable to these groups. Our study did not include a non-WTC asthma
control group to assess for potential differences in the role and the impact of allergen sensitization.
WTC rescue and recovery workers are a unique population given their exposures at the WTC site,
range of occupations and associated exposures prior and after 9/11, healthy worker effect, and a high
prevalence of physical and mental health comorbidities, many of which (e.g., GERD and PTSD) are
associated with worse asthma control. Thus, it is very difficult to identify a control group to perform
robust comparisons of the relationship between allergic sensitization and asthma morbidity in WTC
versus no-WTC populations. However, in a prior study of non-WTC asthma patients recruited from
the same institution [9], we found similar rates of sensitization to cats (41%), mouse epithelium (14%),
dust mites (43%), molds (21%) than those reported in our WTC workers cohort. The prevalence of
sensitization to cockroach was higher in the non-WTC asthma cohort (60% vs. 17%) that could be
related to higher levels of cockroach exposure in this inner-city population and may explain some of
the differences in our results. In this non-WTC population, adjusted analyses showed that allergy to
cockroach, dust mites, cat, mouse, or molds were not associated with increased resource utilization or
worse asthma outcomes. Some exceptions were the presence of dust mite sensitization that was related
to increased use of oral steroids in the year before enrollment, mouse sensitization that was related
with an increased number of hospitalizations, and cat sensitization that showed decreased number to
ED visits during the follow up period. Similarly, our adjusted analyses showed significant associations
between sensitization to some allergens (Dermatophagoides Pteronyssines and cockroach) with markers
of decreased asthma morbidity. We used objective measures of allergen sensitization and validated
cut-offs, however, we did not collect home samples to assess the actual levels of environmental
exposure. Although self-reported measures may be subject to bias, we used validated items that have
been correlated to direct home environmental assessments [16,21,22]. Similarly, we used validated
instruments to assess asthma control and quality of life in study participants. We did not evaluate IgE
sensitization to outdoor allergens, as they play a limited role in asthma exacerbations [45]. We found
that sensitization to some allergens was associated with improved asthma control. However, these
relationships were inconsistent across different asthma outcomes for specific allergens, and thus, more
likely related to random sampling. Conversely, our study was not powered to find small differences in
asthma control and quality of life among sensitized WTC workers; however, our sample was sufficient
for identifying clinically meaningful differences in these outcomes. Finally, we did not assess the
potential impact of outdoor allergens on asthma morbidity levels of WTC workers.
5. Conclusions
In summary, we found no significant associations between indoor allergen sensitization and
exposure to asthma morbidity in WTC workers. Given the high rates of the absence of asthma control
and decreased quality of life in this population, our findings can guide providers in their management
strategies for WTC workers with asthma.
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Abstract: Thousands of lower Manhattan residents sustained damage to their homes following
the collapse of the Twin Towers on 11 September 2001. Respiratory outcomes have been reported
in this population. We sought to describe patterns of home damage and cleaning practices in
lower Manhattan and their impacts on respiratory outcomes among World Trade Center Health
Registry (WTCHR) respondents. Data were derived from WTCHR Wave 1 (W1) (9/2003–11/2004)
and Wave 2 (W2) (11/2006–12/2007) surveys. Outcomes of interest were respiratory symptoms
(shortness of breath (SoB), wheezing, persistent chronic cough, upper respiratory symptoms (URS))
first occurring or worsening after 9/11 W1 and still present at W2 and respiratory diseases (asthma
and chronic obstructive pulmonary disease (COPD)) first diagnosed after 9/11 W1 and present at
W2. We performed descriptive statistics, multivariate logistic regression and geospatial analyses,
controlling for demographics and other exposure variables. A total of 6447 residents were included.
Mean age on 9/11 was 45.1 years (±15.1 years), 42% were male, 45% had ever smoked cigarettes, and
44% reported some or intense dust cloud exposure on 9/11. The presence of debris was associated
with chronic cough (adjusted OR (aOR) = 1.56, CI: 1.12–2.17), and upper respiratory symptoms (aOR
= 1.56, CI: 1.24–1.95). A heavy coating of dust was associated with increased shortness of breath
(aOR = 1.65, CI: 1.24–2.18), wheezing (aOR = 1.43, CI: 1.03–1.97), and chronic cough (aOR = 1.59,
CI: 1.09–2.28). Dusting or sweeping without water was the cleaning behavior associated with the
largest number of respiratory outcomes, such as shortness of breath, wheezing, and URS. Lower
Manhattan residents who suffered home damage following the 9/11 attacks were more likely to
report respiratory symptoms and diseases compared to those who did not report home damage.
Keywords: WTC attack; respiratory symptoms; lower Manhattan residents; cleaning practices
1. Introduction
The terrorist attacks in New York City on 11 September 2001 (9/11) led to the destruction of the
World Trade Center (WTC) Twin Towers and six other adjacent buildings. The collapse of the two
towers released a massive cloud of dust and debris that damaged surrounding buildings within and
IJERPH 2019, 16, 798; doi:10.3390/ijerph16050798 www.mdpi.com/journal/ijerph36
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around the WTC complex, a 16-acre area that was subsequently called Ground Zero [1]. The plume of
dust reached an altitude of 1500 meters and, depending on meteorological conditions, extended to
lower Manhattan and the New York and New Jersey metropolitan areas. More than 100,000 μm per
cubic meter of particles were estimated to be present in the air during the first few minutes after the
collapse of each building [2].
The contents of settled WTC dust have been extensively analyzed and were characterized as a
mixture of cement dust, glass fibers, asbestos, lead, polycyclic aromatic hydrocarbons, polychlorinated
biphenyls, organochlorine pesticides, and polychlorinated furans and dioxins [1,3–5]. Indoor dust was
primarily comprised of inhalable particles (<53 μm). In contrast, most outdoor dust was primarily
comprised of larger particles [6].
Approximately 25,000 lower Manhattan residents were physically and emotionally affected by
this disaster [7]. Two months after the attacks, air quality and surface dust were among the main
concerns of lower Manhattan residents [7]. Most WTC-related residential exposures were caused by
re-suspension of settled indoor dust [2] during cleaning efforts or in poorly cleaned environments.
This is a large motivator for our analyses of cleaning practices.
A number of studies demonstrated the deleterious health effects of household exposures in the
context of the WTC attacks. Most of them were relatively small case-control studies [8–11]. Increased
asthma prevalence was previously reported among WTC Health Registry (WTCHR) enrollees who
experienced a heavy layer of dust in their homes [12]. Acute and chronic exposures were also
associated with lower respiratory symptoms among WTCHR participants [13]. However, prior studies,
specifically Lin et al. [8] and Maslow [13], had limited samples of residents (n = 1317; n = 479,
respectively). Maslow [13] did not evaluate associations between exposures and specific respiratory
symptoms. Although Lin et al. [8] did assess lower and upper respiratory symptoms, they did not
include diagnosed conditions such as asthma or chronic obstructive pulmonary disease.
With a large sample of residents in lower Manhattan and a comprehensive set of outcomes,
the present study describes patterns of home damage and cleaning practices, as a surrogate for
household exposures since measures of exposure in homes is limited. We initially looked at geospatial
relationships between Ground Zero location and exposure and health outcomes. We then conducted
multivariate logistic regression analyses to find potential associations between those variables among
a large sample of WTCHR respondents.
2. Methods
The WTCHR monitors the health of people exposed to the 9/11 WTC disaster through periodic
health surveys and is housed within the New York City Department of Health and Mental Hygiene
(NYCDHMH). The WTCHR is the largest effort in the United States to monitor health after a disaster
of this kind and includes data on 68,444 adults, including lower Manhattan residents, rescue and
recovery workers, and building occupants and passers-by. More details on the WTCHR can be found
elsewhere [14] and online at https://www1.nyc.gov/site/911health/about/wtc-health-registry.page.
For this report, data were derived from WTCHR Wave 1 (W1) survey (baseline), collected between
9/2003 and 11/2004, and Wave 2 (W2) survey (first follow-up), collected between 11/2006 and 12/2007.
We included W1 and W2 participants 18 years and older, whose primary residence on September 11th
was located in lower Manhattan, south of Canal Street. Residents who performed rescue and recovery
work were excluded from this analysis.
The Centers for Disease Control and Prevention (CDC) and NYCDHMH institutional review
boards approved the Registry protocols. A Federal Certificate of Confidentiality was obtained, as was
verbal informed consent.
2.1. Environmental and Household Exposures
In the W1 Survey, respondents were asked if they were outdoors after the towers’ collapse and
to report their location when they first encountered the dust cloud (closest cross street intersection,
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closest landmark, or closest subway stop) [14]. The W2 survey information was used to categorize dust
exposures into “intense”, “some”, and “none”. The “intense” dust exposure was defined as having
been in the dust cloud on 9/11 and reporting at least one of five experiences: being unable to see more
than a few feet; having difficulty walking or finding one’s way; trouble finding shelter; being covered
with dust; or not being able to hear. The “some” category consisted of those who had reported being
in the dust and debris cloud at Wave 1 but who did not experience intense exposure and “none” were
those who reported no dust cloud exposure at all. These categories of exposure to the dust cloud
(1 = none, 2 = some, or 3 = intense) were combined with reported location at the time of first encounter
with the dust cloud (reported at W1) to produce Figure 1 for the geospatial analysis.
Figure 1. Inverse distance weighted (IDW) interpolation of reported levels of dust cloud intensity
(1 = none, 2 = some or 3 = intense) among World Trade Center (WTC) Health Registry respondents
(n = 23,466) (Wave 1 survey, 9/2003–11/2004).
Wave 2 also included detailed questions about conditions inside the homes after 9/11 as well
as cleaning practices and replacing of household items. WTCHR participants were asked about
the presence of “a fine coating of dust on surfaces”, “a heavy coating of dust on surfaces (so thick
one couldn’t see what was underneath)”, “broken window(s)”, “damage to home or furnishings”,
and “debris from the disaster”. In addition, enrollees answered whether or not they had personally
“cleaned ventilation ducts”, “cleaned with a damp cloth or wet mop or wet sponge”, “used a vacuum
(with or without a high-efficiency particulate air or HEPA filter)”, and “dusted or swept without
water.” Moreover, enrollees were inquired whether or not they replaced “carpet or rugs”, “furniture
(replaced or re-upholstered)”, “drapes, blinds or curtains”, and “air conditioners” as a result of the
9/11 events.
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2.2. Health Outcomes
Outcomes of interest were self-reported respiratory symptoms and self-reported physician
diagnoses of respiratory diseases, asked at both W1 and W2 surveys. Symptoms included shortness
of breath, wheezing, persistent chronic cough, and upper respiratory symptoms, first occurring or
worsening after 9/11 and present at W2. Respiratory diseases comprised asthma or reactive airways
dysfunction syndrome (RADS) and chronic obstructive pulmonary disease (COPD), first diagnosed
after 9/11 and present at W2.
2.3. Geospatial Analyses
Initially, to explore potential geospatial relationships between Ground Zero location and exposures
and health outcomes, we mapped exposures and health outcomes of WTCHR resident enrollees in
lower Manhattan using ArcGIS version 10.2 (ESRI, Redlands, CA, USA). These variables were mapped
at the census tract level of geography using 2000 Census tract boundaries. For this part of the analysis,
“yes” responses for any of the health outcomes variables were summed per census tracts (Boolean
OR, not arithmetic sum). Similarly, exposure variables (fine coating of dust on surfaces, heavy coating
of dust on surfaces, broken windows, damage to home or furnishings, and debris from the disaster
was present) were also grouped and categorized as “yes” or “no” and mapped by census tract totals.
The number of enrollees within each census tract was used as the denominator of the proportions
represented on the maps. In addition, point values of dust cloud exposure were modeled using inverse
distance weighted (IDW) interpolation to create a surface representation of the dust levels throughout
lower Manhattan. IDW uses measured values (point locations) to predict values for unmeasured
surrounding areas.
2.4. Statistical Analyses
We examined demographic characteristics, household exposures resulting from the 9/11 attacks,
and cleaning practices among the study population using descriptive statistics (means, standard
deviations, and proportions). We also calculated the prevalence (%) of self-reported respiratory
symptoms and respiratory diseases. The relationship between cleaning practices and conditions inside
the homes after 9/11 was assessed using multivariate logistic regression analyses adjusted for age,
race, education, income, sex. Analyses were also controlled for “priority group”, a stratification of
registrants into higher and lower priority groups for the purposes of targeting and outreach, which
to a degree reflects a resident’s distance from the WTC site. Priority group 1 included residents as of
9/11 at addresses located south of Chamber Street; Group 2 included residents located on or north of
Chamber but south of Canal Street; a third resident group, Group 0, was defined upon recognition of
the inclusion of respondents living on or north of Canal in zip codes overlapping the Canal boundary or
in other NYC boroughs. Also, the analyses were controlled for any exposure outside, to the dust cloud.
Each of the cleaning practices (dusted or swept without water; cleaned with damp cloth, sponge,
or mop; used a vacuum to clean; and cleaned ventilation ducts) was modeled using logistic regression.
Based on medical considerations and plausibility of real relationships being present, the list of all
variables was narrowed to 17 potential explanatory variables for cleaning practices using ‘purposive’
or a priori selection. The predictors or covariates included five home exposures (fine coating of dust,
heavy coating of dust, broken windows, damage in the home or furnishings, presence of debris in
the home). The covariates also included four replacement behaviors (replaced AC, carpets, drapes,
furniture). Lastly, each model contained terms for eight confounders, as listed in Section 3.2 (Table 3).
The cleaning practices themselves, other than the cleaning behavior specified outcome, are also
modeled as predictors. These other cleaning practices were conditioned on the presence of dust in
the home. For example, “cleaned ventilation ducts” was modelled including the other three cleaning
practices as predictors (i.e., dusted or swept without water; used a vacuum to clean; and cleaned with
damp cloth, sponge, or mop). The covariate cleaning practices were considered only if reported in
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conjunction with the presence of either fine or heavy dust (e.g., vacuum and fine or heavy dust had to
be “yes” for the derived covariate “vacuum” to be “yes”). We fitted the four logistic models with all 17
variables included. Adjusted odds ratios (aOR), and their 95% confidence intervals (95% CI), for each
cleaning method are provided in Section 3.2 (Table 3).
Each health outcome variable was modelled in a similar way. Based on medical considerations and
likelihood of real relationships being present, the list of all covariates was narrowed to 21 explanatory
variables for health outcomes (again, ‘purposive’ or a priori selection). Each of the six health outcomes
was modeled using logistic regression with covariates as follows:
(a) Five demographic variables (age at 9/11, race, sex, education, and income);
(b) Resident priority group, indicating degree of registrant recruitment by area (partially a surrogate
for location relative to the WTC site);
(c) Dust cloud exposure category (intense, some, none);
(d) Ever having smoked (at least 100 cigarettes in a lifetime);
(e) Five variables of exposures in the home (broken windows, debris in the home, fine dust, heavy
dust, and damage in the home);
(f) Four variables containing data on behavior regarding replacement of various major items in the
home (having replaced air-conditioning, carpeting, drapes, and furniture); and
(g) Four variables for the presence of cleaning practices, which are conditioned on the presence of
dust in the home.
Again, the covariate cleaning practices were considered only if reported in conjunction with
the presence of either fine or heavy dust (e.g., vacuum and fine or heavy dust had to be “yes” for
the derived covariate “vacuum” to be “yes”). Smoking status was queried as “Have (you) smoked
at least 100 cigarettes in (your) entire life?” Adjusted odds ratios (aOR), and their 95% confidence
intervals (95% CI), for each health outcome were computed for all variables in the model including
demographic, exposure, and cleaning practices. All analyses were performed using SAS version 9.3
(SAS Institute Inc, Cary, NC, USA).
3. Results
A total of 6447 lower Manhattan residents were included in this study. Table 1 shows their
demographic characteristics. Mean age on 9/11 was 45.1 years (±15.1 years). Around 42% were male
and 67% had completed college or post-graduate work. Forty-five percent had ever smoked cigarettes
and 44% reported some or intense dust cloud exposure on 9/11.
Table 1. Demographic characteristics of 6447 Lower Manhattan residents enrolled in the World Trade
Center (WTC) Health Registry.
Characteristic N %
Age on 9/11/2001 (yrs, mean ± SD) 45.1 ± 15.1 -








<High school 504 7.9
High school 738 11.5
Some college 893 14
College + 4265 66.6
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Less than 25K 1322 20.9
25 to <50K 1181 18.6
50 to <75K 836 13.2
75 to <100K 1801 28.4
100K or more 1197 18.9
Ever smoking * 2903 45.4




* Percentages do not reflect total N due to missing values.
3.1. Geospatial Representation of Exposures and Symptoms
Figures 1–3, respectively, display the geospatial distributions of self-reported outdoor location
at the time of first encountering the dust cloud by intensity of exposure, indoor dust and damage to
residences, and any reported respiratory symptoms up to 6 years after the 9/11 attacks. Figures 1 and 2
show more frequent reports of higher indoor and outdoor exposures on edges of lower Manhattan,
especially the western side along the Hudson River. Over 50% of WTCHR enrollees residing in census
tracts in both the lower western and eastern sides of Manhattan reported having dust or debris in the
home. The proportion reporting indoor home exposure declined rapidly further north and east up to
the Registry Canal Street boundary for residents. The distribution of respiratory symptoms depicted
in the Figure 3 map overlaps in large part with the distribution of reported residential exposures.
The percentage of enrollees by census tract who reported any respiratory symptom ranged from less
than 1% furthest North and East approaching Canal Street to 50% or more of enrollee respondents
who lived in census tracts along the Hudson River adjacent to the WTC site.
3.2. Home Damage and Cleaning Practices
Table 2 shows the types of home damage and household cleaning practices of WTCHR lower
Manhattan residents. The majority of residents reported a fine coating of dust on interior surfaces,
while 17% had a heavy coating of dust, enough to make it impossible to see what was underneath.
Only 6% had broken windows and less than 15% reported damage to home or furnishings. Presence of
debris was reported by 12% of the respondents. Cleaning practices varied greatly: more than half of
participants reported cleaning with a damp cloth, sponge, or mop, whereas 23% reported dusting or
sweeping without water. Around 20% of participants replaced carpets, furniture, or drapes, blinds,
and curtains. Almost one third replaced air conditioners (individually, or the building).
41
IJERPH 2019, 16, 798
Table 2. Self-reported household exposures resulting from the 9/11 attacks, cleaning practices, and
other characteristics among 6447 Lower Manhattan residents enrolled in the World Trade Center (WTC)
Health Registry.
Characteristics N * %
Fine coating of dust 3974/6241 63.7
Heavy coating of dust 1067/6251 17.1
Broken windows 368/6256 5.9
Damage to home or furnishings 927/6250 14.8
Presence of debris 759/6256 12.1
Cleaned ventilation ducts 1061/5931 17.9
Cleaned with damp cloth, sponge, or mop 3307/5919 55.9
Used a vacuum to clean 2687/5934 45.3
Dusted or swept without water 1263/5407 23.4
Replaced carpet or rugs 1201/6090 19.7
Replaced furniture 1304/6090 21.4
Replaced drapes, blinds, or curtains 1232/6090 20.2
Replaced air conditioners 1896/6090 31.1
* Changes in denominators are due to non-response.
Figure 2 shows that the majority of respondents reporting any type of home damage were located
near the WTC site.
Figure 2. Proportion of World Trade Center (WTC) Health Registry participants reporting any
fine coating of dust on surfaces, heavy coating of dust on surfaces, broken window (s), damage
to home or furnishings, or debris in their Lower Manhattan residences (n = 6348) (Wave 2 survey,
11/2006–12/2007).
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Figure 3. Proportion of World Trade Center (WTC) Health Registry participants reporting any
respiratory outcome (shortness of breath, wheezing, chronic cough, upper respiratory symptoms,
asthma/reactive airways dysfunction syndrome, chronic obstructive pulmonary disease) (n = 6348)
(Wave 2 survey, 11/2006–12/2007).
Table 3 shows that those who dusted or swept without water were more likely to report the
presence of debris (aOR = 1.31; 95% Confidence Interval (CI) 1.06–1.61) as to other reported exposures.
Table 3. Associations between cleaning practices and home exposures among 6,447 Lower Manhattan
residents enrolled in the World Trade Center (WTC) Health Registry.
Exposure/Cleaning Practices




Cloth, Sponge, or Mop




Fine coating of dust 0.99 (0.82, 1.20) 1.85 (1.59, 2.14) 0.63 (0.53, 0.74) 0.38 (0.27, 0.52)
Heavy coating of dust 1.03 (0.82, 1.29) 1.08 (0.88, 1.33) 0.64 (0.52, 0.79) 0.59 (0.42, 0.83)
Broken windows 1.24 (0.86, 1.79) 0.69 (0.48, 0.99) 0.97 (0.67, 1.39) 0.95 (0.57, 1.59)
Damage to home or furnishings 0.92 (0.73, 1.14) 0.90 (0.72, 1.12) 1.25 (1.01, 1.54) 1.34 (1.01, 1.79)
Presence of debris 1.31 (1.06, 1.61) 1.07 (0.87, 1.33) 1.20 (0.98, 1.48) 1.16 (0.87, 1.53)
Dusted or swept without water - 1.50 (1.26, 1.79) 1.76 (1.50, 2.07) 1.76 (1.43, 2.18)
Cleaned with damp cloth,
sponge, or mop 1.47 (1.23, 1.74) - 4.59 (3.95, 5.34) 3.92 (2.94, 5.23)
Used a vacuum to clean 1.73 (1.48, 2.03) 4.71 (4.04, 5.50) - 1.95 (1.56, 2.43)
Cleaned ventilation ducts 1.74 (1.41, 2.15) 5.28 (3.72, 7.50) 2.08 (1.65, 2.62) -
* Each model has terms for eight confounders: models are adjusted for any effect due to age at 9/11, education,
income level, race, sex, smoking status, and dust cloud exposure and resident priority group. - = not in the particular
logistic model. Each column gives a distinct logistic model fit, with the column heading being the dependent
(response) cleaning practice variable. (Statistically significant adjusted odds ratios in bold).
Using a damp cloth, sponge, or mop was also associated with reporting a fine coating of dust
(aOR = 1.85; 95% CI 1.59–2.14). In contrast, those who used water for cleaning were less likely to
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report broken windows. Lower Manhattan residents who reported using a vacuum to clean, as well
as those who reported cleaning ventilation ducts, were less likely to report a fine or a heavy coating
of dust, but more likely to report damage to home or furnishings, Table 3). Cleaning practices were
also associated with each other, with cleaning with damp cloth, sponge, or mop having the strongest
association with using a vacuum to clean (aOR = 4.71; 95% CI 4.04–5.50) and cleaning ventilation ducts
(aOR = 5.28; 95% CI 3.72–7.50). These results were expected, yet including these terms made for more
thorough modeling.
Prevalence of respiratory outcomes was as follows: shortness of breath (16.1 %), wheezing (10.7%),
chronic cough (6.8%), upper respiratory symptoms (60.8%), asthma or reactive airways dysfunction
syndrome (RADS) (7.9%), and chronic obstructive pulmonary disease (COPD) (5.4%) (Table 4). A total
of 68% of lower Manhattan residents reporting any respiratory outcome were located within 0.5
miles from Ground Zero (Figure 3). Table 5 shows odds ratios and 95% confidence intervals for
respiratory outcomes in relation to several characteristics of home damage and cleaning practices.
(See explanatory comments given previously, as Tables 3 and 5 have the same layout). Those who
reported a heavy coating of dust had 65% (95% CI 1.24–2.18), 43% (95% CI 1.03–1.97) and 59% (95%
CI 1.09–2.28) higher odds of reporting shortness of breath, wheezing, or chronic cough, respectively.
Residents who reported damage to home or furnishings had a 33% (95% CI 1.01–1.75) increased
odds of reporting shortness of breath and 36% (95% CI 1.06–1.74) increased odds of reporting upper
respiratory symptoms. Presence of debris was associated with chronic cough (aOR = 1.56; CI 1.12–2.17)
and upper respiratory symptoms (aOR = 1.56; CI 1.24–1.95). Lower Manhattan residents who reported
replacing air conditioners had higher odds of reporting upper respiratory symptoms (aOR = 1.32;
CI 1.14–1.54). Replacing carpets was associated with increased COPD (aOR = 1.49; CI 1.03–2.16), while
replacing drapes was associates with increased shortness of breath (aOR = 1.31; CI 1.03–1.65). Dusting
or sweeping without water was the cleaning behavior associated with the largest number (three) of
respiratory outcomes. Residents who did that had higher odds of reporting shortness of breath (aOR =
1.37; 95% CI 1.11–1.69), wheezing (aOR = 1.49; CI 1.17–1.90), and upper respiratory symptoms (aOR =
1.28; CI 1.08–1.53). Cleaning with a damp cloth, sponge, or mop and cleaning ventilation ducts were
also associated with some respiratory outcomes including URS for damp cloth (aOR = 1.40; 95% CI
1.18–1.64) and wheezing and cough with ventilation duct cleaning (aOR = 1.48; 95% CI 1.08–2.01 and
aOR = 1.94; 95% CI 1.38–2.73, respectively).
Table 4. Prevalence of self-reported post-9/11, respiratory symptoms and respiratory diseases present
at Wave 2 (W2) (11/2006–12/2007) surveys among 6447 Lower Manhattan residents enrolled in the
World Trade Center (WTC) Health Registry.
Symptom/Disease N * %
Shortness of breath 983/6126 16.1
Wheezing 668/6234 10.7
Chronic cough 439/6415 6.8
Upper respiratory symptoms 3761/6,190 60.8
Asthma/RADS † 434/5466 7.9
Chronic obstructive pulmonary disease 320/5931 5.4
* Changes in denominators are due to non-response. † RADS = Reactive airways dysfunction syndrome.
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Table 5. Post-9/11 respiratory symptoms or diseases present at W2 in relation to home exposures and




Adjusted Odds Ratios (95% Confidence Interval) * for Each Respiratory Condition
Shortness of
Breath
Wheezing Chronic Cough URS ** Asthma/RADS † COPD ‡
Light coating of dust 1.25 (0.98–1.59) 1.10 (0.84, 1.45) 1.06 (0.77, 1.47) 1.11 (0.93, 1.31) 1.01 (0.74, 1.39) 1.19 (0.84, 1.70)
Broken Windows 0.95 (0.60, 1.50) 1.46 (0.91, 2.36) 0.88 (0.68, 1.62) 0.98 (0.66, 1.44) 1.16 (0.63, 2.12) 1.01 (0.51, 1.99)
Heavy coating of dust 1.65 (1.24, 2.18) 1.43 (1.03, 1.97) 1.59 (1.09, 2.28) 1.08 (0.87, 1.35) 1.21 (0.82, 1.79) 1.35 (0.89, 2.05)
Damage to home or
furnishings 1.33 (1.01, 1.75) 1.31 (0.96–1.81) 0.82 (0.56, 1.19) 1.36 (1.06, 1.74) 1.11 (0.74, 1.65) 1.11 (0.73, 1.68)
Presence of debris 1.62 (0.97, 1.64) 1.19 (0.88, 1.61) 1.56 (1.12, 2.17) 1.56 (1.24, 1.95) 0.92 (0.63, 1.35) 0.94 (0.63, 1.40)
Replaced air conditioner 1.06 (0.87, 1.28) 1.08 (0.87, 1.34) 1.24 (0.96, 1.60) 1.32 (1.14, 1.54) 0.91 (0.69, 1.19) 1.31 (0.99, 1.74)
Replaced carpets 0.90 (0.70, 1.17) 1.05 (0.78, 1.41) 1.07 (0.76, 1.50) 1.03 (0.83, 1.28) 1.21 (0.85, 1.73) 1.49 (1.03, 2.16)
Replaced drapes 1.31 (1.03, 1.65) 0.98 (0.75, 1.29) 1.02 (0.74, 1.40) 1.11 (0.90, 1.36) 0.99 (0.71, 1.39) 0.96 (0.67, 1.38)
Replaced furniture 1.24 (0.97, 1.59) 1.13 (0.85, 1.51) 1.24 (0.89, 1.73) 1.14 (0.93, 1.40) 1.40 (0.99, 1.96) 0.89 (0.62, 1.29)
Dusted or swept without
water 1.37 (1.11, 1.69) 1.49 (1.17, 1.90) 1.21 (0.91, 1.61) 1.28 (1.08, 1.53) 1.35 (1.00, 1.81) 1.16 (0.85, 1.61)
Cleaned with damp cloth,
sponge, mop 1.15 (0.92, 1.43) 1.01 (0.79, 1.30) 1.05 (0.78, 1.41) 1.40 (1.18, 1.64) 0.91 (0.67, 1.22) 0.96 (0.69, 1.32)
Cleaned ventilation ducts 1.23 (0.93, 1.64) 1.48 (1.08, 2.01) 1.94 (1.38, 2.73) 1.18 (0.92, 1.53) 1.23 (0.82, 1.82) 1.30 (0.86, 1.96)
Vacuumed 0.96 (0.78, 1.19) 1.06 (0.84, 1.34) 0.95 (0.71, 1.25) 1.01 (0.86, 1.19) 0.99 (0.75, 1.33) 0.94 (0.69, 1.29)
* Each model has terms for eight confounders: models are adjusted for any effect due to age at 9/11, education,
income level, race, sex, smoking status, and dust cloud exposure and resident priority group. ** URS = Upper
respiratory symptoms. † RADS = Reactive airways dysfunction syndrome. ‡ COPD = Chronic obstructive pulmonary
disease. Each column gives a separate logistic model fit, with the column heading being the dependent (response)
health outcome variable. (Statistically significant adjusted odds ratios in bold).
4. Discussion
This is the largest study to evaluate respiratory outcomes among lower Manhattan residents who
reported household exposures as a result of the 9/11 terrorist attacks. Our findings are consistent
with increased respiratory symptoms and diseases, which are associated with several levels of home
damage and different cleaning practices, and corroborate other studies in similar populations [8–11,13]
or subset of the WTCHR resident population [13].
The explosion and collapse of buildings and subsequent fires at Ground Zero produced a large
plume of dust and smoke that released particles and gases into the air. Characterization of both
outdoor and indoor dust samples identified asbestos, glass fibers, lead, and polycyclic aromatic
hydrocarbons (PAHs), among numerous other contaminants [1,4,5]. In fact, indoor samples contained
more inhalable dust particles than did outdoor dust [6]. Our data show that the majority of lower
Manhattan residents in the WTCHR may have been exposed to airborne contaminants because of some
type of home damage following the 9/11 attacks. The presence of dust was the most common problem,
but more severe damage, such as broken windows and furniture, were also reported. A case-control
study comparing lower and upper Manhattan residents found that 30.7% of residents in the affected
region reported some physical damage to their homes and 86.4% reported dust [8]. As expected,
our geospatial analysis demonstrates that a higher proportion of WTCHR participants reporting any
home damage were located in the vicinity of Ground Zero.
As a result of the presence of dust, debris, and other damage, lower Manhattan residents
personally cleaned their homes using a variety of methods. Lin et al. reported that 74.3% of residents
in the affected area personally cleaned their homes [8]. The majority of residents participating in the
present study reported using wet cleaning practices, such as using a damp cloth, sponge, or mop,
which are likely to minimize suspension of dust and have been recommended by the Environmental
Protection Agency (EPA) in that context [3,15]. However, many residents reported dusting or sweeping
without water and even cleaning ventilation ducts by themselves. These practices were associated
with the presence of debris and may have resulted in excessive dust exposure. In addition, numerous
residents reported that household items, such as carpets, furniture, curtains, and air conditioners were
replaced, which may have been associated with more severe damage to their homes. Among other
measures, the EPA designed and implemented a Residential Dust Cleanup Program in 2002, to ensure
that lower Manhattan residents were protected from potential WTC-related exposures [16].
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Upper respiratory symptoms were the most common health outcomes reported by lower
Manhattan residents in the WTCHR. This finding is consistent with other WTC studies among
residents [10] and rescue and recovery workers [17–19]. According to Lin et al., residents living
within 1.5 km of the WTC site experienced a 200 percent increase of at least one persistent upper
respiratory symptom compared to controls in the Upper West Side of Manhattan [10]. Our study also
demonstrates high rates of persistent shortness of breath, wheezing, and chronic cough among lower
Manhattan residents. These findings are in line with those of Lin et al., who reported that increased
rates of lower respiratory symptoms persisted among lower Manhattan residents two and four years
after the 9/11 attacks [9]. Moreover, most residents reporting any persistent respiratory symptoms in
our study were located within a 0.5-mile radius of Ground Zero. Lin et al. also described an apparent
trend when comparing residents below and not below Canal St.: the former had stronger associations
between location and both any new-onset and persistent new-onset respiratory symptoms [9]. Reibman
et al. also reported that four times as many lower Manhattan residents presented wheezing compared
to a control population. In addition, three times as many residents reported cough and shortness of
breath [11].
Our results demonstrate an association between respiratory health outcomes and numerous types
of home damage and cleaning practices. In particular, the presence of a heavy coating of dust was
associated with shortness of breath, wheezing and cough and the presence of debris with chronic cough
and upper respiratory symptoms. Lin et al. reported that upper respiratory symptoms were associated
with both dust and physical damage to home, with statistically significant cumulative incidence ratios
(CIRs) ranging from 1.27 to 1.71. In addition, the association between lower respiratory symptoms
and exposures yielded CIRs between 1.31 and 1.44 [8]. In our study, the use of dry cleaning practices,
such as dusting or sweeping without water, was associated with shortness of breath, wheezing,
and upper respiratory symptoms. In contrast, only one health outcome was associated with cleaning
with a damp cloth, sponge, or mop. It is not clear if the cleaning practice with water provided some
protective effects by limiting re-suspension of dust, since in our analysis the cleaning practices with and
without water were not mutually exclusive. Both practices were also associated with other methods
of cleaning. Furthermore, cleaning practice with water was significantly associated with fine coating
of dust (OR = 1.85; 95% CI, 1.59–2.14) versus cleaning practice without water was not (OR = 0.99;
95% CI, 0.82–1.20). Nevertheless, Lin et al. did not find statistically significant associations between
self-cleaning of homes and lower respiratory symptoms at 2- and 4-year follow ups of lower Manhattan
residents (N = 136 and 69 participants, respectively) [9].
A strength of this study is the ability to demonstrate persistent health outcomes in a large sample
of lower Manhattan residents exposed in their homes to airborne contaminants resulting from the 9/11
terrorist attacks. Our analyses controlled for potential confounders, such as the intensity of exposure
to the cloud of dust and debris, smoking, and priority group or area of recruitment, which may serve
as a surrogate for location in lower Manhattan.
However, this study is subject to several limitations. Self-selection bias may affect our results.
Lower Manhattan residents who developed respiratory symptoms and diseases after 9/11/2001 may
have been more likely to enroll in the WTC registry than asymptomatic persons. Medical records
were not obtained which might have been used to verify reported conditions. In addition, smoking
was defined as ever/never, without taking into account pack-years. Also, there was essentially no
ability to validate the reported exposures quantitatively, because environmental sampling was not
conducted. Nonetheless, it is unlikely that differences between respondents and non-respondents and
misclassification of disease status would have an influence on the intensity of home damage reporting
and selection of cleaning practices. Recall bias is also a limitation since questionnaires for W2 were
applied over 5 years after the event of interest. In an attempt to account for this aspect, we verified
responses on W1 and W2 for consistency. In addition, information on time to return home and use of
respiratory protection while cleaning was not available. It is possible that severely damaged home
inhabitants took longer to return to their homes or did so only after renovations, which potentially
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reduced dust exposures. Similarly, residents may have used different degrees of respiratory protection
while cleaning surfaces. These factors would have reduced the apparent effect of the reported home
damage on respiratory health outcomes.
5. Conclusions
This analysis demonstrates that lower Manhattan residents who suffered home damage following
the 9/11 attacks are more likely to report respiratory symptoms and diseases in the WTCHR. It also
highlights the specific kinds of damage or other specific exposure events, such as cleaning practices,
which are statistically related to such increased symptoms and diseases. These health outcomes
persisted for at least 5–6 years after the event, which may have translated into lower quality of life.
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Abstract: Sarcoid-like granulomatous diseases (SGD) have been previously identified in cohorts
of World Trade Center (WTC) dust-exposed individuals. In the present studies, we analyzed lung
and/or lymph node biopsies from patients referred to our clinic with suspected WTC dust-induced
lung disease to evaluate potential pathophysiologic mechanisms. Histologic sections of lung and/or
lymph node samples were analyzed for markers of injury, oxidative stress, inflammation, fibrosis,
and epigenetic modifications. Out of seven patients examined, we diagnosed four with SGD
and two with pulmonary fibrosis; one was diagnosed later with SGD at another medical facility.
Patients with SGD were predominantly white, obese men, who were less than 50 years old and
never smoked. Cytochrome b5, cytokeratin 17, heme oxygenase-1, lipocalin-2, inducible nitric
oxide synthase, cyclooxygenase 2, tumor necrosis factor α, ADP-ribosylation factor-like GTPase 11,
mannose receptor-1, galectin-3, transforming growth factor β, histone-3 and methylated histone-3
were identified in lung and lymph nodes at varying levels in all samples examined. Three of the
biopsy samples with granulomas displayed peri-granulomatous fibrosis. These findings are important
and suggest the potential of WTC dust-induced fibrotic sarcoid. It is likely that patient demographics
and/or genetic factors influence the response to WTC dust injury and that these contribute to different
pathological outcomes.
Keywords: WTC; fibrotic sarcoid; injury; inflammation; fibrosis
1. Introduction
Following the collapse of the World Trade Center (WTC) towers on 11 September, 2001,
toxic dust was suspended in the air of lower Manhattan and Brooklyn. Over time, rescue and
recovery workers exposed to WTC dust developed various respiratory diseases involving both
the airways (asthma-like airway hyper-reactivity, bronchiolitis), and less commonly, the lung
parenchyma (eosinophilic pneumonia, fibrosis, sarcoid-like granulomatous disease) [1,2]. Most notable
is sarcoid-like granulomatous disease (SGD), which has been diagnosed at relatively high rates in
cohorts of firefighters and rescue workers who have been followed since 2001 [3]. This condition
IJERPH 2019, 16, 815; doi:10.3390/ijerph16050815 www.mdpi.com/journal/ijerph49
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is distinct from frank sarcoidosis which is a diagnosis of exclusion, once other known causes of
granulomatous disease have been ruled out. It may be that WTC dust-induced SGD is a unique
pathology, with potential for specific therapeutic interventions.
Although WTC dust has been extensively characterized [4], little is known about the
pathophysiologic mechanisms underlying the development of SGD and other lung pathologies. Studies
in rodents have reported increased expression of genes associated with inflammation and oxidative
stress in the lung following WTC dust exposure [5,6]. However, in these studies, granulomatous
inflammation was not observed, making determination of the pathogenesis of WTC dust-induced SGD
in humans, problematic.
In this report, we describe the pathologic findings in seven patients exposed to WTC dust
who presented with ambiguous clinical pulmonary diagnoses. In all of the patients, we identified
markers of injury, oxidative stress, inflammation, and epigenetic changes in lung and/or lymph nodes.
Based on pathologic findings, five of the patients demonstrated evidence of SGD and three of these
had peri-granulomatous fibrosis. These findings are important as they suggest the possibility of
development of fibrosis in patients with WTC dust-induced SGD. This may lead to changes in clinical
outcomes and treatment strategies.
2. Methods
2.1. Patients
Investigators at the Environmental and Occupational Health Sciences Institute (EOHSI) of Rutgers
University are part of a New York/New Jersey consortium that has been following a cohort of rescue
and recovery workers exposed to dust and other materials at the WTC site. These individuals included
rescue, recovery, debris-cleanup, law enforcement, and related support service workers, and volunteers
in lower Manhattan (south of Canal St.), the Staten Island Landfill, and/or the barge loading piers,
who worked on-site for at least 4 h/day between 11 and 14 September, 2001, for at least 24 h during
September 2001, or for at least 80 h total time between September and December 2001 [7]. From among
approximately 2000 patients followed at EOHSI, 7 were referred for biopsy between 2007 and 2011,
if a final pulmonary diagnosis despite symptom review and full evaluation including pulmonary
function testing (PFT) and computerized tomography (CT) scan interpretation required tissue analysis.
Patient demographics were collected, including WTC dust exposure levels as described by Wisnivesky
et al. [2]. Lung and/or mediastinal lymph node specimens were obtained for both histopathologic
evaluation and immunohistochemical staining. All subjects gave informed consent for inclusion before
they participated in the study. The study was conducted in accord with the Declaration of Helsinki,
and the protocol was approved by the Ethics Committee of the Rutgers Institutional Review Board.
2.2. Pulmonary Function Testing (PFT)
PFTs were performed using NSpire Health pulmonary functioning testing devices (NSpire Health,
Longmont, CO, USA), that were calibrated in the Rutgers University Robert Wood Johnson Medical
School Pulmonary Function Laboratory. Test results were interpreted according to American Thoracic
Society guidelines and results collected for each patient [8].
2.3. CT Scans
Tidal breathing CT was performed from lung apex to lung base without the use of intravenous
contrast material. All results were interpreted by board-certified radiologists.
2.4. Sample Collection, Histology and Immunohistochemistry
We collected lung samples by transbronchial biopsy (TBB) from 3 patients, and by video-assisted
thoracoscopy (VATS) from 2 patients. Three patients had mediastinal lymph node biopsies obtained
via mediastinoscopy (Med). Samples were fixed in 3% paraformaldehyde for 4 h and then transferred
50
IJERPH 2019, 16, 815
to 50% ethanol. Histological sections (4 μm) were prepared and stained with hematoxylin and
eosin (H and E) or Masson’s trichrome stain. Tissues were analyzed by a board-certified pulmonary
pathologist (M. Deen) for the extent of inflammation, including macrophage and neutrophil localization,
alterations in alveolar epithelial barriers, fibrin deposition, edema, granuloma formation, and fibrosis.
Representative images were acquired at high resolution (magnification 60×) using an Olympus VS120
Virtual Microscopy System, scanned and viewed using OlyVIA version 2.6 software (Olympus Life
Sciences, Center Valley, PA, USA).
For immunohistochemistry, tissue sections were deparaffinized with xylene (4 min, ×2) followed
by decreasing concentrations of ethanol (100%–50%) and finally, water. After antigen retrieval using
citrate buffer (10.2 mM sodium citrate, 0.05% Tween 20, pH 6.0) and quenching of endogenous
peroxidase with 3% H2O2 for 10–30 min, sections were incubated for 1–4 h at room temperature
with 5–100% goat serum to block nonspecific binding. This was followed by overnight incubation
at 4 ◦C with rabbit IgG or rabbit polyclonal anti-cytochrome b5 (1:250, Abcam, Cambridge, MA,
USA), anti-cytokeratin 17 (1:1000, Abcam), anti-heme oxygenase (HO)-1 (1:650, Enzo Life Sciences,
Farmingdale, NY, USA), anti-lipocalin (Lcn)-2 (1:250, Abcam), anti-inducible nitric oxide synthase
(iNOS) (1:500, Abcam), anti-cyclooxygenase (COX)-2 (1:100, Abcam), anti-tumor necrosis factor
(TNF)α (1:50, Abcam), anti-ADP-ribosylation factor-like GTPase (ARL)11 (1:100, Bioss Antibodies,
Woburn, MA, USA), anti-mannose receptor (MR)-1 (1:500, Abcam), anti-galectin (Gal)-3 (1:400,
R&D Systems, Minneapolis, MN, USA), anti-transforming growth factor (TGF)β (1:50, Abcam),
anti-histone H3 (1:50, Cell Signaling, Danvers, MA, USA), or anti-mono-methyl histone H3K4 (1:100,
Cell Signaling) antibodies. Sections were then incubated with biotinylated secondary antibody (Vector
Labs, Burlingame, CA, USA) for 30 min at room temperature. Binding was visualized using a DAB
(3,3’ diaminobenzidine) peroxidase substrate kit (Vector Labs). Sections of lung and/or lymph nodes
from all 7 subjects were analyzed for each antibody.
3. Results
3.1. Patient Demographics and Diagnoses
Patient demographics are presented in Table 1. The patients were predominantly male (100%),
white (non-Hispanic; 100%), and former smokers (57%). Based on pathological findings (see below),
patients were divided into two groups; those with SGD (n = 5) and those with other pathology
(n = 2). Of the patients with SGD, 100% were white males, overweight or obese (BMI = 25–29 (20%);
BMI ≥ 30 (80%)), 80% were <50 years old (mean age 43.5), and 60% never smoked (Table 1). Four of
the five patients with SGD had an intermediate WTC dust exposure level, and one had a high level of
exposure [2]. The two non-SGD patients had high WTC dust exposure levels (Table 1). The clinical,
radiographic and pathologic characteristics of patients undergoing biopsy are presented in Table 2.
The reasons for biopsy in patients with SGD (patients #1–5) were mediastinal/hilar adenopathy and
pulmonary nodules (Table 2). Other patients displayed a mix of lymphadenopathy, fibrosis, nodules,
and emphysema. Of patients with SGD, patients #1 and #2 had normal pulmonary function, while
patients #3 and #4 displayed restrictive physiology and patient #5 had mixed obstruction and restriction
(Table 3). The two patients without SGD (#6 and #7) had restrictive physiology (Table 3).
3.2. Pathological Results
Biopsy samples from three of the seven patients (patients #1, #3 and #4) showed well-formed
non-caseating granulomas in lymph nodes suggesting SGD; patient #2 exhibited scant, poorly formed
granuloma in the lung (Table 2 and Figure 1). In two of the patients (#3 and #4), only lymph nodes
were biopsied; in one patient (#2), only lung parenchyma was biopsied. In patient #1, both lymph
nodes and lung were biopsied, and both tissue types exhibited non-caseating granulomas (Figure 1).
Masson’s trichrome staining of tissues revealed the presence of well-formed granulomas and evidence
of peri-granulomatous fibrosis in lymph nodes of patients #1, #3 and #4 (Figure 2). Of the other three
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patients without granulomatous changes (#5–#7), pathological diagnoses in the lung included mild
fibrosis, bronchial inflammation and acute and chronic lung injury (Table 2 and Figure 1). Patient #5
was diagnosed later with SGD at another medical facility after obtaining additional tissue via VATS.
Table 1. Demographic characteristics of patients undergoing biopsy.
Characteristics Total Number (%) SGD Number (%) Other Diseases Number (%)
Gender
Male 7 (100) 5 (100) 2 (100)
Female 0 (0) 0 (0) 0 (100)
Age
<50 4 (57) 4 (80) (0)
50–59 1 (14) 1 (20) 0 (0)
60–69 2 (29) 0 (0) 2 (100)
Race/Ethnicity
White (non-Hispanic) 7 (100) 5 (100) 2 (100)
Black (non-Hispanic) 0 (0) 0 (0) 0 (0)
Hispanic 0 (0) 0 (0) 0 (0)
Smoking Status
Current 0 (0) 0 (0) 0 (0)
Past 4 (57) 2 (40) 2 (100)
Never 3 (43) 3 (60) 0 (0)
BMI (kg/m2)
< 25 0 (0) 0 (0) 0 (0)
25–29 3 (43) 1 (20) 2 (100)
30–39 4 (57) 4 (80) 0 (0)
WTC Exposure Category [2]
Very High 0 (0) 0 (0) 0 (0)
High 3 (43) 1 (20) 2 (100)
Intermediate 4 (57) 4 (80) 0 (0)
Low 0 (0) 0 (0) 0 (0)
Abbreviations: SGD, sarcoid-like granulomatous disease; BMI, body mass index; WTC, World Trade Center.
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FEV1 (%) FVC (%) FEV1/FVC (%) VC (%) TLC (%)
1 98 100 97 98 93 103 WNL
2 100 104 96 103 109 104 WNL
3 88 84 104 81 82 85 Mild RTLD
4 98 94 104 83 73 69 Mild RILD
5 42 58 72 51 62 69 Severe Mixed OLD & RILD
6 98 87 112 80 78 57 Mild RILD
7 80 77 104 80 77 86 Mild RTLD
Abbreviations: PT#: patient number; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; VC: vital
capacity; TLC: total lung capacity; DLCO: diffusing capacity for carbon monoxide; WNL: within normal limits;
RTLD: restrictive thoracic lung disease; RILD: restrictive interstitial lung disease; OLD: obstructive lung disease.
Bolded values were below normal confidence intervals.
 
Figure 1. Histology of lung and lymph nodes. Biopsies of lung (top and middle panels) and lymph
nodes (bottom panels), collected from World Trade Center (WTC) rescue and recovery workers, were
sectioned and stained with Hematoxylin and Eosin (H&E). Inset, patient number. Magnification, 20×;
arrows, alveolar macrophages; arrowheads, lymphocytes.
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Figure 2. Trichrome staining of lung and lymph nodes. Biopsies of lung (top panel) and lymph nodes
(bottom panels), collected from WTC rescue and recovery workers were sectioned and stained with
Masson’s trichrome. Inset, patient number; NC, tissue not collected. Magnification, 13.2×.
3.3. Expression of Markers of Injury, Oxidative Stress, Inflammation, Fibrosis, and Epigenetic Changes
Analysis of tissue sections by immunohistochemistry revealed the presence of cytochrome b5 and
cytokeratin 17, markers of injury in lung (patients #1, # 2, #5, #6 and #7) and lymph nodes (patients #1, #3
and #4) (Figure 3). Whereas cytochrome b5 expression was uniformly distributed throughout the lung,
including alveolar macrophages and epithelial cells, cytokeratin 17 was more prominent in alveolar
macrophages. However, the intensity of expression of both of these markers varied between patients.
Markers of oxidative stress including HO-1 and Lcn-2 were upregulated in alveolar macrophages and
lymph node biopsies from all patients (Figure 4). As observed with cytochrome b5 and cytokeratin 17,
the intensity of expression varied between patients. We also noted upregulation of the proinflammatory
proteins iNOS, COX-2, TNFα, and ARL11 to varying degrees in alveolar macrophages and lymph
nodes in all patient samples examined (Figures 5 and 6). Anti-inflammatory/pro-fibrotic markers of
macrophage activation, including MR-1, the galactoside-binding lectin, Gal-3, and TGFβ were also
upregulated (Figures 7 and 8). Additionally, histone H3 and methylated (K4) histone H3K4, epigenetic
markers of inflammation/fibrosis were identified in lung and lymph nodes with varying intensities in
all patient samples examined (Figure 9).
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Figure 3. Cytochrome b5 and cytokeratin 17 expression in lung and/or lymph nodes collected from
WTC rescue and recovery workers. Sections were immunostained with antibody to cytochrome b5
or cytokeratin 17. Binding was visualized using a 3,3’ diaminobenzidine (DAB) peroxidase substrate
kit. One representative section from each patient is shown. Inset, patient number. Magnification, 60×;
arrows, alveolar macrophages.
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Figure 4. Hemeoxygenase (HO)-1 and Lipocalin (Lcn)-2 expression in lung and/or lymph nodes
collected from WTC rescue and recovery workers. Sections were immunostained with antibody to HO-1
or Lcn-2. Binding was visualized using a DAB peroxidase substrate kit. One representative section
from each patient is shown. Inset, patient number. Magnification, 60×; arrows, alveolar macrophages.
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Figure 5. Inducible nitric oxide synthase (iNOS) and Cyclooxygenase (COX)-2 expression in lung
and/or lymph nodes collected from WTC rescue and recovery workers. Sections were immunostained
with antibody to iNOS or COX-2. Binding was visualized using a DAB peroxidase substrate kit.
One representative section from each patient is shown. Inset, patient number. Magnification, 60×;
arrows, alveolar macrophages.
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Figure 6. Tumor necrosis factor (TNF)α and ADP-ribosylation factor-like GTPase (ARL)11 expression
in lung and/or lymph nodes collected from WTC rescue and recovery workers. Sections were
immunostained with antibody to TNFα or ARL11. Binding was visualized using a DAB peroxidase
substrate kit. One representative section from each patient is shown. Inset, patient number; NA, tissue
not available. Magnification, 60×; arrows, alveolar macrophages.
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Figure 7. Mannose receptor (MR)-1 and Galectin (Gal)-3 expression in lung and/or lymph nodes
collected from WTC rescue and recovery workers. Sections were immunostained with antibody to
MR-1 or Gal-3. Binding was visualized using a DAB peroxidase substrate kit. One representative section
from each patient is shown. Inset, patient number. Magnification, 60×; arrows, alveolar macrophages.
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Figure 8. Transforming growth factor (TGF)β expression in lung and/or lymph nodes collected from
WTC rescue and recovery workers. Sections were immunostained with antibody to TGFβ. Binding was
visualized using a DAB peroxidase substrate kit. One representative section from each patient is shown.
Inset, patient number; NA, tissue not available. Magnification, 60×; arrows, alveolar macrophages.
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Figure 9. Histone H3 and methylated (K4) histone H3K4 expression in lung and/or lymph nodes
collected from WTC rescue and recovery workers. Sections were immunostained with antibody to H3
or H3K4. Binding was visualized using a DAB peroxidase substrate kit. One representative section
from each patient is shown. Inset, patient number; NA, tissue not available. Magnification, 60×;
arrows, alveolar macrophages.
4. Discussion
The present studies report that five of the seven patients referred to our clinic for diagnostic
evaluation exhibited SGD, as evidenced by non-caseating granulomas in lung and/or lymph nodes.
SGD has previously been described among a subset of WTC rescue and recovery workers [9,10].
Mechanisms underlying the development of this disease remain unknown [11–15]. Non-caseating
granuloma formation is a type of foreign body reaction which involves trapping of remnants of
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foreign materials that cannot be degraded and/or destroyed by macrophages [16]. The appearance
of non-caseating granulomas in WTC dust-exposed patients is in line with findings that WTC
dust contained organic and inorganic particles which have been implicated in the development
of granulomatous pulmonary disease [17].
Inflammation and oxidative stress are common responses to inhalation of particles and fibers
including silica and asbestos, components of WTC dust, and they are thought to be involved in
pulmonary disease pathogenesis [18–20]. As a first step in elucidating WTC dust-induced SGD
mechanisms, we analyzed the expression of markers of oxidative stress, inflammation, and injury
in lung and/or lymph nodes of WTC dust-exposed patients followed in our clinic. Lung and/or
lymph node samples from all patients examined stained positively for markers of pro-inflammatory
M1 macrophages including iNOS, COX-2, TNFα and ARL11 [21–23]. iNOS and COX-2 mediate
the production of reactive nitrogen species and proinflammatory eicosanoids, respectively. These
mediators are known to contribute to M1 macrophage activation and lung injury induced by diverse
toxicants, and they may play a similar role in the pathogenic response to WTC dust [21]. In this regard,
COX-2 has been reported to be upregulated by silica, a component of WTC dust, in rodents, cultured
fibroblasts, and in sarcoid granulomas [4,18,24–26]. ARL11 has recently been identified as a regulator
of proinflammatory macrophage activation and TNFα release [22,27]. TNFα has been implicated in
lung injury induced by silica [26], suggesting a potential mechanism of disease pathogenesis following
WTC dust exposure.
Previous studies showed that WTC dust induces oxidative stress [5,6]. Consistent with these
reports, tissue samples from all patients examined were found to stain positively for the oxidative
stress markers, HO-1 and Lcn-2. In addition to their anti-oxidant activity, these proteins promote
anti-inflammatory responses. Macrophage Lcn-2 has previously been shown to reduce granulomatous
inflammation in mycobacterial pulmonary infections [28]. Upregulation of HO-1 and Lcn-2 in
granulomas of WTC dust-exposed patients may reflect a compensatory attempt to limit inflammation
and granuloma progression. Increases in proinflammatory macrophage mediators and oxidative stress
were associated with lung damage as evidenced by upregulation of cytochrome b5 and cytokeratin 17
in macrophages and epithelial cells. Similar increases in these proteins have been reported in acute
lung injury induced by inhaled ozone and S. aureus enterotoxin [23,29,30].
The activity of proinflammatory/cytotoxic M1 macrophages is balanced by anti-inflammatory/
pro-fibrotic M2 macrophages, which downregulate inflammation and initiate wound repair. However,
when overactivated, M2 macrophages promote fibrosis [21]. Findings that macrophages in histologic
sections of WTC dust-exposed patients stained positively for MR-1 and Gal-3 suggest M2 macrophage
activation [31]. This is in accord with findings that Gal-3 promotes M2 polarization of macrophages
and contributes to lung fibrosis [32,33].
Coordinate with the presence of M2 macrophages, we found that tissue samples stained positively
for the pro-fibrotic protein TGF β. Of note, patients with well-formed granulomas (#1, #3 and #4)
also exhibited peri-granulomatous fibrosis, as evidenced by trichrome staining. Fibrotic sarcoidosis is
characterized pathologically as fibrotic destruction at sites of prior granulomatous inflammation [34].
The granulomas are thought to function as a nidus for the development of fibrosis that can encompass
larger areas of the respiratory tract, resulting in collagen deposition in broncho-vascular tracts and
interlobular septae, cystic distortion and honeycombing of the lung [35,36]. It remains to be determined
if peri-granulomatous fibrosis in our series is an early indicator of progressive fibrotic disease in patients
with WTC dust-induced SGD. The most recent follow up of a large WTC dust-exposed firefighter
cohort with SGD did not report clinical evidence of fibrotic disease [13]. Our pathological series
suggests that fibrosis may develop in these patients with time. This is important as the development
of fibrosis in sarcoidosis represents a significant change in the clinical course that is associated with
increased morbidity and mortality [34,35].
It is important to note that expression of inflammatory proteins was observed in all patients
exposed to WTC dust, regardless of the presence of granulomas. As we did not have controls to assess
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for comparison, a causal link has not been established. It is likely that specific patient demographics,
such as smoking, obesity, age, and/or genetic/epigenetic factors influence the immune response to
WTC dust injury, contributing to different pathological outcomes. In this regard, our patients with
SGD were predominantly non-smokers, obese and <50 years of age at diagnosis. This is similar to
the demographic profile of larger cohorts of New York City firefighters and first responders exposed
to WTC dust [3,13]. Evidence suggests that sarcoidosis is more likely to develop in young, obese,
non-smokers [37,38]. These factors are known to affect the adaptive immune response by inducing
T-cell differentiation towards a Th1 phenotype [39–42]. This may contribute to the development of
WTC dust-induced SGD. Lung and lymph node biopsies in our cohort, also stained positively for
histone H3 and H3K4, suggesting the possibility that epigenetic factors may also contribute to SGD.
All five patients with SGD had intermediate/high exposure to WTC dust. Previous studies
demonstrated a strong correlation between WTC dust exposure levels and the development of
lung disease with very high exposure levels causing the most disease [2]. Our studies suggest that
intermediate levels of WTC dust exposure may be a sufficient risk factor for developing SGD with
fibrosis. It is also possible that heterogeneity in WTC dust, such as composition (silica, metal) and
particle size, affect the pathologic response [36]. These possibilities require further investigation.
Limitations
In this case series studies, we are limited in any inferences we can make about associations, since
our sample size was small and non-random, and we did not have case-matched controls.
5. Conclusions
In summary, our studies demonstrate the presence of SGD in five of seven patients exposed to
intermediate/high levels of WTC dust. Lung and/or lymph nodes exhibited signs of oxidative stress,
inflammation, tissue damage, and fibrosis. This was associated with upregulation of proinflammatory
and pro-fibrotic markers and epigenetic alterations. Our observations of peri-granulomatous fibrosis
in some of the patients with SGD are novel. Further studies are required to elucidate the precise
mechanisms underlying this pathology in subsets of WTC dust-exposed patients.
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Abstract: Dust created by the collapse of the World Trade Center (WTC) towers on 9/11 included
metals and toxicants that have been linked to an increased risk of pulmonary fibrosis (PF) in the
literature. Little has been reported on PF among WTC responders. This report used self-reported
physician diagnosis of PF with an unknown sub-type to explore the association between levels of WTC
dust exposure and PF. We included 19,300 WTC responders, enrolled in the WTC Health Registry in
2003–2004, who were followed for 11 years from 2004 to 2015. Exposure was defined primarily by
intensity and duration of exposure to WTC dust/debris and work on the debris pile. Stratified Cox
regression was used to assess the association. We observed 73 self-reported physician-diagnosed PF
cases, with a PF incidence rate of 36.7/100,000 person-years. The adjusted hazard ratio (AHR) of PF
was higher in those with a medium (AHR = 2.5, 95% CI = 1.1–5.8) and very high level of exposure
(AHR = 4.5, 95% CI = 2.0–10.4), compared to those with low exposure. A test for exposure—response
trend was statistically significant (Ptrend = 0.004). Future research on WTC dust exposure and PF
would benefit from using data from multiple WTC Health Program responder cohorts for increased
statistical power and clinically confirmed cases.
Keywords: World Trade Center disaster; pulmonary fibrosis; dust
1. Introduction
The collapse of the World Trade Center (WTC) towers resulting from the terrorist attack on 11
September 2001 (9/11) produced a dense cloud of dust and debris that spread widely and contained
toxic substances including heavy metals (e.g., titanium), silica, asbestos fibers, and wood dust [1,2].
WTC responders were potentially highly exposed as a result of performing rescue and recovery work
on the WTC site including searching for remains, firefighting and debris removal work that continued
through June 2002 [3]. Of those involved in the rescue/recovery activities, nearly half were directly
exposed to the dust cloud (blackout conditions) on 9/11 [3]. In total, 93% of WTC responders had
commenced work on the site by the end of September, 2001 [3].
Short and longer-term health effects of 9/11 associated with intense dust/fume exposure include
a number of respiratory diseases or symptoms, such as asthma, chronic obstructive pulmonary disease
(COPD) and upper or lower respiratory symptoms [4–9]. A small number of cases of pulmonary
fibrosis (PF) among WTC responders were reported in the first eight years following 9/11 [4,10,11].
PF is an interstitial lung disease, characterized by scarring (fibrosis) formed over time in the structural
lung tissue between alveoli (or air sacs) [12]. Lung biopsies in four out of seven previously healthy
WTC responders in a case series study revealed histologic patterns that were consistent with interstitial
disease, following imaging that identified suspected interstitial disease after 9/11 exposure [10].
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In another case series from the WTC Environmental Health Center (WTC EHC), five of six patients,
who underwent surgical biopsy based on CT findings suggestive of diffuse interstitial disease of
fibrosis, had pathologic findings of mild to moderate patchy interstitial fibrosis [11]. Moreover, these
two case series that included mineralogical analyses of the available tissues found the presence of
metals, silica, aluminum silicates, carbon nanotubes, chrysotile asbestos and calcium phosphate or
sulfate [10,11]. Four cases of bilateral pulmonary fibrosis were also reported among New York City
firefighters [4]. All of these initial observations from individual patients provided important clues to
the occurrence of this rare disease among 9/11-exposed individuals.
WTC dust may be responsible for the reported PF cases as the substances known to be associated
with PF in occupational studies include heavy metals (e.g., titanium), silica, and wood dust [13–19],
which were also found in WTC dust [1,2]. However, little is known about the occurrence of PF in this
population over time and whether the level of WTC dust exposure would be associated with PF in
an observational study in which WTC responders with PF could be compared to those who do not
have PF.
Using self-reported survey data on PF from the World Trade Center Health Registry [20],
we investigated the incidence of PF and assessed the association between WTC dust exposure and
PF in a large longitudinal cohort of WTC responders during an 11-year median follow-up period.
We hypothesized that the intensity of WTC dust exposure is associated with increased risk of PF.
2. Materials and Methods
2.1. Study Population
The World Trade Center Health Registry (Registry) was established in 2003–2004 as an exposure
cohort study designed to monitor the long-term health effects of the September 11 attacks among
rescue/recovery workers and persons who lived, worked, or attended school in lower Manhattan.
The Registry’s methods have been published elsewhere [5,20]. Briefly, in 2003–2004 (enrollment,
Wave 1 survey) over 71,000 people were enrolled and completed a telephone (95%) or in-person
(5%) interview. Participants were identified either through lists provided by employers, government
agencies, and other entities or by responding to an outreach campaign (30% list identified, 70%
self-identified). At enrollment, data on demographics, exposure incurred during and after 9/11,
and health information were collected. Since Wave 1 (W1), three follow-up surveys have been
conducted, in 2006–2007 (Wave 2, W2), 2011–2012 (Wave 3, W3), and 2015–2016 (Wave 4, W4).
Physician diagnosis of PF was first inquired about in W3 and repeated in W4; therefore, only those
who participated in W3 or W4 and completed a question related to PF diagnosis were included in this
study. To test our hypothesis, we focused our study sample on WTC responders, who presumably
experienced more intense dust exposure than those not involved with rescue/recovery. We defined
WTC responders in this present study as those who worked at least one shift at the WTC site providing
rescue, recovery, clean-up, construction, or support services from 11 September 2001 to 30 June
2002, and who provided information related to work and exposure at the WTC site anytime during
the 9 months of rescue/recovery operations. Those younger than 18 years on 11 September 2001
or of unknown age were excluded. The final sample of responders included firefighters, police,
emergency medical services/medical/disaster personnel, construction/engineering workers, affiliated
or unaffiliated volunteers, other government workers, and sanitation workers.
The Centers for Disease Control and Prevention (CDC) and the New York City Department of
Health and Mental Hygiene institutional review boards approved the World Trade Center Health
Registry protocol.
2.2. PF Definition
Self-reported physician-diagnosed PF between 2004 and 2015 was the endpoint of interest. In W3
and W4, we inquired about whether the enrollee had ever been told by a physician that they had PF and
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the associated year of diagnosis. If WTC responders participated in both W3 and W4, the first report
of the year of diagnosis was used, and PF was defined as consistent PF information being provided
on both surveys. If responders participated in W3 or W4 but not both, the year of diagnosis reported
at the respective survey was used. As we only had the year of diagnosis available, the midpoint of
the reported year (June 30) was used as the diagnosis date. To reduce the subjectivity of self-reported
physician-diagnosed PF, we added self-reported shortness of breath in the 30 days prior to reporting
PF to the case definition. Shortness of breath is one of the most common symptoms presented by
PF patients, due to scarring and thickening in the lung tissue. We excluded self-reported PF cases
diagnosed prior to Registry enrollment or 2004 and those participants who had no symptoms of
shortness of breath in the 30 days prior to reporting PF, had missing years of diagnosis, or inconsistent
information on PF diagnosis. Individuals with sarcoidosis were excluded because not all cases of
sarcoidosis are pulmonary and we were unable to differentiate these cases within our study. These
included sarcoidosis identified either from the Registry’s in-depth study through a medical record
review [21], or from the New York State Department of Health’s SPARCS (Statewide Planning and
Research Cooperative System) inpatient data (2000–2015) using ICD-9 diagnosis code 135 or ICD-10
D86. Only 20% of persons with sarcoidosis develop fibrotic lung disease [22], although there has been
a demonstrated association between WTC exposure and sarcoidosis among responders [21,23,24].
2.3. WTC Dust Exposure and Covariates
Physical exposure to dust at the WTC site was based on self-reported WTC exposures that were
collected at enrollment [25]. The WTC dust exposure composite score, developed using a modified
Delphi method, took information on date of arrival, duration of work at the site, dates or time period
working on the pile and being near the WTC site, or exposure to dust/debris resulting from the collapse
of buildings on 9/11 into account. The sum of WTC dust exposure scores for each WTC responder was
analyzed both as a continuous variable (actual sum scores) for trend and as an ordinal scale variable
for analysis of PF risk at each exposure quartile. The latter, based on quartiles of the summed points,
was categorized as: Low (Q1 ≤ 25%), medium (Q2), high (Q3), and very high (Q4 > 75%).
Covariates identified in the literature as potential risk factors were included in the multivariable
analysis, including age, gender, race and ethnicity, income, and smoking status (current, former or
never), which were reported at enrollment. We also examined the prevalence of comorbidities in our
WTC responders by PF status, as some physical and mental health conditions frequently co-exist or
are highly prevalent in persons with idiopathic PF which is the most common type of PF [26]. Medical
conditions were based on self-reports in W3 or W4 of having been told by a medical professional that
the participant had the condition. Conditions included chronic obstructive pulmonary disease (COPD),
diabetes, gastroesophageal reflux disease (GERD), obstructive sleep apnea (OSA), asthma, depression,
anxiety, or post-traumatic stress disorder (PTSD).
2.4. Statistical Analysis
Incident rate of PF by characteristics and WTC exposure were summarized using crude incidence
rates and expressed as PF per 100,000 person-years of follow-up. The association of WTC dust exposure
with time to PF diagnosis was assessed using Cox proportional hazards regression modeling. To test
for proportionality, we assessed time dependent covariates by creating interactions of all predictors and
a function of survival time and included these in the model. We found that “smoking” did not satisfy
the proportional hazard assumption, and therefore, carried out a stratified Cox proportional hazards
regression for the analysis. In the stratified Cox model, “smoking” was controlled by stratification [27].
Results of multivariable analysis were expressed as adjusted hazard ratios (AHR) with 95% confidence
intervals (CI). Person-years of follow-up began on the date of enrollment and ended at the time of PF
diagnosis or were censored on the last follow-up (W3 or W4 survey completion date, whichever was
most recent). All statistical analyses were performed using SAS software (SAS Institute, Cary, NC,
USA V9.4). Two-sided p values of less than 0.05 were considered significant.
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3. Results
Of a total of 29,721 WTC responders, enrolled in the Registry in 2003–2004, 19,300 WTC responders
met eligibility criteria for data analyses. Excluded were those younger than 18 years old on 9/11 or
deceased prior to enrollment (N = 205), non-participants of W3 and W4 (N = 8181), those with missing
reports of PF or year of diagnosis (N = 1172), those with inconsistent reports, missing information on
shortness of breath or pre-2004 PF (N = 837), sarcoidosis (N = 1), or missing data on WTC exposure
(N = 25).
The characteristics of the study sample at enrollment are presented in Table 1. The median age
of responders at enrollment was 41 years (interquartile range, 34–48 years). Responders included in
this study were predominantly male (77.8%), non-Latino white (75.6%), and had an annual household
income ≥$50,000 (70.2%). With respect to smoking status at baseline, the percent of former smokers
was 29.3% among non-Latino whites, 19.9% in non-Latino blacks, 24.6% in Latinos, and 16.4% in
Asians; the percent of current smokers was 15.2% among non-Latino whites, 15.7% in non-Latino
blacks, 17.7% in Latinos, and 15.3% in Asians.
Table 1. Characteristics and World Trade Center (WTC) dust exposure of study sample at enrollment.










Non-Latino white 14,586 75.6













WTC dust/debris exposure level
Quantile 1 (Low) 4772 24.7
Quantile 2 (Medium) 4670 24.2
Quantile 3 (High) 4800 24.9
Quantile 4 (Very high) 5058 26.2
A total of 73 incident cases of PF were reported among 19,300 responders over the study period
between 2004 and 2015, which totaled 199,113.6 person-years. The overall incidence rate of PF was
36.7 per 100,000 person-years. The PF incidence rate was higher in the older age groups, males, Latino
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or Asian, those with low household income, current smokers and those with higher WTC exposure
(Table 2).
Table 2. Incidence rate of self-reported physician-diagnosed pulmonary fibrosis (PF) according to
socio-demographics and WTC dust exposure (N = 19,300).





Total 73 199,113.6 36.7 29.2, 46.1
Age, year
<45 (22–44) 29 107,890.0 26.9 18.7, 38.7
45–64 40 85,721.3 46.7 34.2, 63.6
≥65 4 5502.3 72.7 27.3, 193.6
Gender
Male 61 154,690.0 39.4 30.7, 50.7
Female 12 44,427.5 27.0 15.3, 47.6
Race/Ethnicity
Non-Latino white 45 151,627.3 29.7 22.2, 40.0
Non-Latino black 2 13,788.0 14.5 3.6, 58.0
Latino 17 22,846.3 74.4 46.3, 119.7
Asian 5 4334.8 115.3 48.0, 277.0
Other/unknown 4 6517.1 61.4 23.0, 163.5
Household income ($)
<50,000 22 43,168.1 51.0 33.6, 77.4
≥50,000 46 140,651.4 32.7 24.5, 43.7
Missing 5 15,294.1 32.7 13.6, 78.5
Smoking status
Never 31 112,062.1 27.7 19.5, 39.3
Former 19 55,556.1 34.2 21.8, 53.6
Current 22 30,295.1 72.6 47.8, 110.3
Missing 1 1200.3 83.3 11.8, 591.0
WTC dust/debris
exposure level
Quantile 1 (Low) 8 49,491.8 16.2 8.1, 32.3
Quantile 2 (Medium) 19 48,128.3 39.5 25.2, 61.9
Quantile 3 (High) 18 49,446.7 36.4 22.9, 57.8
Quantile 4 (Very high) 28 52,046.8 53.8 37.2, 77.9
In multivariable analysis, taking socio-demographics into account, we observed an
exposure—response relationship between WTC dust exposure and PF (Table 3) (p for linear trend =
0.004). Compared to those with a low level (Q1) of exposure, approximately 2.5 times as many WTC
responders in the 2nd and 3rd quantiles were experiencing PF, and those in Q4 (the highest level
of exposure) experienced the highest AHR during the follow-up period. AHR at each quartile was
significantly elevated compared to that at the lowest level.
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Table 3. Adjusted hazard ratios (AHR) for self-reported physician-diagnosed pulmonary fibrosis (PF)
according to socio-demographics and WTC dust exposure (N = 19,300).
Variable AHR * 95% CI















WTC dust/debris exposure level
Quantile 1 (Low) referent
Quantile 2 (Medium) 2.51 1.09–5.80
Quantile 3 (High) 2.34 0.99–5.51
Quantile 4 (Very high) 4.51 1.96–10.38
Ptrend for WTC exposure ** 0.0043
* Adjusted for demographic variables. ** Test for dose-response relationship.
Distribution of comorbidity by self-reported physician-diagnosed PF is presented in Table 4.
The prevalence of co-existing physical conditions (e.g., GERD, OSA, asthma, COPD or emphysema,
and diabetes) and mental disorders (e.g., depression, PTSD and anxiety) among PF patients was
significantly higher than it was in those without PF (p = 0.030 for diabetes, and p < 0.001 for all other
conditions). Of these comorbid conditions, GERD (69.4%) and OSA (68.5%) had the highest prevalence
among individuals with PF.
Table 4. Distribution of comorbidity by self-reported physician-diagnosed pulmonary fibrosis (PF)
status *.
Conditions Reported in W3 or W4
PF No. PF
No. % No. %
Physical conditions
Gastroesophageal reflux disease (GERD) 50 69.4 6069 31.7
Obstructive sleep apnea (OSA) 50 68.5 4820 25.2
Asthma 44 60.3 4378 22.9
Chronic obstructive pulmonary disease
(COPD) or emphysema 33 45.8 1406 7.3
Diabetes 15 20.8 2429 12.7
Mental disorders
Depression 39 54.9 4583 26.0
PTSD 34 48.6 3593 20.6
Anxiety 25 36.8 2829 16.3
* Not mutually exclusive. p < 0.001 for all comorbidity listed in the table between two groups, except for diabetes
(p = 0.030).
72
IJERPH 2019, 16, 825
4. Discussion
In this longitudinal WTC exposure cohort of 19,300 responders, a total incidence rate of PF was
36.7 per 100,000 person-years between 2004 and 2015. Although little is reported on prevalence of PF
in general populations, we do know that idiopathic pulmonary fibrosis (IPF), the most common type
of PF, has an estimated prevalence of 14–63 cases per 100,000 population, and incidence of 6.8–17.4
per 100,000 population in the United States, dependent on the case definition [28]. Supporting our
hypothesis, we observed that WTC dust exposure increased the risk of PF in an exposure—response
relationship among WTC responders. AHR at each quartile was significantly elevated compared to
that at the lowest quartile.
4.1. WTC Dust and PF
WTC dust may be a plausible source of PF risk due to its unique characteristics and components
that are known to be linked to PF. Particle size (>90% between 2.5 and 100 μm) of WTC dust can be
inhaled and deposited in the airways and lungs when the airborne concentrations are high [1,29].
Second, the highly alkaline nature of the pulverized building materials can cause both physical and
chemical irritation to the respiratory and gastroesophageal epithelia [1,30]. Third, readily airborne
resuspension can increase surface re-contamination levels of WTC dust both indoors and outdoors [30].
Of the 287 chemicals and chemical groups identified from environmental sampling of the area around
the WTC in New York City [31], asbestos and glass fibers, crystalline silica, various metals, volatile
organic compounds, polychlorinated polycyclic compounds, and polycyclic aromatic hydrocarbons
were included. Some of the chemical toxic components identified from WTC dust, such as heavy
metals (e.g., titanium), silica, asbestos fibers, and wood dust, have been linked to PF [2,32]. Taken
together with early reports of PF among WTC exposed patients [10,11], the unique characteristics of
WTC dust and its toxic components might explain our observed significant exposure—response effect
of WTC dust exposure on PF among WTC responders.
Recently, a review of inflammatory response to inhalation of causative chemicals in WTC was
suggested as a possible mechanism of a link between WTC dust and PF [32]. A dysregulated
inflammatory response can gradually evolve into a pathogenic fibrotic response when inflammation
becomes persistent [33]. Our findings of the association between WTC dust exposure and PF remain to
be confirmed by an in-depth study using clinically confirmed cases over an extended follow-up period.
4.2. Comorbidity in PF
WTC responders with PF had significantly higher pulmonary and non-pulmonary comorbidities
compared with those without PF, aligning with the high prevalence of co-existing physical or mental
health conditions in idiopathic PF (IPF) patients in the literature. Raghu et al., in his review, found
that prevalence of COPD in IPF patients ranged from 6 to 67%, of obstructive sleep apnea from 6 to
91%, of GERD from 0 to 94%, and of diabetes from 10 to 33% [26]. Depression and anxiety are also
reported to be associated with dyspnea and other measures of fibrosis severity [34]; 50% of PF patients
have depression and 30% have anxiety [34]. Consistent with the literature, PF in this study frequently
co-existed with the physical or mental health conditions mentioned above. The comorbidities reported
in responders with PF have also been reported to be significantly associated with WTC exposure among
affected populations either in WTC rescue/recovery workers or local community members [7,30,35,36].
Although 9/11-exposed populations are at high risk for comorbidities [6,9,37], the much higher
prevalence of comorbidities among PF cases than in those without PF further supports the association
between WTC dust and PF observed in this study and warrants further study. Additionally, the
significantly high comorbidity rate among PF patients may have an important clinical impact [26,38].
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4.3. Possible Limitations with Self-Reported PF
Our findings should be interpreted with caution. The nonspecific self-reported
physician-diagnosed PF is a fundamental limitation of this study. Lack of clinical information for
case confirmation, such as high-resolution computed tomography (HRCT) findings, lung function
and serologic tests, raises a concern with regard to the accuracy of PF ascertainment. To help mitigate
the limitation, we defined PF by adding a concurrent symptom of shortness of breath. However,
we do not have data on the severity of shortness of breath in the Registry cases, as this symptom is
generally progressive in PF patients. We were also unable to identify types of PF due to lack of clinical
information; there are over 200 types of PF [12]. Future study using clinical diagnosis of PF is needed
to corroborate our findings.
In this study we observed similar socio-demographic differences that have been reported in the
prevalence of PF, which provides some confidence in the use of self-reported PF. Females, non-Latino
blacks and non-smokers tend to have a lower prevalence of PF than those who are male, of a
non-African origin, and smokers [28,39]. Consistent with the literature, we observed that the PF
incidence rate was lower among non-Latino blacks, and much higher among Latino compared to
non-Latino whites [40]. However, the higher risk for PF among Asians in this study, compared
to non-Latino whites, was not expected and not consistent with findings from other studies [41].
PF among Latino and Asians was significantly associated with WTC dust exposure, independent of
smoking status and other demographics at baseline. Even though smoking is a known risk factor
for PF and varied by race/ethnicity in this study, smoking did not explain our observed association
between WTC dust exposure and PF. Further study is warranted to explain some inconsistent findings
in racial differences in PF.
4.4. Other Potential Biases
Potential attrition bias due to non-response to W3 and W4 may have influenced the observed
results. A previous Registry study by Yu found that compared to W3 participants, non-participants
were younger, more likely to be male, non-white, and to have low household income [42].
The difference in demographics between participants and non-participants is a concern. However,
the non-response to W3 was not associated with WTC exposures (e.g., injury as a result of the 9/11
attacks, witnessing of traumatic events and being caught in the dust cloud on 9/11 morning), or chronic
diseases reported at enrollment (e.g., asthma, emphysema, diabetes and heart disease) [42]. Thus,
attrition bias in our study may be minimal. In addition, knowing that early treatment is crucial to
improve PF prognosis [43], participation in W3 or W4 might have been partly affected by the survival
and severity of the PF condition, which we were not able to assess due to lack of information on
PF treatment.
Some of the WTC responders enrolled in the Registry may also have enrolled in the WTC
Health Program for medical monitoring and treatment. The availability of the WTC Health
Program that provides health monitoring through periodic visits to responders and includes a chest
radiograph [42,44] may have provided increased screening for lung disease to WTC responders
compared to screening provided to those not exposed or the general public, and thus may lead to
potential detection bias. However, such bias would not be expected to differ between those with a
lower exposure level and those with a higher level of exposure, as all WTC responders meet the WTC
Health Program criteria for monitoring.
The development of PF is considered to be multifactorial [45]; environmental or occupational
exposure prior to, or outside of, 9/11 rescue recovery efforts may have contributed to disease
development and progression. Lack of control for potential confounders among responders such as
other occupational exposure, family history, history of viral infections [46] or genetic factors might
bias the observed results. However, data on these potential confounders were not available.
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5. Conclusions
Despite the limitations, this study found evidence of the association between WTC dust and
PF risk among WTC responders, adding evidence to the literature of occupational exposure and
self-reported PF. Specifically, PF may be another 9/11-related health condition among the exposed
population. PF is an uncommon but serious condition that often co-exists with other health conditions
that the 9/11-exposed population is at risk of developing. Awareness and early detection of PF
among at-risk 9/11-exposed populations may slow the progress of the condition by early intervention.
While on-going surveillance of PF is needed, in-depth research using medically-verified cases and
pooled cases from multiple WTC Health Program cohorts (to increase sample size) would help to
better understand the relationship between WTC dust exposure and PF.
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Abstract: Fifteen years after the disaster, the World Trade Center Health Registry (Registry) conducted
The Health and Quality of Life Survey (HQoL) assessing physical and mental health status among
those who reported sustaining an injury on 11 September 2001 compared with non-injured persons.
Summary scores derived from the Short Form-12 served as study outcomes. United States (US)
population estimates on the Physical Component Score (PCS-12) and Mental Component Score
(MCS-12) were compared with scores from the HQoL and were stratified by Post-traumatic Stress
Disorder (PTSD) and injury status. Linear regression models were used to estimate the association
between both injury severity and PTSD and PCS-12 and MCS-12 scores. Level of injury severity
and PTSD history significantly predicted poorer physical health (mean PCS-12). There was no
significant difference between injury severity level and mental health (mean MCS-12). Controlling
for other factors, having PTSD symptoms after 9/11 predicted a nearly 10-point difference in mean
MCS-12 compared with never having PTSD. Injury severity and PTSD showed additive effects on
physical and mental health status. Injury on 9/11 and a PTSD history were each associated with
long-term decrements in physical health status. Injury did not predict long-term decrements in
one’s mental health status. Although it is unknown whether physical wounds of the injury healed,
our results suggest that traumatic injuries appear to have a lasting negative effect on perceived
physical functioning.
Keywords: injury; physical health; mental health; World Trade Center disaster; Short Form-12 (SF-12);
HQoL; 9/11
1. Introduction
The World Trade Center (WTC) disaster on 11 September 2001 exposed thousands of persons to
both environmental pollutants and psychological trauma, which have had long-term physical and
psychological ramifications. Having been injured on 9/11 has emerged as a common risk factor for
both physical and mental health conditions [1–3]. For example, one study found that, among those
injured on the day of the 9/11 disaster, the likelihood of having been diagnosed with a physical
health condition, including respiratory disease problems (i.e., asthma, chronic bronchitis, emphysema)
and/or circulatory disease (i.e., heart attack, angina, stroke) increased with the number of types of
injuries they sustained (e.g., burn, head injury, and musculoskeletal) [4]. Injury on 9/11 also increased
the likelihood of posttraumatic stress disorder (PTSD) 2-fold to 3-fold, which was measured by a
post-traumatic stress checklist (PCL) screening instrument after adjusting for demographic factors and
other WTC-related exposures [2,3]. In addition, physical injury has been reported as a risk factor for
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psychological sequelae among persons directly affected by other disasters, such as Hurricane Ike [5]
and the 2004 Southeast Asia tsunami [6].
In general, among those who experience serious injuries, psychological distress related to anxiety,
depression, or post-traumatic stress disorder (PTSD) can persist for years after the injury [6]. For
instance, in a meta-analysis of the long-term impacts of injuries incurred in motor vehicle crashes,
ranging from serious spinal cord injuries to less life-threatening musculoskeletal injuries, showed that
the injuries had large impacts on psychological distress that, in some cases, increased in magnitude
over time [7].
Serious injuries can also result in increased vulnerability to physical health conditions in the absence
of psychological pathology [8]. This suggests that an injury, in addition to its immediate physical damage,
can have long-term effects on physical health without an intervening psychological factor.
Given that mortality from injury has declined substantially because of treatment advances,
the primary focus for non-fatal injuries currently is the impact of injuries on functionality and quality of
life. For instance, Danish patients injured between 1995 and 2005 were more likely than a non-injured
group of people to experience poor/very poor health [9]. In the Netherlands, from 1999 to 2000,
limitations in mobility, self-care, and the ability to conduct daily activities were self-reported by
severely injured adult patients followed up between 12 and 18 months post-injury [10]. Long-term
declines in overall physical and mental health status following trauma were found in studies in Oslo,
Australia, and the United States (US) using standard instruments (e.g., Short Form 36, Brief Pain
Inventory, and Short Form 12) [11–13]). In the Danish study, Toft observed the effects on overall health
up to 10 years after the injury [9] and for at least 2 years for both physical and mental health when
compared with national norms [12,14]. In most cases, a greater relative decline in physical health
compared with mental health was observed. However, researchers typically do not include in their
assessment the relationship between PTSD and functional health status, especially physical health, nor
do they employ a non-injury comparison group.
A prior qualitative inquiry of persons who sustained an injury on 9/11 found injured persons
reported that their injuries were debilitating and limited daily activities, especially musculoskeletal
injuries that required multiple surgeries with physical therapy [15]. In addition, quality of life and
social integration problems emerged among participants in the study regardless of whether they had a
history of PTSD [15].
This study examines the long-term effects of injury sustained on 9/11, including functional
effects and a comparison group without injury. Based on the findings from the qualitative study,
we hypothesized that the severity of the 9/11 injury would predict deficits in health status for both
physical and mental health domains. We also hypothesized that PTSD history would be sufficient
—but not a necessary factor—in observed long-term detriments in physical and mental health, as
measured by the Short Form-12 (SF-12). In addition, it was hypothesized that the presence of other
factors, such as social support and self-efficacy, would ameliorate the impact of injury and PTSD on
physical and mental health status.
2. Materials and Methods
The World Trade Center Health Registry (Registry) is a prospective cohort that monitors
the physical and mental health of 71,426 persons exposed to the attacks on 11 September 2001.
The populations at risk included rescue/recovery workers who were involved in rescue, recovery,
and disaster clean-up from 11 September 2001 to 30 June 2002. This includes residents who lived
south of Canal Street in lower Manhattan on 9/11, persons who worked and were present south of
Canal Street on 9/11, passersby and others who were occupants of destroyed or damaged buildings
on 9/11, and students who were registered at, or staff employed by, schools located south of Canal
Street. The Registry enrolled 17% of an estimated 409,492 persons in the populations-at-risk identified
by the Registry [16], which varied from 34% of rescue/recovery workers to 11% of passersby. Since the
enrollment survey in 2003–2004 (Wave 1), the Registry has conducted three health surveys: Wave 2 in
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2006–2007, Wave 3 in 2011–2012, and Wave 4 in 2015–2016 (See references 2 and 17 for more detail on
methods and participation) [2,17,18]. The Registry was approved by the New York City Institutional
Review Board and Federal Centers for Disease Control and Prevention (15005).
2.1. Study Sample
From 10 March 2017 to 30 June 2017, the Registry conducted the Health and Quality of Life Survey
(HQoL). Eligibility for this survey included completing all four Registry survey waves, being at least
18 years of age, and speaking English. Two groups were invited by email or mail to participate in the
survey. The first group (n = 2699) included persons who reported on Wave 1 that they sustained one
or more of the following injuries on 9/11: cut, abrasion, or puncture wound; sprain or strain; burn;
broken bone or dislocation; and concussion or head injury. Those who reported “other injury” or “eye
injury” only were not included. The second group (n = 2598) consisted of a non-injured comparison
group of randomly selected persons who did not report any type of injury, including “other injury” or
“eye injury.” The overall participation rate was 76%, with a final sample of n = 2038 for the injury group
and n = 1995 for the comparison group. For the purposes of the current study, we further restricted
the sample to persons who were south of Chambers Street on 9/11/2001 (n = 2583 excluded) and
who inconsistently reported that they were injured or not injured on 9/11 in both the Wave 1 survey
and the HQoL (n = 1185 excluded). This resulted in n = 948 for the injured group and 1818 for the
non-injured comparison of SF-12 outcomes [19].
2.2. SF-12 Outcomes
The HQoL survey included a series of questions referred to as the Short Form Health Survey-12,
Version 1 (SF-12) [20]. The SF-12 was derived from the SF-36 to provide an efficient method for assessing
overall physical and mental health functioning through a mean physical health Component summary
score (PCS-12) and a mean mental health component summary score (MCS-12). The summary scores
are based on combinations of SF-36 questions that were identified as representing overall physical
and mental status and that were highly correlated with the SF-36 overall physical and mental health
summary scores. The SF-12 consists of physical health domains of general health (one question), pain
interferes with functioning (one question), role physical (two questions, less able to perform routine tasks),
and overall physical functioning (two questions). Mental health domains include vitality (one question),
social functioning (one question), mental health (two questions), and role emotional (two questions)
(less able to engage emotionally). Both of the SF-12 summary scores are highly correlated with SF-36
(r = 0.95) and have acceptable test-retest reliabilities (PCS-12 r = 0.89 and MCS-12, r = 0.76) [21].
2.3. Level of Injury Severity
An estimate of the level of injury severity was defined using follow-up questions on the
HQoL questionnaire, which asks about the most serious injury sustained on 11 September 2001.
Four categories were derived for this analysis, which are no injury, low severity, medium severity,
and high severity. Low severity represents persons with superficial injuries not requiring medical
intervention or care based on no reported need for medical care, use of support (e.g., crutch), or
physical therapy. Medium severity applies to persons with injuries that required supportive and
rehabilitative care, such as staying in bed for at least a day, requiring a crutch, or participating in
physical therapy, but did not require using a wheelchair, going to a hospital, or surgery. High severity
indicates that the injury required a hospital emergency department visit, surgery, or a wheelchair
during recovery from the injury. The ‘no injury’ group included persons who reported no type of
injury sustained on 9/11 on both the Registry Wave 1 and HQoL.
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2.4. History of PTSD
We included the presence or absence of probable PTSD based on PCL scores of 44 or greater on
any prior Registry survey waves (2003–2004, 2006–2007, 2010–2011, or 2015–2016). Probable PTSD was
assessed in all Registry survey waves using a 17-item 9/11-specific PCL [22]. The 17 items correspond
to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) PTSD symptoms [23]. Each
stressor-specific item, such as “feeling very upset when something reminded you of the events
of 9/11,” was scored on a 5-point scale for experience of the symptom during the past 30 days
(1 = not at all to 5 = extremely). The PCL score has been shown to have good temporal stability,
internal consistency (>0.75), test-retest reliability (0.66), and high convergent validity [24], with overall
diagnostic efficiency = 0.90, sensitivity = 0.94, and specificity = 0.86 [25].
2.5. Other Covariates
Sociodemographic characteristics of the study sample such as gender, age at time of HQoL survey,
race/ethnicity group, education level, eligibility group (rescue/recovery worker, resident, area worker,
passerby), and marital status were included in the analytical models. Other covariates that have a
potential association with physical and mental health functioning including smoking history (W4),
social support, and self-efficacy were also controlled for in the analysis.
Because low levels of social support are associated with an increased burden of chronic PTSD [26],
we included a measure of social support as a covariate. The presence of social support and/or
self-efficacy described below also has a likely role in faster recovery from injury [27]. The instrument
we used for measuring social support was the Medical Outcomes Study (MOS) Modified Social Support
Survey [28,29]. Respondents were asked a series of questions about their support system, such as:
“Is someone available to take you to the doctor if you need to go?”, “to have a good time with?”, “to
hug you?”, “to prepare your meals if you are unable to do it yourself?”, and “to understand your
problems?” Items were rated on “0” (none of the time) to “4” (all of the time) by the respondent. Out
of a possible sum of 20 for the five questions, persons with scores <17 (median score for the entire
sample) were assigned to a low social support category.
Self-efficacy, which is correlated with emotional health and optimism, was measured using five
questions from the 10-item General Self-Efficacy Scale (GSE) [30]. The items were: “It is easy for
me to stick to my aims and accomplish my goals”, “I am confident that I could deal efficiently with
unexpected events”, “Thanks to my resourcefulness, I know how to handle unforeseen situations”,
“I can remain calm when facing difficulties because I can rely on my coping abilities”, and “No matter
what comes my way, I am usually able to handle it” [31]. The respondent rated each question using
the following scale: 1 = not true at all, 2 = hardly true, 3 = moderately true, and 4 = exactly true. Scores
ranged from 4 to 20 with a score equal to or greater than the median self-efficacy summary score of
17, which was used as the criterion for possessing self-efficacy. A variable representing diagnosed
chronic conditions including asthma, heart disease, gastroesophageal reflux syndrome (GERS), and
other non-neoplastic lung conditions was examined in relation to the outcomes in bivariate analyses.
The variable was not controlled for in analytical models because these could have been on the causal
pathway between injury and physical or mental health functioning [32].
2.6. Statistical Analysis
The primary outcomes of this analysis were physical and mental health summary component
scores (PCS-12 and MCS-12). First, age-standardized mean PCS-12 and MCS-12 scores by gender
and injury and PTSD status were compared with national data obtained from a study of a normative,
non-institutionalized US sample [33]. The HQoL scores of those without injury or PTSD were age
standardized to the age distribution (by 10-year age groups) provided by Hanmer et al., 2006 [33].
Internal comparisons were then done using persons with no injury and no PTSD as a comparison to
persons with injury and no PTSD, persons with no injury and ever PTSD, and persons with injury and
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ever PTSD. Paired t-tests of PCS-12 and MCS-12 means at p < 0.05 level of significance were used to
identify differences in these comparisons.
In addition, mean MCS-12 and PCS-12 scores and standard deviations were calculated for
descriptive results stratified by injury severity levels and PTSD status as well as other covariates
included in this study. Analysis of variance was used to determine if the means for each variable were
significantly different in the bivariate analysis.
Multivariable analysis consisted of linear regression models of PCS-12 and MCS-12 scores with
an injury severity level and PTSD ever and never included as primary predictors, controlling for age at
the time of HQoL survey, gender, race/ethnicity, education, smoking status, eligibility group, marital
status, social support, and self-efficacy. Negative or positive betas represented the amount of change
in the PCS-12 or MCS-12 score relative to the referent for the factor of interest.
Additional analysis was done to assess the interaction between injury severity and PTSD in their
association with PCS-12 and MCS-12 means. A cross-product interaction term for injury severity and
PTSD status was included in linear regression models for PCS-12 and MCS-12. In addition, a composite
variable (variable representing the cross-product term in the regression model) was also created that
combined the four levels of injury severity and PTSD (ever/never) with no injury and never PTSD as
the reference for the following groups: no injury and ever PTSD, low severity injury and ever PTSD,
medium severity injury and ever PTSD, high severity injury and ever PTSD in order to represent the
combined effects of level of injury severity and PTSD.
3. Results
The mean Physical Component Score (PCS-12) for the entire HQoL sample was 43.3. The Mental
Component Score (MCS-12) was 46.6. However, when the means were restricted to the ‘no injury
and never PTSD’ group, they provided an approximate comparison to population-level measures
of PCS-12 and MCS-12 (such as those provided by Hanmer, 2006 [33]), which were based on a US
nationally representative sample (Table 1).
Table 1. Mean PCS-12 and MCS-12 for the US population and mean PCS-12 and MCS-12 for selected
HQoL groups by gender.
Source
Male Female
N PCS-12 MCS-12 N PCS-12 MCS-12
Non-institutionalized US adults * 7463 48.9 52.0 8819 47.0 50.4
HQoL: No injury and never PTSD ** 768 45.5 50.7 589 44.1 49.4
HQoL: No injury and never PTSD *** 768 44.4 52.4 589 43.6 49.7
HQoL: Injury and never PTSD 200 39.8 52.5 95 41.4 48.8
HQoL: No injury and ever PTSD 156 40.8 39.7 198 40.9 39.0
HQoL: Injury and ever PTSD 343 34.8 38.5 263 35.4 36.9
* [33] ** Age standardized based on age distribution from Hanmer, 2006. *** Underlined are Non-age standardized
for a comparison.
Specifically, men in the HQoL ‘no injury and never PTSD’ group had an age standardized mean
PCS-12 of 45.5 compared with 48.9 from Hanmer. For this same group, the age standardized mean
MCS-12 for men from the HQoL study was 50.7 compared to 52.0 in the Hanmer sample [33]. Women
had mean scores that were less than three points different between HQoL and Hanmer for both PCS-12
and MCS-12. The mean PCS-12 for ‘no injury and never PTSD’ for women was 44.1 compared with
47.0 for Hanmer and 49.4 for mean MCS-12 compared with 50.4 based on Hanmer estimates [33].
Within our sample, injury of any severity level without PTSD diminished physical health by
five points for men (PCS-12 mean: 39.8 vs. 44.6, t = 6.6, p < 0.0001 for injury and never PTSD vs.
for no injury and never PTSD, respectively) and two points for women (PCS-12 mean: 41.9 vs. 43.6,
t = 2.2, p < 0.029 for injury and never PTSD vs. for no injury and never PTSD, respectively) (Table 1).
However, injury without PTSD did not produce a significant difference for either men or women for
82
IJERPH 2019, 16, 1054
mean MCS-12 compared with no injury and never PTSD. Among men and women without injuries,
those with PTSD had lower mental and physical health scores than those without PTSD (for men:
PCS-12: 40.8 vs. 44.4, t = 4.8, p < 0.0001, MCS-12: 39.7 vs. 52.4, t = 4.4, p < 0.0001, for women: PCS-12:
40.9 vs. 43.6, t = 3.7, p < 0.0001, MCS-12: 39.0 vs. 49.7, t = 11.9, p < 0.0001). The injury and ever PTSD
group PCS-12 and MCS-12 mean scores for men and women had lower values than the other groups.
Overall, 380 (13.7%) of study enrollees had high severity injuries on 9/11/2001 and 960 (36.8%)
reported symptoms indicative of ever having PTSD (Table 2). Both PCS-12 and MCS-12 mean scores
were lower for persons with more severe injuries (F = 105.6, p < 0.0001 for PCS-12: F = 53.9, p < 0.0001
for MCS-12) and a history of PTSD (F = 271.9, p < 0.0001 for PCS-12: F = 27.7, p < 0.0001 for MCS-12).
Persons with high injury severity had the lowest PCS-12 mean score (37.0) compared with those with
no injury (46.6) and those with ever PTSD had a lower MCS-12 mean score (38.4) compared with those
with never PTSD (51.2).
Table 2. Mean SF-12 Physical Health Component Scores (PCS-12) and mean Mental Health Component









N % Mean SD Mean SD
Total Sample 2766 100 41.3 9.2 46.9 12.1
Injury Severity *
None 1818 65.7 43.6 8.2 48.8 11.2
Low 120 4.3 40.9 10.2 45.6 13.1
Medium 448 16.2 37.0 9.1 42.5 12.7
High 380 13.7 37.0 8.7 42.1 12.8
PTSD **
Ever 960 36.8 37.8 8.8 38.6 11.5
Never 1652 63.2 43.7 8.4 51.2 9.9
Gender
Male 1547 55.9 41.6 9.2 47.9 12.0
Female 1219 44.1 41.7 8.7 45.5 12.1
Age at Injury Survey (Years)
30–44 313 11.3 45.7 6.8 45.6 11.9
45–54 708 25.6 43.0 9.0 45.6 11.9
55–64 935 33.8 40.8 9.2 46.5 12.2
65–99 810 29.3 39.6 8.7 49.1 11.8
Race/Ethnicity
White 2056 74.3 42.1 9.0 47.4 12.1
Black 261 9.4 40.9 8.9 45.6 12.5
Hispanic 264 9.5 39.5 8.9 43.6 11.6
Asian 109 3.9 41.0 8.7 48.1 12.4
Other 76 2.8 40.3 9.1 46.5 11.4
Education at Wave 1
High School or Less 407 14.7 38.5 8.6 45.1 13.1
Some College 566 20.5 39.4 9.1 45.5 12.6
College and Post-Grad 1787 64.7 42.9 8.7 47.7 11.7
Eligibility Group
Rescue/Recovery 626 22.6 38.7 9.6 47.4 12.3
Resident 317 11.5 42.6 8.1 46.5 12.2
Area Worker 1591 57.5 42.6 8.7 47.1 11.9
Passerby 232 8.4 41.6 9.1 44.6 12.5
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N % Mean SD Mean SD
Marital Status at Wave 4
Married/Cohabitating 1873 68.4 42.0 9.0 47.8 11.8
Divorced/Separated/Widowed/Never Married 867 31.6 40.9 8.9 44.7 12.6
Social Support at Wave 4
Low 1191 44.1 40.4 9.2 42.2 12.5
High 1512 55.9 42.6 8.7 50.4 10.5
Self-Efficacy at Wave 4
Yes 1189 43.5 43.3 8.7 52.4 9.8
No 1544 56.5 40.4 9.0 42.5 12.0
Smoking—Wave 4
Current 159 5.8 40.1 9.0 43.4 11.5
Former 853 31.3 41.3 9.0 46.8 12.4
Never 1713 62.9 42.0 9.0 47.3 12.0
Any Chronic Disease—Wave 4 ***
Yes 211 8.6 37.8 9.0 44.2 13.3
No 2241 91.4 42.0 8.9 47.1 12.0
* Severity was missing on 55 individuals due to missing data on medical intervention after injury, ** PTSD checklist
score ≥44 on any prior WTCHR survey, *** Diagnosed chronic conditions included asthma, heart disease, GERS,
and non-neoplastic lung conditions.
With regard to demographic characteristics, the mean PCS-12 and MCS-12 scores for females
were slightly lower than for males (Table 2), which indicates slightly worse physical and mental health
status for females when compared with men. In addition, PCS-12 mean scores decreased with age
(i.e., physical health status worsened with increasing age), while MCS-12 mean scores increased with
age (i.e., mental health status was relatively better with increasing age). Hispanic individuals had
the lowest mean PCS-12 score (39.5) compared with other race/ethnicity groups. Persons with less
than a high school education also exhibited the lowest mean score for PCS-12 (38.5) when compared
with those with a college degree or higher. The same patterns were seen with the mean MCS-12 scores
with the exception of age for which individuals younger than 45 years of age had the lowest mean
MCS-12 score (45.6). Among Registry eligibility groups, rescue/recovery workers had a lower PCS-12
mean score (38.7) relative to other registry groups, but there was no significant difference between the
eligibility groups for MCS-12 mean scores (F = 1.98, p = 0.115). In addition, persons with low social
support and low self-efficacy had lower PCS-12 and MCS-12 mean scores when compared with those
with high social support and self-efficacy.
The estimated betas (β) represent the results of linear regression as either increases or decreases of
PCS-12 and MCS-12 mean scores relative to a reference category for each characteristic after controlling
for other factors (Figures 1 and 2). PCS-12 mean scores were significantly lower for persons with
medium or high severity injuries than for those with no injury (medium severity β = −4.4, 95%
confidence interval (CI), −5.4 to −3.3, high severity β = −4.1 95% CI, −5.2 to −3.0). In contrast,
there was no significant relationship between MCS-12 mean score and injury severity on 9/11 in
multivariable models, which was similar to results from the bivariate analysis.
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Figure 1. Linear regression of PCS-12 (physical health functioning) as a function of injury severity,
PTSD history, demographic, and other factors. The betas are the predicted changes in mean scores
relative to the reference category. Controlled for all variables included in figure. PTSD check list score
≥44 on any prior WTCHR survey.
Persons who had a history of probable PTSD had significantly lower summary scores for both
PCS-12 and MCS-12 when compared with those with no history of PTSD. However, the beta coefficients
for PTSD predicting mental health functioning were three times greater than those for predicting
physical health functioning (β = −9.7, 95% confidence interval (CI) −10.6 to −8.7 for MCS-12 and
PTSD, β = −2.8, 95%, CI −3.6 to −2.0 for PCS and PTSD).
Linear regression estimates of PCS-12 or MCS-12 differences for other factors in Figures 1 and 2
mirrored the results of bivariate comparisons for covariates represented in Table 2. For instance,
persons with more than a high school education had significantly higher PCS-12 mean scores than
those with less than a high school education, but there was no statistically significant relationship
between education and mental health functioning. With regard to eligibility groups, rescue/recovery
workers had significantly lower PCS-12 mean scores relative to residents, area workers, and passerby
groups, but they had a significantly higher MCS-12 mean score (p < 0.001). Other notable findings for
covariates included social support at Wave 4 that was predictive of mental functioning but not physical
functioning, and self-efficacy significantly predicted both physical and mental health functioning.
In addition, smoking history was not associated with PCS-12, but being a former smoker was a
statistically significant predictor of lower MCS-12 mean scores (p < 0.001). Being diagnosed with a
chronic disease prior to the assessment of physical and mental health functioning was not included in
the model because it has been shown to be in the pathway for health, as measured by SF-12 [34]. In a
sensitivity analysis, the inclusion of this measure in the model did not substantively alter the results.
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Figure 2. Linear regression of MCS-12 (mental health functioning) as a function of injury severity,
PTSD history, demographic, and other factors. The betas are the predicted changes in mean scores
relative to the reference category. Controlled for all variables included in the figure. PTSD checklist
score ≥44 on any prior WTCHR survey.
The interaction between the injury severity level and probable PTSD on physical and mental
health functioning was evaluated in a separate linear regression model in which the results are
depicted in Figure 3 (PCS-12) and Figure 4 (MCS-12). Overall, although the interaction was not
statistically significant, the combination of greater injury severity level and having a history of PTSD
were associated with declines in the physical health status. However, injury severity had minimal
influence on the association between PTSD history and mental health status. Specifically, people who
had both a history of probable PTSD and medium or high severity injury had a substantially lower
overall physical health status when compared with those with no injury and no PTSD (Figure 3).
With regard to one’s mental health status, PTSD had a dominant impact on mental health functioning
in comparison with any severity level of injury. Those with a history of PTSD (ever PTSD) had mean
scores of up to 12 points lower when compared with those without PTSD regardless of the injury status
or level (Figure 4).
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Figure 3. Adjusted regression beta coefficients for PCS-12 predicted by a combination of PTSD and the
injury severity level.
Figure 4. A combination of PTSD history and the injury severity level predicted adjusted regression
beta coefficients for MCS-12.
4. Discussion
Based on prior research, we hypothesized that being injured on 11 September 2001 due to
attacks on the World Trade Center would have long-term consequences on quality of life. In this
study, we assessed both physical and mental health functioning using the well validated SF-12 health
status instrument. The assessment demonstrated significant deficits for both the physical and mental
health status among those who were injured on 9/11 and/or those with ensuing PTSD symptoms.
For instance, there was a 7 to 10 point (women and men, respectively) deficit in SF-12 physical health
summary score for those with an injury on 9/11 and no history of probable PTSD compared with
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population-based measures of the physical health status. Moreover, levels of injury severity, as defined
by the degree of medical intervention following the 9/11 injury, had a dose-response association
with a magnitude of the physical health function decrement but no association with mental health
functioning. Thus, being injured on 9/11 is a major risk factor for long-term physical health effects
among those directly exposed to the attacks, which represents a continued impact on a substantial
population of affected persons.
Our finding that injury on 9/11 had an impact on physical functioning 15 years after sustaining an
injury on 11 September 2001 indicates the extent to which an injury can diminish a person’s long-term
capacity to function. Few other studies have assessed the functional health status after this length
of time following an injury even though some have found significant deficits after shorter periods.
For example, one study reported an 80% increased likelihood of reporting poor health among injured
individuals when compared with non-injured individuals five years after the injury occurrence [9].
There are a number of plausible mechanisms for a disaster-related injury to have long-term effects on
physical health. First, the physical damage of the injury could persist as chronic pain and interfere with
normal activity. Second, an injured person may be vulnerable for developing chronic disease, such as
cardiovascular disease, due to inactivity secondary to the injury [1,35]. Third, people who are injured
are more likely to engage in behavioral risks (e.g., smoking, alcohol consumption, or lack of exercise),
which can result in diminished physical health through a number of possible pathways [36]. However,
we did not find an association between smoking and physical health, as measured by PCS-12.
A history of probable PTSD was also the primary factor associated with the decline of both physical
and mental health functioning. Specifically, PTSD had a significant effect on physical functioning with
a three-point decrement in a physical health composite score between those with ever PTSD versus
those with no history of PTSD after controlling for other factors, including injury severity. However,
there was a three-fold greater likelihood of a history of probable PTSD predicting adjusting for injury
severity and other covariates. This is in accord with several studies that have assessed the impact of
mental health stress on overall mental health using SF-12 domain mean scores. For instance, a study
on veterans of the 1991 Gulf War reported a negative correlation between the level of military stressors
and mean MCS, as measured by the SF-12 and Military Service Experience questionnaire [37]. Another
study reported that the mental health checklist scores that assessed the presence of psychological
disorders including PTSD, depression, or general anxiety disorder, which were significantly negatively
correlated with MCS-12 [38].
Other studies have similarly reported that injury impacts physical health more than mental
health [11]. Two explanations are that the presence of comorbid conditions is associated with reduced
capacity for self-care among injured persons [12], or that chronic conditions fully mediate the impact
of 9/11 exposure on physical health status and partially mediate mental health status, as measured by
SF-12 [34]. However, models run in our sensitivity analyses indicated that the regression coefficients
for injury or PTSD were not altered for PCS-12 means, regardless of whether the number of diagnosed
conditions were included in the models, which indicates that a history of the measured chronic
conditions was not necessary for the injury and physical health relationship.
While injury severity was significantly related to a physical health decrement but not mental
health decrement, a history of PTSD increased the likelihood of worse functioning for each level of
injury severity for both physical and mental health. The obverse was evident when injury increased
the PTSD-related decline in mental health.
The findings from a prior qualitative study on the same population represented in this study
suggested that being injured diminished the quality of life both physically and mentally regardless of
PTSD status [15]. By using a much larger sample with standardized measures of physical and mental
health functioning, we did not discern an independent relationship between injury severity and mental
health functioning, but rather that PTSD symptoms were a dominant factor for overall mental health
functioning, as measured by the SF-12.
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Many of the associations between demographic characteristics and other factors (e.g., social
support) with physical and mental health summary scores were similar to those that have been
reported for other populations. For instance, physical health functioning declined with age, but not
mental health status, as exemplified by a mean PCS-12 score of 49 for 30-year-olds to 44-year-olds and
a mean score of 42 for those 65 years and older. Similarly, another study based on a large US national
survey reported a PCS-12 mean score that was −0.85 less than the population norm for 30–39 year
olds and −5.1 for those aged 65 to 69. However, there was an increase by age for MCS-12 mean scores
from −0.12 less than the population norm for those aged 30 to 39 to +2.4 years for those aged 60 to
69 years [39]. Gopinath [14] also reported a −1.5 decline in PCS-12 mean for each additional 10 years
of age, but no change for the mean MCS-12 based on persons with minor musculoskeletal injuries.
With regard to gender, other studies have noted that men have higher mean scores on PCS-12 than
women, but similar mean MCS-12 scores [33,39] consistent with results from this study. Although we
did not specifically evaluate the association between PTSD history for men and women separately with
mental health status, the finding that there were no differences between men and women is surprising
because women generally have higher PTSD rates than men [40,41]
With regard to other factors, Soberg [11] reported a three-fold higher level of physical and mental
health summary scores within a year following injury for those with post-high school education
compared with those with a high school-only education. However, in our study, we did not find a
significant association between the educational level and MCS-12 or PCS-12. Other factors, such as
social support or self-efficacy, were not typically included as factors in studies using PCS-12 or MCS-12.
However, Kiely [42] reported that less social support among injured persons six months after injury
was associated with a mental health deficit, as measured by the MCS-36, but not with physical health,
as measured by the PCS-36. Our study had similar results.
The findings from this study indicate that both PCS-12 and MCS-12 are sensitive to long-term
changes in health status and general health functioning many years after the disaster. The patterns of
association between demographic and socio-behavioral factors concur with the magnitude of change in
the PCS-12 and MCS-12 in various reports based on general population data and in studies specific to
injured persons. The degree to which SF-12 is a strong indicator of health status is evident by the SF-12
having a dose-response relationship to a biologically based assessment of physical health referred to as
a frailty index [43].
This study has several key strengths. First, we were able to assess physical and mental health
status after a much longer period since the original event was compared with other studies. Second,
we had a sufficient sample of persons injured on 11 September 2001 as well as a comparison group
of non-injured persons to assess the combined influence of multiple characteristics longitudinally on
physical and mental health status.
However, the study is also subject to some limitations. First, there is likely self-selection bias on
a number of dimensions. For example, we only included persons who had participated in all of the
registry follow-up surveys. A large proportion of persons in the cohort were also self-selected for
original enrollment in the registry. An assessment of the impact of follow-up survey participation in
the registry found that an increased propensity to participate in surveys was related to an absence of
chronic conditions [17]. However, the overall physical and mental health of those who had no injury
and never had PTSD in this study were not substantively different from the general US population.
Second, we relied on self-report, which is especially problematic for key predictors in this study
including having been injured on 9/11 and probable PTSD. Nonetheless, we defined being injured and
injury severity in a way that minimized the bias of self-report by eliminating persons who provided
inconsistent responses concerning their injury on 9/11 between what was reported at the registry
enrollment survey and what was reported in the HQoL survey. Lastly, we do not have information
on psychiatric conditions or vulnerabilities prior to the 9/11 trauma, which would have permitted
controlling for this factor in the association of PTSD history with physical and mental health status.
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5. Conclusions
In this study, we documented convincing evidence that many persons injured on 11 September
2001 were experiencing diminished physical health 15 years after the event. To put it into context, the
mean PCS-12 score for persons injured without PTSD is comparable to reported mean PCS-12 scores
for those with cerebral aneurysms (39.5) or congestive heart failure (42.8) [44,45]. Given that many
persons who sustained an injury on 11 September 2001 also subsequently suffered from symptoms of
PTSD, we found that, after adjusting for other factors, the combined effect of severe injury with PTSD
yielded significant deficits in both physical and mental health functioning when compared with those
who were not injured and did not experience PTSD. Even though, over the course of years since the
injury, the physical wounds of the injury could have healed in some cases, our results suggest that
traumatic injuries appear to have a lasting effect on perceived physical functioning. The discontinuity
between adequate physical functioning and significantly lower quality of life is a phenomenon that
has been observed among injured persons and could occur in this population [39] even though we do
not have evidence that directly supports this relationship. Nonetheless, the results from this study can
be generalized to the long-term health burden at both the individual and societal level from nonfatal
injuries sustained in natural or man-made disasters.
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Abstract: Background: This study sought to examine whether handgrip strength (HGS), a measure of
muscle strength and a biomarker of aging, was associated with post-traumatic stress disorder (PTSD)
in a cohort of World Trade Center (WTC) responders at midlife. Methods: HGS was assessed utilizing
a computer-assisted hand dynamometer administered to a consecutive sample of men and women
(n = 2016) who participated in rescue and recovery efforts following the World Trade Center (WTC)
attacks and subsequently attended monitoring appointments in Long Island, NY. PTSD symptom
severity and depressive symptoms were assessed using the PTSD specific-trauma checklist (PCL-S)
and the Patient Health Questionnaire (PHQ-9). General linear models were used to examine the
association of WTC-related PTSD with HGS after adjusting for confounders. Results: The sample
was at midlife (mean age = 53.3) when assessed, and 91.3% were men. Nearly 10% of the sample
had probable PTSD (PCL ≥ 44) with concomitant depression (PHQ ≥ 10), while 5.1% had probable
PTSD without depression. Average HGS was 57.4 lbs. (95% confidence interval (95% CI): 56.6–58.1)
among men and 36.1 lbs. (95% CI = 33.8–38.5) among women. Mean HGS of those with probable
PTSD with concomitant depression was lower (45.9 lbs., 95% CI = 43.6–48.2) than responders with
only PTSD (49.1 lbs., 95% CI = 46.0–52.4) and those without PTSD or depression (57.5 lbs., 95% CI
= 56.2–57.8). Subdomain analyses of PTSD symptoms revealed that re-experiencing symptoms at
enrollment (p = 0.003) was associated with lower HGS after adjusting for depressive symptoms
and other confounders. Discussion: Results suggested that higher WTC-related PTSD symptom
severity was associated with lower HGS. Results support ongoing work suggesting that PTSD may
be associated with more rapid physical aging. The potential for developing interventions that might
simultaneously improve physical and mental health in the aftermath of trauma may be considered.
Keywords: 9/11 disaster; handgrip strength; WTC responders; PTSD; depression; aging
1. Introduction
Hand grip strength (HGS) is an indicator of upper body strength that quantifies the amount of
static force with which a person’s hand can squeeze a dynamometer [1]. Often used as a marker of
overall muscular strength, HGS is negatively associated with physical frailty [2]. Diminishing HGS is
IJERPH 2019, 16, 1128; doi:10.3390/ijerph16071128 www.mdpi.com/journal/ijerph93
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associated with muscle wasting and is commonly observed in older age, suggesting that it may act as
a biomarker for aging. Poorer HGS is also associated with increased disability and mortality [3].
In addition to physical health, HGS has shown association with mental health outcomes.
For example, a number of studies examining adults in midlife and older have reported that depressive
symptoms were associated with HGS [4,5], while another study among Australians aged 85 years
and older also found that lower HGS was associated with worse functional, psychological, and social
health [3]. Additionally, higher HGS was shown to be associated with better cognitive performance
among older participants with major depression, and those with bipolar disorder, as well as among
healthy controls [6] and, in a second study maximal HGS was found to be associated with cognitive
performance in the general population, and among those with schizophrenia [7].
Despite associations with a variety of health outcomes, to date no work has examined associations
between HGS and symptoms of posttraumatic stress disorder (PTSD) in individuals who have
experienced a severe trauma. Our recent work has suggested that PTSD may increase risk of cognitive
aging [8] and physical functional limitations [9], suggestive of the potential for more rapid aging.
This study therefore sought to determine whether weaker HGS is also associated with PTSD. Since
PTSD is often comorbid with depression, we further examined whether the association, if any, of HGS
with PTSD was magnified by the presence of depression. Lastly, since PTSD is a heterogeneous disorder,
we further examined whether HGS had differential associations with PTSD symptom domains.
2. Materials and Methods
2.1. Participants and Procedure
The Centers for Disease Control and Prevention, in the year 2002, established a monitoring and
treatment program for those who responded to the World Trade Center (WTC) terrorist attacks of 11
September 2001 by participating in rescue and recovery efforts. Since then, more than 33,000 responders
have enrolled in the WTC general responder population (GRP) [10]. The WTC Wellness Program at
Stony Brook University (SBU) monitors more than 8000 of these responders primarily residing on
Long Island, NY. This SBU cohort is similar in terms of exposure, sex, and age to those enrolled in the
GRP [10], with the majority being males (92.0%), most of them working in law enforcement (71.5%)
during 9/11, with an average age of 38.9 years at the time of the WTC attack. Most SBU responders
(85.0%) have continued to return to either Nassau or Suffolk county clinics within 18 months of their
prior visit.
In 2016, the SBU WTC Wellness program began assessing responders’ HGS as a part of their
functional assessment. The current study includes a consecutive sample of responders (n = 2016) who
were monitored between April 2016 and September 2017. The study was approved by the Stony Brook
University Ethics Review Board (IRB approval No. 604113); responders provided informed, written
consent. In comparison with the SBU population of responders who were eligible for research but did
not complete the functional assessment, those who completed the functional assessment were 0.85
years younger (p < 0.001) and were less likely to be women (p = 0.004), but had similar occupations on
11 September 2001 (p = 0.115), showed similar levels of current PTSD (p = 0.521), and similar baseline
PTSD Checklist (PCL) scores (p = 0.455).
2.2. Assessment of HGS
HGS was assessed for both hands only if responders did not self-report any trouble with their
hands, shoulders, or wrists and if they felt that they would be able to safely complete the assessment.
Vernier dynamometers were administered by trained healthcare providers to measure and record
HGS among responders sitting upright in chairs with arm rests such that their elbow formed close
to a right angle while they squeezed the dynamometer between their thumb and other fingers with
maximum strength for 10 s. Each responder completed two trials for each hand beginning with the left
hand. Force was measured in pounds (lbs.) and recorded in a computer with Logger Pro software
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(Vernier®Software & Technology, Beaverton, OR, USA). The data were exported as. csv files, cleaned
and the maximum HGS was used for this study. The average of two trials were computed, followed by
the average of two hands which was the outcome for this study.
2.3. Assessment of PTSD Symptoms
PTSD symptoms were assessed at each monitoring visit using the PTSD checklist, specific trauma
version tailored to the WTC disaster (PCL-S trauma specific version) [11]. At each monitoring
visit, respondents rated the extent to which they were bothered by 17 DSM-IV WTC-related PTSD
symptoms during the past month on a scale from 1 (not at all) to 5 (extremely). The PCL has
good internal consistency and convergent validity [12]. The total PCL score was used to categorize
respondents into those who had or did not have probable WTC-related PTSD, using a cut-off of
44 [11]. Four PTSD symptom clusters were also analyzed: avoidance, hyperarousal, negative affect
and re-experiencing symptoms.
2.4. Assessment of Depressive Symptoms
Symptoms of depression were measured by the Patient Health Questionnaire with nine items
(PHQ-9). Probable depression was indicated by a PHQ-9 score of 10 or higher. WTC responders
were categorized based on whether they had both probable PTSD and probable depression; probable
PTSD without depression; or neither PTSD nor depression. Depression only group was not considered
because of very few responders who had depression without PTSD symptoms.
2.5. Covariates
A number of variables that could be potentially associated with health and functional status
were considered including age in years at the time of HGS assessment and gender. According to
educational attainment, responders were categorized into those who did not finish high school, those
who graduated high school, those with some college education, those with an undergraduate degree,
and those who have been to graduate school. Race/ethnicity was categorized as non-Hispanic White,
non-Hispanic Black, Hispanic, Asian, and others. Responders were categorized as single, married,
and separated or divorced or widowed depending on their marital status. Current employment status
was given as working full time, working part time, being disabled or on medical leave, retired, and laid
off or unemployed. Annual household income (US$) was categorized as 50,000 or less, more than
50,000 to 70,000, more than 70,000 to 100,000 and higher than 100,000. According to their self-reported
general health, responders had excellent, very good, good, fair, or poor general health. Responders’
self-reported hand-dominance was taken into account to classify them as right-handed, left-handed,
or ambidextrous.
Taking into account the severity of responders’ exposure to the WTC disaster, four exposure
groups—very high, high, intermediate, and low—were created based on the work of Wisnivesky
et al. [13]. The very high exposure group comprised of those who worked more than 90 days at
the WTC site, were exposed to the dust cloud due to the collapse of WTC buildings, and worked at
least some time on the pile of debris. Rescue workers who were exposed to the dust cloud but either
worked on-site less than 90 days or did not work on the debris pile, were categorized to have had high
exposure. Workers with intermediate exposure were exposed to the dust cloud and either worked
between 40 days and 90 days or did not work on the debris pile. Workers in the lowest exposure group
worked less than 40 days on-site, were not exposed to dust from the collapse, and did not work on the
debris pile.
2.6. Statistical Analysis
Descriptive sample statistics, including means and standard deviations of maximum HGS were
computed. Average of two runs from each hand was calculated followed by the average from both
hands. Means and/or proportions were computed for all independent variables and covariates.
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Linear regression was performed to examine bivariate associations of mean HGS with
WTC-related probable PTSD and all other independent variables. Mean HGS were compared between
different levels of each variable and 95% confidence intervals (CI) were computed for the means.
Estimates of regression coefficients and their respective p-values were reported. A two-tailed α = 0.05
was utilized to determine statistical significance. Multivariable general linear models were used to
examine the association of WTC-related PTSD with HGS after adjusting for covariates.
In separate analyses, scores for individual PTSD domains were used to examine whether
re-experiencing symptoms, avoiding situations reminiscent of the WTC event, negative changes
in beliefs and feelings, or hyperarousal symptoms were associated with HGS, after adjusting for
depression (PHQ-9) scores and other covariates.
3. Results
The mean age of the sample was 53.3 (SD: 7.9) years with a range from 35.1 to 85.0 at the time of
their HGS assessment, and 91.3% were men (Table 1).
Table 1. Distribution of handgrip strength (HGS) with independent variables among World Trade
Center (WTC) responders (n = 2023).
Characteristics Mean (SD)/Number (%) Mean HGS (lbs.) (95% CI)
Age in years 53.3 (7.9) 55.5 (54.8–56.3)
Gender
Men 1847 (91.3) 57.4 (56.6–58.1)
Women 176 (8.7) 36.1 (33.8–38.5)
Race/ethnicity
Non-Hispanic White 0 1613 (85.8) 56.2 (55.3–57.0)
Non-Hispanic Black 1 86 (4.6) 50.8 (47.2–54.4)
Hispanic 2 156 (8.3) 52.7 (50.0–55.4)
Asian 3 19 (1.0) 52.6 (44.9–60.3)
Other 4 7 (0.4) 47.9 (35.3–60.5)
Hand dominance
Right 1721 (85.1) 55.4 (54.6–56.2)
Left 208 (10.3) 55.5 (53.1–57.8)
Ambidextrous 94 (4.7) 58.4 (54.9–61.8)
Marital status
Single 107 (5.3) 49.9 (46.6–53.1)
Married 1678 (83.0) 56.1 (55.3–56.9)
Separated/Divorced/Widowed 238 (11.8) 53.8 (51.6–56.0)
Education
Did not finish high school 55 (2.8) 51.6 (47.0–56.1)
Graduated high school 349 (17.8) 53.5 (51.7–55.3)
Some college 935 (47.7) 55.6 (54.5–56.7)
Undergraduate degree 467 (23.8) 57.6 (56.1–59.2)
Graduate school 155 (7.9) 55.0 (52.3–57.7)
Current employment status
Working full time 1153 (57.6) 58.8 (57.8–59.7)
Working part time 147 (7.3) 56.9 (54.2–59.6)
Disabled/on medical leave 106 (5.3) 50.6 (47.5–53.8)
Retired 572 (28.6) 50.1 (48.7–51.4)
Laid off/unemployed 25 (1.3) 51.3 (44.8–57.8)
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Table 1. Cont.
Characteristics Mean (SD)/Number (%) Mean HGS (lbs.) (95% CI)
Annual income (USD)
0 to 50,000 181 (11.7) 54.9 (52.5–57.4)
>50,000 to 70,000 428 (27.7) 55.2 (53.6–56.8)
>70,000 to 100,000 678 (43.9) 56.1 (54.8–57.4)
>100,000 258 (16.7) 56.4 (54.4–58.5)
Level of WTC exposure
Low 331 (18.0) 53.9 (52.1–55.8)
Intermediate 1092 (59.4) 56.1 (55.1–57.1)
High 339 (18.5) 56.2 (54.4–58.0)
Very high 75 (4.1) 53.6 (49.8–57.5)
WTC-related PTSD
Probable PTSD (PCL-S ≥ 44) with
depression (PHQ-9 ≥ 10) 200 (9.9) 45.9 (43.6–48.2)
Probable PTSD without depression 104 (5.1) 49.2 (46.0–52.4)
No PTSD or depression 1719 (85.0) 57.0 (56.2–57.8)
Self-reported general health
Excellent 87 (4.4) 61.4 (57.9–64.9)
Very good 461 (23.1) 59.6 (58.1–61.1)
Good 990 (49.7) 56.7 (55.7–57.7)
Fair 381 (19.1) 49.3 (47.6–50.9)
Poor 75 (3.8) 41.7 (38.0–45.5)
Total numbers vary between variables because only responders with valid response for each variable are included.
The majority (86%) were non-Hispanic White (NHW). The average maximal HGS was 55.5 lbs.
(SD 17.1) with a minimum of 7.5 lbs. and a maximum of 109.0 lbs. There was no significant difference
in HGS and hand dominance. There was a decrease in maximum HGS with increasing age: every year
older age was associated with a decrease in maximum HGS by 0.5 lbs. (p < 0.0001) (Table 3). Women
had mean maximum HGS being more than 21 lbs. lower than men. Among racial/ethnic groups,
non-Hispanic Blacks had significantly lower HGS than NHWs. Those who were on disability or on
medical leave and those who were retired at the time of the study had significantly lower HGS than
those who were working full-time on 9/11/2001. Having fair or poor self-reported general health was
associated with lower HGS than those with excellent health. Mean HGS of responders with probable
PTSD with concurrent depression was 11 lbs. lower (p < 0.0001), whereas mean HGS of responders
with probable PTSD without depression was 8 lbs. lower (p < 0.0001) than those without either PTSD
or depression.






Age in years −0.53 (<0.0001) −0.52 (<0.0001)
Gender
Men Ref. Ref.
Women −21.23 (<0.0001) −21.8 (<0.0001)
Race/ethnicity
Non-Hispanic White Ref. Ref.
Non-Hispanic Black −5.38 (0.04) 0.48 (0.81)
Hispanic −3.44 (0.11) −2.23 (0.15)
Asian −3.58 (0.89) −2.28 (0.53)
Other −8.26 (0.70) −15.74 (0.27)
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Left 0.09 (0.36) −0.71 (0.54)
Ambidextrous 3.00 (0.22) 3.82 (0.05)
Marital status
Single Ref. Ref.
Married 6.25 (0.0007) 0.91 (0.65)
Separated/Divorced/Widowed 3.94 (0.12) 1.46 (0.52)
Education
Did not finish high school Ref. Ref.
Graduated high school 1.96 (0.93) 4.90 (0.06)
Some college 4.06 (0.42) 4.42 (0.08)
Undergraduate degree 6.07 (0.09) 4.59 (0.08)
Graduate school 3.47 (0.69) 3.01 (0.30)
Current employment status
Working full time Ref. Ref.
Working part time −1.84 (0.71) −1.05 (0.51)
Disabled/on medical leave −8.13 (<0.0001) −5.04 (0.02)
Retired −8.72 (<0.0001) −2.17 (0.03)
Laid off/unemployed −7.47 (0.17) −6.41 (0.14)
Annual income (USD)
0 to 50,000 Ref. Ref.
>50,000 to 70,000 0.25 (0.99) 2.55 (0.08)
>70,000 to 100,000 1.18 (0.84) 2.90 (0.04)
>100,000 1.54 (0.78) 4.17 (0.01)
Level of WTC exposure
Low Ref. Ref.
Intermediate 2.17 (0.18) 1.60 (0.15)
High 2.28 (0.31) 2.44 (0.07)
Very high 0.30 (0.99) −3.93 (0.08)
WTC-related PTSD
Probable PTSD (PCL-S ≥ 44)
with depression (PHQ-9 ≥ 10) −11.11 (<0.0001) −5.33 (0.0005)
Probable PTSD without
depression −7.8 (<0.0001) −3.04 (0.14)
No PTSD or depression Ref. Ref.
Self-reported general health
Excellent Ref. Ref.
Very good −1.76 (0.89) −0.86 (0.69)
Good −4.72 (0.08) −1.72 (0.41)
Fair −12.11 (<0.0001) −7.27 (0.001)
Poor −19.65 (<0.0001) −15.52 (<0.0001)
Only responders with non-missing responses for each variable are included. Ref.: Reference category.
In multivariate analysis, being in fair or poor health was associated with lower HGS than those
with excellent health (Table 3). Responders with both WTC-related probable PTSD and depression,
but not those with PTSD without depression, had significantly (p = 0.0005) lower mean HGS than
those without PTSD or depression. Higher age and female gender remained significantly associated
with lower HGS, while race/ethnicity was no longer statistically significant. Mean HGS of those
who were disabled or on medical leave and those retired was significantly lower than those working
full-time. While income levels had no significant relationship in bivariate analyses, multivariable
analysis revealed that HGS of responders with income between US$ 70,000 and 100,000, and those with
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annual income higher than US$ 100,000 were higher by 3lbs. (p = 0.04) and 4 lbs. (p = 0.01) respectively,
in comparison with those earning US$ 50,000 or less. Levels of WTC exposure did not show significant
relationship with mean HGS in either bivariate or multivariate analyses.
Subdomain Analyses
On further examination of the PTSD domains (results not shown in table), higher severity of
re-experiencing symptoms was significantly associated with lower HGS while all other domains
showed no such relationship after controlling for other domains and all other covariates. Increase in
re-experiencing score by one point was associated with a decrease in HGS by 0.45 lbs. (p = 0.0032);
since those with the worst symptom severity have symptom scores 15 or 20 points above those with
no symptoms, this translates into substantial and large differences in HGS.
4. Discussion
Lower HGS, after adjusting for sex, is increasingly seen as a biomarker of aging [5,14–17].
Our study similarly revealed that max HGS was associated with older age, supporting this view.
Additionally, our study revealed that those with probable WTC-PTSD, with and without concomitant
depression had significantly lower maximal HGS than those without either PTSD or depression.
Examining individual PCL domain scores revealed that the re-experiencing symptom cluster was
specifically associated with HGS, a finding that remained significant even after adjusting for covariates
and other PTSD symptoms.
A remarkable finding was that the mean HGS of WTC responders in this study, many of whom
were in the law enforcement and are usually shown to have “healthy worker” effects, is not as high
as might typically be expected. Based on normative data published by Mathiowetz et al., the mean
HGS of adults in the 50–54 year-old age range—the mean age of our sample—was 102–114 lbs. for
men and 57–66 lbs. for women [18]. Among respondents to the Health and Retirement Survey in
2006–2012, the mean HGS of 55–59-year-old men was 38–43 kg or 84–95 lbs., while it was 22–28 kg
or 49–62 lbs. for women [17]. By comparison, the mean HGS was 57.4 lbs. for men and 36.1 lbs.
for women in our sample. Unlike our sample, which comprised of responders with varying degrees
of exposure to the WTC trauma, both of the aforementioned studies involved civilian populations.
Moreover, adjustable-handle Jamar®dynamometer and Smedley®spring-type dynamometer were
used as opposed to the Vernier dynamometer used in our study. Future research needs to examine
whether lower HGS in our cohort can be attributed to their exposure to the traumatic WTC experiences,
and/or due to differences in the instruments used. Our findings should be interpreted with caution,
however, as lower HGS among WTC responders may also be attributed to PTSD-related weakness,
easy fatigability, and neurasthenia, as evidenced from symptoms experienced by war veterans [19].
Our finding of lower maximal HGS among WTC responders with WTC-related PTSD and
depression are along the lines of those reported by Clouston et al. when current PTSD was associated
with a two-fold higher risk of functional limitations as indicated by Short Physical Performance Battery
(SPPB) scores of 9 or lower [9]. Specifically, current PTSD showed strong adjusted associations with
slower walking speeds (<0.8 m/s), slower chair-rise speed (<0.39 rises/s), and balance problems.
Previous research by Keller-Ross and colleagues (2014) found that veterans with PTSD have greater
fatigability as well as greater fluctuations in force exerted by their handgrip muscles [20]. It is possible
that PTSD affects physical functioning and HGS through similar pathways. Furthermore, depending
on their mental health and motivation, not all responders may have exerted adequate effort when
asked to take the HGS test. However, this concern may have been partially addressed as our analyses
took depressive symptoms, in addition to symptoms of PTSD, into consideration. It is notable that of
all the PTSD domains, re-experiencing symptoms emerged as most significantly associated with lower
HGS. This is comparable to prior work where re-experiencing symptoms were found to be consistently
associated with cognitive impairment among WTC responders [8]. Re-experiencing symptoms that
include sudden intrusive memories of the traumatic event, nightmares, flashbacks, and other feelings
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of distress, have been noted to be early markers of mental pathology [21,22]. Findings from our current
study suggest that these symptoms can affect individuals both physically and mentally.
Future research may focus on the association between HGS and PTSD symptoms among
populations with other traumatic experiences. There is some evidence that resistance training can
lead to better cognitive functioning among the elderly through a posited reversal of age-related
deterioration of the brain white matter [23,24]. It will be important to complete the clinical picture
by examining other trauma-related symptoms, including depression. It might be useful to explore
whether HGS improvement may help address some PTSD symptoms, in addition to the existing modes
of management. It is also possible that changes in HGS precede changes in PTSD symptoms or higher
HGS at baseline protects against psychological symptoms, as similar hypotheses have been postulated
for cognitive decline as well. The integrity of white matter has been linked to optimum physical and
mental functioning; therefore, the same underlying mechanisms could predispose responders to lower
HGS as well as PTSD and depression symptoms.
Limitations
This is the first study to examine HGS in a large sample of WTC responders, and the first to
report associations between PTSD and HGS. A key limitation of this study is its cross-sectional nature,
limiting our ability to investigate possible reverse causation. Since we found associations between
PTSD symptoms measured at program enrollment visits, which occurred on average 8–10 years before
HGS was assessed, the potential for reverse causation is greatly reduced. However, the relationship
could be bidirectional, and a potential common pathology that predisposes to both PTSD symptoms
and muscular weakness might be the most valuable take-away from our study. It is, therefore, critical
that future work examine associations between PTSD symptoms and changes to HGS over time.
The generalizability of this study to the general population, given that responders in this study are
residents of Long Island, NY, with a majority being highly educated White males. The WTC responders
were exposed to a very unique event—the 9/11 attacks and its aftermath—which may not result in
similar physical exposures and, therefore, concomitant PTSD complexity, severity, or chronicity that
is similar to symptoms experienced after other traumatic exposures. This study does not, as well,
consider the impact of childhood exposures to stressful events though such events have been found to
worsen mental health [25]. Nevertheless, many of the findings among veterans and healthy adults
from different countries provide similar overall conclusions.
5. Conclusions
This, to our knowledge, is the first study examining the association of HGS with PTSD with
or without coexisting depressive symptoms in a large cohort exposed to a severe traumatic event.
Our finding that PTSD symptoms in general, and re-experiencing in particular, are associated with
lower HGS fifteen years after a significant traumatic event could have clinical implications in the
potential for HGS to be a “biomarker” of aging in the context of severe and chronic PTSD. Furthermore,
and similar to prior findings, this points out to the potential for interventions targeting physical
strength also having a beneficial effect on responders’ mental health, or vice versa.
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Abstract: The health consequences of the 9/11 World Trade Center (WTC) terrorist attacks are well
documented, but few studies have assessed the disaster’s impact on employment among individuals
exposed to the disaster. We examined the association between 9/11-related health conditions and
early retirement among residents and workers who resided and/or worked near the WTC site on
9/11, and the association between such conditions and post-retirement income loss. The study
included 6377 residents and/or area workers who completed the WTC Health Registry longitudinal
health surveys in 2003–2004 and 2006–2007, and the 2017–2018 Health and Employment Survey.
Logistic regression models were used to examine the associations. We found that 9/11-related health
conditions were significantly associated with the likelihood of early retirement. Residents and/or area
workers with more physical health conditions, especially when comorbid with posttraumatic stress
disorder (PTSD), were more likely to retire before age 60 than those with no conditions. For retirees,
having PTSD or PTSD comorbid with any number of physical conditions increased the odds of
reporting substantial post-retirement income loss. Disaster-related outcomes can negatively impact
aging individuals in the form of early retirement and income loss. Long-term effects of major disasters
must continue to be studied.
Keywords: 9/11 impact; retirement; chronic disease; PTSD; disaster; income loss
1. Introduction
Many studies have documented the short-term health impacts of the World Trade Center (WTC)
11 September 2001 attacks, while longer-term observations of various chronic physical and mental
health conditions continue to be reported among individuals exposed to the disaster [1–3]. However,
relatively few studies have assessed the economic impact of the 9/11 attacks. It was noted that
New York City (NYC) earnings at an aggregate level had $2.8 billion losses in the first three months
post-9/11 [4]. For NYC industries, losses ranged from $3.6 to $6.4 billion in the nine months following
the disaster [5]. Despite the well-established association between disaster exposure and impaired health
among the 9/11-exposed population, few studies have examined the economic impact of 9/11-related
poor health. One such study found that during the seven years after 9/11, nearly half of accidental
disability retirements for NYC firefighters were for 9/11-related injuries or illnesses [6]. Another study
conducted by the WTC Health Registry found a significant association between 9/11-related poor
health and early retirement or job loss [7].
Unlike our first published work that focused on the 9/11 economic impact for non-uniformed
rescue and recovery workers [7], this analysis concentrated on retirement and post-retirement
well-being for residents and area workers who resided and/or worked near the WTC site on 9/11.
Previous research showed that different groups of survivors, such as rescue and recovery workers,
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local residents, area workers, passersby, and students and school staff, may have had different
health outcomes, both physical and mental, due to their varying levels of disaster exposure [1,8,9].
Consequently, health-related retirement may also differ for different groups of survivors. Furthermore,
retirement options available to rescue and recovery workers, especially uniformed workers, as
compared to residents and area workers, can be a key factor in making retirement decisions and
must be linked to the subsequent economic outcome [10–13].
Retirement trends were shifting during the mid-1990s into the 2000s irrespective of the effects of
the 9/11 disaster, as fewer people were retiring at younger ages compared to the 1970s and 1980s [14].
Trends of employer pension plans becoming rarer, a healthier population overall, fewer labor-intensive
jobs, less employer-sponsored health benefits for retirees under age 65, and an older full retirement
age for Social Security have resulted in people retiring at older ages than earlier generations [15].
In tandem, retirement patterns have become more complex with many individuals transitioning from
full-time to part-time work or working again after retirement [15]. Early retirement, therefore, is an
important factor to consider for economic assessments, as it can strongly affect one’s well-being (such
as post-retirement income) for the remainder of one’s life.
Poor health has been linked to early retirement in numerous studies for different population
groups or countries. Self-perceived poor health was a risk factor for early exit from the labor force
through early retirement, unemployment, or both [16–20]. Other studies found an association between
a variety of health conditions, such as respiratory, cardiovascular, musculoskeletal diseases, cancer, and
other chronic conditions, and premature labor force exit [16,17,19,21–23]. However, health problems
are not the only factor that impacts decisions about early retirement; one’s financial situation is another
key factor in this decision-making process [24,25]. Experiencing a layoff or having a spouse who
retires early increases one’s likelihood of retiring early whereas being able to take a new job that
requires fewer hours or offers higher pay is protective against retiring early [26]. Multiple studies
have concluded, however, that health, even a subjective assessment of health, is the most important
predictor of early retirement [24–26].
Previous studies of 9/11 health impact showed elevated prevalence of many chronic physical
conditions, posttraumatic stress disorder (PTSD), and physical-mental comorbidity among disaster
survivors [1,9,27–32]. We examined 9/11-related health conditions and PTSD comorbidity in the
current analysis of health’s impact on early retirement. We also went one step further and assessed
whether or not those physically and/or mentally affected by the disaster continued to experience
decline in their well-being after retirement in terms of substantial income loss.
In 2017–2018, the WTC Health Registry conducted an in-depth study on health and employment
for a sub-sample of its enrollees. Detailed information on employment, retirement, health insurance,
and other economic indicators collected from this survey, coupled with detailed health data collected
from the Registry’s longitudinal surveys administered in waves since 2003, provided an opportunity
to further investigate the impact of 9/11-related health on retirement and post-retirement well-being.
As in our previous study [7], the number of 9/11-related chronic physical health conditions and PTSD
were used to measure post-9/11 health status. We hypothesized that the more 9/11-related health
conditions an individual had, the more likely he or she would be to retire before age 60. Furthermore,
for those who had already retired, the number of post-9/11 conditions they suffered was associated
with the degree of their post-retirement income loss.
2. Materials and Methods
2.1. Study Population
The WTC Health Registry maintains a longitudinal cohort that was established in 2002 following
the 11 September 2001 terrorist attacks with the aim of monitoring the long-term health outcomes in
individuals exposed to the events of 9/11 in NYC. In 2003–2004, the Registry enrolled 71,426 rescue or
recovery workers, Lower Manhattan residents, area workers, passersby, and students or school staff
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by conducting its first health survey (Wave 1). Eligible enrollees have since been invited to participate
in three additional health surveys in 2006–2007 (Wave 2), 2011–2012 (Wave 3), and 2015–2016 (Wave 4)
as well as a number of in-depth studies. Previous Registry publications provide a more detailed
description of this cohort [1,8].
From September 2017 to March 2018, the Registry conducted the Health and Employment Survey
(HES) with a sample pool of English-speaking enrollees under 75 years of age (as of 2017) who
completed at least Waves 1 and 2. Enrollees who reported retirement or unemployment due to
disability/health at any of the three follow-up surveys (Waves 2–4) were invited to participate in the
HES study along with a roughly equivalent number of not-yet retired age-matched enrollees. In total,
23,036 enrollees were invited to complete the HES, and the response rate reached 65%. The US Centers
for Disease Control and Prevention (3793) and the NYC Department of Health and Mental Hygiene
(02058) institutional review boards approved the Registry protocol and the HES protocol (17047),
including the use of the data.
This study used data collected from the HES and was limited to those who lived or worked
near the WTC site on 11 September 2001. During analyses, the HES data were merged with the
Registry’s four waves of health survey data to obtain 9/11-related health information for the study
sample. We excluded 341 enrollees who had retired before the 9/11 disaster, as our focus was on the
link between 9/11-related health and retirement. The final study sample was 6377 enrollees, which
included 3486 retired and 2891 not-yet-retired enrollees. Of the 3486 retirees, 1234 retired before age 60,
2143 retired at or after age 60, and 109 did not report time of retirement. Additionally, 2395 enrollees
reported post-retirement income loss.
2.2. Study Outcomes: Early Retirement and Post-Retirement Income Loss
In the HES, enrollees were asked if they were currently retired and, if retired, for the month and
year of retirement. This information was used to calculate retirement age. In the analytical model,
a dichotomous outcome variable was created for early retirement which was defined as having retired
before reaching the age of 60.
Those self-reporting retirement in the HES were also asked if their total post-retirement personal
income after taxes changed as compared to pre-retirement and in which direction; if they responded
that their income had decreased, a follow-up question asked for the percentage of decrease (<25%, 25%
to 50%, >50%). A dichotomous outcome variable for post-retirement income loss was created for those
who reported substantial income loss which was defined as having over 50% of income decrease.
2.3. Chronic Physical Health Conditions and PTSD Measure
Starting in Wave 1, Registry enrollees were asked in each of the follow-up wave surveys whether
they had ever been told by a doctor or other health professional that they had any of more than a dozen
listed health conditions and the year of first diagnosis if diagnosed. For this study, asthma, heart disease
(coronary heart disease, angina, heart attack, or other heart disease), stroke, lung disease (emphysema,
chronic bronchitis, reactive airways dysfunction syndrome, sarcoidosis, pulmonary fibrosis, or other
lung disease), diabetes, gastroesophageal reflux disease, and autoimmune disease (multiple sclerosis or
amyotrophic lateral sclerosis, rheumatoid arthritis, or other autoimmune disease) were selected, as all
have been reported to be elevated among 9/11 exposed individuals [27,33–39]. If an enrollee reported
a diagnosis for any of the seven selected types of conditions in or after 2001, we categorized them as
having a 9/11-related chronic physical health condition. Probable PTSD was assessed at every wave
of the Registry survey via a 9/11-specific PTSD Checklist-Civilian Version (PCL-17) scale. A cut-off
score of 44 or greater at any wave was used to define probable PTSD as in prior published Registry
studies [1]. Co-occurrence of any of the seven selected types of physical conditions and probable PTSD
was then defined as 9/11-related physical–mental comorbidity in this study.
The total number of chronic physical conditions, comorbid with PTSD or not, was used as the
health indicator in the analytical models.
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2.4. Sociodemographic Characteristics and Other Covariate Measures
Sociodemographic characteristics of the study sample were measured by sex, age at 11 September
2001, race/ethnicity, household income, education, and marital status. A quantitative 9/11 exposure
measure was also included in the analysis as it is closely associated with PTSD [1]. The exposure
measure combines disaster information, such as dust cloud exposure, injury, witnessing horror,
bereavement, and home evacuation experience, collected from both Waves 1 and 2 into a 12-item score
that was collapsed into four categories: 0–1 as no/low exposure, 2–3 as medium, 4–5 as high, and six
or greater as very high exposure.
2.5. Statistical Analyses
Two logistic regression models were used to calculate the adjusted odds ratio (AOR) and 95%
confidence intervals (95% CI) to measure the association between 9/11-related health conditions and






= β0 + β1X1 + β2X2 + · · ·+ βkXk (1)
where p is the probability of our outcome occurring, β0 is the intercept, β1, . . . , βk are the regression
coefficients, and X1, . . . , Xk are the predictors or covariates included in the model (described above).
The adjusted odds ratio was estimated by taking the exponential of the regression coefficients in
the model.
The first model included 4125 non-retired enrollees and early retirees, and aimed to demonstrate
the relationship between poor health (measured by the number of 9/11-related health conditions with
and without PTSD) and the likelihood of retiring before age 60, while adjusting for sociodemographic
factors and disaster exposure.
The second model included 2395 enrollees who reported income loss after retirement and
investigated the association between 9/11-related health conditions and substantial post-retirement
income loss while adjusting for disaster exposure and all sociodemographic characteristics included in
the first model except for age at 11 September 2001. Even though post-retirement income decreases
are common and subject to lower tax rates and less work-related expenses [40], this analysis aimed
to reveal that substantial income decrease (percentage of decrease larger than 50%) was associated
with health.
The analyses for this study were conducted in SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
3. Results
Among 4125 residents and area workers who lived or worked near the WTC site on 9/11, 1234
(29.9%) reported having retired before age 60 (Table 1). Sociodemographic characteristics that were
significantly associated with early retirement included age, race/ethnicity, total household income,
marital status, and education. Not surprisingly, younger enrollees were less likely to report that
they had retired under age 60, as they may have not yet retired at all. Compared to non-Hispanic
white residents and area workers, non-Hispanic black and Hispanic residents and area workers
both had higher odds of reporting early retirement (AOR = 1.7, 95% CI: 1.3–2.1; AOR = 1.3, 95%
CI: 1.0–1.7). Enrollees who were in the three higher household income groups ($50,000–<$75,000,
$75,000–<$150,000, and ≥$150,000) each had higher likelihoods of experiencing early retirement. Those
in the highest income group (≥$150,000) were more than twice as likely as those in the lowest income
group (<$25,000) to have early retirement (AOR = 2.2, 95% CI: 1.5–3.2). On the contrary, the likelihood
of reporting early retirement dropped by about 40% (AOR = 0.6, 95% CI: 0.4–0.7) and 70% (AOR
= 0.3, 95% CI: 0.3–0.4), respectively, for those with a college or post-graduate degree compared to
those with high school and below education. Enrollees who were widowed had a higher likelihood of
experiencing early retirement compared to those who were married or living with a partner (AOR =
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1.5, 95% CI: 1.0–2.3). Sex and 9/11-related disaster exposure did not show significant association with
early retirement for residents and area workers.
Table 1. Early retirement, chronic physical health conditions and post-traumatic stress disorder (PTSD)
comorbidity, and other characteristics among non-retired and early retired enrollees.
Sample Characteristics
Retirement Status Likelihood of Early
RetirementNot Retired (N, %) Retired Early (N, %)
2891 70.1 1234 29.9 AOR a 95% CI b
Sex
Female 1481 68.1 693 31.9 Ref
Male 1410 72.3 541 27.7 1.0 0.8, 1.1
Age on 9/11
0–24 31 93.9 2 6.1 0.1 0.0, 0.6
25–44 1089 79.1 287 20.9 0.5 0.4, 0.6
45–64 1771 65.2 945 34.8 Ref
Race/ethnicity
Non-Hispanic white 2085 72.1 805 27.9 Ref
Non-Hispanic black 304 59.3 209 40.7 1.7 1.3, 2.1
Hispanic 253 64.4 140 35.6 1.3 1.0, 1.7
Non-Hispanic Asian 155 77.9 44 22.1 0.9 0.6, 1.3
Other race or multi-racial 94 72.3 36 27.7 0.9 0.6, 1.4
Total household income in 2002, $
<25,000 167 72.3 64 27.7 Ref
25,000 to <50,000 473 70.0 203 30.0 1.1 0.8, 1.6
50,000 to <75,000 477 68.3 221 31.7 1.6 1.1, 2.3
75,000 to <150,000 924 71.2 373 28.8 1.6 1.1, 2.3
≥150,000 564 71.4 226 28.6 2.2 1.5, 3.2
Education
High school diploma or lower 335 54.1 284 45.9 Ref
Some college or college graduate 1583 70.0 677 30.0 0.6 0.4, 0.7
Post-graduate 964 78.2 268 21.8 0.3 0.3, 0.4
Marital status
Married or living with partner 1852 69.8 803 30.2 Ref
Divorced or separated 415 69.5 182 30.5 0.9 0.7, 1.1
Widowed 57 53.8 49 46.2 1.5 1.0, 2.3
Never married 552 74.1 193 25.9 0.9 0.7, 1.2
Disaster exposure
Low/none 630 70.6 262 29.4 Ref
Medium 1264 70.9 520 29.1 0.9 0.8, 1.1
High 784 70.8 323 29.2 0.8 0.7, 1.1
Very high 213 62.3 129 37.7 1.1 0.8, 1.5
Number of chronic conditions c without PTSD
0 1289 76.8 390 23.2 Ref
1 527 68.7 240 31.3 1.5 1.2, 1.8
2 193 67.2 94 32.8 1.4 1.1, 1.9
≥3 61 59.8 41 40.2 1.9 1.2, 3.0
Number of chronic conditions c with PTSD
0 324 73.6 116 26.4 1.2 0.9, 1.6
1 238 65.2 127 34.8 1.7 1.3, 2.2
2 153 57.1 115 42.9 2.5 1.9, 3.4
≥3 106 48.8 111 51.2 3.4 2.4, 4.7
a AOR: Adjusted odds ratio and was adjusted for all factors listed in this table. b 95% CI: 95% confidence interval.
c Chronic physical health conditions include asthma, heart diseases, stroke, lung diseases, diabetes, gastroesophageal
reflux disease (GERD), and autoimmune diseases.
Having chronic 9/11-related physical health conditions without PTSD was found to be
significantly associated with early retirement in a dose-response manner with the odds of reporting
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early retirement increasing as the number of conditions increased (AOR = 1.5, 95% CI: 1.2–1.8; AOR =
1.4, 95% CI: 1.1–1.9; AOR = 1.9, 95% CI: 1.2–3.0 for those with one, two, and three or more conditions
without PTSD, respectively) (Table 1). When chronic physical conditions were comorbid with PTSD,
the likelihood of experiencing early retirement increased further and also in a dose-response manner.
For example, for residents or area workers who had three or more 9/11-related physical conditions
and PTSD, their odds of reporting early retirement were more than three times higher than those
who did not have any of the selected conditions or PTSD (AOR = 3.4, 95% CI: 2.4–4.7). Interestingly,
having PTSD alone did not significantly increase one’s odds of early retirement as compared to those
who did not have any physical conditions (AOR = 1.2, 95% CI: 0.9–1.6). To test the robustness of the
association of 9/11-related health and early retirement, we performed a sensitivity analysis using an
Ordinary Least Squares model by replacing the dichotomous early retirement outcome variable with
a continuous variable measuring actual age at retirement. Our results showed findings consistent with
the early retirement model results: The coefficients for enrollees who suffered one, two, or three or
more physical conditions comorbid with PTSD (coefficients = −1.82, −2.89, and −2.92, respectively,
and all with p < 0.0001) were all significant with the retirement age decreasing by an average of
two to three years compared to those who did not have any 9/11-related chronic conditions (results
not shown).
Approximately 73% of retirees in the study sample reported that their post-retirement income
had decreased as compared to their pre-retirement income, while 19% reported no significant income
changes, and 8% reported increased post-retirement income. Although post-retirement income loss
seemed to be a norm for retirees regardless of their retirement age, among those who reported decreased
income, a significantly higher proportion (45.9% vs. 33.7% in Table 2) of early retirees reported an
income decrease of more than 50% (p < 0.0001). Because of the significant association of 9/11-related
poor health and early retirement demonstrated in Table 1, we further tested if 9/11-related poor health
was directly linked to retirees’ post-retirement financial status.
Table 2. Percentage of post-retirement income loss among retirees reporting decreased income.
Retirement Age (Years)
Post-Retirement Income Loss, % Total, N
≤50% (N = 1437) >50% (N = 889) 2326
<60 54.1 45.9 859
≥60 66.3 33.7 1467
Table 3 presents results on the association between 9/11-related health and the likelihood of
having more than 50% of income decrease after retirement among enrollees who reported decreased
income. Only three sociodemographic characteristics were associated with substantial post-retirement
income loss: race/ethnicity, total household income, and education. More specifically, non-Hispanic
black residents and area workers were 30% less likely to report income loss greater than 50% as
compared to non-Hispanic white residents and area workers (AOR = 0.7, 95% CI: 0.6–1.0). Other
racial/ethnic groups did not show significantly higher or lower odds of experiencing substantial
income loss compared to non-Hispanic whites. Compared to the lowest income group (<$25,000),
the three middle income groups ($25,000–<$50,000, $50,000–<$75,000, and $75,000–<$150,000) were
less likely to have substantial income loss (AOR = 0.5, 95% CI: 0.3–0.8; AOR = 0.6, 95% CI: 0.3–0.9;
AOR = 0.6, 95% CI: 0.4–1.0, respectively); however, the highest income group (≥$150,000) did not
show significantly higher or lower odds of experiencing substantial income loss. Enrollees with some
college experience or a college degree had a significantly higher likelihood of substantial income
loss compared to enrollees with lower education attainment (AOR = 1.2, 95% CI: 1.0–1.6). Each
level of 9/11-related disaster exposure was highly associated with post-retirement income loss in
a dose-response manner. The highest level of exposure increased the odds of having substantial income
loss by 2.5 times compared to those with little or no exposure (AOR = 2.5, 95% CI: 1.7–3.6).
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Table 3. Post-retirement income loss, chronic physical health conditions and post-traumatic stress
disorder (PTSD) comorbidity, and other characteristics among retirees reporting decreased income.
Sample Characteristics
Post-Retirement Income Loss more than 50% Likelihood of Substantial
Income LossNo (N, %) Yes (N, %)
1469 61.3 926 38.7 AOR a 95% CI b
Sex
Female 787 63.3 456 36.7 Ref
Male 682 59.2 470 40.8 1.0 0.8, 1.2
Race/ethnicity
Non-Hispanic white 990 59.1 685 40.9 Ref
Non-Hispanic black 234 69.6 102 30.4 0.7 0.6, 1.0
Hispanic 145 66.5 73 33.5 0.8 0.5, 1.1
Non-Hispanic Asian 57 58.8 40 41.2 1.1 0.7, 1.7
Other race or multi-racial 43 62.3 26 37.7 1.0 0.5, 1.7
Total household income in 2002, $
<25,000 46 47.9 50 52.1 Ref
25,000 to <50,000 255 68.5 117 31.5 0.5 0.3, 0.8
50,000 to <75,000 280 67.3 136 32.7 0.6 0.3, 0.9
75,000 to <150,000 499 64.4 276 35.6 0.6 0.4, 1.0
≥150,000 226 48.3 242 51.7 1.3 0.8, 2.1
Education
High school diploma or lower 299 65.9 155 34.1 Ref
Some college or college graduate 780 60.0 521 40.0 1.2 1.0, 1.6
Post-graduate 380 60.8 245 39.2 1.0 0.8, 1.4
Marital status
Married or living with partner 961 60.7 623 39.3 Ref
Divorced or separated 236 59.9 158 40.1 1.2 0.9, 1.6
Widowed 66 71.0 27 29.0 0.7 0.4, 1.1
Never married 195 63.1 114 36.9 1.0 0.8, 1.4
Disaster exposure
Low/none 362 71.7 143 28.3 Ref
Medium 653 63.6 373 36.4 1.4 1.0, 1.7
High 360 55.8 285 44.2 1.7 1.2, 2.2
Very high 94 42.9 125 57.1 2.5 1.7, 3.6
Number of chronic conditions c without PTSD
0 546 65.7 285 34.3 Ref
1 316 64.6 173 35.4 1.1 0.9, 1.5
2 129 68.6 59 31.4 0.9 0.6, 1.3
≥3 59 62.8 35 37.2 1.4 0.9, 2.2
Number of chronic conditions c with PTSD
0 118 53.2 104 46.8 1.7 1.2, 2.5
1 114 53.0 101 47.0 1.8 1.2, 2.5
2 104 55.9 82 44.1 1.6 1.1, 2.3
≥3 83 48.8 87 51.2 1.9 1.3, 2.7
a AOR: Adjusted odds ratio and was adjusted for all factors listed in this table. b 95% CI: 95% confidence interval.
c Chronic physical health conditions include asthma, heart diseases, stroke, lung diseases, diabetes, gastroesophageal
reflux disease (GERD), and autoimmune diseases.
Substantial post-retirement income loss was also significantly associated with the number of
9/11-related health conditions but only for those who suffered from PTSD alone or PTSD comorbid
with physical conditions. In other words, enrollees without PTSD who only had chronic physical
health conditions did not have higher odds of losing more than 50% of their income post-retirement
compared to those who had no health conditions. Once enrollees had PTSD, their likelihood of having
substantial income loss increased significantly as compared to those without any health conditions
(e.g., AOR = 1.7, 95% CI: 1.2–2.5). PTSD comorbid with one or more physical health conditions had
a similar effect on enrollees’ odds of experiencing substantial income loss as PTSD alone.
109
IJERPH 2019, 16, 1177
4. Discussion
The impact of the 9/11 disaster on early retirement and post-retirement well-being among
survivors has rarely been studied until now. This study examined the association of 9/11-related
health and early retirement for residents and area workers who resided and/or worked near the
WTC site on 9/11. Furthermore, we assessed the longer-term impact of 9/11-related health on
post-retirement income loss among survivors.
Sixteen years after the 9/11 disaster, among the 3486 retired residents and area workers in our
study sample, about 35% had retired before reaching 60 years of age. Early retirement was found to
be significantly associated with chronic 9/11-related physical health conditions in a dose-response
manner, and a sensitivity analysis estimating the magnitudes of the effects in terms of years of work
lost found consistent results. More specifically, the likelihood of reporting early retirement versus
not-yet retired grew as the number of physical health conditions increased. The odds of reporting
early retirement increased further when these conditions were comorbid with PTSD but not when
PTSD was reported in the absence of any 9/11-related physical conditions. These findings suggest
that residents or area workers who suffered from 9/11-related PTSD but not other chronic physical
conditions were not more likely to retire early due to this mental health condition alone; several
explanations may clarify this. One reason is that PTSD may not severely impact daily working life,
especially if the PTSD is mild. Only 6% of the early retirees in this study sample reported having
Accidental Disability Retirement (ADR), a benefit available to members of certain plans if they become
permanently physically or mentally incapacitated and are unable to perform the duties of their job due
to an accident that took place on the job [41]. The percentage of early retirees with ADR and PTSD
but no other chronic condition is even lower (4%), which suggests the proportion of enrollees with
severe PTSD alone is low. Another potential reason is that stigma associated with a mental health
condition such as PTSD may prevent one from recognizing the condition, let alone coping with it by
retiring early.
Despite the fact that PTSD alone did not show a significant association with reporting early
retirement, this study found that residents and area workers with PTSD alone or PTSD comorbid with
any number of physical conditions were significantly more likely to experience substantial income
loss post-retirement. PTSD comorbid with one or more physical health conditions had a similar
effect, in terms of significance and magnitude, on the odds of experiencing substantial income loss as
PTSD alone. Having any number of physical conditions (including three or more conditions) in the
absence of PTSD was not significantly associated with substantial post-retirement income loss, which
suggests PTSD is the key and driving factor in this association. The economic impact of 9/11-related
PTSD, although not directly reflected in the form of early retirement, tended to be stronger in the
long-term as individuals suffering PTSD were less likely to assume income-generating activities that
could ultimately lead to significant income loss. Like having PTSD alone, disaster exposure did not
show a significant association with early retirement but was highly related to post-retirement income
loss. The absence of exposure’s effect in the model for early retirement is likely a result of having the
9/11-related health measure in the same model absorbing its effect. We re-ran our model for Table 1
without the health measure and found that disaster exposure at a very high level was significantly
associated with 50% higher likelihood of early retirement (AOR = 1.5, 95% CI: 1.1–2.0, results not
shown) compared to those who had low or no exposure during the disaster. This finding implies that
the health measure we chose for this study represented the impact of this disaster well. A closer look
at the data suggested that enrollees in the highest category of the 9/11 exposure scale were most likely
to have suffered PTSD or PTSD comorbid with physical health conditions (results not shown) which
made their comparable associations with the two outcomes unsurprising.
Similar to the findings in our earlier study [7], those with higher household income or lower
education were more likely to report early retirement than staying in the labor force as compared
to the low income group or higher education achievers. This seemingly contradictory impact of
high income and low education reflects the complexity of the retirement decision-making process.
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For residents and area workers with 9/11-related poor health, having a higher income may have
allowed them to voluntarily retire early or made them more likely to afford early retirement without
considerable additional financial concern compared to having a lower income. On the other hand, the
early retirement decision for the lower education group was less likely to be a “choice”, as their low
education (usually accompanied with low income) and poor health may not have allowed them to
maintain their work, especially when the work was more physical or manual in nature. The association
of lower socioeconomic status and higher risk of involuntary labor force exit was also found in previous
studies [42,43].
This study provided evidence of a strong association between 9/11-related poor health and early
retirement among survivors who lived and worked near the WTC site. Furthermore, with additional
information collected from the HES, we demonstrated, for the first time, the significant impact of
9/11-related PTSD and 9/11-related physical–mental comorbidity on substantial post-retirement
income loss. Our findings suggest that after labor force exit, poor health, especially PTSD,
continued to adversely affect survivors’ overall well-being in the form of considerable income
reduction. The compromised post-retirement well-being as a result of poor health did not come
as a surprise because many of the affected people could have involuntarily experienced early
retirement before securing their full retirement benefits; or, they might be less likely to participate in
any income-generating activities, particularly if they experienced mental health or physical–mental
comorbidity issues after retirement. This lasting effect of poor health, along with the fact that certain
race/ethnicity (Hispanic and non-Hispanic black) and low education groups are more likely to retire
early, should direct future 9/11-related resources by placing a greater focus on limiting sharp income
loss and providing adequate and affordable health care services to retirees from various vulnerable
groups to maintain a certain level of quality of life.
One notable advantage of this study is that we directly assessed the relationship between
9/11-related health and post-retirement income loss using statistical modeling. This investigation
provides the first look at one aspect of survivors’ well-being beyond retirement and will lead to
additional exploration of the economic impact of 9/11, such as the relationship between substantial
income loss and worsening health and its associated high medical cost, poor health reducing survivors’
ability to re-enter the workforce to compensate for post-retirement income loss, and how survivors’
retirement plans directly affect their post-retirement well-being. In addition, future research should also
assess other aspects of post-retirement well-being such as retirees’ current health status or health-related
quality of life (as in an ongoing study by our group) and insurance coverage. These results will not
only give us a broader picture of retirees’ overall well-being but also help estimate the realistic gap on
health care access in terms of making policy recommendations.
5. Conclusions
This study found that 9/11-related health conditions were significantly associated with the
likelihood of early retirement among residents and area workers who survived the 9/11 attacks.
The likelihood of reporting early retirement increased as the number of health conditions increased.
Having PTSD alone was not associated with early retirement; however, PTSD was the driving factor out
of all 9/11-related health conditions studied that was linked to substantial income loss post-retirement.
For future studies of 9/11 economic impact, our findings emphasize the key role that PTSD may play
in the longer-term.
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Abstract: The World Trade Center (WTC) Environmental Health Center (EHC) is a treatment program
for community members with exposure to the 9/11 terrorist attack and its physical and emotional
aftermath. Compared to the general responders program, the WTC EHC is diverse with equal gender
distribution, representation of many races and ethnicities, and a wide range of social economic
status. Patients in the WTC EHC were initially enrolled for physical symptoms, most of which were
respiratory, however a large portion of the enrollees scored positive for probable posttraumatic stress
disorder (PTSD). In this paper we identify patient characteristics associated with probable PTSD.
We also determine the characteristics associated with the longitudinal change of PTSD symptoms,
including persistence and remittance, using the widely used Posttraumatic Check List-17 (PCL)
cut-off value of 44, as well as changes in PCL total score and symptom cluster scores in patients of
Low and High PTSD symptom severity. Few patients with elevated scores achieved a score below 44.
However, longitudinal improvement in PCL score at follow-up was identified for patients with High
PTSD scores (PCL > 57.5). Changes in PCL symptom clusters differed between those with High and
Low PCL scores. These data suggest improvement over time in PCL score that differs depending on
the severity of the score and variable responses in the PCL symptom clusters.
Keywords: PTSD symptom change; PCL score; longitudinal analysis; PTSD cluster; WTC survivors;
9/11 disaster
1. Introduction
The terrorist attack on the World Trade Center (WTC) on 11 September 2001 resulted in a vast
environmental disaster with the collapse of the WTC towers. Local community members and first
responders had potential for both acute massive dust inhalation from the dust clouds created as
the WTC buildings collapsed (WTC dust cloud), as well as chronic inhalation and topical exposure
from re-suspended dust and fumes from the fires that burned for months [1–4]. Exposed community
members include local residents, local workers, school children, and those passing by as tourists
or commuters. Well-described adverse medical health effects in this population include persistent
lower respiratory symptoms (LRS) [5–11]. Many of these community members witnessed destruction,
death and dismemberment and often experienced fear of their own death as they escaped collapsing
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buildings or engulfment by blinding dust clouds. Some individuals were exposed to extended rescue
and recovery efforts, or displacement from homes and workplaces due to clean up efforts of damaged
or contaminated buildings. Well-described mental health symptoms in the community include those
associated with posttraumatic stress disorder (PTSD), depression, and anxiety [6,12,13].
The World Trade Center Environmental Health Center (WTC EHC) was established to treat and
monitor the health conditions of community members that resulted from exposure to the event and its
aftermath [14]. The initial funding of the program limited inclusion in the treatment program to those
with physical symptoms [4,11]. As a result, patients with exposure-based mental health symptoms
but no physical symptoms were not eligible for enrollment in the treatment program during its initial
years. Despite this, from the program’s beginning, the Initial and Monitoring visit evaluations included
assessment of both physical and mental health symptoms.
We have previously described mental health symptoms in the WTC EHC population [13]. We now
report the longitudinal change of PTSD symptoms in our original cohort who self referred for physical
complaints. Our goal was to identify factors associated with persistent or remitted PTSD symptoms
over two time points including demographic characteristics, WTC exposures and baseline severity of a
PTSD screening instrument score. We also examined differences among changes in symptom clusters
consistent with PTSD heterogeneity.
2. Methods
2.1. Subjects
Patients who enrolled in the WTC EHC at Bellevue Hospital between August 2005 and February
2009 were included in the analysis. At that time, a physical complaint was the only criterion for
enrollment [4,11]. The Institutional Review Board of New York University School of Medicine approved
the research database (NCT00404898) and only data from patients who signed informed consent were
used for analysis. Patients were included in the analysis if they had data including WTC exposure,
physical and mental health questionnaires from an Initial visit between August 2005 and February 2009,
and a subsequent Monitoring visit. All Monitoring visits were between October 2009 and May 2016.
2.2. WTC Exposures and Medical Assessment
Upon enrollment in the WTC EHC, patients completed a multi-dimensional, interviewer-administered
questionnaire that included demographic information and characterizations of WTC-related exposure [11].
Individuals were classified as positive for dust cloud exposure if they reported having been in a WTC
dust cloud created by the collapsing buildings on 11 September 2001. Potential for WTC acute and chronic
exposures were characterized by classification into four additional categories: local resident (resident),
local worker, cleanup worker and other.
Patients who reported more than 5 pack-year history of tobacco use were defined as ever smokers.
Body mass index (BMI) of patients was calculated using information gathered during the Initial
medical visit. The presence and severity of lower respiratory symptoms (LRS) of wheeze, cough,
chest tightness and dyspnea, as well as the upper respiratory symptom of rhinitis or sinusitis were
measured by standardized health questionnaires [11]. Patients with symptoms more than twice per
week during the month preceding enrollment were considered positive for any LRS or sinus symptoms.
Spirometry was performed in accordance with American Thoracic Society/European Respiratory
Society standards [15] on a Viasys Vmax spirometer (Yorba Linda, CA). Patients were categorized as
abnormal if they had a reduced forced vital capacity (FVC), reduced forced expiratory volume in one
second (FEV1), or a reduced ratio of FEV1/FVC [16].
2.3. Mental Health Symptom and Treatment Assessments
The Posttraumatic Check List-17 (PCL) [17] was used to measure PTSD symptom presence and
severity. A score ≥ 44 was considered positive for probable PTSD (PTSD+), and a score < 44 was
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considered negative for probable PTSD (PTSD−) [9]. We evaluated the longitudinal change in PCL
score using a comparison of PCL scores at Initial and Monitoring visits. We defined those who scored
positive for probable PTSD at both Initial and Monitoring visits as Persistent PTSD and those who
scored positive at their Initial visit and negative at their Monitoring visit as Remitted PTSD. PTSD
symptom severity was further defined by the level of the initial PCL score as follows: < 44, No
PTSD; 44–57.5, Low PTSD; > 57.5, High PTSD. The “Low” and “High” categories were defined using
57.5 as the cut point as this number is the median score among those with a score ≥ 44. Questions
from the PCL-17 were also matched to the DSM-V diagnostic criteria for characterization into four
clusters as previously described [13], reflecting symptoms of re-experiencing, avoidance, negative
cognitions/mood, and arousal. An average score for each patient was calculated for each cluster,
ranging between 1–5.
We used the Hopkins Symptom Checklist for depression and anxiety (HSCL-25) [18]. These scales
provided scores of depression (HSCL-D) and anxiety (HSCL-A) severity with a score ≥ 1.75 considered
to suggest probable depression or probable anxiety. The CAGE Questionnaire was used to screen for
problem alcohol use, with a score ≥ 2 used to categorize persons with probable alcohol abuse [19].
We collected self-reported mental health treatment information during the Monitoring
examination. Treatment for a mental health condition was defined to include any type of reported
treatment. Treatment was included if it was reported as individual psychotherapy for ≥ one month,
group psychotherapy treatment for ≥ 2 months, or prescribed pharmacologic treatment.
2.4. Statistical Methods
Categorical variables were summarized using counts and percentages and the significance of
between-group difference was assessed by Chi-square test. Continuous variables were summarized
using median and interquartile range (IQR) and difference between independent groups was assessed
by Wilcoxon rank-sum test (i.e., Mann-Whitney test), and between correlated groups using Wilcoxon
signed rank test. Logistic regression was used to quantify the association between binary outcomes
(e.g., probable PTSD) and covariates of interest. Linear regression was used to quantify the association
between continuous outcome (e.g., PCL score) and covariates of interest. Multivariate models were
constructed using selected covariates that were significant in univariate analyses. Observed mental
health treatment was not randomized in this study cohort and therefore direct comparison of treated
versus untreated groups would not be meaningful due to potential associated biases. To overcome
this issue, we used the propensity score method to discuss potential existence of treatment effect on
the longitudinal changes of PCL scores. A value of P < 0.05 was used to test for two-sided statistical




WTC exposure history, physical and mental health data gathered at Initial and Monitoring visits
were available for 738 patients. The median time between visits was 3.43 years (Q1, Q3; 2.88, 4.32).
Most patients (Table 1) were > age 45 (69%), with a similar number of males (49%) and females (51%).
Many were Hispanic (44%), had an annual individual income of < $30,000 and had a ≤ 12th grade
level of education (40%). Local workers comprised the largest exposure category (47%). Fifty per cent
reported having been caught in the WTC dust cloud. Most patients (90%) had LRS, and 57% reported
sinus symptoms. Lung function was within normal limits in most (64%).
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(n = 454) p-Value
Gender, n (%) 0.24
Female 375 (51) 152 (53.5) 223 (49)
Male 363 (49) 132 (46.5) 231 (51)
Age, n (%) 0.24
<45 229 (31) 81 (29) 148 (33)
≥45 509 (69) 203 (71) 306 (67)
Race/ethnicity, n (%) 0.001
Hispanic 323 (44) 149 (52) 174 (38)
Non-Hispanic white 205 (28) 66 (23) 139 (31)
Non-Hispanic black 142 (19) 45 (16) 97 (21)
Asian 49 (7) 14 (5) 35 (8)
Other 19 (3) 10 (4) 9 (2)
Education, n (%) 0.003
≤High school 292 (40) 132 (47) 160 (35)
>High school 445 (60) 152 (54) 293 (65)
Income, n (%) <0.0001
≤$15,000/year 301 (42) 148 (54) 153 (35)
$15,000–$30,000/year 145 (21) 49 (18) 96 (22)
>$30,000/year 265 (37) 76 (28) 189 (43)
BMI, n (%) 0.80
≤30 466 (64) 177 (63) 289 (64)
>30 262 (36) 102 (37) 160 (36)
Ever smoker, n (%) 0.21
yes 287 (39) 118 (42) 169 (37)
no 451 (61) 163 (58) 284 (63)
Exposures
WTC dust cloud exposure, n (%) 0.14
yes 361 (49) 148 (53) 213 (48)
no 377 (51) 130 (47) 234 (52)
Exposure classification, n (%) 0.12
Local worker 340 (47) 127 (45) 213 (47)
Resident 140 (19) 45 (16) 95 (21)
Clean-up worker 171 (23) 77 (27) 94 (21)
Other 80 (11) 33(12) 47 (10)
Symptoms
Lower respiratory symptoms
Any Lower Respiratory Symptoms 0.001
yes 663 (90) 266 (95) 397 (87)
no 75 (10) 15 (5) 57 (13)
Spirometry 0.17
normal 472 (64) 173 (61) 299 (66)
abnormal 266 (36) 111 (39) 155 (34)
Upper respiratory symptoms
Sinus congestion 0.79
yes 408 (56) 153 (56) 255 (57)
no 330 (44) 122 (44) 195 (43)











(n = 454) p-Value
Depression, n (%) <0.0001
yes 404 (55) 265 (93) 139 (31)
no 19 (7) 315 (69)
Anxiety, n (%) <0.0001
yes 277 (38) 202 (71) 75 (17)
no 461 (62) 82 (29) 379 (83)
Cage, n (%) 0.02
yes 50 (7) 27 (10) 23 (5)
no 688 (93) 250 (90) 428 (95)
Univariate analysis. Categorical variables presented as frequencies and percentages and difference between 2
groups assessed by the Chi-Square test.
As noted above, the criterion for enrollment in this early program was the presence of physical,
but not mental health symptoms. Despite this, many patients scored positive for probable PTSD
(PTSD+; 38%, n = 284), depression (55%), and anxiety (38%) at their Initial visit. Symptoms suggestive
of alcohol misuse were reported in 7% of the population. Categories were not mutually exclusive.
3.2. Characteristics Associated with PTSD Symptoms at Initial Visit
We compared demographic characteristics, medical symptoms, lung function and comorbid
conditions in PTSD+ (n = 284) and PTSD− (n = 454) patients at their Initial visit (Table 1; see methods
section for category description). Patients who self-reported as Hispanic (p = 0.001), had income ≤
$15,000/year or ≤ 12th grade education were more likely to score PTSD+ (p < 0.001, 0.003 respectively).
The presence of any LRS symptom (p = 0.001) was associated with being PTSD+. Those PTSD+ were
also more likely to report probable depression and anxiety (both p < 0.0001) and to report alcohol
misuse (p = 0.02). In a multivariate logistical regression using any significant variable, the presence
of physical symptoms of LRS (OR = 2.21; p = 0.05), as well as co-morbid mental health symptoms of
probable depression (OR = 18.11; p < 0.0001), probable anxiety (OR = 4.64; p < 0.001), or alcohol misuse
(OR = 2.45; p = 0.05), remained significant (data not shown).
3.3. Demographic and WTC Exposure Characteristics Associated with Persistent and Remitted PTSD
As shown (Table 2), 279 patients who scored PTSD+ at their initial visit could be classified
as Persistent or Remitted as described in the methods section (5 patients with incomplete baseline
characteristics were excluded from analysis). The majority of patients (n = 214) remained Persistent,
while few patients (n = 65) fit criteria for Remitted. Race/ethnicity and baseline depression status were
associated with being Persistent (p = 0.01 and 0.04 respectively) in univariate analysis. No covariates
were significant in multivariate analysis (data not shown).
119
IJERPH 2019, 16, 1215









Gender, n (%) 0.20
Female 109 (51) 39 (60)
Male 105 (49) 26 (40)
Age, n (%) 0.91
<45 61 (28.5) 19 (29)
≥45 153 (71.5) 46 (71)
Race/ethnicity, n (%) 0.01
Hispanic 119 (56) 28 (43)
Non-Hispanic white 52 (24) 12 (18)
Non-Hispanic black 30 (14) 14 (22)
Asian 6 (3) 8 (12)
Other 7 (3) 3 (5)
Education, n (%) 0.58
≤High school 97 (45) 32 (49)
>High school 117 (55) 33 (51)
Income, n (%) 0.16
≤$15,000/year 107 (52) 39 (63)
$15,000 - $30,000/year 40 (19) 6 (10)
>$30,000/year 59 (29) 17 (27)
BMI, n (%) 0.25
≤30 138 (65) 36 (57)
>30 74 (35) 27 (43)
Ever smoker, n (%) 0.90
yes 89 (42) 28 (43)
no 122 (58) 37 (57)
Exposures
WTC dust cloud exposure, n (%) 0.12
yes 117 (56) 28 (44)
no 93 (44) 35 (56)
Exposure classification, n (%) 0.37
Local worker 101 (48) 25 (38)
Resident 32 (15) 11 (17)
Clean-up worker 58 (27) 18 (28)
Other 21(10) 11 (17)
Symptoms
Lower respiratory symptoms
Any Lower Respiratory Symptoms 0.85
yes 200 (95) 62 (95)
no 11 (5) 3 (5)
Spirometry 0.30
normal 134 (63) 36 (55)
abnormal 80 (37) 29 (45)
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yes 123 (59) 28 (45)
no 85 (41) 34 (55)
Positive mental health score
Depression, n (%) 0.04
yes 203 (95) 57 (88)
no 11 (5) 8 (12)
Anxiety, n (%) 0.11
yes 157 (73) 41 (63)
no 57 (27) 24 (37)
Cage, n (%) 0.94
yes 21 (10) 6 (10)
no 189 (90) 56 (90)
* Univariate analysis, n = 279 (five subjects with incomplete baseline characteristics are excluded from analysis.
Categorical variables presented as frequencies and percentages and difference between 2 groups assessed by the
Chi-Square test.
3.4. Longitudinal Assessment of Severity of PTSD Symptoms
A dichotomous evaluation as Remitted or Persistent may be insensitive to a heterogeneous
decrease of the PCL score. We therefore directly studied changes in the PCL score. Patients were
grouped into severity categories based on their PCL score at Initial visit as No PTSD, Low PTSD,
or High PTSD (Table 3; see methods section for description of grouping). High PTSD patients had
a 9-point reduction in the median score between visits (p < 0.0001), consistent with a statistically
significant improvement in PCL score. In contrast, the decrease in median PCL score in the Low PTSD
patients did not reach significance. Despite these improvements, the median score at Monitoring
remained ≥ 44 in both groups. There was a small but statistically significant increase of median PCL
score among the No PTSD group, and the median score at Monitoring remained < 44.
Table 3. Longitudinal assessment of PTSD score in severity categories.
PCL Status No PTSD (n = 454) Low PTSD (n = 142) High PTSD (n = 142)
Initial (PCL1) 27 (20, 35) 51 (47, 54) 66 (62, 70)
Monitoring (PCL2) 32 (23, 41) 49 (42, 58) 57 (49, 66)
Change (PCL1-PCL2) −4 (−12, −2) 2 (−6, 9) 9(2, 17)
p-value <0.0001 0.11 <0.0001
Continuous variables presented as Median and IQR (Q1, Q3) and difference between 2 groups assessed by Wilcoxon
signed rank test.
The possibility exists that treatment modified the PCL score over time. Our study was not
designed to evaluate treatment, however we used the observed treatment status, as defined in the
methods section, to develop propensity scores from logistic regression with relevant predictors
including race/ethnicity, income, and initial mental health scores included in the model. High
propensity scores of being treated were positively correlated with decreases in longitudinal PCL scores
(p < 0.0001; data not shown).
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3.5. PTSD Symptom Clusters Over Time
The heterogeneity within PTSD can also be described by the symptom clusters that comprise
the overall score. We therefore examined change in score of each PTSD symptom cluster within our
PTSD severity categories (Table 4). Patients with Low PTSD showed significant improvement only
in the arousal cluster score (p = 0.01); we were unable to detect a significant change in the score of
any of the other clusters. In contrast, those with High PTSD improved significantly on all clusters
(re-experiencing, p = 0.0003; avoidance, p = 0.001; negative thoughts/emotions and arousal, p < 0.0001).
A slight increase in all cluster scores was noted in those who scored below threshold on initial visit.
Table 4. PCL cluster scores at Initial and Monitoring visit in PTSD severity categories.
Symptom Severity Level Visit Re-Experiencing Avoidance NegativeThoughts/Mood Arousal
No PTSD (n = 454)
Initial 1.4 (1.0, 2.0) 1.0 (1.0, 2.0) 1.2 (1.0, 1.8) 1.8 (1.1, 2.4)
Monitoring 1.6 (1.2, 2.4) 2.0 (1.0, 3.0) 1.5 (1.0, 2.2) 2.0 (1.4, 2.8)
p-value <0.0001 <0.0001 <0.0001 <0.0001
Low PTSD (n = 142)
Initial 2.6 (2.2, 3.0) 3.0 (2.0, 4.0) 2.8 (2.4, 3.3) 3.6 (3.0, 3.8)
Monitoring 2.8 (2.2, 3.4) 3.0 (2.5, 4.0) 2.7 (1.8, 3.2) 3.2 (2.6, 4.0)
p-value 0.23 0.45 0.06 0.01
High PTSD (n = 142)
Initial 3.8 (3.4, 4.2) 4.0 (3.5, 5.0) 3.8 (3.2, 4.2) 4.2 (3.8, 4.6)
Monitoring 3.2 (2.6, 4.0) 3.5 (3.0, 4.5) 3.1 (2.4, 3.8) 3.7 (3.0, 4.2)
p-value 0.0003 0.001 <0.0001 <0.0001
Cluster scores are median of questions noted and IRQ (Q1, Q3) and difference between 2 groups assessed by
Wilcoxon signed rank test.
4. Discussion
In this paper we characterize mental health scores in patients who had enrolled in a community
program for physical symptoms after a traumatic event and describe characteristics associated with
PTSD symptom scores in this population, as well as changes in scores over time. Our population
was a diverse race/ethnic population with many of low income and education. Importantly, despite
enrollment in the program for physical symptoms, many patients scored positive for probable PTSD.
We did not observe many patients with remittance of PTSD symptoms defined as a score below
44, however we identified patients who had improvement in PCL scores, particularly in those who
were more symptomatic as reflected in higher PCL scores on enrollment in the program. Moreover,
we showed improvement in each PTSD symptom cluster score in patients with more severe PTSD
symptoms, whereas those with milder PTSD symptoms had more limited improvement.
We identified many patients who scored positive for probable PTSD despite enrolling in a program
for physical symptoms. High rates of PTSD have been well described in civilian populations who
are not trained for trauma [9,20–22]. Our patients were recruited for physical symptoms and were
not specifically seeking mental health treatment. High mental health scores were only incidentally
reported, reinforcing the need to perform mental health screening in all disaster-exposed populations.
Moreover, these high rates may in part be due to the diversity of the population, including many
with low income and education, factors previously reported to be associated with the development of
PTSD [21,23]. In addition, the presence of co-morbid physical symptoms, including lower respiratory
symptoms, and mental health symptoms was also associated with probable PTSD, reinforcing the
need to consider co-morbid presentations [6,24,25].
Few studies have examined the longitudinal change in mental health symptoms in WTC
community members, [6,26–29] particularly in those who have sought care for physical, or even
mental health symptoms as a result of their exposure. To begin to analyze the change in symptoms
over time in our highly affected population we used a simple cut-off value that is often used to
determine whether an individual should undergo further evaluation, and has been used in numerous
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epidemiologic studies in WTC-exposed populations [9]. Most (77%) of the patients in the study
remained symptomatic when the group was dichotomized into Persistent or Remitted based on this
score. This finding suggests that these symptoms were refractory as has been described in some
WTC exposed populations [22,30] and underscores the importance of studying and improving patient
management. Alternatively, this finding may suggest that this dichotomous evaluation is insensitive
for the identification of more subtle changes in the level of PTSD symptoms. Indeed, we noted changes
in PCL scores when evaluated as a continuous variable in subgroups of patients. In addition, the PCL
may have low sensitivity in identifying functional improvement.
There was wide variation in the PCL score in our population, suggesting heterogeneity within the
severity of symptoms. When we compared the change in PCL score as a continuous variable, patients
who had a higher score at their Initial visit had a significant improvement in their score. This finding
was not seen in those who began with a lower score. Importantly, neither group reduced their median
score below our cut-off threshold. This finding suggests that there is improvement, although there
may to be differences in responsivity.
Our study was not designed to evaluate treatment, however, we used the observed treatment
status to develop propensity scores from logistic regression with relevant predictors and showed
that high propensity scores of having received treatment were positively correlated with decreases in
longitudinal PCL scores. These data suggest a relationship between treatment and improvement in
PCL score and reinforce the need for clinical trials to study the role of individual treatment modalities
and potential treatment effect.
We have previously suggested heterogeneity of PTSD within this community population [13].
However, few studies examine longitudinal changes in the individual components that comprise
PTSD. Symptom cluster trajectories have been shown to have a variable course in, for example,
traumatically injured populations [31]. We show an improvement in score in those with High PTSD at
initial evaluation, suggesting that there may be differences in the components of these higher scores
that can be modified. When we evaluated this question by examining changes within symptom
clusters, patients with higher PCL scores at Initial visit showed improvement across all clusters. This
finding suggests that patients with greater PTSD symptom severity at Initial visit have responsiveness
across all components of PTSD. Patients with lower PCL scores reflecting less symptom severity only
improved significantly on the arousal cluster, suggesting that this cluster of symptoms may more easily
attenuated. Their failure to completely return to levels below threshold suggest the possibility of some
level of intractability.
There are limitations to this study. We studied a civilian population at only two time points,
limiting the ability to identify fluctuations in symptom presentation. The population under study was
exposed to the same traumatic event, which is a strength of the study. However, this unique exposure
may also limit the generalizability of these results. Participants were self-referred patients seeking
treatment for physical symptoms related to exposure to the WTC disaster and were not selected from a
wider group of WTC exposed community members, raising the potential for selection bias for these
symptoms. The possibility exists, too, that the role of treatment was inadequately evaluated and
patients with higher scores might have been more likely to have received treatment, with subsequent
bias, in our evaluation. We used the PCL-17 to assess PTSD symptoms. Although this is a commonly
used tool, it can be subject to recall bias, sensitivity, and specificity [32]. Certain variables were not
completely assessed and included in the analysis, such as pre and post-trauma variables. These
limitations reinforce the need for more studies.
5. Conclusions
Our goal was to understand longitudinal patterns of PTSD in a cohort of WTC exposed community
members seeking help for physical ailments related to the exposure. Many patients scored positive for
probable PTSD, which was associated with physical and mental health comorbidities. Few patients
remitted, when analyzed as a threshold score, and no we could not identify variables associated with
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remittance or persistence after multivariate analysis. However, we detected improvement in scores in
patients with persistence; the decrease was significant for those with more severe PTSD symptoms.
Heterogeneity in response was also observed in changes in PTSD symptom clusters, where we showed
improvement in each PTSD symptom cluster score for patients with more severe PTSD symptoms,
whereas those with milder PTSD symptoms improved only on the arousal cluster.
An understanding of the patterns of longitudinal PTSD symptoms is important for trauma
management in this and other populations. Identifying the variability in changes in PTSD symptom
clusters can also help to target treatment. Moreover, studies suggest that PTSD symptoms do not
remain stable over a lifetime, but may change and even reactivate with aging, suggesting the need for
further study evaluation [33]. Understanding the patterns of longitudinal symptoms in this cohort will
assist in identifying patients at high risk for chronicity and in guiding timely, effective interventions.
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Abstract: Background: World Trade Center (WTC) dust-exposed subjects have multiple comorbidities
that affect sleep. These include obstructive sleep apnea (OSA), chronic rhinosinusitis (CRS),
gastroesophageal-reflux disorder (GERD) and post-traumatic stress disorder (PTSD). We examined
the impact of these conditions to sleep-related outcomes. Methods: Demographics, co-morbidities
and symptoms were obtained from 626 WTC (109F/517M), 33–87years, BMI = 29.96 ± 5.53 kg/m2)
subjects. OSA diagnosis was from a 2-night home sleep test (ARESTM). Subjective sleep quality,
sleep-related quality of life (QOL, Functional Outcomes of Sleep Questionnaire), excessive daytime
sleepiness (Epworth Sleepiness Scale), sleep duration and sleep onset and maintenance complaints
were assessed. Results: Poor sleep quality and complaints were reported by 19–70% of subjects
and average sleep duration was 6.4 h. 74.8% of subjects had OSA. OSA diagnosis/severity was not
associated with any sleep-related outcomes. Sleep duration was lower in subjects with all conditions
(p < 0.05) except OSA. CRS was a significant risk factor for poor sleep-related QOL, sleepiness,
sleep quality and insomnia; PTSD for poor sleep-related QOL and insomnia; GERD for poor sleep
quality. These associations remained significant after adjustment for, age, BMI, gender, sleep duration
and other comorbidities. Conclusions: Sleep complaints are common and related to several health
conditions seen in WTC responders. Initial interventions in symptomatic patients with both OSA and
comorbid conditions may need to be directed at sleep duration, insomnia or the comorbid condition
itself, in combination with intervention for OSA.
Keywords: obstructive sleep apnea; comorbid insomnia; sleep-related quality of life; chronic sinusitis;
sleepiness; WTC responders
1. Introduction
Following the World Trade Center (WTC) disaster, many responders who worked in rescue,
recovery and debris removal were exposed to high concentrations (greater than 100,000 μm/m3
total particles) of debris [1]. This exposure was associated with an increased risk of developing
obstructive sleep apnea (OSA) [2], chronic rhinosinusitis (CRS) [3], post-traumatic stress disorder
(PTSD), gastroesophageal reflux disease (GERD), anxiety and depression [4] all of which may be
IJERPH 2019, 16, 1229; doi:10.3390/ijerph16071229 www.mdpi.com/journal/ijerph127
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associated with sleep disruption. We recently reported a high prevalence of OSA in WTC responders
related to chronic rhinosinusitis [5].
OSA is often associated with poor quality of life and sleepiness, likely from the associated sleep
fragmentation and intermittent hypoxia. Although there is a weak relationship between presence of
OSA and/or severity of OSA and sleep complaints and daytime outcomes, this correlation appears
to be quite variable [6–10]. Sleep duration and insomnia may be additional factors affecting the
relationship of OSA to sleepiness [6,9]. There is also increasing evidence that medical conditions that
often coexist with OSA, such as CRS, anxiety, depression, PTSD and GERD, are associated with sleep
complaints [11–17] and may confound the relationship between OSA and sleep-related quality of life
outcomes. The independent contribution of each of these conditions to sleep-related complaints and
the associated quality of life has not been closely examined.
Data on sleep-related quality of life, sleepiness and sleep duration were collected as part of a
larger study (WTCSNORE) examining the role of nasal pathology in the pathophysiology of OSA in
643 WTC responders. We evaluated the relative contribution of sleep duration and comorbid illness to
these outcomes in this population.
2. Materials and Methods
Study Population: The WTCSNORE study is a recently completed National Institute for
Occupational Safety and Health (NIOSH) funded (#U01OH01415) study to examine the effect of
nasal pathology on OSA in WTC responders. Between March 2013 and December 2016 we enrolled
643 subjects with no history of OSA and without reported loud and frequent snoring prior to 11
September 2001 from the WTC health programs at Rutgers Robert Wood Johnson Medical School,
New York University School of Medicine and Icahn School Medicine at Mt. Sinai. The study protocol
was approved by the Institutional Review Boards of Rutgers RBHS (Pro2012002164), NYU School
of Medicine (I12-02578) and the Icahn School of Medicine at Mount Sinai (HS#16-00511) and all
subjects signed informed consent. Subjects were considered ineligible if they had been diagnosed with
gross skeletal alterations affecting the upper airway (e.g., micrognathia) or unstable chronic medical
conditions known to affect OSA (chronic heart failure, stroke), were pregnant or had intent to become
pregnant within the period of the protocol, were unable to sign informed consent form, were currently
on treatment for OSA, were a habitual snorer prior to 9/11/2001, or had a diagnosis of OSA prior to
9/11/2001. In all subjects we obtained demographic data and the following metrics were assessed:
(1) Sleep-related Quality of life (QOL) was assessed using the Functional Outcomes of Sleep
Questionnaire (FOSQ) [18]. The FOSQ is a validated 30-item questionnaire that is used to
assess the impact of disorders of excessive sleepiness on activity of daily living. It consists of 5
subscales evaluating activity level, vigilance, intimacy, general productivity and social outcomes
and has a possible combined score that ranges from 5 (poor) to 20 (excellent). A score < 17 is
taken to indicate poor sleep-related quality of life.
(2) Excessive daytime sleepiness was evaluated with the Epworth Sleep Scale (ESS), a well-validated
questionnaire that asks the subject to rate the likelihood of falling asleep in 8 commonly
encountered situations [19]. Possible scores range from 0 (the least sleepy) to 24 (the most
sleepy). A score of > 10 defines presence of excessive daytime sleepiness.
(3) A questionnaire regarding sleep and snoring was administered that included questions regarding
bed and wake up times, duration of sleep (hours/night), frequency of difficulty falling and
maintaining sleep per week, and overall quality of sleep. Quality of sleep was rated on a 4-point
scale (1: excellent, 2: good, 3: fair, and 4: poor); poor sleep quality was defined as ≥ 3. Sleep
onset insomnia was defined as present when the subject reported having trouble falling asleep at
least 1–2 times a week, and sleep maintenance insomnia was recorded when a subject reported
waking up early and not being able to go back to sleep at least 1–2 days per week.
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(4) Home monitoring for OSA: Subjects wore an ARESTM Unicorder (SleepMed, Inc., West Palm
Beach, FL, USA) at home for 2 nights, with a pre-addressed mailer to return the device to the sleep
lab. The ARESTM Unicorder is a home sleep test device that has been validated against full in-lab
polysomnography [20,21], shows high sensitivity for OSA (0.98) and is routinely used in clinical
practice for home monitoring of OSA. It is worn on the forehead and does not require additional
wires to external devices. It measures oxygen saturation and pulse rate from reflectance oximetry,
airflow from a nasal cannula/pressure transducer, snoring via acoustic microphone and head
movement actigraphy and head position from accelerometers. The ARESTM respiratory data
were analyzed as follows: Data from the monitor were autoscored and then manually edited
by a single trained sleep technician and reviewed by a sleep expert. Apneas were scored when
there was a reduction in airflow to less than 10% of baseline for >10 s. Hypopneas 4% were
scored for >30% reduction in airflow associated with 4% or more decrease in oxygen saturation.
Hypopneas with arousals (HypopneasArsl) were scored for visible reduction (>30% reduction) in
airflow associated with surrogates of arousal (head movement, changes in snoring, or changes in
pulse rate combined with disappearance of inspiratory flow limitation and a marked (>150%)
increase in flow amplitude) at the end of the event, but <4% decrease in oxygen saturation [22].
AHI4% was calculated as Apneas+Hypopneas4% divided by total valid recording time in hours
(h). The Respiratory Disturbance Index (RDI) was calculated as Apneas + Hypopneas 4% +
HypopneasArsl divided by total valid recording time. Using these metrics, we define OSA as
present when AHI4% ≥ 5/h or when RDI ≥ 15/h. When OSA is present by this definition,
severity was graded by the AHI4%: mild (AHI4% < 15/h), moderate (AHI4% ≥ 15/h but < 30/h)
or severe (AHI4% ≥ 30/h) [23].
(5) Chronic rhinosinusitsis (CRS): CRS was defined based on epidemiological criteria used in the
European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) [24,25]. Subjects were
considered CRS+ if two or more of the following symptoms were reported as present for >8
weeks: (1) nasal blockade/obstruction (2) nasal discharge, (3) facial pain and (4) reduction in or
loss of smell. At least one symptom had to be nasal blockade or discharge.
(6) In addition, we quantified the subjects’ perception of nasal congestion of each individual nostril
by asking them to close one nostril while in the supine position and rate the level of congestion
in the free nostril on a scale from 1 to 10, 1 being totally blocked/congested and 10 being totally
open/uncongested. The lowest score (denoting greater congestion) of the two self-reported
values from the left and right nostril was used for analysis.
(7) Comorbid conditions: Information on comorbid Anxiety/Panic, Depression, GERD and PTSD
were obtained from a combination of self-report of physician diagnosis (GERD) obtained in our
WTCSNORE questionnaire, standardized questionnaires (Depression, Panic disorder, PTSD) and
from the certified conditions listed in WTC Health Program General Responder Data Center
(GERD, Depression, Anxiety and Panic Disorder and PTSD) for each subject using the annual visit
closest in time to the sleep study. If any of the sources used identified the presence of a co-morbid
condition the subject was coded as positive for that condition. Depression was assessed by the
patient health questionnaire (PHQ), PTSD (PTSD symptom checklist), panic (PHQ) and anxiety
from the GAD-7 [26–29].
Assessment of other relevant variables and Statistical Analysis: Presence/absence of CRS, OSA,
PTSD, Anxiety/Depression and GERD were defined as Yes/No (+/−) variables. Summary statistics
were calculated and differences were compared using chi-square test for discrete categorical variables
and two-sample t-test for continuous data. For skewed continuous variables, we used Wilcoxon test
instead. Logistic regression analyses, with (i) sleep-related QOL (FOSQ ≥ 17 vs <17), (ii) Excessive
Daytime Sleepiness (EDS) (Epworth sleepiness score >10 vs ≤10), (iii) Poor sleep quality (+/−),
(iv) Sleep Onset Insomnia (+/−) and (v) and Sleep Maintenance Insomnia (+/−) as the dependent
variables and OSA, CRS, GERD, PTSD, Anxiety/Panic and Depression as the independent variables
were used to evaluate the association of sleep parameters and each of the independent variables
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before and after controlling for age, BMI, gender, sleep duration and the other variables. Statistical
significance was defined by p < 0.05. All statistical analyses were performed using SAS v9.4 (SAS
Institute Inc., Cary, NC, USA).
3. Results
We analyzed data from 626/643 subjects from the parent WTC study (WTCSNORE) in whom
CRS data was available. Subjects were predominantly middle-aged men. The demographic data,
sleep duration, sleep-related quality of life and sleep complaints are provided in Table 1. 74.8% of
subjects had OSA diagnosed by home monitoring, predominantly mild OSA. 47.1% of the subjects were
identified as CRS+ by questionnaire, 19.3% had depression, 23.5% had PTSD, 23.5% had anxiety/panic
and 52% had GERD.
Table 1. Demographics of the study participants.
Variable N of Valid Data Summary
Age (years, Mean ± SD) 626 52.8 ± 8.6
BMI (kg/m2, Mean ± SD) 626 29.9 ± 5.5
Female (%) 626 109 (17.3%)








Snoring (Yes, %) 626 312 (49.8%)
Quality of Life (FOSQ) (Mean ± SD)
Good, ≥17 (%)
Poor, <17 (%)
566 17.4 ± 2.6
62.0%
38.0%
Sleepiness (ESS, Mean ± SD)
Sleepy, >10 (%)
Not Sleepy, ≤10 (%)
620 8.3 ± 4.8
31.3%
68.7%
Poor Sleep Quality (Yes, %) 623 441 (70.8%)
Sleep Onset Insomnia (Yes, %) 609 296 (48.6%)









CRS + (%) 626 295 (47.1%)
Depression + (%) 612 118 (19.3%)
PTSD + (%) 612 144 (23.5%)
Anxiety and Panic Disorder + (%) 612 144 (23.5%)
GERD + (%) 564 293 (52%)
Notes: BMI-Body Mass Index, ESS- Epworth sleepiness scores, FOSQ- Functional Outcome of Sleep Questionnaire,
OSA-Obstructive Sleep Apnea, PSTD-Post Traumatic Stress Disorder, GERD- Gastroesophageal Reflux Disease.
Shorter sleep duration (in hours) was observed in subjects with CRS (CRS+ = 6.3 ± 1.4
vs CRS- = 6.5 ± 1.2, p = 0.03), PTSD (PTSD+ = 6.1 ± 1.5 vs PTSD- = 6.5 ± 1.3, p=0.01),
anxiety/panic (anxiety/panic+ =6.0 ± 1.4 vs anxiety/panic- =6.5 ± 1.3, p < 0.0001) and depression
(depression+ = 6.0 ± 1.4 vs depression- = 6.5 ± 1.3, p = 0.001) but not GERD (GERD+ = 6.4 ± 1.3 vs
GERD- = 6.4 ± 1.3, p = NS) and OSA (OSA+ = 6.4 ± 1.3 vs OSA- = 6.4 ± 1.3, p = NS). Subjects with
OSA were older than those without OSA, were predominantly male and had higher BMI, but did
not differ in sleep duration, ESS, FOSQ or perception of nasal congestion. Subjects with CRS, PTSD,
Anxiety/Panic, Depression and GERD showed greater sleepiness by ESS, worse sleep-related QOL by
FOSQ and greater perceived nasal congestion than those without the condition. Of note, subjects with
CRS had slightly higher BMI and OSA severity (See Table 2).
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Shorter sleep duration was significantly associated with worse sleep-related quality of life (FOSQ
< 17, OR = 0.76 95% CI = 0.63, 0.92, p = 0.004), worse sleep quality (OR = 0.61, 95% CI 0.50, 0.74,
p < 0.0001), increased sleepiness (ESS > 10, OR = 0.84, 95% CI 0.72, 0.99, p = 0.03), sleep onset insomnia
(OR = 0.63, 95% CI 0.53, 0.74, p < 0.0001) and maintenance insomnia (OR = 0.54, 95% CI 0.43, 0.67, p <
0.0001) using a logistic model controlled for age, BMI, OSA and all comorbidities. In addition, gender
was associated with worse sleep-related quality of life (FOSQ) and presence of sleep onset insomnia
(p < 0.05). Sleep-related quality of life (FOSQ) and sleepiness (ESS) were significantly negatively
correlated (r = −0.62 95% CI −0.67 to −0.57, p < 0.0001) but there was no correlation between sleep
disordered breathing indices (SDB, AHI4% or RDI) and FOSQ (r = −0.05 for logAHI4% and r = −0.01
for logRDI, p = NS) or SDB and ESS (r = 0.05, for logAHI4%, r = 0.03, for logRDI, p = NS).
In our dataset, we were unable to demonstrate differences in quality of life, sleepiness, sleep
quality, sleep onset insomnia, and sleep maintenance insomnia between subjects with and without
OSA. However, presence of the other comorbid conditions (CRS, PTSD, Anxiety/Panic, Depression
and GERD) were all significantly associated with worse quality of life, increased sleepiness, worse
sleep quality and sleep onset and maintenance insomnia. (Table 3)


































































































Notes: Asterisk (*) denotes a p-value of <0.05. Cross (†) denotes a p-value of <0.01. Double dagger (‡) denotes a
p-value of <0.0001.
Table 4 summarizes the risk of each of the conditions on sleep-related outcomes and shows the
associations of quality of life (FOSQ), excessive daytime sleepiness (ESS), sleep quality, sleep onset
insomnia and maintenance insomnia with OSA severity, CRS and other co-morbid conditions. Model
1 is the unadjusted data, Model 2 adjusts for age, BMI and sleep duration and Model 3 adjusts for age,
BMI, gender, sleep duration and other co-morbid condition. Our data did not show any statistically
significant relationship between OSA and any of the sleep-related outcomes. CRS is a significant risk
factor for poor quality of life, excessive daytime sleepiness and sleep complaints even in an adjusted
model. PTSD was a significant risk factor for poor quality of life, sleep onset insomnia and sleep
maintenance insomnia. GERD was a risk factor for poor quality of sleep. Figure 1 is a graphical
representation of these odds ratios in Model 3.
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Table 4. Odds ratio and 95% CI for presence of poor sleep-related quality of life (FOSQ < 17),
sleepiness, poor quality sleep and insomnia in subjects with each condition compared to subjects
without this condition.
Model 1 Model 2 Model 3
OR 1 95% CI OR 2 95% CI OR 3 95% CI
Poor Quality of Life
(FOSQ < 17)
OSA Severity
Mild OSA vs. No OSA 1.21 (0.80, 1.84) 1.02 (0.65, 1.59) 0.87 (0.51, 1.47)
Moderate OSA vs. No OSA 1 (0.60, 1.67) 0.8 (0.46, 1.41) 0.73 (0.36, 1.45)
Severe OSA vs. No OSA 1.46 (0.78, 2.72) 0.98 (0.50,1.95) 1.09 (0.48, 2.49)
CRS 2.58 ‡ (1.85, 3.60) 2.44 ‡ (1.72, 3.46) 2.48 ‡ (1.62, 3.80)
GERD 1.79 † (1.27, 2.53) 1.80 † (1.24, 2.60) 1.14 (0.74, 1.76)
PTSD 4.23 ‡ (2.85, 6.27) 3.93 ‡ (2.60, 5.94) 3.18 † (1.72, 5.9)
Anxiety/Panic 3.21 ‡ (2.18, 4.72) 2.87 ‡ (1.91, 4.29) 1.18 (0.66, 2.12)
Depression 3.99 ‡ (2.62, 6.09) 3.61 ‡ (2.33, 5.59) 1.62 (0.85, 3.11)
Sleepiness (ESS>10)
OSA Severity
Mild OSA vs. No OSA 1 (0.65, 1.54) 1.07 (0.67, 1.71) 0.9 (0.53, 1.52)
Moderate OSA vs. No OSA 1.08 (0.63,1.84) 1.2 (0.67, 2.15) 1.07 (0.55, 2.08)
Severe OSA vs. No OSA 1.16 (0.60, 2.22) 1.09 (0.53, 2.24) 0.97 (0.42, 2.22)
CRS 2.16 ‡ (1.53,3.06) 1.93 † (1.34, 2.77) 1.80 † (1.17, 2.76)
GERD 1.82 † (1.27, 2.62) 1.73 † (1.18, 2.55) 1.2 (0.78, 1.87)
PTSD 3.10 ‡ (2.10, 4.58) 2.71 ‡ (1.80, 4.09) 1.64 (0.89, 3.02)
Anxiety/Panic 2.55 ‡ (1.73, 3.76) 2.03 † (1.35, 3.06) 1.12 (0.63, 2.01)
Depression 3.06 ‡ (2.02, 4.63) 2.62 ‡ (1.70, 4.05) 1.99 (1.05, 3.76)
Poor Sleep Quality
OSA Severity
Mild OSA vs. No OSA 1.16 (0.75, 1.77) 1.21 (0.75, 1.94) 1.05 (0.62, 1.78)
Moderate OSA vs. No OSA 1.38 (0.81,2.37) 1.28 (0.70, 2.36) 1.04 (0.51, 2.13)
Severe OSA vs. No OSA 1.55 (0.78,3.10) 1.39 (0.64, 3.04) 1.31 (0.55, 3.15)
CRS 2.27 ‡ (1.58,3.25) 2.20 ‡ (1.49,3.25) 1.95 † (1.24, 3.07)
GERD 2.16 ‡ (1.48,3.14) 2.21 ‡ (1.46, 3.33) 1.67 * (1.06, 2.64)
PTSD 2.97 ‡ (1.80,4.90) 2.45 † (1.44, 4.16) 2.13 (0.96, 4.76)
Anxiety/Panic 3.13 ‡ (1.88,5.22) 2.38 † (1.40, 4.06) 1.49 (0.71, 3.13)
Depression 2.45 † (1.45, 4.14) 1.96 * (1.13, 3.42) 0.95 (0.42, 2.14)
Sleep Onset Insomnia
OSA Severity
Mild OSA vs. No OSA 0.89 (0.59, 1.33) 0.79 (0.52, 1.20) 0.85 (0.53, 1.38)
Moderate OSA vs. No OSA 1.13 (0.69,1.86) 0.94 (0.56, 1.57) 0.96 (0.51, 1.79)
Severe OSA vs. No OSA 1.1 (0.59,2.04) 0.83 (0.43, 1.61) 1.05 (0.49, 2.24)
CRS 1.88 ‡ (1.36, 2.60) 1.85 † (1.34, 2.55) 1.63 * (1.10, 2.41)
GERD 1.51 * (1.08, 2.12) 1.44 * (1.02, 2.02) 0.99 (0.66, 1.47)
PTSD 5.25 ‡ (3.38, 8.15) 5.22 ‡ (3.34, 8.14) 4.69 ‡ (2.49, 8.86)
Anxiety/Panic 2.52 ‡ (1.70, 3.75) 2.48 ‡ (1.66, 3.70) 1.26 (0.71, 2.23)




Mild OSA vs. No OSA 1.1 (0.65, 1.87) 0.93 (0.54, 1.60) 0.85 (0.46, 1.56)
Moderate OSA vs. No OSA 1.07 (0.56, 2.04) 0.8 (0.41, 1.58) 0.56 (0.25, 1.26)
Severe OSA vs. No OSA 1.18 (0.54, 2.58) 0.78 (0.34, 1.80) 0.75 (0.29, 1.95)
CRS 2.54 ‡ (1.67, 3.87) 2.49 ‡ (1.63, 3.81) 2.41 † (1.44, 4.04)
GERD 1.29 (0.84, 1.98) 1.2 (0.77, 1.85) 0.74 (0.44, 1.24)
PTSD 3.68 ‡ (2.39, 5.68) 3.62 ‡ (2.33, 5.63) 3.53 ‡ (1.82, 6.88)
Anxiety/Panic 2.89 ‡ (1.87, 4.45) 2.85 ‡ (1.83, 4.42) 1.24 (0.64, 2.37)
Depression 2.74 ‡ (1.74, 4.33) 2.57 ‡ (1.62, 4.09) 1.06 (0.52, 2.16)
Notes: Asterisk (*) denotes a p-value of <0.05. Cross (†) denotes a p-value of <0.01. Double dagger (‡) denotes
a p-value of <0.0001; 1: Unadjusted odds ratio estimates. 2: For responses of “Poor quality of sleep”, “Sleepy”
and “FOSQ”, the odds ratio estimates are adjusted for age, BMI and sleep duration; for responses of “Sleep onset
Insomnia” and “Sleep Maintenance Insomnia”, the odds ratio estimates are adjusted for age and BMI. 3 For
responses of “Poor quality of sleep”, “Sleepy” and “FOSQ”, the odds ratio estimates are adjusted for Age, BMI,
gender, sleep duration, and all other comorbidities; for response “Sleep onset Insomnia” and “Sleep Maintenance
Insomnia”, the odds ratio estimates are adjusted for age, BMI, gender and all other comorbidities.
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Figure 1. Odds ratio and 95% CI for each comorbid condition as a risk factor for adverse sleep outcomes.
4. Discussion
In this large dataset of WTC responders with and without OSA, CRS and other comorbidities
that are known to impact sleep and quality of life, we show a significant relationship of sleep-related
quality of life, sleepiness and sleep complaints to CRS and PTSD but little or no relationship to the
presence of OSA. In patients with OSA, comorbidities that have typically been emphasized include
hypertension, arrhythmias, stroke and other cardiovascular diseases [30–32]. Our data show that it
may also be important to assess other comorbidities that directly impact sleep complaints.
The absence of a relationship between OSA and sleep complaints is not entirely unexpected. While
sleepiness is one of the main symptoms of OSA, there is significant variability between individuals and
the relationship of OSA (or OSA severity) to quality of life (QOL) and sleepiness has been inconsistent,
especially in non-clinical populations [7–10]. Our data show that controlling for co-morbid conditions
did not help explain the variability in OSA and sleep outcomes. Our dataset has a high prevalence of
OSA, but the OSA severity (median AHI4% 11.0/h, median RDI 26.0/h in subjects with OSA) was
slightly lower than earlier studies of predominantly moderate-severe OSA subjects [33]. However,
OSA severity in our cohort is comparable to recent studies in clinical populations [6]—that also did
not show a relationship between OSA severity and sleepiness.
Supporting the validity of our self-reported variables, we show the expected relationship between
reduced sleep duration and sleepiness and sleep complaints [6]. Average sleep duration has decreased
over the recent decades with over 40% of the U.S. population reporting habitual sleep time below
the recommended 7–8 h [34]. The association of reduced sleep duration with poor cardiometabolic
outcomes [35,36] highlights the importance of our finding of overall short sleep duration in the entire
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cohort (average 6.4 h with majority having sleep duration <7h) and suggests the need for further
investigation and possible intervention.
Our results are also consistent with recent literature showing that individuals with CRS complain
of poor sleep and demonstrate poor QOL related to sleep disruption [11,37,38]. However, these studies
did not control for OSA severity or sleep duration. We hypothesized that the sleep complaints in
CRS could be due to an increase in OSA, but instead found only a relationship to reduced sleep
duration. Subjects with CRS in our study reported greater perception of nasal congestion when awake,
suggesting that discomfort from congestion during sleep results in the reduced sleep duration and
may account for this finding. However, the relationship of CRS to poor sleep remained even after
controlling for sleep duration. We have shown a relationship of CRS to level of WTC exposure [5], and
chronic inflammation has also been shown to be part of CRS; it is possible that systemic mediators of
inflammation such as cytokines contribute to sleep disruption [37,39].
Poor sleep and sleepiness have also been shown in patients with mental health conditions like
PTSD, anxiety and depression [8,40,41]. In our dataset all these conditions were highly correlated with
one another, but also correlated with sleep complaints.
Although the relationship of sleep related outcomes to comorbid conditions remained significant
despite controlling for BMI in the models, subjects with each of the conditions had a higher BMI than
those without (see Table 2). Obesity is associated with short sleep duration [42] and may impact the
sleep-related complaints in these subjects.
Strengths of our study include the large well-characterized dataset of subjects naïve to OSA
treatment, objective measurement of OSA in all subjects, concurrent assessment of sleep complaints
and data on confounders and comorbid conditions.
One potential limitation is that the incidence of both OSA and comorbid conditions was high in
our cohort that is comprised mainly of male subjects. However, it has been demonstrated that the
severity and type (obstructive vs central) of the OSA in the WTC responders was not different from a
general clinic population, suggesting generalizability of our findings, of the correlations and of our
causal inferences [43]. Furthermore, other specific groups such as veterans, the elderly [44,45] and
some general populations have been shown to have a similarly high prevalence of OSA and these
co-morbid conditions, and we suggest that our inferences may apply to these groups also. Another
potential limitation is that while OSA was objectively assessed in all subjects, all other variables were
based on a combination of self-report diagnoses, questionnaire and certification data from the general
WTC database with possibility of being overestimated. However, our prevalence estimates are similar
to those reported in WTC rescue and recovery workers [46].
5. Conclusions
Our data highlight the high prevalence of sleep-related complaints and poor quality of sleep in
WTC responders. Our results challenge the often accepted clinical practice that in a patient with sleep
complaints, the most urgent treatment needs to be directed to any OSA found. While OSA undoubtedly
produces sleep symptoms in some, the role of other frequently found comorbid conditions, including
CRS, PTSD, Anxiety/Panic, Depression and GERD, should not be underestimated and perhaps
pursued more aggressively earlier. Initial interventions in symptomatic patients with both OSA and
comorbid conditions may need to be directed at sleep duration, insomnia or the comorbid condition in
combination with intervention for OSA.
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OSA Obstructive Sleep Apnea





GERD Gastroesophageal Reflux Disorder
PTSD Post Traumatic Stress Disorder
WTC World Trade Center
FOSQ Functional Outcomes of Sleep Questionnaire
QOL Quality of Life
AHI4% Apnea Hypopnea (with 4% O2 desaturation) Index
RDI Respiratory Disturbance Index
SDB Sleep Disordered Breathing
PAP Positive Airway Pressure
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Abstract: An increased incidence of thyroid cancer among 9/11 rescue workers has been reported,
the etiology of which remains unclear but which may, at least partly, be the result of the increased
medical surveillance this group undergoes. This study aimed to investigate thyroid cancer in World
Trade Center (WTC) responders by looking at the demographic data and questionnaire responses of
thyroid cancer cases from the Mount Sinai WTC Health Program (WTCHP). WTCHP thyroid cancer
tumors were of a similar size (p = 0.4), and were diagnosed at a similar age (p = 0.2) compared to a
subset of thyroid cancer cases treated at Mount Sinai without WTC exposure. These results do not
support the surveillance bias hypothesis, under which smaller tumors are expected to be diagnosed
at earlier ages. WTCHP thyroid cancer cases also reported a past history of radiation exposure and a
family history of thyroid conditions at lower rates than expected, with higher than expected rates of
previous cancer diagnoses, family histories of other cancers, and high Body Mass Indexes (BMIs).
Further research is needed to better understand the underlying risk factors that may play a role in the
development of thyroid cancer in this group.
Keywords: thyroid cancer; 9/11 disaster; World Trade Center; surveillance bias
1. Introduction
An increased incidence of thyroid cancer has been reported in the Mount Sinai World Trade Center
(WTC) responders [1], WTC-exposed fire fighters [2], and the New York City (NYC) Department of
Health exposed residents [3] with an excess risk in the range of two to three times the incidence
reported by New York City, New York State, and other national reference populations. This is despite
the fact that established risk factors for thyroid cancer, such as exposure to radiation or iodine-131 [4,5],
have not been reported in connection to Ground Zero [6]. The 9/11 attack did result in residents
and responders being acutely exposed to several carcinogens mixed with dust and particles [1,7–9],
although the direct link with WTC exposure and increased risk of cancer in WTC first responders
remains unclear. Moreover, while the time and length of exposure of these responders have been
reconstructed from questionnaires, this measure is clearly imprecise as recall bias is an important factor
in a situation of extreme stress [10].
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A possible explanation for the excess number of thyroid cancers observed in the responders
cohort is over-diagnosis of thyroid cancer because of increased surveillance [11]. The large number of
respiratory health issues developed by responders after their exposure to WTC dust has prompted
a higher rate of diagnostic imaging of the chest, thus increasing the possibility of a chance thyroid
nodule discovery [12,13]. Preliminary evidence, however, examining the thyroid nodules of WTC first
responders found that all tissue samples tested were positive for biomarkers of malignancy, suggesting
that while surveillance bias may be occurring, over-diagnosis of false-positives cannot sufficiently
explain the excess risk of thyroid cancer observed in this group [14].
Disentangling the roles of various contributors to this excess risk of thyroid cancer would have
major clinical and preventive consequences for the WTC responders. The aims of this study were to
(a) examine non-modifiable demographic factors such as age, sex, race or ethnicity, as well as other
contributing exposures predating thyroid cancer diagnosis; and (b) to better describe these WTC
cancers and the similarities and differences of WTC thyroid cancers to non-WTC thyroid cancers.
2. Methods
2.1. Participant Selection and Enrollment
One of the cohorts in which excess thyroid cancer risk has been observed [1] is the Mount
Sinai World Trade Center Health Program (WTCHP). Responders who participated (as employees or
volunteers) in the rescue, recovery, and cleanup efforts at the WTC sites have been enrolled at Mount
Sinai in the WTCHP, which is funded under the James Zadroga 9/11 Health and Compensation Act
of 2010, on the basis of eligibility criteria including type of duties, site location, and dates and hours
worked [15]. The medical protocol for the monitoring program includes self-administered physical
and mental health questionnaires, as well as a physical examination, laboratory tests, spirometry, and a
chest radiograph [15,16]. Over 27,000 responders have had a least one monitoring visit in the WTCHP
and have consented for their data to be aggregated, of which a total of 20,984 have consented for their
records to be used for medical research [15].
Cancer cases were identified through periodical linkage with the cancer registries of New York,
New Jersey, Pennsylvania, and Connecticut, as these states account for 98% of the responders’
residencies at time of WTCHP enrollment. The full linkage methodology has been described
elsewhere [15]. Only thyroid cancer cases validated by a cancer registry, and only those whose
enrollment into the WTCHP pre-dated their cancer diagnosis, were considered eligible to participate
in this study. Between 2002 and 2013 there were 73 eligible first responders who had developed
thyroid cancer.
Eligible participants were contacted by phone, and those interested in participating were mailed an
initial letter further explaining the research project, along with a consent form and brief questionnaire.
This questionnaire was sectioned, with questions asking about past exposure to radiation, family
medical history, personal medical history, smoking history, and other demographic information.
Participants filled out the questionnaire at home and returned it by mail using a pre-stamped and
pre-addressed return envelope. Participants had the contact information of the research assistant
working on the project if they had any questions. In one case the questionnaire was filled out over the
phone as the participant had trouble reading and writing. A signed copy of their study consents was
mailed back to each participant. Of the 73 participants in the WTCHP cohort of responders who were
eligible to be contacted, four had to be excluded because they did not speak English or because they
had no viable contact information. Of the remaining 69 WTC thyroid cancer cases, 35 (51%) consented
to completing the questionnaire. The study protocol was approved by the Icahn School of Medicine at
Mount Sinai’s Institutional Review Board (IRB-17-01323).
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2.2. Data Processing and Statistical Analysis
Upon return of the questionnaires, the data were input into excel to create a database of
questionnaire responses, and this database was uploaded into SAS for statistical analysis. Some
questionnaire responses were collapsed to make results more interpretable. If a participant reported
having had an X-ray of their head or neck, a computed tomography (CT) scan of their head, neck
or chest, or having had radiation therapy in the head or neck region predating their thyroid cancer
diagnosis they were considered as having had some sort of radiation exposure. A diagnosis of another
cancer was recorded and specified if that cancer diagnosis predated or postdated their diagnosis of
thyroid cancer. BMI was calculated using the self-reported height and weight of the study participants,
and with the cutoffs used for underweight, overweight and obese were <25, 25–30 and >30 kg/m2,
respectively, as suggested by the Center for Disease Control and Prevention [17].
The data obtained from the questionnaires, as well as the initial data reported by the WTCHP (age
at diagnosis, race, gender, histology, marital status, education and smoking status) were compared to
a sample of thyroid cancer from the Mount Sinai Cancer Registry generated by an official from the
Cancer Registry. This sample was limited to those diagnosed with thyroid cancer and treated at Mount
Sinai between 2002 and 2013, in order to cover a comparable time-frame.
Chi-square test, or Fisher’s exact test for small sample size were used to compare WTC and Sinai
Registry data for categorical variables. Wilcoxon Rank Sum Test was used for continuous variables not
normally distributed. All statistical analysis was conducted using SAS version 9.4 (SAS Institute Inc.,
Cary, NC, USA).
3. Results
There were 73 thyroid cancer cases from the WTCHP cohort and these were compared to 949
thyroid cancer cases from the Mount Sinai Cancer Registry. The majority of thyroid cancer cases were
white, both in the WTCHP group (71.9%) and in the Mount Sinai Cancer Registry (70.2%) (p = 0.8).
There was, however, a statistically significant difference in gender (p < 0.0001), with WTCHP cases
more likely to be male (78.1%). There was no significant difference between the two groups in terms
of tumor size (p = 0.4), and the mean tumor size was small in both the WTCHP and the Mount Sinai
group, 1.4 cm and 1.8 cm, respectively. Age at diagnosis was also similar between the two groups
(p = 0.2); the mean age for those diagnosed after WTC exposure was 48.9 years while the Mount Sinai
Registry mean diagnosis age was 51 years old. There was a statistically significant difference in terms
of histology (p = 0.04), with those in the WTCHP cohort more likely to be diagnosed with a subtype
of papillary carcinoma. There was also a statistically significant difference between the WTCHP and
Mount Sinai group in terms of smoking (p = 0.0385), whereby those in the WTCHP group were more
likely to be current smokers, and in terms of marital status (p < 0.0001), with those in the WTCHP
cohort being more likely to be married (Table 1).
Out of the 69 eligible WTC thyroid cancer cases, 35 (51%) consented to complete the questionnaire.
Those who consented and completed the questionnaire did not differ significantly in terms of race,
gender, age at diagnosis or histology than those who did not participate in the study (data not shown).
A total of 23% of cases reported some sort of radiation exposure. While only 9% reported a family
history of thyroid health issues (either a benign goiter or thyroid cancer), 67% reported a family history
of other cancer types. Additionally, 21% reported a previous history of cancer before the diagnosis
of thyroid cancer. The majority of the study cohort had a BMI between 25 and 30 Kg/m2 (44%) or
>30 kg/m2 (44%). Most participants (62%) reported that their thyroid cancer was diagnosed as a
consequence of routine or incidental medical surveillance, and not because they went to a doctor with
symptoms consistent with thyroid cancer (Table 2).
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WTCHP (n = 73) Sinai Cancer Registry
(n = 949) p Value
n % n %
Race/Ethnicity 0.8177
White 41 71.9 634 70.2
Black 3 5.3 68 7.5
Other 13 22.8 201 22.3
Gender <0.0001
Female 16 21.9 695 73.3
Male 57 78.1 253 26.7
Tumor Size (cm) Mean (1.4) SD (1.2) Mean (1.8) SD (1.9) 0.4053
Age at Diagnosis Mean (48.9) SD (8.0) Mean (51.0) SD (16.2) 0.2252
Histology ˆ 0.0363
Papillary Carcinoma 66 90.4 792 83.5
Papillary Adenocarcinoma NOS (63.6%) (58.7%)
Papillary Carcinoma Follicular Variant (28.8%) (22.0%)
Papillary Microcarcinoma (3.0%) (17.7%)
Papillary Carcinoma Columnar Cell (4.5%) (1.6%)
Other Adenocarcinoma 5 6.9 41 4.3
Oxyphilic Adenocarcinoma (60.0%) (46.3%)
Follicular Adenocarcinoma (40.0%) (53.7%)
Other 2 2.7 116 12.2
Smoking Status 0.0385
Current Smoker 3 5.1 14 1.5
Former or Never Smoker 56 94.9 925 98.5
Marital Status <0.0001
Married or Partnered 42 70.0 519 59.7
Separated or Divorced 12 20.0 56 6.4
Single 3 5.0 241 27.7
Widowed 3 5.0 53 6.1
* Race nWTC = 57, nregistry = 903; gender nWTC = 73, nregistry = 948; tumor size nWTC = 27, nregistry = 753; age
at diagnosis nWTC = 73, nregistry = 949; histology nWTC = 73, nregistry = 94, marital status nWTC = 60, nregistry =
869. ˆ Histology is based on International Classification of Diseases for Oncology (ICD-O-3) coding: Papillary
adenocarcinoma NOS = 8260, oxyphilic adenocarcinoma = 8290, follicular adenocarcinoma NOS = 8330, papillary
carcinoma follicular variant = 8340, papillary microcarcinoma = 8341, papillary carcinoma columnar cell = 8344.
Table 2. WTC thyroid cases questionnaire responses (n = 35).




Family History of Thyroid Issues
Yes 3 8.8
No 31 91.2
Family History Other Cancer
Yes 22 66.7
No 11 33.3
Personal History of Another Cancer
Before Thyroid Cancer 7 20.6
After Thyroid Cancer or Unknown dx Date 8 23.5






Because of Symptoms 21 61.8
Due to Routine Screening or Unrelated Medical Event 13 38.2
* Missing data for family history of other cancer (1), family history of other cancer (2), personal history of other
cancer (1), smoking history (1), BMI (1), diagnosis method (1).
142
IJERPH 2019, 16, 1258
4. Discussion
Whether or not surveillance bias is occurring in the WTCHP cohort, and the extent to which this
bias may be contributing to the increased incidence of thyroid cancer among first responders, remains
unclear. The similar clinical characteristics observed between the WTCHP responders and those in
the Mount Sinai Registry suggest that the excess risk of thyroid cancer in first responders cannot be
adequately explained by surveillance bias alone. Under the surveillance bias hypothesis, we would
expect increased detection of small thyroid nodules [11,18], yet there was no statistical difference
between the average tumor size of the WTCHP and Mount Sinai Registry groups. Moreover, the
average age at diagnosis was similar between the two groups, while if surveillance bias was introduced
then smaller cancers should have been detected at an earlier age in the WTC cohort. It is important
to consider how surveillance bias may be occurring across the US as a whole; previous research has
found that much of the national increase in thyroid cancer incidence can be attributed to an increase in
small (<1 cm) tumors, unlikely to be found in the absence of routine or incidental surveillance [11].
Moreover, the majority of WTC participants reported that their cancers were diagnosed due to routine
or incidental screening, which may be higher than the expected rate of asymptomatic thyroid cancer
detection [19].
The WTCHP and Mount Sinai thyroid cancer groups statistically differed in terms of gender,
histology, smoking history and marital status; they were not statistically different in terms of race.
Comparison of gender between the two groups, however, is difficult to interpret, since the WTCHP is
composed predominantly of males [20]. WTCHP thyroid cancer cases were more likely to be papillary
histology, which tend to have a favorable prognosis [21]. Moreover, those in the WTCHP cohort
were more likely to be current smokers when compared to the Mount Sinai Registry group, though
the number of reported current smokers was small for both groups. It remains controversial what
affect smoking has on thyroid cancer risk; a decrease in risk of thyroid cancer in men who are current
smokers has actually been observed, although there is no known biological justification for this [22,23].
WTCHP respondents with thyroid cancer were also more likely to be married or have a partner; data
indicate reduced mortality from cancer associated with being married as opposed to being single,
possibly because of increased social support [24].
While WTCHP thyroid cancer cases do not appear to be clinically distinct, their reported risk
factors and carcinogenic exposure history may be uncommon. Only about 23% reported having had
some sort of previous diagnostic radiation exposure before their thyroid cancer diagnosis, while other
studies have found that this number could be as high as 85%, even suggesting this type of radiation
exposure contributes to the carcinogenic process [25].
Increased BMI is also associated with increased risk of thyroid cancer [26] and 44.1% of WTCHP
responders reported a BMI 25–29 km/m2, with an additional 44.1% reporting a BMI >30 km/m2.
Neta et al. reported 15.9% and 12% of the thyroid cancer cases having a BMI of 25–29, and ≥30 km/m2,
respectively, which is lower than what was observed in the WTCHP cohort. However, these percentages
seem to be in keeping with what has been reported for the overall WTCHP general responder cohort,
suggesting that the thyroid cancer cases represent a random subset of the total group in terms of
BMI [25].
Moreover, few WTCHP responders (8.8%) reported in their questionnaire that they had a family
history of thyroid cancer or benign thyroid issues. Having a first-degree relative with thyroid cancer
is known to increase thyroid cancer risk [27]. Other studies have found that as high as 15.6% of
thyroid cancer cases report a family history of thyroid cancer [25,28]. A family history of another
malignant disease has also been shown to be associated with thyroid cancer [29], and having a family
history of cancer was reported by 66.7% of WTCHP respondents. This is higher than reported by
past research, which found that 49% of thyroid cancer cases reported a family history of cancer in
first-degree relative [29]. It is possible that some WTC respondents may have reported past cancers of
relatives more distant than first-degree relatives, thus inflating the statistic.
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Having a previous cancer diagnosis has also been shown to be associated with thyroid cancer [30],
and 20.6% of WTCHP respondents reported having had another cancer before being diagnosed with
thyroid cancer. This is higher than what was reported in the SEER database [31], where only 10.9%
of thyroid cancer cases had another cancer predating thyroid cancer diagnosis. It is possible that
this is related to the fact that WTC responders are at an increased risk for several types of cancer,
including prostate cancer [1]; an alternative explanation could be an increased familial risk among
WTCHP responders.
The WTCHP responders were also likely (23.5%) to develop a second primary cancer after thyroid
cancer, which is in keeping with the observed increase in risk of secondary cancers associated with
a primary thyroid cancer [32]. This number is higher, however, than what would be expected based
on SEER registry data, whereby just 8% of thyroid cancer cases developed a second type of tumor.
Again, it remains unclear if this increased risk of multiple primary cancers is because of WTC dust and
debris exposure having a carcinogenic effect on 9/11 first responders or because of other genetic or
environmental factors.
This study had some limitations, which includes a small sample size that may have been affected
by recall bias, since participants were asked about past exposure and family history. Although selection
bias could have been possible, an attempt was made to verify that those who participated were not
statistically different from those who chose not to.
Among the strengths, this study represents an important contribution to the literature by helping
to fill the gap in understanding why 9/11 first responders experience an increased risk of thyroid
cancer. The descriptive epidemiology presented here will hopefully inform future, more in-depth
studies that may explain this phenomenon. Future research on germline and somatic tumor alterations
of these cancers may help to shed light on the possibility of a WTC-related carcinogenic mechanism.
5. Conclusions
Cancer surveillance of WTC first responders should continue, and specifically thyroid health
should be part of regular screening procedures. Ultrasound techniques instead of radiation-based
diagnostic procedures might be a more appropriate first step approach.
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Abstract: Background: Sarcoidosis is a granulomatous disease involving intrathoracic and extrathoracic
organs. Genetic and environmental factors, such as exposure to World-Trade Center (WTC) dust
after 9/11, may play a role in clinical presentation. Characterization of sarcoidosis in community
members with exposure to the WTC dust can provide further insight into the relationship between
environmental exposure and sarcoidosis. Methods: Patients with documented sarcoidosis were
identified in the WTC Environmental Health Center (EHC), a treatment program for community
members. Demographic and clinical data were collected from standardized questionnaires and
chart review. Organ involvement was assessed with a standard instrument. Results: Among
patients in the WTC EHC, 87 were identified with sarcoidosis after 9/11. Sarcoidosis cases were
more likely African-American, local workers, and had more respiratory symptoms, compared with
non-sarcoidosis WTC EHC patients. Many (46%) had ≥ Scadding stage 3 on chest imaging, and had
reduced lung function measures. Extrathoracic involvement was identified in 33/87 (38%) with a
diversity of organs involved. Conclusions: WTC-exposed sarcoidosis in community members is often
characterized by severe pulmonary disease and a high rate of diverse extrathoracic involvement.
Further analysis is required to characterize the course of disease progression or resolution.
Keywords: sarcoidosis; World Trade Center (WTC); Scadding stage; lung function; severe lung
disease; extrathoracic sarcoidosis; cardiac sarcoidosis
1. Introduction
Sarcoidosis is a multisystem granulomatous disease of unknown etiology that is currently
considered a genetically primed abnormal immune response to an antigenic exposure or trigger [1].
Rather than a single disease entity, sarcoidosis may be a constellation of “sarcoidoses,” with a
characteristic pattern of organ involvement, depending upon the underlying genotype and triggering
exposure. Exposure to the dust and fumes from the destruction of the World Trade Center (WTC) on 11
September 2001 (9/11) has been suggested to be one such trigger with sarcoidosis diagnoses described
in WTC-exposed members of the Fire Department of the City of New York (FDNY), those involved
in rescue and recovery efforts (responders), and community members (“survivors”) with WTC dust
exposure [2–7]. Increased incidence rates have been reported for the firefighters and responders [2,3,6].
Whereas sarcoidosis can affect nearly all organs and tissues, intrathoracic involvement including
hilar and mediastinal lymph nodes and/or lungs is the most common presentation [8,9]. However,
extrathoracic involvement often distinguishes sarcoidosis from other granulomatous diseases and
contributes to its diagnosis [9]. Indeed, in a large survey of sarcoidosis patients (A Case Control
IJERPH 2019, 16, 1291; doi:10.3390/ijerph16071291 www.mdpi.com/journal/ijerph147
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Etiologic Study of Sarcoidosis; ACCESS) 95% of the population had intrathoracic involvement and
50% extrathoracic involvement [8]. The presence of extrathoracic involvement was associated with
age, race and sex [8]. In addition, differences in progression of intrathoracic and extrathoracic organ
involvement were noted; intrathoracic involvement improved or remained stable whereas extrathoracic
involvement typically increased over time [10,11]. Development of new organ involvement was more
common in African-Americans [10]. The characteristics of sarcoidosis associated with WTC exposure,
particularly those in community members, are less well described. A recent study of the clinical
course of WTC-related sarcoidosis in the WTC-exposed Fire Department of the City of New York
(FDNY) suggested a phenotype with a high rate of cardiac and rheumatologic (bone/joint) involvement,
suggesting a unique response to their environmental exposure [7].
The WTC Environmental Health Center (WTC EHC) is a treatment program for self-referred
community members, or “survivors,” with medical and mental health conditions secondary to acute
exposure to the WTC dust on 9/11 (dust cloud) and/or chronic exposure to the WTC dust and fumes in
their homes and/or workplaces over the ensuing days and months [12]. These community members
include local residents, local workers, students, those involved in clean-up activities, and those who
were passing by on 9/11. In contrast to the firefighter and responder populations, nearly 50% of the
community members are women, and are of diverse race/ethnicity [13]. This heterogeneity and diversity
of exposure to the WTC dust and fumes distinguishes them from the WTC-exposed responders, and
their unique exposure sets them apart from the non-exposed general population. Characteristics of
community members with sarcoidosis have been incompletely described. Exploration of their clinical
presentation in comparison to other sarcoid variants may help us to better understand the relationship
between exposure and sarcoidosis phenotype, providing further insight into sarcoidosis etiology. We
now report a case series of community members in the WTC EHC with a diagnoses of post 9/11
sarcoidosis to further characterize the clinical presentation of sarcoidosis in this unique population. We
describe similarities and differences between this population and other WTC and non-WTC sarcoidosis.
2. Materials and Methods
2.1. Study Population
2.1.1. Inclusion-Exclusion Criteria
Patients were included for review if they were enrolled in the Bellevue Hospital WTC EHC with a
“certified” diagnosis as defined by the Centers of Disease Control (https://www.cdc.gov/wtc/handbook.
html#certifications) and signed consent to have their data analyzed. By federal rules, WTC-exposed
sarcoidosis cases allowed to enroll in the WTC EHC must have intrathoracic involvement presumed
secondary to their relevant WTC exposure. The Institutional Review Board of New York University
School of Medicine approved the research database (NCT00404898), and only data from patients
who provided informed consent were used for analysis. Patients were included for analysis if they
had biopsy proven sarcoidosis or chest imaging with characteristic findings of sarcoidosis defined as
bilateral symmetrical mediastinal and/or hilar adenopathy, perilymphatic nodules, or fibrosis with
bronchial distortion, at time of diagnosis or initial evaluation and without alternative etiology [9].
Signs or symptoms suggesting extrathoracic involvement such as confirmed uveitis or characteristic
rash with concomitant elevated ACE level, were also used to establish a diagnosis [9]. Patients with a
sarcoidosis diagnosis that predated 9/11 were excluded from analysis.
2.1.2. “Non-Sarcoidosis” Comparison Population
Study cases were compared to WTC exposed community members without sarcoidosis. In
addition to WTC exposure, their entry into the WTC EHC required a physical complaint and diagnosis
(e.g., lower or upper airway disease, GERD, other interstitial lung disease and/or cancer).
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2.2. Clinical Evaluation
Pathology reports were reviewed for all patients with available information to confirm histologic
culture-negative, noncaseating granulomas. For those without a biopsy, imaging reports were reviewed
to confirm characteristic findings. Information on demographic and clinical characteristics, including
WTC and other exposures, were obtained from a standardized questionnaire completed upon entry into
the WTC EHC [13]. Information in this questionnaire included direct exposures to the WTC dust clouds,
potential for exposure in the home or workplace, and duration of exposure in the home or workplace
prior to cleanup. The Modified Medical Research Council (mMRC) questionnaire was used to assess
dyspnea. Additional clinical information obtained at entry into the WTC EHC included complete blood
count, metabolic panel, and liver enzyme levels. Lung function measurements performed as routine
screening were assessed. Chart reviews were performed to obtain additional information including
CXR, computed tomography (CT) scans, ophthalmologic findings, EKG and advanced cardiac imaging.
Additional diagnostic studies, e.g., serum angiotensin-converting enzyme (ACE) and serum vitamin D
(25-hydroxy and 1,25 dihydroxy) levels obtained in the WTC EHC at time of entry into the program or
during subsequent evaluation, were also reviewed.
2.3. Assessment of Disease Severity and Organ Involvement
Sarcoidosis cases were staged for pulmonary disease by both CXR and/or CT scan using Scadding
staging: stage 0: no adenopathy or infiltrates; stage 1: hilar and mediastinal adenopathy alone; stage 2:
adenopathy and pulmonary infiltrates; stage 3: pulmonary infiltrates alone; and stage 4: pulmonary
fibrosis [14]. Radiographic studies were selected for review based on temporality to disease onset with
images used that were closest to date of diagnosis.
The World Association of Sarcoidosis and Other Granulomatous Diseases (WASOG) organ
assessment instrument was used to categorize sarcoidosis involvement of each organ system at time of
initial evaluation [15]. A finding of “highly probable” or “at least probable” was considered diagnostic
for organ involvement. Positive findings on cardiac MRI (cMRI) were required to confirm a diagnosis
of cardiac sarcoidosis, “at least probable” criteria by WASOG [15]. Other cardiac imaging modalities
obtained after time of initial visit included electrocardiograms, echocardiograms, and continuous
ambulatory ECG monitoring. These were reviewed for findings suggestive of possible cardiac
involvement. Determination of ocular involvement required documentation of an ophthalmology
visit in which fundoscopic findings confirming sarcoidosis were described. Patients with a brain MRI
demonstrating characteristic abnormal enhancement after initial WTC clinic visit were identified as
having neurologic involvement of sarcoidosis. Abnormal electromyography (EMG) findings were
considered “suggestive but not diagnostic;” a field of “no consensus” in the WASOG organ assessment
instrument [15]. Patients were identified as having cutaneous manifestations if biopsies showed
pathognomonic granulomas and/or a dermatologist documented rashes with characteristic morphology
“at least probable” or “highly probable” by WASOG [15]. Liver, spleen or gastrointestinal involvement
was identified from available pathology, CT or MRI imaging.
2.4. Statistics
Descriptive statistics were used to summarize the study cohort. We used count and percentage
for categorical variables and median and IQR (Q1, Q3) for continuous variables. Univariate analyses
were performed to compare the demographic characteristics, clinical characteristics, laboratory values
and pulmonary function metrics between sarcoidosis patients and non-sarcoidosis patients and also
between sarcoidosis patients who had lung disease at Scadding stage 1–2 and those who had stage
3–4 disease. The comparison tests include χ2 test for categorical variables and Mann-Whitney U test
for continuous factors. Fisher exact test was performed in place of χ2 test if the expected count of
a category was less than 5. All statistical analyses were accomplished using SAS 9.4 software (SAS
Institute Inc., Gary, NC, USA). p-Values < 0.05 were considered statistically significant.
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3. Results
3.1. Demographic Characteristics
Among 5849 community members at Bellevue Hospital enrolled between 17 August 2005 and 30
March 2018 with signed consents for analysis, 98 were identified with WTC-related sarcoidosis as per
defined federal rules. Patients with a sarcoidosis diagnoses that predated 9/11 (n = 11) were excluded
from analysis. This resulted in 87 individuals with sarcoidosis available for analysis. Biopsy-proven
sarcoidosis was identified in 77, and an imaging diagnosis was obtained for 10. Sarcoidosis diagnosis
occurred on average 7 years (SD = 4.5) after 9/11/2001 and 3 years (SD = 4.8) before enrollment in the
WTC EHC, with mean time to enrollment being 10 years (SD = 4.4) after 9/11/2001.
As far as the 5751 non-sarcoidosis community members, patients without lung function values
(n = 607) were excluded to allow meaningful comparison of pulmonary physiology. For these
non-sarcoidosis patients (n = 5144), time to enrollment in the WTC EHC occurred on average 9 years
(SD = 3.8) after 9/11/2001.
Basic exposure and demographic characteristics are shown (Table 1). Many (51%) of the
WTC-exposed community members with sarcoidosis were caught in the dust cloud on 9/11/2001, and
most were local workers (73%). Almost half were female (48%) and the majority were never smokers
(67%). Patients with sarcoidosis had a median age of 40 years on 9/11. Race/ethnicity was diverse
with 44% reporting as black/African-American, 36% white and 18% Hispanic. We did not identify a
statistically significant association between WTC dust cloud exposure and sarcoidosis status in WTC
EHC. Those with sarcoidosis were more likely to be African-American and local workers compared
with patients without sarcoidosis.
Table 1. Basic demographic characteristics.
Characteristic Non-Sarcoidosis (N = 5144) Sarcoidosis (N = 87) p-Value
Age on 9/11/2001, yr, median (Q1, Q3) 43 (35, 50) 40 (33, 45) 0.015 *
Age on Initial Visit, yr, median (Q1, Q3) 59.7 (52, 67) 57.5 (51, 62) 0.017 *
Gender, n (%) 0.8
Female 2551 (50) 42 (48)
Male 2593 (50) 45 (52)
Race/Ethnicity, n (%) <0.0001 ***
Asian 427 (8) 2 (2)
Hispanic 1483 (29) 15 (18)
NH-Black 942 (19) 38 (44)
NH-White 2176 (43) 31 (36)
Native American 11 (0.2) -
Other 51 (1) -
Ever smoke cigarettes, n (%) 0.2
Yes 2032 (40) 29 (33)
No 3087 (60) 58 (67)
WTC Exposure Category, n (%) <0.0001 ***
Local worker 2751 (53) 63 (73)
Resident 1163 (23) 8 (9)
Rescue/Recovery/Other 603 (12) 15 (17)
Clean-up worker 613 (12) 1 (1)
WTC Dust Cloud Exposure, n (%) 0.6
Yes 2711 (53) 44 (51)
No 2388 (47) 43 (49)
p-Value: *** < 0.0001; * < 0.05.
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3.2. Clinical Characteristics
Entry into the WTC EHC required a physical complaint and diagnosis, and most patients entered
with respiratory symptoms and diagnoses consistent with asthma, chronic obstructive pulmonary
disease or interstitial lung disease. Despite the frequency of these diagnoses, those with sarcoidosis
were more likely to report dyspnea, cough and wheeze ≥ two times/week within 4 weeks of entry into
the clinic, as well as a decreased exercise tolerance after 9/11 (Table 2). Many reported comorbid nasal
drip or sinus congestion (57%) and heartburn (49%) while some endorsed rash (38%).
Table 2. Respiratory symptoms at time of enrollment.
Symptom, n (%) Non-Sarcoidosis (N = 5144) Sarcoidosis (N = 87) p-Value
Cough 3278 (64) 67 (78) 0.009 **
Wheezing 2608 (51) 58 (67) 0.004 **
Dyspnea with exercise 3929 (77) 76 (89) 0.009 **
Dyspnea at rest 1731 (34) 49 (56) <0.0001 ***
MMRC 0.03 *
<3 3509 (79) 56 (69)
≥3 928 (21) 25 (31)
p-Value: *** < 0.0001; ** < 0.01; * < 0.05.
Lung function measurements including pre and post bronchodilator (bd) spirometry, lung volume
and diffusion capacity measures were evaluated in patients with sarcoidosis compared with the
non-sarcoidosis patients (Table 3). Sarcoidosis patients had a reduced FEV1 and pre-bronchodilator
FEV1/FVC compared with non-sarcoidosis patients. Sarcoidosis patients were also characterized
according to Scadding stage based on chest imaging. Thirty-six of 79 (46%) sarcoidosis patients with
available chest imaging had severe lung disease defined as Scadding stage 3 or 4. Patients with more
severe radiographic disease had reduced FEV1, FVC and DLCO compared with patients with milder
radiographic changes (Table 3).
Table 3. Lung function: Stage 1–2 vs. Stage 3–4 pulmonary sarcoidosis.
Non-Sarcoidosis
(N = 5144)







Stage 1–2 (N = 43)
Lung Disease
Stage 3–4 (N = 36)
FEV1, L, median (%†)
Pre bd 2.69 (90) 2.86 (88) 2.10 (75) 0.03 * 0.002 **
Post bd 2.80 (94) 3.01 (89) 2.06 (77) 0.02 * 0.0004 **
FVC, L, median (%†)
Pre bd 3.51 (92) 3.55 (92) 3.02 (83) 0.25 0.03 *
Post bd 3.56 (93) 3.68 (89) 2.78 (81) 0.13 0.008 **
FEV1/FVC, %†
Pre bd 78 76 75 0.04 * 0.65
Post bd 80 79 79 0.27 0.42
TLC, L, median (%) 5.15 (91) 4.83 (90) 4.39 (67) 0.22 0.22
DLCO, mmHg, median (%) 19.15 (87) 19.50 (84) 15.10 (60) 0.11 0.013 *
FEV1: forced expiratory volume in one second; FVC: forced vital capacity; TLC: total lung capacity; DLCO: diffusing
capacity of the lungs for carbon monoxide; bd: bronchodilator; %†: National Health and Nutrition Examination
Survey (NHANES) III reference values [16]; p-Value: *** < 0.0001; ** < 0.01; * < 0.05.
3.3. Organ Involvement
Thirty-three (38%) of the sarcoidosis patients had evidence of extrathoracic involvement: 19
(22%) had two organs involved, 10 (12%) had three organs involved, and 5 (6%) had ≥ four. Diverse
organ involvement was identified; however, ocular involvement (15%) was the most common
extrathoracic manifestation followed by skin (13%). Fewer had confirmed nervous system (3%)
or cardiac (6%) involvement (Table 4). There were no significant differences in demographic or
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WTC exposure characteristics for isolated intrathoracic (n = 54) versus extrathoracic disease, severe
lung disease (Scadding Stage 3 or 4; n = 36), or extent of extrathoracic organ involvement (3 or
more organ systems involved; n = 15). Few patients (9/62; 15%) had elevated ACE levels. Median
neutrophil-to-lymphocyte ratio (NLR) was 2.4, compared to a reported mean of 1.65 in an adult,
non-geriatric, healthy population [17].
Table 4. Organ involvement.
Organ System, n (%) Sarcoidosis (N = 87)
Intrathoracic *
Stage 1 18 (23)
Stage 2 25 (32)
Stage 3 17 (22)





Bone marrow 2 (2)
Skin 11 (13)









* All with certified pulmonary involvement; eight without readily available chest imaging for review (n = 79).
3.4. Cardiac Sarcoidosis: Screening and Diagnosis
Electrocardiograms were available for review in 75 individuals; 10 had abnormalities suggestive
of potential cardiac sarcoidosis, including left or right bundle branch block, left anterior fascicular block
or other interventricular conduction delay. Subsequent transthoracic echocardiogram was performed
in 7/10 of these patients. The majority (86%) had normal left ventricular ejection fraction without any
associated wall motion abnormalities.
A total of 14 patients were referred for advanced cardiac imaging (either cMRI or PET). 6/14 were
referred due to abnormal ECG, echocardiogram, and/or continuous ambulatory ECG monitoring;
the remaining eight were referred due to concerning cardiac symptoms alone (e.g., atypical chest
pain, palpitations, dizziness/syncope). Cardiac involvement was confirmed in 5/14 patients, one
with a supporting myocardial biopsy and two with an unremarkable screening study. Many patients
were awaiting advanced cardiac imaging at the time of this publication, including 7 patients with an
abnormal EKG and 6 with abnormal continuous ambulatory ECG monitoring.
4. Discussion
We described the clinical characteristics of a heterogeneous cohort of WTC-exposed community
members, or “survivors,” with post-9/11 sarcoidosis. The demographic characteristics of the WTC
EHC population with sarcoidosis differed from the FDNY, with many more patients who were female
or who identified as African American or Hispanic. These characteristics were more similar to the
general population described in ACCESS and the cohort from Medical University of South Carolina
(MUSC) [8,10,11].
By definition, WTC-exposed sarcoidosis cases must have intrathoracic involvement (100%).
However, the WTC-exposed survivors with sarcoidosis differed from other sarcoidosis variants—the
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WTC-exposed FDNY cohort as well as previously reported non-exposed general population(s)—in
terms of severity of their intrathoracic disease [7,8,10,11]. Forty-six percent had Scadding stage 3
or 4 on initial evaluation chest imaging, indicating advanced pulmonary involvement, which was
associated with reduced lung function measures. This frequency of severe disease is higher than that
described in the initial ACCESS study (15% with stage 3 or 4) and even greater than that described
in the FDNY cohort (7%) [7,8]. Importantly, the MUSC study, which evaluated the last available
radiograph allowing for progression of Scadding stage, still described lower rates (27%) of stage 3
or 4 disease than that identified in the WTC EHC cohort (46%). The severity of intrathoracic disease
is consistent with the respiratory symptoms reported at time of enrollment (Table 2). However, it is
unknown whether our cohort represents those with more symptomatic, severe disease rather than
sarcoidosis all-comers given the distinct self-referral entry into the WTC-EHC.
The frequency of extrathoracic involvement (38%) was slightly less than that reported in ACCESS
(50%) [8]. However, the extrathoracic involvement in the WTC-EHC was distinguished by its variety
and extent of extrathoracic organs involved. Similar to general population studies with comparable
race/ethnic distribution, ocular and skin involvement were most common [8,10,11]. This is in contrast
to the predominantly Caucasian male FDNY cohort, for which eye and skin involvement were
relatively rare (5% and 2% respectively) [7]. Rare, but unique organ involvement included thyroid
(1%), gastrointestinal (2%) and the appendix (1%). The extent of organ involvement (17% with three or
more organs involved), was similar to that reported in the general population (20%) [8]. However,
unlike the ACCESS and MUSC studies where African Americans tended to have more organs involved,
we detected no significant differences in demographic variables for intrathoracic versus extrathoracic
disease or extent of extrathoracic organ involvement [8,10,11].
Cardiac sarcoidosis remains a challenging diagnosis with current guidelines recommending
advance cardiac imaging only in patients with symptoms, abnormal (ECG), or abnormal
echocardiogram [18,19]. However, screening modalities have limited sensitivity; a study on predictors
of cardiac sarcoidosis cited a sensitivity of 58% for ECGs and 62% for echocardiograms [20]. While
continuous ambulatory ECG monitoring for 24 hours or more has higher sensitivity (89%), it has low
specificity (21%) [20]. The rate of confirmed cardiac sarcoidosis (6%) in the survivor cohort is consistent
with that of non-WTC general population studies, with clinically evident cardiac sarcoidosis manifested
by conduction abnormalities, ventricular arrhythmias, and/or heart failure evident in only 2–7% of
sarcoidosis patients [8,10,11]. Although cardiac sarcoidosis was clinically detected in 16% (19/57) of the
WTC-exposed FDNY cohort at follow-up, this may have been due to increased screening in relatively
asymptomatic patients [7]. A lower threshold for advanced cardiac imaging in the survivor population
might result in higher rates of detection, beyond those already awaiting confirmatory diagnostics.
This study has several limitations. Complete analyses of all patients were not possible due
to missing data. Many patients referred to the WTC EHC also receive care at outside institutions,
including some critical components of sarcoidosis screening for extrathoracic disease. Thus data from
other institutions may not have been captured by our study, leading to potential underreporting of
extrathoracic organ involvement. Furthermore, although a standardized approach to diagnosis and
evaluation was recommended at the WTC EHC, diagnostic studies were varied. Patients shared
a common WTC exposure; however, the degree and extent of that exposure, including differences
among the WTC dust characteristics, is known to vary, complicating the environmental exposure
analysis. Patients had ranging dates of initial sarcoidosis diagnosis. Given the tendency of sarcoidosis
organ involvement to increase per year, it is likely that patients in our cohort with more recent dates
of diagnosis will continue to develop extrathoracic involvement as time progresses. In addition,
longitudinal analysis was confounded by irregular follow-up by many patients, and visit incongruity
made it difficult to compare number of organs involved per equivalent time period. Additional
analyses are needed to further characterize clinical course.
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5. Conclusions
Our data suggest a WTC-exposed sarcoidosis phenotype in community members or “survivors”
often characterized by severe pulmonary disease and diverse extrathoracic involvement. These
characteristics differ from those described for the FDNY. Similarities to general population studies
are likely secondary to comparable gender and race/ethnicity distribution with differences in severity
of pulmonary disease and rare organ involvement potentially explained by WTC exposure. Further
analysis is required to characterize the course of disease progression or resolution.
Author Contributions: Conceptualization, K.M.H., A.K. and J.R..; methodology, K.M.H., S.M., Y.Z.; software, Y.Z.
and Y.S.; validation, Y.Z. and Y.S.; formal analysis, K.M.H., S.M., J.R., Y.Z. and Y.S.; investigation, K.M.H., S.M. and
Y.Z.; resources, A.K., Y.Z. and Y.S.; data curation, K.M.H., S.M., Y.Z. and Y.S.; writing—original draft preparation,
K.M.H. and S.M.; writing—review and editing, K.M.H., A.K., J.R., Y.Z. and Y.S.; visualization, Y.Z.; supervision,
K.M.H., Y.S. and J.R.; project administration, Y.S. and J.R.; funding acquisition, Y.S. and J.R.
Funding: This research was supported by the City of New York, US Centers for Disease Prevention and Control
(CDC) and the National Institute of Occupational Safety and Health (NIOSH) contracts 200–2017–93327 and
200–2017–93427, as well as the National Institute of Environmental Health Sciences grant 5P30ES000260.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to
publish the results.
References
1. Valeyre, D.; Prasse, A.; Nunes, H.; Uzunhan, Y.; Brillet, P.-Y.; Müller-Quernheim, J. Sarcoidosis. Lancet 2014,
383, 1155–1167. [CrossRef]
2. Izbicki, G.; Chavko, R.; Banauch, G.I.; Weiden, M.D.; Berger, K.I.; Aldrich, T.K.; Hall, C.; Kelly, K.J.; Prezant, D.J.
World Trade Center “Sarcoid-Like” Granulomatous Pulmonary Disease in New York City Fire Department
Rescue Workers. Chest 2007, 131, 1414–1423. [CrossRef] [PubMed]
3. Crowley, L.E.; Herbert, R.; Moline, J.M.; Wallenstein, S.; Shukla, G.; Schechter, C.; Skloot, G.S.; Udasin, I.;
Luft, B.J.; Harrison, D.; et al. “Sarcoid like” granulomatous pulmonary disease in World Trade Center disaster
responders. Am. J. Ind. Med. 2010, 54, 175–184. [CrossRef] [PubMed]
4. Jordan, H.T.; Stellman, S.D.; Prezant, D.; Teirstein, A.; Osahan, S.S.; Cone, J.E. Sarcoidosis Diagnosed After
September 11, 2001, Among Adults Exposed to the World Trade Center Disaster. J. Occup. Environ. Med.
2011, 53, 966–974. [CrossRef] [PubMed]
5. Parsia, S.S.; Yee, H.; Young, S.; Turetz, M.L.; Marmor, M.; Wilkenfeld, M.; Kazeros, A.; Caplan-Shaw, C.E.;
Reibman, J. Characteristics of Sarcoidosis in Residents and Workers Exposed to World Trade Center (WTC)
Dust, Gas and Fumes Presenting for Medical Care. Am. Thorac. Soc. 2010, A1740. [CrossRef]
6. Webber, M.P.; Yip, J.; Zeig-Owens, R.; Moir, W.; Ungprasert, P.; Crowson, C.S.; Hall, C.B.; Jaber, N.;
Weiden, M.D.; Matteson, E.L.; et al. Post-9/11 Sarcoidosis in WTC-Exposed Firefighters and Emergency
Medical Service Workers. Respir. Med. 2017, 132, 232–237. [CrossRef] [PubMed]
7. Hena, K.M.; Yip, J.; Jaber, N.; Goldfarb, D.; Fullam, K.; Cleven, K.; Moir, W.; Zeig-Owens, R.; Webber, M.P.;
Spevack, D.M.; et al. Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters. Chest 2017,
153, 114–123. [CrossRef] [PubMed]
8. Baughman, R.P.; Teirstein, A.S.; Judson, M.A.; Rossman, M.D.; Yeager, H.; Bresnitz, E.A.; DePalo, L.;
Hunninghake, G.; Iannuzzi, M.C.; Johns, C.J.; et al. Clinical Characteristics of Patients in a Case Control
Study of Sarcoidosis. Am. J. Respir. Crit. Care Med. 2001, 164, 1885–1889. [CrossRef] [PubMed]
9. Valeyre, D.; Bernaudin, J.-F.; Uzunhan, Y.; Kambouchner, M.; Brillet, P.-Y.; Soussan, M.; Nunes, H. Clinical
Presentation of Sarcoidosis and Diagnostic Work-Up. Semin. Respir. Crit. Care Med. 2014, 35, 336–351.
[PubMed]
10. Judson, M.A.; Baughman, R.P.; Thompson, B.W.; Teirstein, A.S.; Terrin, M.L.; Rossman, M.D.; Yeager, H.;
McLennan, G.; Bresnitz, E.A.; DePalo, L.; et al. Two year prognosis of sarcoidosis: the ACCESS experience.
Sarcoidosis Vasc. Diffus. Lung Dis. 2003, 20, 204–211.
11. Judson, M.A.; Boan, A.D.; Lackland, D.T. The clinical course of sarcoidosis: presentation, diagnosis, and
treatment in a large white and black cohort in the United States. Sarcoidosis Vasc. Diffus. Lung Dis. 2012, 29,
119–127.
154
IJERPH 2019, 16, 1291
12. Reibman, J.; Levy-Carrick, N.; Miles, T.; Flynn, K.; Hughes, C.; Crane, M.; Lucchini, R.G. Destruction of the
World Trade Center Towers. Lessons Learned from an Environmental Health Disaster. Ann. Am. Thorac. Soc.
2016, 13, 577–583. [CrossRef] [PubMed]
13. Reibman, J.; Liu, M.; Cheng, Q.; Liautaud, S.; Rogers, L.; Lau, S.; Berger, K.I.; Goldring, R.M.; Marmor, M.;
Fernandez-Beros, M.E.; et al. Characteristics of a Residential and Working Community with Diverse Exposure
to World Trade Center Dust, Gas, and Fumes. J. Occup. Environ. Med. 2009, 51, 534–541. [CrossRef] [PubMed]
14. Scadding, J.G. Prognosis of Intrathoracic Sarcoidosis in England. BMJ 1961, 2, 1165–1172. [CrossRef]
[PubMed]
15. Judson, M.A.; Costabel, U.; Drent, M.; Wells, A.; Maier, L.; Koth, L.; Shigemitsu, H.; Culver, D.A.; Gelfand, J.;
Valeyre, D.; et al. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical
tool. Sarcoidosis Vasc. Diffus. Lung Dis. 2014, 31, 19–27.
16. Hankinson, J.L.; Odencrantz, J.R.; Fedan, K.B. Spirometric Reference Values from a Sample of the General
U.S. Population. Am. J. Respir. Crit. Care Med. 1999, 159, 179–187. [CrossRef] [PubMed]
17. Forget, P.; Khalifa, C.; Defour, J.-P.; Latinne, D.; Van Pel, M.-C.; De Kock, M. What is the normal value of the
neutrophil-to-lymphocyte ratio? BMC Res. Notes 2017, 10, 995. [CrossRef] [PubMed]
18. Mehta, D.; Lubitz, S.A.; Frankel, Z.; Wisnivesky, J.P.; Einstein, A.J.; Goldman, M.; Machac, J.; Teirstein, A.
Cardiac Involvement in Patients with Sarcoidosis. Chest 2008, 133, 1426–1435. [CrossRef] [PubMed]
19. Hulten, E.; Aslam, S.; Osborne, M.; Abbasi, S.; Bittencourt, M.S.; Blankstein, R. Cardiac sarcoidosis—State of
the art review. Cardiovasc. Diagn. Ther. 2016, 6, 50–63. [PubMed]
20. Freeman, A.M.; Curran-Everett, D.; Weinberger, H.D.; Fenster, B.E.; Buckner, J.K.; Gottschall, E.B.; Sauer, W.H.;
Maier, L.A.; Hamzeh, N.Y. Predictors of Cardiac Sarcoidosis Using Commonly Available Cardiac Studies.
Am. J. Cardiol. 2013, 112, 280–285. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
155




Unmet Mental Health Care Needs among Asian
Americans 10–11 Years After Exposure to the World
Trade Center Attack
Winnie W. Kung 1,*, Xiaoran Wang 1, Xinhua Liu 2, Emily Goldmann 3 and Debbie Huang 2
1 Fordham University, Graduate School of Social Service, 113 West 60th Street, New York, NY 11375, USA;
xwang150@fordham.edu
2 Columbia University, Mailman School of Public Health, 722 W 168th Street, New York, NY 10032, USA;
xl26@cumc.columbia.edu (X.L.); dh2652@cumc.columbia.edu (D.H.)
3 New York University, College of Global Public Health, 715/719 Broadway, 10th floor, New York,
NY 10003, USA; esg236@nyu.edu
* Correspondence: kung@fordham.edu
Received: 28 February 2019; Accepted: 5 April 2019; Published: 11 April 2019
Abstract: This study investigated the prevalence of unmet mental health care needs (UMHCN)
and their associated factors among 2344 Asian Americans directly exposed to the World Trade
Center (WTC) attack 10–11 years afterwards. Given the pervasive underutilization of mental health
services among Asians, their subjective evaluation of unmet needs could provide more nuanced
information on disparities of service. We used the WTC Health Registry data and found that 12% of
Asian Americans indicated UMHCN: 69% attributing it to attitudinal barriers, 36% to cost barriers,
and 29% to access barriers. Among all the factors significantly related to UMHCN in the logistic
model, disruption of health insurance in the past year had the largest odds ratio (OR = 2.37, 95%
confidence interval: 1.61–3.48), though similar to functional impairment due to mental disorders.
Post-9/11 mental health diagnosis, probable mental disorder and ≥14 poor mental health days in
the past month were also associated with greater odds of UMHCN, while greater social support
was associated with lower odds. Results suggest that continued outreach efforts to provide mental
health education to Asian communities to increase knowledge about mental illness and treatment
options, reduce stigmatization of mental illness, and offer free mental health services are crucial to
address UMHCN.
Keywords: unmet mental health care needs; Asian Americans; World Trade Center attack; disaster;
mental health conditions; mental health service use; health insurance; social support; stressful
life events
1. Introduction
Numerous studies have examined the mental health impact of the September 11, 2001 attack at
the World Trade Center (WTC) on those who were directly exposed to the disaster, but fewer have
investigated these individuals’ use of mental health services [1,2]. While Asian Americans constituted
a sizeable number of those affected by the disaster [3] and there has been a well-documented history
of underutilization of mental health services within this population [4], our team was the first to study
this group’s mental health service use and its associated factors (the authors, in press). In this study,
we further investigate the unmet mental health care needs (UMHCN) of Asian Americans affected by
the WTC attack and correlates of having unmet needs.
Mental health service utilization is a typical measure of whether mental health care needs are
met among persons with potential mental health issues [5]. It has been used as an objective measure
to detect systemic disparities in service provision and access across sociodemographic groups [6].
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However, we cannot assume that receiving services is equivalent to having mental health needs
met [5,7]. Individuals’ subjective perception of UMHCN is an important measure to complement the
objective information on treatment use and reveals the “actual demand for service” [7] or treatment
gap. According to the National Comorbidity Survey-Replication, help seeking for mental health
treatment is often delayed; for example, studies have noted a median lag of 12 years between the
onset of posttraumatic stress disorder (PTSD) and the initial treatment contact [8]. Together with the
often delayed symptom manifestation and worsening of symptoms with time [9], investigation of
UMHCN some years after the WTC attack is important. This study examines the UMHCN of Asian
Americans 10–11 years after the disaster. We aimed to better understand the extent of such unmet
needs and their associated factors to inform outreach efforts in this underserved population and to
find ways to provide more effective services to meet their needs. This is especially relevant given the
provision of public funds to monitor and provide needed health and mental health treatment to eligible
individuals affected by the WTC attack through the James Zadroga 9/11 Health and Compensation Act
being extended until 2090 [10]. Meeting such unmet mental health needs may not only reduce human
suffering but also ameliorate economic loss that incurs to society due to compromised productivity
and increased future treatment costs when untreated conditions deteriorate [11].
UMHCN may be more common among individuals with specific clinical, sociodemographic,
and behavioral characteristics. Individuals who have more mental health issues, including those with
formal diagnoses or symptoms of probable mental disorder, may have more mental health care needs
and are thus more likely to feel such needs not being met. However, since UMHCN captures the
subjective perception of these needs, those who do not have a formal or probable diagnosis but feel that
their needs have not been met should also be considered [5]. Furthermore, many individuals without
apparent mental disorders also consume services [12]. The fact that the majority of ethnic and racial
minorities with a diagnosable mental disorder did not receive pertinent treatment despite contacts
with the health care system in the previous year [12] and the questionable validity and reliability of
mental health assessment tools for minority groups [13] increase the need to examine Asian Americans
without formal clinical evaluation to understand their subjective UMHCN. Poorer perception of mental
well-being and greater subsequent impaired functioning in work, family or social life may also cause
them to recognize that their mental health needs are not being met. Functional impairment may be
even more important than mental health symptoms themselves among Asians, who tend to minimize
their psychological distress [14], particularly for those who have fewer resources to sustain themselves
and their families when they cannot perform their expected roles, especially work role, which is highly
valued among Asians [15].
Limited economic resources such as low or unreliable income and the lack or disruption of health
insurance coverage may also be practical barriers that could result in UMHCN [6]. Likewise, access
barriers such as unavailability of culturally-relevant and linguistically-appropriate mental health
services, lack of knowledge of available services, or inconvenience in service use like distance and
long waiting periods may also lead to UMHCN [16]. These practical barriers may have a particularly
strong impact on Asian Americans given their lower prevalence of English proficiency (76.5%) [17]
and shortage of bilingual mental health services [18,19].
In addition to practical barriers, UMHCN can also be a result of “subjective chosen unmet
needs” [6], in which individuals with mental health issues refuse to seek help due to beliefs such as the
fear of stigma associated with being identified as mentally ill or needing psychiatric help [20,21].
These attitudinal or emotional barriers may be aggravated among Asians due to their cultural
tendency to link mental illness to moral failure such as punishment by God or ancestors for one’s past
transgressions [22] and weakness in spiritual strength, causing shame and disgrace to family [23]. As a
result, the need to seek treatment could pose a threat to one’s self-esteem [24,25].
Social support resources may also determine UMHCN. Social networks can provide emotional
support, which may buffer the psychological impact of trauma [26] and subsequently reduce the
need for professional help [27]. These networks can also provide practical support through sharing of
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information about available mental health services and alleviating access barriers, such as providing
child care [5]. Asians’ tendency to handle personal issues within close circles of family and friends
may reduce their perceived need for help from outsiders, especially professionals [13,28]. Moreover,
the social network’s attitude towards mental health issues and treatment could also aggravate the fear
of stigma associated with using external help [25]. Further, those who have mental health issues but
are unaware of such a need would understate their unmet need [6,29]. It was noted that minorities,
including Asians, with limited English proficiency tend to be less likely to identify mental health care
needs [30].
Not only could individuals who have received mental health treatment still find their needs
unmet, prior studies, including those on the WTC attack, consistently find that individuals who have
used services in the past are more likely to report UMHCN [2,5,7,27]. It is suggested that those who
have received treatment before are more aware of the range of potential help to which they have no
access, or they may better recognize the limitations of these services [5]. Those with prior experience
with mental health services may also express greater dissatisfaction with the quality of treatment they
receive [7]. Minority populations, in particular, may be more likely to receive inconsistent diagnoses or
inappropriate medication, or be offered treatments that are not evidence-based [13,31]. Service users
may also judge treatments to be inadequate when their expectations are not met. If their expectations
are unrealistic, such as a quick fix, they can be corrected through good communication between service
providers and consumers. However, for many minorities, including Asians, this is harder to attain due
to the different socioeconomic, cultural, and linguistic backgrounds between consumers and service
providers [32–34]. Studies indicate that minorities often find that their service providers do not listen
to or understand them [35,36]. For mental health treatment to be effective, verbal communication
between recipients and providers is of paramount importance so that consumers’ subjective experience
can be understood and providers can effectively monitor and provide treatment. This applies not only
to counseling where a therapeutic alliance is the vehicle for change [37,38] but also for pharmacological
treatment, in which trust is often tied to medication compliance [39]. When discrimination is
experienced by minority service recipients, including Asians [26,40], such negative encounters can
leave them feeling that their mental health needs have not been met.
The underutilization of mental health service among Asian Americans has been well documented
for decades [4] and was noted to have persisted in more recent reviews [34]. However, it is possible
that the widely publicized and acknowledged trauma of the WTC attack could reduce the stigma
of mental illness, thereby normalizing the need for mental health service and increasing awareness
of unmet needs. This study aimed to examine the prevalence and factors associated with UMHCN
among this understudied and marginalized Asian American population 10–11 years after the disaster.
2. Methods
2.1. Study Participants
The World Trade Center Health Registry: The current study used data collected from the
WTC Health Registry (hereafter referred to as the Registry). Funded by the US Federal Emergency
Management Agency (FEMA), the Registry was developed in 2002 through the collaboration of the New
York City Department of Health and Mental Hygiene and the Agency for Toxic Substances and Disease
Registry to monitor the long-term health effects of the 9/11 attacks. Eligible participants included
rescue and recovery workers, workers in the WTC and nearby buildings, passersby, and residents in
lower Manhattan. Data were collected in 2003–2004 (wave 1), 2006–2007 (wave 2), 2011–2012 (wave 3),
and 2015–2016 (wave 4). At wave 1, 71,437 participants age 18 or above were recruited. Full details of
the recruitment and data collection processes have been described elsewhere [41,42].
Current Study Participants: To understand longer-term UMHCN among Asian American
participants in the Registry, this study employed wave 3 data collected 10–11 years after the disaster.
We included all adult participants (aged 18 or older) at wave 3 who self-identified as Asian American
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(N = 2538). We then excluded those with missing values for UMHCN and those with pre-9/11 mental
health diagnosis. A total of 2344 Asians were included in the final analytic sample. Institutional Review
Board approvals were obtained from the first and second authors’ affiliated institution, the Centers for
Disease Control and Prevention, and the New York City Department of Health and Mental Hygiene.
2.2. Measures
Unmet mental health care needs (UMHCN) were the outcome of interest and were captured
by asking if, in the past 12 months, the respondent “needed mental health care or counseling but
didn’t receive it”. Attributions for UMHCN were divided into attitudinal barriers, which included
endorsement of any one or more of the statements: “preferred to manage myself”, “didn’t think
anything could help”, “afraid to ask for help or of what others would think” or “didn’t get around
to it or didn’t bother.”; cost barriers, which included endorsement of “couldn’t afford to pay” or
“no insurance or not covered by insurance.”; and access barriers, which included endorsement of
any one or more of the statements: “did not know where to go or what kind of doctor to go to for
care”, “problems with transportation, scheduling, childcare, or other family responsibilities”, or “was
unable to find a provider who could diagnose or treat my condition.” Participants could check all that
applied; thus, the three categories were not mutually exclusive. Sociodemographic variables included
gender (female or male), education (college graduate or college graduate/higher, collected at wave
1), age (18–24, 25–44, 45–64, 65+, calculated at wave 3), marital status (married/living with partner,
divorced/separated/widowed, or never married, collected at wave 3), household income, nativity,
and employment status (collected at wave 3). WTC attack exposure quantified direct disaster exposure
and was measured as the number of distinct disaster experiences endorsed (collected in waves 1 and
2), including having been in a damaged/collapsed building during the attack, witnessing three or
more horrific events (e.g., saw a plane hit a tower), experiencing intense dust cloud, sustaining any
injury (excluding eye irritation), fearing being injured/killed, having a relative die in 9/11, having a
friend die in 9/11, having a co-worker die in 9/11, being a rescue/recovery worker, losing possessions
due to damage, being evacuated from one’s home for at least 48 hours after the attack, and losing a
job because of 9/11 [2]. The total number of exposures was then divided into three categories: 0, 1–3,
more than 3 exposures.
Mental health conditions included four factors. (1) Post-9/11 mental health diagnosis was measured
as a dichotomous variable, indicating whether or not participants reported being diagnosed with
depression, PTSD, or anxiety disorder other than PTSD by a doctor or other mental health professional
after 2001, the year of the attack. If the participant reported any diagnoses having occurred in 2001,
we considered the diagnoses to have happened after 9/11 if the respondent did not report any
traumatic event other than the WTC attack experienced before 9/11. We used respondents’ wave
2 data to supplement their answers in wave 3 to reduce recall bias. (2) Number of probable mental
disorders, which indicated symptom severity, was defined as the number of current probable mental
disorders in the past 30 days for which respondents met criteria as measured by the PTSD Checklist,
Civilian Version (PCL-C, score ≥44) [43], Patient Health Questionnaire Depression Scale (PHQ-8,
score ≥10) [44], and Generalized Anxiety Disorder scale (GAD-7, score ≥10) [45]. Within each of the
measures, if a certain item was missing, it was coded as “0”; item scores were then summed to see if
the respondent met the criteria for the probable disorders based on the cutoff scores indicated above. A
variable was then created to indicate the total number of distinct probable disorders present (range 0–3).
Individuals who had no response for a certain measure altogether were categorized as not having that
disorder. It should be noted that these measures indicated probable PTSD, depression, and generalized
anxiety disorder, and were not clinical diagnoses. (3) Functional impairment captured the level of
difficulty associated with working, taking care of things at home or getting along with others due to
PTSD or depression symptoms in the last 30 days from “not difficult at all” to “extremely difficult”.
We derived a composite score using the highest level of functional impairment associated with either
disorder. Based on the frequency distribution, we dichotomized the variable into “not difficult at all”
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as not impaired, and “at least somewhat difficult” or higher as impaired. (4) Poor mental health days was
measured by asking respondents to report the number of days in the past 30 days when their mental
health was not good, which was dichotomized as <14 days and ≥14 days. The number of probable
mental health diagnoses and the number of poor mental health days were measured within the same
time frame and were moderately correlated (Spearman correlation coefficient r = 0.46, p < 0.0001).
We included both in the analyses—the former as an indication of distinct probable disorders and the
latter as a more general subjective measure of mental health.
Social support was measured using five items related to perceived social support received in the
past 12 months, including how often someone was available to take the respondent to the doctor, have
a good time with them, hug them, prepare meals if they are unable to do it themselves, and understand
their problems. Each item was rated on a Likert scale from 1 (none of the time) to 5 (all of the time)
(recoded as 0–4). Item scores (Cronbach’s alpha = 0.92) were summed to create a total score and
divided into quartiles (0–6, 7–11, 12–15, and 16–20). Stress events was defined as experiencing one of
the following in the last 12 months: Could not pay for food, housing, or other basic necessities for a
period of 3 months or longer; serious family problems involving spouse, child, or parent; took care of a
close family member or friend with a serious or life-threatening illness; serious legal problem; and/or
lost someone close due to accidental death, murder, or suicide.
Mental health service use was defined as having seen a doctor or health professional or taken any
prescription medication for depression, PTSD, anxiety disorder, or nerves, emotions, or other mental
health problems or having sought treatment for PTSD symptoms in the past 12 months.
Lacking or disrupted health insurance refers to not having health care insurance at any point in
the past 12 months.
2.3. Statistical Analyses
To avoid bias due to exclusion of all missing data and to preserve sample size, we used a
“missing” category for all factors with missing values. We examined the distribution of participant
characteristics using frequencies and percentages and calculated the prevalence of UMHCN within
categories of each factor. We used Chi-square tests to assess bivariate associations between each
factor and UMHCN. We also conducted logistic regression analyses, with the outcome of UMHCN,
to examine its associations with predictors of interest, adjusting for sets of covariates hierarchically.
Mental health condition variables were the main predictors in Model 1, controlling for age, gender,
and other sociodemographic as well as WTC exposure variables. Covariates no longer associated with
the outcome in the model were removed, with the exception of age and gender, which are important
demographic variables in their own right. Model 1 included pre-9/11 mental health diagnosis, number
of probable mental disorders, functional impairment due to PTSD or depression, and poor mental
health days, as well as the covariates of age, gender, and income. Model 2 included an additional
set of predictors related to social support and stressful events. Model 3 extended Model 1 by adding
mental health service use and health insurance, since their unique contribution is of interest based on
the literature. Model 4 included both social support and stressful events as well as health insurance
and service use, controlling for all variables in Model 1. We derived covariate-adjusted odds ratios
(aOR) and 95% confidence intervals (CI) from the estimated model parameters to aid interpretation.
All analyses were conducted using SAS 9.4 [46].
3. Results
Characteristics of the study sample are described in Table 1. The majority of the sample was
25–44 or 45–64 years (79.48%), male (51.54%), had a college degree or higher (57.04%), had a household
income of $50,000 or more (55.50%), was employed (64.33%), married or cohabitating (66.60%), and was
foreign-born or did not report nativity (70.05%). Close to two-thirds of the participants experienced
1–3 WTC-related exposures (64.29%).
160
IJERPH 2019, 16, 1302















18–24 78 3.33 8 10.26
0.17
25–44 736 31.40 98 13.32
45–64 1127 48.08 119 10.56
65+ 403 17.19 56 13.90
Gender
Male 1208 51.54 140 11.59
0.442Female 1076 45.90 136 12.64
Missing 60 2.56 5 8.33
Education
<College graduate 902 38.48 133 14.75
0.001≥College graduate 1337 57.04 136 10.17
Missing 105 4.48 12 11.43
Income
<$50,000 915 39.04 171 18.69
<0.001≥$50,000 1301 55.50 95 7.30
Missing 128 5.46 15 11.72
Employment status
Employed 1508 64.33 149 9.88
<0.001Unemployed 815 34.77 121 14.85
Missing 21 0.90 11 52.38
Marital status
Married/cohabiting 1561 66.60 159 10.19
<0.001
Divorced/separated/widowed 324 13.82 54 16.67
Never married 439 18.73 63 14.35
Missing 20 0.85 5 25.00
Nativity US born 702 29.95 77 10.97 0.002Foreign-born/unreported 1642 70.05 204 12.42
WTC Attack Exposure
WTC Exposure
0 452 19.28 40 8.85
<0.0011–3 1507 64.29 167 11.08




No 2103 89.72 212 10.08




0 1807 77.09 129 7.14
<0.001
1 243 10.37 49 20.16
2 129 5.50 39 30.23
3 145 6.19 60 41.38




Not impaired 1008 43.00 45 4.46
<0.001Some impairment 1043 44.50 222 21.28
Missing 293 12.50 14 4.78
Poor mental health
days
<14 1874 79.95 155 8.27
<0.001≥14 415 17.70 117 28.19
Missing 55 2.35 9 16.36




0-6 504 21.50 121 24.01
<0.001
7-11 481 20.52 71 14.76
12-15 527 22.48 39 7.40
16-20 742 31.66 29 3.90
Missing 90 3.84 21 23.33
Stressful events in the
last 12 months
No 1793 76.49 163 9.09
<0.001Yes 551 23.51 118 21.42
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Mental Health Service Use and Health Care Resources
No health insurance
at any point within 12
months
No 2031 86.65 189 9.31
<0.001Yes 227 9.68 67 29.52
Missing 86 3.67 25 29.07
Service use in past 12
months
No 1562 66.64 158 10.12
<0.001Yes 369 15.74 99 26.83
Missing 413 17.62 24 5.81
UMHCN = unmet mental health care need, DV = dependent variable, WTC = World Trade Center, PCL = PTSD
checklist, PHQ-8 = Patient Health Questionnaire, GAD-7 = generalized anxiety disorder, PTSD = posttraumatic
stress disorder. All p-values were from Chi-square tests using data with missing category excluded.
Over 10% had a post-9/11 mental health diagnosis, 22.91% had at least one probable mental
disorder, 44.50% had at least some functional impairment due to PTSD or depression symptoms,
and 17.70% reported 14 or more poor mental health days in the past 30 days. Over 15% used mental
health services in the past 12 months, and approximately 12% had UMHCN in the past 12 months.
Among the 281 participants with UMHCN, attitudinal barriers were the most attributed cause for
unmet need (68.68%), followed by cost barriers (36.30%) and access barriers (28.47%).
Having UMHCN was significantly associated with several demographic, WTC attack exposure,
psychosocial, and clinical factors (Table 1). Higher prevalence of unmet mental health needs was
present among those with lower education, lower household income, those who were unemployed,
divorced/separated/widowed, and were foreign-born or had unreported nativity. Greater proportion
of unmet needs was also noted among those who experienced >3 WTC-related exposures, at least
one past year stressful event, and among those with less social support. UMHCN was also more
prevalent among those with post-9/11 mental health diagnosis, those with current mental health
disorders/impairment, those lacking or having interrupted health insurance, and those who used
mental health services in the past 12 months.
In covariate-adjusted regression analysis, mental health and demographic factors other than
gender were associated with greater odds of UMHCN across all four models, although several
of these associations were attenuated in models with additional covariates (Table 2). Among the
sociodemographic variables, income was significantly associated with UMHCN in all models.
Participants younger than 45 years of age had higher odds of unmet needs than those that were
older. Adjusting for age, gender, and income, the four variables representing mental health conditions
were all significantly associated with UMHCN. Specifically, participants having post-9/11 mental
health diagnosis; functional impairment due to PTSD or depression; 14 or more poor mental health days
in the past month; and greater number of probable mental disorders had higher odds of unmet mental
health needs. Model 2 showed additional effects of stress and social support; the odds of UMHCN
were greater among those who experienced at least one stressful event in the past year but lower
among those with greater social support. Inclusion of these two factors seemed to slightly attenuate
the associations between the outcome and some Model 1 variables, such as income, comorbidity,
and functional impairment, but strengthened the effect of age and post-9/11 mental health diagnosis.
When controlling for age, gender, income, and mental health conditions in Model 3, the odds of
UMHCN greatly increased with the lack of or disrupted health insurance in the past year but were not
associated with mental health service use in the past year. The addition of the factors for disrupted
health insurance and mental health service use slightly attenuated the associations of all factors in
Model 1 with the outcome.
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Table 2. Covariate-adjusted odds ratio (aOR) and 95% confidence interval (CI) derived from logistic
models for UMHCN (N = 2344).
Factors
Model 1 Model 2 Model 3 Model 4















































































































Mental Health Service Use and Health Care Resources
No health insurance at any















PCL = PTSD Checklist, PHQ = Patient Health Questionnaire, GAD = Generalized Anxiety Disorder, PTSD =
posttraumatic stress disorder. Each model includes variables for which there are estimates provided in that column.
Model 4 included all factors of interest. Greater odds of UMHCN were noted with an increase
in number of probable mental disorder (meeting criteria for one vs. no disorder , aOR = 1.59, 95%
CI: 1.05–2.39; 2 vs. 0 disorder, aOR = 1.76, 95% CI: 1.08–2.86; 3 vs. 0 disorder, aOR = 2.33, 95% CI:
1.42–3.81), among those with a post-9/11 mental health diagnosis (aOR = 1.61, 95% CI: 1.08–2.38),
functional impairment (aOR = 2.36, 95% CI: 1.60–3.48), and having 14 or more poor mental health days
(aOR = 1.53, 95% CI: 1.09–2.16). Being aged 25–44 vs. 65 or older (aOR = 1.67, 95% CI: 1.07–2.60) and
having a lower vs. higher income (aOR = 1.61, 95% CI: 1.15–2.25) were also associated with greater
odds of unmet needs. In Model 4, greater social support was associated with lower odds of unmet
need (45–75% reduction), while having experienced stressful events (aOR = 1.32, 95% CI: 0.96–1.81,
p = 0.08) and lacking or disrupted health insurance in the past year (aOR = 2.37, 95% CI: 1.61–3.48) were
both associated with greater odds of UMHCN. Compared to results in Model 2, further controlling
for health insurance and service use attenuated the effect of stressful event but had no impact on
the association between social support and UMHCN. Similarly, compared to results in Model 3, the
addition of social support and stressful events slightly attenuated the effect of health insurance on
odds of UMHCN.
4. Discussion
A sizeable proportion of Asian Americans had UMHCN 10–11 years after direct exposure to
the WTC attack (12%), which is much higher than that reported in other community samples (e.g.,
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4.5%) [5], indicating greater unmet needs in those affected by this mass trauma more than a decade
later. The prevalence of UMHCN is also higher than that reported among the Asian group at wave
2 of the Registry, which was 5–6 years after the disaster (4.4%) [2]. This may be related to delayed
manifestation of PTSD symptoms and deferred mental health service use [8]. This high prevalence of
UMHCN may also be attributed to dwindling of resources for free services provided by governmental
and nongovernmental organizations after the attack (e.g., Project Liberty and American Red Cross
9/11 Fund) [47,48]. This is consistent with our finding that lack or disruption of health insurance had
the strongest association with UMHCN among all other factors.
Among those who reported UMHCN, attitudinal barriers were most common, followed by cost
and access barriers. This is in line with other studies that have reported attitudinal barriers (e.g.,
acceptability) as more likely causes of unmet needs compared to other tangible barriers, such as
accessibility and availability of mental health services [5]. Within those who attributed their unmet
need to attitudinal barriers, “prefer to manage myself” was the most endorsed item (62.1%, not shown
in tables), which may indicate the desire to keep the issue private and potentially related to being
“afraid to ask for help/of what others would think” (25.4%). Both may be manifestations of fear of
stigma. Other common reasons like “didn’t get around to it/didn’t bother” (37.8%), and “don’t think
anything could help” (34.2%) may reflect the tendency to undervalue treatment due to the lack of
knowledge about mental illness and its treatment. These figures are disconcerting since these Asian
Americans had been directly exposed to the WTC attack and should have heard of its mental health
impact from the media. It is possible that they no longer relate their mental health need to the disaster
a decade later.
In terms of factors associated with UMHCN, it is noteworthy that those who lacked or had
disrupted insurance in the past year had more than twice the odds of having unmet needs than
those who did not. However, this was consistent with greater odds of UMHCN for individuals from
household income of <$50,000 than those of higher income, and the significant association persisted
throughout the hierarchical regression models. Close to 40% of Asian participants reported household
income below $50,000, and 15% were unemployed; thus, they may not be able to afford or willing to
pay for services to meet their mental health needs. This is consistent with cost being the second most
common reason for UMHCN after attitudinal barriers. Asians at the prime years of their lives (25–44)
had significantly higher odds of having UMHCN, which may reflect the challenges of financial and
family-related responsibilities [49,50].
The association between mental health conditions and UMHCN noted in this study is expected,
since less favorable mental health conditions would increase mental health care needs and thus lead to
a higher chance that the need is not being met. The finding is consistent with reports from previous
studies based on the Registry across race [27] and other data [7]. These mental health factors were
all significant in their association with the outcome throughout the four models. It is of interest to
note that among the mental health factors, functional impairment from PTSD or depression had the
strongest association with UMHCN, with even higher odds compared to having comorbidity of three
probable mental disorders, which indicated severe symptomatology. This may reflect Asians’ tendency
to dismiss their mental health need unless it interferes with their daily functioning [14]. Further, those
with a low income and those who were unemployed may also be less able to compensate for their
inability to perform expected roles at work and at home to sustain themselves and their families,
which may cause them to recognize their UMHCN. The association between post-9/11 mental health
diagnosis and UMHCN suggests that Asian Americans who had previous contact with mental health
professionals may have been more aware of their mental health needs and when those needs were not
met, whether or not they continued treatment.
Asian Americans with stressful life events in the past year, including financial and health
challenges to themselves or families, could tax their coping resources and thus increase mental
health issues and thereby heighten the awareness of their UMHCN. However, social support may
have alleviated unmet needs by reducing access barriers to mental health care by providing practical
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assistance [5] such as child care or meal preparation when individuals sought mental health care, or
accompanying them to see the doctor. At the same time, the relatively higher mental health stigma
noted among Asian Americans in general [51] may have attenuated the positive impact of social
support on UMHCN in this study. The fact that attitudinal barriers were the most common reasons
for UMHCN among Asians may also indicate fear of stigma within the social network should they
seek mental health services. Thus, exploration of the perception of stigma within the community
or within social networks and its relation to unmet needs is an important area of future inquiry in
disaster-affected Asian communities.
The lack of association between previous mental health service use and UMHCN found in this
study contrasts with findings from most studies in which previous consumers were more likely to
indicate unmet needs [5,27], potentially due to dissatisfaction with the quality of treatment, recognition
of potential help that they cannot access, or limitations of services in providing desired help after being
exposed to the formal mental health care system [5]. This nonsignificant finding was unexpected also
because it contradicts with our expectation that there would be higher dissatisfaction with mental
health treatment among Asians due to poorer quality of service [4] and lower therapeutic alliance
due to cultural and linguistic barriers [34,35]. It is possible that the smaller proportion of Asian
Americans having received mental health services (e.g., compared to the non-Hispanic white group,
15.7% vs. 26.6%; the authors, in press) limited statistical power. However, the tendency of Asian
Americans to terminate treatment prematurely [13] suggests that they may be less exposed to the
mental health care system, hence less likely to recognize the range of available treatment that is
inaccessible to them, and therefore less likely to indicate UMHCN [5]. Moreover, lower mental health
literacy could also prevent them from recognizing an unmet need [25], also called “unperceived unmet
need” [6]. Furthermore, their mental health need might have been satisfied through effective mental
health services such as those provided by the WTC Health Program [52], or the use of alternative
healing methods such as traditional Chinese medicine [53] or other folk healing within their unique
communities [54].
4.1. Study Limitations and Strengths
The findings of this study should be considered in light of the study’s limitations. The study was
unable to capture ethnic diversity among Asian Americans in the sample. While there are similarities
among Asian ethnic groups, it is possible that the various factors we examined may be associated
with UMHCN differentially among the Asian subgroups [55–57]. Further, since UMHCN is captured
by self-report without any clinical record for confirmation, which could indicate individuals’ mental
health care needs and premature termination; when individuals are unaware of their mental health
need, this could cause underestimation of its prevalence. This is particularly an issue for many Asian
Americans who have limited mental health knowledge and the tendency to ignore their psychological
distress [13,14]. The prevalence of unmet needs may also be underestimated due to social desirability
bias, in which participants avoided reporting mental health care needs to avoid stigma [25]. The lack
of information on the duration of previous treatment, number of visits to mental health service,
type of providers seen, or satisfaction with services also limited our ability to assess the impact of
previous mental health service use on UMHCN. Due to sample size limitations, we were also unable to
assess specific factors associated with UMHCN due to attitudinal, cost, and access barriers separately.
Further inquiry in this regard could better inform strategies to ameliorate the effects of these specific
barriers. Finally, since the investigation is based mainly on cross-sectional data from wave 3, causal
relationships could not be established.
Despite these limitations, this study is the single largest investigation of UMHCN among Asian
Americans who were directly exposed to the WTC attack, and the first large-scale study examining
Asians’ subjective perception of their UMHCN after a massive trauma. The direct assessment
of individuals’ subjective perception of unmet needs has the advantage of capturing a potential
service gap without assuming that a mental health service need is satisfied with service use alone.
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The comprehensive recruitment and follow-up efforts of the Registry through the use of Asian-language
interviewers and outreach efforts [42] enabled the inclusion of individuals who were not proficient
in English, which constituted a large proportion of the Asian American population (75%) [17].
The longitudinal design of the study allows for examination of longer term unmet needs, which
is critical in light of the often delayed manifestation of PTSD symptoms and service use [8].
4.2. Study Implications
Our finding suggests that a substantial proportion of Asian Americans have UMHCN a decade
after the WTC attack, which was even greater than that noted 5 years prior in another study [2].
This may indicate that continued outreach efforts to this community are necessary to provide treatment
options. During the years after the disaster, with heightened awareness of its impact through media
coverage and outreach efforts from government and nongovernmental organizations, mental health
services were made more readily available. However, with time, the number of organizations providing
free services and public awareness of some continued programs declined, potentially increasing
practical barriers such as accessibility and cost. Thus, programs such as the Registry’s Treatment
Referral Program which reaches out to enrollees who lived or worked near the disaster area and
reported a physical and/or mental health symptom should be continued long term [58]. Since those
with worse current mental health conditions and previous diagnoses have higher odds of UMHCN,
they should also be targeted for interventions that bring them to treatment and to improve treatment
adherence. To ensure that culturally competent mental health service providers are available is also
important [21] to increase continuation and satisfaction with services in fully meeting their needs.
Since the largest proportion of UMHCN among Asian Americans exposed to the WTC attack was
attributed to attitude about mental illness and its treatment, a “subjective chosen unmet need” [6],
public mental health education may well be key to address unmet needs with this population.
Increasing knowledge about the cause, manifestation, and course of mental illness could help to
reduce stigma, increase awareness of individuals’ mental health needs, and promote appropriate
expectations of the treatment process so as to encourage service use and reduce dropout. These public
education efforts should be tailored to the languages, needs, and cultures of the various minority
communities [21]. The importance of post-disaster large-scale public mental health education and
outreach efforts is also relevant for future disasters.
Another important implication of this study’s findings is the strong role of health insurance,
income, and employment in unmet needs. This suggests that free mental health care related to the
WTC attack should be continued. The WTC Health Program under the WTCHR has provided health
and mental health services to individuals directly exposed to the disaster, and outreach efforts to
affected individuals through the Treatment Referral Program continues to date. Enrollees who lived
or worked in the 9/11 disaster area and reported a physical and/or mental health symptom were
encouraged to seek care from 9/11-specialty providers [52]. This program should be continued given
the considerable UMHCN noted in this study among the Asians, who may not be able to afford
needed services. Although the James Zadroga 9/11 Health and Compensation Act enacted in 2010
was extended through 2090 [10], the recent report on the September 11th Victim Compensation Fund
released in February 2019 is concerning, which revealed funding insufficiency and needs for reduced
awards due to greater claim than anticipated [59]. Congress would need to consider providing more
resources for free services through adequate compensation of treatment expenses. Given the long-term
nature of mental illnesses, especially PTSD, this is an important consideration.
With the persistent and striking underutilization of mental health services among Asian
Americans, the value of the subjective account of UMHCN to better understand the actual demand
for mental health services and the perceived adequacy and quality of treatment [7] becomes more
important, and research along this line is necessary. In future studies, ethnicity within the Asian
American population should be disaggregated to gain a more nuanced understanding of unique unmet
needs and their specific barriers so that improvement in outreach efforts and mental health treatment
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could be made to ameliorate the disparities in mental health services [6]. Further, for those who have
used mental health services before and still find their needs unmet, we need to understand in greater
depth the “dosage” of services received, whether or not it was premature termination, and reasons for
their dissatisfaction. More detailed exploration of the stigma Asians ascribe to mental health problems
and treatment should be explored so that relevant community mental health education can more
effectively address any misunderstanding.
5. Conclusions
The prevalence of UMHCN among Asian Americans directly exposed to the WTC attack remained
sizeable a decade after the attack, and the cause of unmet need was attributed most frequently to
attitudinal barriers, followed by cost and access barriers. Thus, continued outreach efforts to Asian
communities through public mental health education to increase knowledge about mental illness and
the value of and options for mental health treatment, and to destigmatize the illness and treatment, is of
paramount importance. Free and convenient access to mental health services to eligible individuals
through adequate allocation of public funding is crucial to ensure that issues of cost and access will also
not prevent individuals from addressing their mental health needs. Further exploration of subjective
perception of UMHCN to provide information on the actual demand for mental health services and
ways to improve treatment among Asian Americans is also warranted.
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Abstract: The World Trade Center Health Registry includes 9/11 survivors who have been surveyed
about their health conditions over time. The prevalence of posttraumatic stress disorder (PTSD)
remains high among the cohort and is a risk factor for cognitive impairment or dementia. We thus
sought to examine the degree to which confusion or memory loss (CML)—potential symptoms
of cognitive decline—are occurring among enrollees aged 35–64 years. Cognitive reserve theory
suggests that higher levels of education and engaging in cognitively challenging activities can create
stronger neural connections, offering protection against cognitive decline. We hypothesized that
enrollees with less cognitive reserve would be more likely to report CML. In this study, we: (1)
estimated the incidence of CML in our study sample; (2) identified indicators of cognitive reserve (e.g.,
indicators of educational attainment, social support); and (3) determined whether CML is associated
with cognitive reserve level, stratified by PSTD status. First, we described demographics of the
study sample (n = 14,574) and probable PTSD status, also stratifying by CML. Next, we conducted a
latent class analysis on two groups: those with probable PTSD and those without probable PTSD,
creating classes with varying cognitive reserve levels. Finally, using adjusted log binomial models,
we predicted risk of CML based on cognitive reserve level. The probable PTSD group (n = 1213) and
not probable PTSD group (n = 13,252) each had four latent classes: low, medium-low, medium-high,
and high cognitive reserve. In the probable PTSD model, compared to the high cognitive reserve
class, those with medium-low cognitive reserve were 35% more likely to report CML (relative risk
(RR) = 1.4, 95% confidence interval (CI): 1.1, 1.7). Among the not probable PTSD group, those with
low and medium levels of cognitive reserve were significantly more likely to report CML (RR = 1.8
and 1.4, respectively). Overall, those with less cognitive reserve were more likely to report CML
regardless of PTSD status.
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1. Introduction
The terrorist attacks on the World Trade Center (WTC) in New York City (NYC) on 11 September
2001 resulted in thousands of deaths and non-fatal injuries. Survivors of the attacks also witnessed
traumatic events and were exposed to dust and debris related to the towers’ collapse, the health effects
of which include posttraumatic stress disorder (PTSD), asthma, cancer, and other conditions [1–3].
Seventeen years after the event, survivors continue to exhibit effects. As the cohort ages, the prevalence
of chronic conditions associated with older age will likely increase. Mild to severe forms of cognitive
decline affect a large number of Americans, particularly those over the age of 65 years, though they can
affect younger individuals as well [4,5].
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Co-morbid health conditions can put one at greater risk for cognitive decline; PTSD is associated
with greater likelihood of developing cognitive impairment or various forms of dementia [6–12]. It is
possible that 9/11-related exposures and resulting health conditions may put enrollees at greater risk
for cognitive decline than the general population [11,13]. Research has shown elevated levels of PTSD
among the WTC Health Registry (WTCHR) cohort in the years following the disaster [1,14]. Research by
Clouston et al. (2017) examined WTC responders from the WTC Health Program and found that 14.8%
of responders had cognitive dysfunction identified via a battery of tests. This proportion was larger
than expected compared to normative data from age-matched healthy adults. Cognitive dysfunction
was also associated with PTSD symptom severity and working at the 9/11 site for more than five
weeks [11].
People who are less socially isolated (i.e., engaging in more social activities and having larger
social networks) are less likely to have cognitive problems later in their lives [15,16]. Research has
also shown that increases in “out of home” activities and walking duration can be protective against
cognitive impairment as well [17]. Similarly, social interaction and cognitive control skills specific to
certain kinds of occupations appear to be protective against neurodegeneration [18–22]. Engaging in
cognitively stimulating activities is also positively associated with cognition [22,23]. Research shows
that greater levels of cognitive reserve may help to stave off the symptoms of early forms of cognitive
decline, leading to more time spent in good health [24,25]. Cognitive reserve theory suggests that
higher levels of education, as well as engaging in cognitively challenging activities, can create stronger
neural connections, which may offer protection against cognitive decline symptoms [5,20,22,25–28].
The more cognitive reserve a person has, the more plastic and adaptable their brain is; a brain with
more plasticity can handle damage more effectively before showing clinical symptoms [25,29–31].
Questions about confusion and memory loss were included on the two most recent WTCHR major
surveys, allowing researchers to better understand the degree to which early signs of cognitive decline
may be occurring among this population. Rather than assessing the direct link between 9/11-related
health conditions, such as PTSD and cognitive decline, this study focused on identifying certain
individual-level factors that may be protective against confusion or memory loss among WTCHR
enrollees. In this study, self-reported confusion or memory loss is a surrogate measure for potential
cognitive issues. It is not intended to be a substitute for cognitive testing or a clinical diagnosis.
The goals of this study were to: (1) estimate the degree of self-reported confusion or memory loss
among those exposed to the WTC attacks; (2) identify indicators of cognitive reserve (with a particular
focus on social support) that can be created from survey variables (i.e., indicators of educational
attainment, marital status, employment status, social support, social integration, and physical activity);
and (3) determine whether confusion or memory loss is associated with differing levels of cognitive
reserve. We hypothesized that groups with less cognitive reserve would be more likely to report
confusion or memory loss.
2. Materials and Methods
2.1. Study Population and Sample
The WTCHR maintains a longitudinal cohort of over 71,000 enrollees who were exposed to the
terrorist attacks on 11 September 2001. Enrollees in the registry have been surveyed about their
exposures to the disaster as well as their short- and long-term health effects in four major surveys:
wave 1 (2003–2004), wave 2 (2006–2007), wave 3 (2011–2012), and wave 4 (2015–2016). Health effects
will continue to be monitored for years to come. Enrollees include rescue/recovery workers, residents,
area workers, passers-by, and students and staff from local schools. The WTCHR was approved by the
institutional review boards of the Centers for Disease Control and Prevention (CDC) (3793) and the
NYC Department of Health and Mental Hygiene (02-058).
The study sample consisted of enrollees in the WTCHR who met certain criteria (see Figure 1).
Individuals in the study had to have completed the wave 3 and wave 4 surveys, both of which contained
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the self-reported confusion or memory loss questions. Because we were interested in the earlier/milder
forms of cognitive decline, we limited our sample to enrollees who were between the ages of 35 and
64 years at the time of the wave 4 survey. We excluded those with a history of stroke [11]. Finally,
individuals who reported confusion or memory loss at wave 3 were excluded from the study sample,
as we wanted the majority of the predictor variables used in the analysis to precede the outcome of
interest, which was confusion or memory loss at wave 4. This also allowed for a better approximation
of cognitive decline, as the outcome was measuring a change in self-reported confusion or memory
loss between wave 3 and wave 4. The total study sample included 14,574 enrollees.
Figure 1. Study sample inclusion criteria.
2.2. Study Variables
The outcome of interest was confusion or memory loss measured by the wave 4 question as follows:
“During the last 12 months, have you experienced confusion or memory loss, other than occasionally
forgetting the name of someone you recently met?” Cognitive reserve was measured by seven
dichotomized indicators: educational attainment, marital status, employment status, number of close
friends, communication with friends in last 30 days, people who understand your problems, and general
physical activity. PTSD status at wave 3 was classified using the total score from the Post-Traumatic
Stress Disorder Checklist (PCL) scale [1,32]. The scale includes measures of re-experiencing, avoidance,
and arousal symptoms, and a score of 44 or greater indicates probable PTSD. Demographic factors and
other covariates used in this study included gender, age group, race/ethnicity, history of depression,
history of anxiety disorder, history of drug or alcohol use problems, and smoking status.
2.3. Data Analysis
First, we described the study sample by basic demographics, probable PTSD status, and the
seven indicators that measured cognitive reserve. Then, we performed a latent class analysis and
identified a latent class membership, or cognitive reserve level in this case, for each individual in
the study sample based on the seven indicators mentioned above. Latent class analysis is a process
through which distinct classes are created using a set of chosen variables wherein each record gets
assigned to one latent class [33]. We used SAS PROC LCA [34], a statistical procedure for latent class
analysis, and reviewed the outputted statistics to assess model fit, comparing the fit for 2, 3, 4, and 5
classes [33,35]. Determining that four classes provided the optimal fit, we then grouped the classes
by probable PTSD status, as we knew it was likely to be a risk factor for confusion or memory loss.
Latent class composition differed by probable PTSD status, so we conducted two separate latent class
analyses: one for those with probable PTSD and one for those without probable PTSD. Those analyses
resulted in four latent classes for each group. Next, we predicted the risk of confusion or memory
loss in wave 4 by latent class membership (i.e., cognitive reserve level) using log binomial modeling.
We chose this method because it produces an unbiased estimate of the relative risk whether the disease
is rare or common, whereas logistic regression produces odds ratios, which approximate the relative
risk for only rare diseases [36]. We ran adjusted models on the probable PTSD group and not probable
PTSD group, adjusting for most of the covariates described above. We did not include age group in the
models because we did not expect it to be a major predictor of the outcome, largely due to our study
sample being limited to middle-aged enrollees. All analyses were completed with SAS 9.4 software.
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3. Results
Self-reported confusion or memory loss was common among the study sample, despite the age
group being limited to middle-aged individuals—those between the ages of 35 and 64 years (see
Table 1). A total of 3262 out of 14,574 (22%) enrollees in the study sample reported confusion or memory
loss at wave 4. About 8% of enrollees had probable PTSD at wave 3, and the majority of the study
sample was male (62%). There were twice as many enrollees between the ages of 55 and 64 years in
this study compared to those between the ages of 35 and 44 years (43% vs. 19%, respectively). In the
total study sample, 60% of enrollees had at least a bachelor’s degree. Most enrollees were married
or living with a partner in wave 3: 72%. More than four out of five enrollees (84%) were currently
employed at the time of the wave 3 survey. Overall level of social integration was high among the study
sample; nearly all respondents reported having at least three close friends and having visited, talked,
or emailed with friends at least twice in the past 30 days (87% and 94%, respectively). Two-thirds of
enrollees reported high levels of social support—specifically, that someone was available to understand
their problems most or all of the time. Over three-quarters of the study sample reported being very or
somewhat physically active in general.
When stratifying these factors by confusion or memory loss status, there were some proportional
differences. The proportion of probable PTSD was much greater among those with confusion or memory
loss compared to those without confusion or memory loss (17% vs. 6%, respectively). Among those
with confusion or memory loss, 50% had a bachelor’s degree or higher level of education; 62% of those
without confusion or memory loss had at least a bachelor’s degree. Higher levels of social support were
reported by those without confusion or memory loss: 71% of them had people available to understand
their problems compared to 58% of those who reported having confusion or memory loss. Similarly, a
larger proportion of those without confusion or memory loss reported being very or somewhat physically
active compared to those with confusion or memory loss (81% vs. 70%, respectively).
The initial latent class analysis on the total study sample indicated that class membership differed
significantly based on probable PTSD status at wave 3 (results not shown). However, for both the
probable PTSD group and the not probable PTSD group, four classes were determined to be optimal
based on the model fit statistics from the latent class analysis. The four classes were assigned as follows
in both groups: low cognitive reserve, medium-low cognitive reserve, medium-high cognitive reserve,
and high cognitive reserve (referent).
Among those with probable PTSD, class 1, the low cognitive reserve class, constituted about 15%
of the group (see Table 2). This group had low levels of social integration and social support (e.g., only
8% of class 1 members reported that someone was available to understand their problems most or all
of the time); members were also characterized by overall lower levels of educational attainment, being
less likely to be married, having medium levels of current employment, and having lower levels of
physical activity. Notable differences between class 2 (8%, medium-low cognitive reserve) and class 3
(37%, medium-high cognitive reserve) are that class 2 had low levels of educational attainment, and
class 3 had low levels of social support. Class 4 (40%, high cognitive reserve) was the referent group:
having medium levels of educational attainment, being very likely to be married, reporting high
levels of social integration and support, having medium levels of current employment, and reporting
medium levels of physical activity.
Similar results were presented in Table 2 for those who did not have probable PTSD. Class 4 (high
cognitive reserve) made up the majority of the not probable PTSD group: 61%. This group was the
referent due to the high proportion of the cognitive reserve indicators therein:, with 73% having at
least a bachelor’s degree, 79% married or living with a partner, 90% being currently employed, 97%
having three or more close friends, 100% who visited/talked/emailed with friends at least twice in last
30 days, 93% having someone available to understand your problems most or all of the time, and 86%
being very or somewhat physically active in general.
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Table 1. Description of study sample demographics and cognitive reserve indicators.
Sample Characteristics
Total Study Sample




(n = 3262, 22%) 1,2
n (%)
No Confusion or
Memory Loss at W4
(n = 11,312, 78%) 1,2
n (%)
Probable PTSD
Yes 1213 (8.3%) 550 (16.7%) 663 (5.9%)
No 13,252 (90.9%) 2675 (82.0%) 10,577 (93.5%)
Gender
Male 8975 (61.6%) 2016 (61.8%) 6959 (61.5%)
Female 5599 (38.4%) 1246 (38.2%) 4353 (38.5%)
Age group
35–44 years 2827 (19.4%) 570 (17.5%) 2257 (20.0%)
45–54 years 5526 (37.9%) 1277 (39.2%) 4249 (37.6%)
55–64 years 6221 (42.7%) 1415 (43.4%) 4806 (42.5%)
Educational attainment
Bachelor’s degree or more 8693 (59.7%) 1666 (51.1%) 7027 (62.1%)
Less than a bachelor’s degree 5820 (39.9%) 1576 (48.3%) 4244 (37.5%)
Marital status
Married or living with partner 10,482 (71.9%) 2269 (69.6%) 8213 (72.6%)
Divorced/separated, widowed, or never married 4033 (27.7%) 979 (30.0%) 3054 (27.0%)
Employment status
Currently employed 12,193 (83.7%) 2671 (81.9%) 9522 (84.2%)
Not currently employed 2335 (16.0%) 579 (17.8%) 1756 (15.5%)
Number of close friends
Have 3 or more close friends 12,719 (87.3%) 2720 (83.4%) 9999 (88.4%)
Have 0–2 close friends 1452 (10.0%) 448 (13.7%) 1004 (8.9%)
Communicate with friends
Visited/talked/emailed with friends at least twice in
last 30 days 13,681 (93.9%) 2950 (90.4%) 10,731 (94.9%)
Did not visit/talk/email with friends at least twice
in last 30 days 729 (5.0%) 265 (8.1%) 464 (4.1%)
People who understand your problems
Someone is available to understand your problems
most or all of the time 9952 (68.3%) 1888 (57.9%) 8064 (71.3%)
Someone is available to understand your problems
none to some of the time 4401 (30.2%) 1311 (40.2%) 3090 (27.3%)
Physical activity
Very or somewhat physically active in general 11,413 (78.3%) 2287 (70.1%) 9126 (80.7%)
Not or not very physically active in general 3096 (21.2%) 951 (29.2%) 2145 (19.0%)
1 Column percentages may sum to <100% due to missing data. 2 Column percentages may sum to >100% due to
rounding. PTSD: posttraumatic stress disorder; W4: wave 4.
Using the latent class groups as predictors for confusion or memory loss at wave 4, we ran separate
log binomial models for those with probable PTSD and those without probable PTSD, controlling for
relevant covariates (see Table 4). The medium-low cognitive reserve group was significantly more
likely to report confusion or memory loss compared to the high cognitive reserve group among the
probable PTSD group (relative risk (RR) = 1.35, 95% confidence interval (CI): 1.08, 1.69). Significant
covariates in the probable PTSD model included female gender (RR = 0.84, 95% CI: 0.72, 0.97) and
history of drug or alcohol use problems (RR = 1.26, 95% CI: 1.03, 1.53). Other covariates approached
statistical significance, as did the relative risks for the low cognitive reserve and medium-high cognitive
reserve groups. Among the non-probable PTSD group, however, every cognitive reserve group was at
significantly greater risk of confusion or memory loss compared to the referent. The low cognitive
reserve group was 81% more likely than the high cognitive reserve group to report confusion or
memory loss at wave 4. The medium-low and medium-high groups were approximately 40% more
likely to report confusion or memory loss compared to the referent. Significant covariates in the not
probable PTSD group model included black non-Hispanic race (RR = 1.16, 95% CI: 1.02, 1.31), other
race (RR = 1.19, 95% CI: 1.04, 1.35), history of depression (RR = 1.26, 95% CI: 1.14, 1.39), history of
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anxiety disorder (RR = 1.13, 95% CI: 1.00, 1.27), history of drug or alcohol use problems (RR = 1.40,
95% CI: 1.20, 1.65), being a former smoker (RR = 1.20, 95% CI: 1.11, 1.29), and being a current smoker
(RR = 1.18, 95% CI: 1.05, 1.33).
Table 2. Latent class membership by probable PTSD status based on cognitive reserve indicators.
Cognitive Reserve Indicators

















Proportion in each latent class
Bachelor’s degree or more 0.345 0.050 0.588 0.504 0.331 0.183 0.673 0.725
Married or living with partner 0.572 0.665 0.466 0.797 0.772 0.817 0.445 0.792
Currently employed 0.747 0.080 0.768 0.809 0.778 0.697 0.850 0.895
Have three or more close friends 0.398 0.728 0.742 0.901 0.421 0.955 0.818 0.969
Visited/talked/emailed with friends
at least twice in last 30 days 0.245 0.766 0.998 0.966 0.527 0.939 0.978 0.995
Someone is available to understand
your problems most or all of the time 0.083 0.432 0.036 0.866 0.266 0.880 0.005 0.933
Very or somewhat physically active
in general 0.491 0.255 0.662 0.730 0.627 0.724 0.725 0.859
1 109 records did not have valid Post-Traumatic Stress Disorder Checklist (PCL) scores at wave 3 (W3), so the total
does not sum to n = 14,574; 2 Numbers presented are probability of indicator among that class.
































high cognitive reserve Referent – Referent –
Gender
Female 0.84(0.72, 0.97) 0.017
0.93
(0.86, 1.00) 0.055
Male Referent – Referent –
Race/ethnicity
White non-Hispanic Referent – Referent –
Black non-Hispanic 1.06(0.84, 1.34) 0.609
1.16
(1.02, 1.31) 0.020
Hispanic 1.09(0.90, 1.32) 0.376
1.06
(0.95, 1.20) 0.304


















History of depression 1.15(0.99, 1.33) 0.074
1.26
(1.14, 1.39) <0.0001
History of anxiety 1.01(0.86, 1.18) 0.908
1.13
(1.00, 1.27) 0.050




Never smoker Referent – Referent –
Former smoker 1.11(0.95, 1.29) 0.187
1.20
(1.11, 1.29) <0.0001




Our hypothesis was that enrollees with greater levels of cognitive reserve would be less likely to
report confusion or memory loss, and our results support this. The relationship between cognitive
reserve and confusion or memory loss was similar regardless of PTSD status. For both the probable
PTSD and not probable PTSD groups, we found that groups with greater cognitive reserve were less
likely to report confusion or memory loss, although the association was more significant and stronger
for the group without probable PTSD. This finding suggested that for those who did not have probable
PTSD, cognitive reserve factors may play an even more important role in modifying or delaying
cognitive decline processes among 9/11 survivors.
Cognitive reserve indicators in this study included educational attainment, social integration,
social support, marital status, current employment status, and physical activity. For simplicity, the
four classes for both groups (probable PTSD and not probable PTSD) were assigned equivalent names
(i.e., low, medium-low, medium-high, or high cognitive reserve) despite their composition differing
somewhat between the two groups. Generally, the medium-high, medium-low, and low cognitive
reserve groups were at greater risk of having confusion or memory loss at wave 4 compared to the
high cognitive reserve groups. There was an interesting discrepancy among the probable PTSD group
in that the medium-low cognitive reserve group actually had the greatest relative risk, suggesting that
it was the true low cognitive reserve group. In looking at the composition of the medium-low group,
we posit that the very low probability of individuals having a bachelor’s degree or higher is the factor
driving the increased risk for confusion or memory loss.
Theories on cognitive reserve are rooted in research showing that neural connections can change
throughout an individual’s life [37]—often described as brain plasticity [25,37]. Individuals with
greater cognitive reserve are able to process cognitive information more efficiently or use different
strategies to reason through issues [27], even using additional brain regions related to memory task
performance [38–40]. Even later in life, positive behaviors that increase one’s cognitive reserve can
have an effect. For instance, cognitive training that promotes memory control and strategies for real-life
memory challenges has been shown to be beneficial among older adults [41]. Although educational
attainment is often the simplest and most direct proxy for cognitive reserve, our results show that
other modifiable factors may be instrumental in protecting against confusion or memory loss as well.
People who are active (physically and mentally) and those who engage or feel supported by others
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have better cognitive outcomes than those who are most isolated. Being socially engaged with others
can be cognitively demanding, helping to boost one’s level of cognitive reserve [15].
A healthy lifestyle and better cognitive functioning are protective against countless other negative
health outcomes as well [42–44]. Maximizing time lived in good health has a positive impact on
the individual and societal levels. Greater life expectancy typically involves more years lived with
cognitive impairment. However, greater educational attainment (and presumably, greater cognitive
reserve) has proven to be associated with increased life expectancy and fewer years of cognitive
impairment [25].
Gender, race/ethnicity, history of depression, history of drug or alcohol use problems, and smoking
status were also associated with the outcome in our models. Existing literature has suggested that
memory issues are correlated with anxiety and depression [45]. The nature of psychiatric comorbidities
is complex, and multiple studies have concluded that risk of cognitive decline is greater among those
with comorbid PTSD and depression [8,46], though depression on its own may not increase risk [46].
In fact, cognitive reserve may exert more influence than depression; Lee et al. determined that among
those with greater levels of educational attainment, better memory function was seen regardless
of depressive mood [28]. Ambient air pollutants or fine particulate matter may be associated with
declines in domain-specific cognitive functions or development of mild cognitive impairment [13,47],
but the composition of the dust cloud resulting from the attacks of 11 September 2001 differed from
these exposures in composition and duration [48]. For these reasons, we did not include this type of
exposure as a covariate.
Limitations of this study include limited generalizability to the broader NYC or United States
population; enrollees in the WTCHR are a trauma-exposed population with a high prevalence of
PTSD. Generalizability may be further limited because we excluded people with confusion or memory
loss at wave 3, thereby lowering the proportions of confusion or memory loss at wave 4 as well as
proportions of PTSD at wave 3; our study sample was healthier than the source population from which
it was derived. Another limitation arises because we did not perform cognitive testing on enrollees,
so we cannot easily compare our results to research that used this approach. A third limitation is
that the questions from the WTCHR survey are very similar to those from the Behavioral Risk Factor
Surveillance System [4,49], but they are not identical, so we cannot compare our numbers to those
from the general population. Another limitation is that the validity of self-reported cognitive measures
can be questionable, particularly for individuals who do have symptoms of impairment. However,
those with mild cognitive impairment do not underreport their cognitive issues as much as those with
dementia [50]. Also, our study sample is limited to middle-aged enrollees who are less likely to suffer
from severe cognitive issues than older adults. Response bias and social desirability bias may lead to
an underestimate of the outcome if individuals do not accurately report their confusion or memory loss
as well. Finally, the probable PTSD group was much smaller than the not probable PTSD group (8% vs.
92% of total study sample, respectively), meaning that statistical power could have been limited for
that group.
Strengths of this study include the fact that we were able to describe change in confusion or
memory loss between wave 3 and wave 4, enabling us to approximate the outcome as mild cognitive
decline. Also, the WTCHR cohort is a diverse cohort of approximately 71,000 people, giving us
sufficient statistical power to detect relevant associations. Our results also support other research that
has found that PTSD is an important risk factor for cognitive decline. Among our study sample, the
incidence of confusion or memory loss among those with probable PTSD at wave 3 was 45%, while the
incidence among those without probable PTSD was 20%.
5. Conclusions
There are elevated levels of PTSD among the WTCHR cohort [1,14]. Because PTSD is associated
with cognitive impairment [6–12], we examined the degree to which confusion or memory loss was
reported among our study sample. We were interested in how cognitive reserve levels might affect
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confusion or memory loss, as many of these factors are modifiable. Despite a high prevalence of PTSD
among the source population, the majority of the cohort does not have PTSD; those individuals may
still be at risk for cognitive decline. Our findings show that confusion and memory loss affect more
than one in five enrollees in our study sample, and level of cognitive reserve affects likelihood of
developing confusion or memory loss. Those with higher educational attainment, more social support,
and greater levels of physical activity are less likely to report confusion or memory loss than those with
less cognitive reserve overall. Three of the seven indicators used to create cognitive reserve levels in
this study highlighted social support or social integration; their presence helps decrease likelihood of
reporting symptoms of cognitive impairment. Results suggest that this is true for those with probable
PTSD as well as those without probable PTSD, though the effects were stronger for those without
probable PTSD. We believe that all members of the cohort could benefit from engaging in activities that
promote cognitive reserve, resulting in lower likelihood of experiencing confusion or memory loss and
improved overall health.
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Abstract: The evolution of lung function, including assessment of small airways, was assessed
in individuals enrolled in the World Trade Center Environmental Health Center (WTC-EHC).
We hypothesized that a bronchodilator response at initial evaluation shown by spirometry or in small
airways, as measured by forced oscillation technique (FOT), would be associated with improvement
in large and small airway function over time. Standardized longitudinal assessment included pre
and post bronchodilator (BD) spirometry (forced vital capacity, FVC; forced expiratory volume in
1 second, FEV1) and FOT (resistance at 5 Hz, R5; resistance at 5 minus 20 Hz, R5–20). Longitudinal
changes were assessed using linear mixed-effects modelling with adjustment for potential confounders
(median follow-up 2.86 years; 95% measurements within 4.9 years). Data demonstrated: (1) parallel
improvement in airflow and volume measured by spirometry and small airway function (R5 and
R5–20) measured by FOT; (2) the magnitude of longitudinal improvement was tightly linked to the
initial BD response; and (3) longitudinal values for small airway function on FOT were similar to
residual abnormality observed post BD at initial visit. These findings suggest presence of reversible
and irreversible components of small airway injury that are identifiable at initial presentation.
These results have implications for treatment of isolated small airway abnormalities that can be
identified by non-invasive effort independent FOT particularly in symptomatic individuals with
normal spirometry indices. This study underscores the need to study small airway function to
understand physiologic changes over time following environmental and occupational lung injury.
Keywords: airway physiology; dust; environmental health; forced oscillation; respiratory function;
small airway disease
1. Introduction
The WTC Environmental Health Center (WTC-EHC) is a program for treatment of community
members with medical and mental health symptoms as a result of exposure to the disaster that occurred
in New York on 9/11/2001. Lower respiratory symptoms (LRS) have been reported in WTC dust exposed
community members and responders [1–10]. There are multiple reports of changes in spirometry
associated with LRS, and importantly, small airway abnormalities have been associated with LRS even
in the presence of normal spirometry [4–6,8,11–13]. Longitudinal improvement in LRS and spirometry
is reported in many, although symptoms have often persisted [3,5,14,15]. Of note, structural changes
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within the airways and/or parenchyma have been demonstrated in community members, suggesting
a potentially irreversible component of lung injury [16]. These findings suggest an admixture of
reversible and irreversible components of lung injury in response to WTC dust exposure.
We hypothesized that a bronchodilator response at initial evaluation shown by spirometry or
in small airways, as measured by forced oscillation technique (FOT), would be associated with
improvement in large and small airway function over time. FOT was selected as a noninvasive test
based on demonstrated ability to capture small airway dysfunction in WTC dust exposed populations
even when airflow remains normal when assessed by spirometry [4,5,11,17,18]. Reduction of airflow
on spirometry may not occur in the setting of isolated small airway disease due to the large aggregate
cross-sectional area of the distal airways [19–21]. FOT overcomes this limitation by providing
measures of non-uniformity of airflow distribution that reflect regional functional abnormalities in the
small airways [22–24].
Based on the above considerations, longitudinal data for lung function using spirometry and FOT
to capture small airway function were analyzed in community members enrolled in the WTC EHC.
The study was designed to determine: (1) whether FOT measures of small airway function improved
over time, and (2) whether the bronchodilator response at initial evaluation was associated with a
reversible component of lung injury shown by longitudinal improvement in lung function.
2. Materials and Methods
2.1. Patients
Adult patients were self-referred to the WTC EHC with medical and/or mental health symptoms
related to September 11, 2001 exposures as previously described [2]. Patients were included in this
analysis if they had valid spirometry and FOT, which included bronchodilator testing at their initial
evaluation and at least one subsequent spirometry and FOT evaluation. The Institutional Review
Board of New York University School of Medicine approved the research database (NCT00404898),
and only data from patients who provided informed consent were used for analysis.
2.2. Procedures
At initial visit to the WTC EHC patients completed a multi-dimensional interviewer-administered
questionnaire that included questions relating to demographic characteristics, WTC-related dust
exposures, presence and severity of respiratory symptoms, and history of tobacco use [2]. Patients were
treated for asthma-like symptoms according to guidelines for asthma management [25], and evaluated
with further additional studies if findings were inconsistent with asthma.
2.3. Spirometry and FOT Measurements
At initial visit all patients were referred for objective assessment of lung function using spirometry
and FOT which was performed within a single location (André Cournand Pulmonary Physiology
Laboratory, Bellevue Hospital). Spirometry and FOT were routinely performed on all patients before
and 15 min after bronchodilator (BD) administration (2.5 mg albuterol sulfate delivered via nebulizer
over 5 min) according to standard ATS/ERS guidelines [26,27]. FOT is a noninvasive test that measures
the relationship between pressure and airflow fluctuations applied externally to the respiratory
system during tidal breathing to determine the respiratory system resistance. Measurements included
resistance assessed at an oscillating frequency of 5 Hz (R5) and frequency dependence of resistance
calculated as the difference between resistance at 5 and 20 Hz (R5–20). R5–20 provides a measure
of non-uniformity of airflow distribution that correlates with frequency dependence of compliance
measured by invasive esophageal manometry, an established test of small airway function [22–24,28,29].
Predicted values for spirometry measures were derived from NHANES III [30]. and abnormal
spirometry was defined by forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC),
or FEV1/FVC measurements below the lower limit of normal (LLN) [31]. A positive BD response
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(+BD) on spirometry was defined according to ATS/ERS guidelines as a ≥12% and ≥200 cc increase
in FEV1 and/or FVC after bronchodilator [26]. FOT was performed under tidal breathing (Jaeger
IOS®, Vyaire Medical, Yorba Linda, CA, USA). Measurements included respiratory resistance at 5
Hz (R5) and the difference in resistance from 5 to 20 Hz (R5–20) as an index of frequency dependence
of resistance (FDR). Upper limits of normal (ULN) for R5 and R5–20 (0.396 kPa/L/s and 0.075 kPa/L/s,
respectively) were based on measures in asymptomatic non-smoking subjects with normal spirometry
in our laboratory (n = 80) and the values are in the range of published estimates of normative
data [18,32]. A positive BD response for IOS measurements was defined as a decrease in R5 of
≥0.135 kPa/L/s, based on the 95th percentile for BD response in healthy adults in normative data on
forced oscillation [32].
2.4. Definitions
WTC dust cloud exposure was defined by patient report of having been caught in a dust cloud
created by a building collapse on 9/11. Patients were further classified as local residents, local workers
or clean-up workers based on their description of location and activities. New-onset lower respiratory
symptoms were defined by the presence of at least one symptom of wheezing, chest tightness,
or dyspnea with onset after 11 September 2001. Symptomatic patients at initial presentation to the
WTC EHC were defined based on a symptom frequency ≥2 times per week in the four preceding
weeks. Patients were classified as a smoker if they had >5 pack year lifetime history of tobacco use.
2.5. Statistical Methods
Continuous variables were summarized using median and interquartile range (IQR) and compared
across groups using nonparametric Kruskal-Wallis test. Categorical variables were summarized by
counts and proportions and compared using Chi-squared test. A linear mixed-effects model was
used to investigate longitudinal changes in lung function using each repeated spirometry and FOT
measurement. In each model a fixed linear effect of the follow-up time (defined as duration since initial
visit) on a measure of respiratory function was estimated with adjustment for potential confounders.
Among the considered confounders, gender, race/ethnicity, income, WTC exposure category, dust cloud
exposure did not substantively change the results and thus only age, BMI, and smoking history were
included in the final models. Random intercept and slope were assumed to explain within-subject
correlation among repeated measurements and among-subject heterogeneity.
Separate models were fit with pre-BD FVC, FVC% of predicted, FEV1, FEV1% of predicted,
and FEV1/FVC as dependent variables. To analyze longitudinal changes in FOT parameters,
similar models were fit with pre-BD R5 and R5–20 as the dependent variables. A p value < 0.05 was
used to indicate statistical significance. Analyses were conducted using R (version 3.0.2, R Foundation
for Statistical Computing, Vienna, Austria) and SPSS® (version 20.0, IBM® Corp, Armonk, NY, USA).
3. Results
3.1. Patient Demographics and Characteristics
A total of 1146 adult patients were enrolled in the WTC EHC between 29 October 2002 and 20
February 2013 who fit inclusion criteria. Patients were subsequently excluded from analysis if their
studies were repeated within 180 days (n = 133), if post BD data were not available (n = 119), or if
longitudinal data for either spirometry or FOT were not available (n = 153). The final analytic cohort
consisted of 741 adult patients who met criteria for longitudinal study. Patient characteristics are shown
in Table 1. The cohort had a median age of 51 at enrollment, with an equal distribution of males and
females. Many patients were overweight with a median BMI of 28.1 (IQR 24.7–32.4) kg/m2. The cohort
was racially and ethnicity diverse, with the largest single group identifying themselves as Hispanic
(36%). Less than a quarter (24%) of patients had a smoking history, with few (13%) reporting current
tobacco use. The cohort included predominantly local workers (51%), with fewer local residents (20%)
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and clean-up workers (17.0%). Over half (52%) were caught in the dust cloud caused by the collapse of
the World Trade Center towers on 9/11. The group was highly symptomatic with 93% reporting LRS
that began after 9/11 and persisted at the time of enrollment in the WTC EHC.
Table 1. Patient characteristics at initial visit (n = 741).
Characteristic Value
Age, median (IQR) 51 (44–59)
Gender; (M/F, %) 50/50







Income/year ≤ $15,000 286 (39)
Smoking history
>5 pack-year 177 (24)
Current smoker 96 (13)
WTC exposure category
Local worker 378 (51)




Caught in WTC dust cloud 382 (52)
Lower respiratory symptoms 691 (93)
Data are presented at n (%) unless otherwise noted. IQR: interquartile range; BMI: body mass index; WTC: World
Trade Center.
3.2. Lung Function at Initial Visit
The results of lung function evaluation at the initial visit are shown in Table 2. Median values
for spirometry were within the normal range for pre-BD FVC, FEV1, and FEV1/FVC (median 92%
predicted, 88% predicted, and 77% respectively). The percentage of individuals with values below
the LLN for FVC, FEV1, and FEV1/FVC were 22, 28, and 20%, respectively. Only 58 patients (8%)
met ATS/ERS criteria for a positive BD response on spirometry. Since 93% of the subjects developed
respiratory symptoms after the WTC attack, data prior to the disaster were generally not available.
Table 2. Lung function at initial visit (n = 741).
Pre-BD Post-BD
Spirometry
FVC (%predicted) 92 (81–103) 92 (81–103)
FEV1 (%predicted) 88 (76–99) 92 (80–103)
FEV1/FVC 77 (71–81) 79 (74–84)
FOT
R5 (kPa/L/s) 0.489 (0.375–0.615) 0.428 (0.328–0.527)
R5–20 (kPa/L/s) 0.098 (0.055–0.168) 0.074 (0.041–0.128)
Data are presented at median (IQR). BD: bronchodilatory FOT: forced oscillation technique.
In contrast to spirometry measurements, the majority of patients had abnormal oscillometry
measurements, with an elevated median pre-BD R5 and R5–20 (0.489 and 0.098 cm H2O/L/sec,
respectively), consistent with presence of airway dysfunction not evident on spirometry. The median
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decrease in these parameters after BD for the total cohort was 14% for R5 and 23% for R5–20. A positive
BD response on oscillometry was noted 163 patients (22% of the cohort).
3.3. Longitudinal Spirometry Measurements
Patients were followed for a median of 2.86 years (IQR 1.8–3.7 years), with 95% of the repeated
measurements occurring within 4.9 years. Table 3 shows the results from linear mixed-effects modeling
adjusted for age, smoking, BMI, baseline pre-BD FEV1 %predicted, and baseline pre-BD FVC %predicted.
Spirometry measurements in the cohort improved over time for FVC and FEV1 (36 ± 6 mL and 22 ±
4 mL/year respectively, p < 0.001); these changes in absolute values corresponded to an improvement in
% of predicted FVC = 0.80 ± 0.17% per year and % of predicted FEV1 = 0.60 ± 0.17% per year (p < 0.001
for both analyses). Subgroup analysis demonstrated that individuals with abnormal spirometry at
initial visit had a significantly greater improvement in both FVC and FEV1 over time than those with
normal spirometry at initial visit (p < 0.003 for both variables, data not shown).
Table 3. Longitudinal change in spirometry parameters.
Whole Cohort Abnormal Spirometry






ΔFVC (mL/year) 36 ± 6 * 43 ± 10 * 28 ± 9 ** 122 ± 28 *
ΔFEV1 (mL /year) 22 ± 4 * 29 ± 7 * 16 ± 7 ** 91 ± 7 *
* p < 0.001; ** p < 0.05.
We evaluated whether patients with a positive BD response on spirometry at baseline had greater
improvement in spirometry parameters over time compared with those who had a negative BD
response. To conduct this analysis, data analyzed were limited to the 270 individuals with abnormal
spirometry testing at baseline. Demographic characteristics did not differ between the group with
(−) or (+) BD response at baseline. Initial values for FEV1 and FEV1/FVC were lower in patients with
a (+) BD response compared with those with a (−) BD response (FEV1 67% predicted [IQR 54–75]
vs 74% predicted [IQR 67–82], p < 0.001; FEV1/FVC 64% [IQR 59–71] vs 72% [IQR 67–81], p < 0.001).
Whereas both groups showed improvement in FVC and FEV1 over time, the improvement was greater
in the individuals with a (+) BD response at baseline compared with those with a (−) BD response
(ΔFVC = 122 ± 28 vs. 28 ± 9 mL/year; ΔFEV1 91 ± 7 vs. 16 ± 7 mL/year). Neither group demonstrated
longitudinal change in FEV1/FVC. Although robust improvement in spirometry values were noted in
the patients with (+) BD response, 70.7% demonstrated longitudinal values for FVC and/or FEV1 that
remained in the abnormal range.
3.4. Longitudinal FOT Measurements
Table 4 shows results for longitudinal assessment of lung function using oscillometry. In contrast
to spirometry, the group as a whole failed to demonstrate change in either R5 or R5-20. Subgroup
analysis of individuals who had abnormal oscillometry at initial evaluation demonstrated decline in
resistance when assessed as R5 (slope = −0.007 kPa/L/sec per year, p< 0.05).
Table 4. Longitudinal change in oscillometry parameters.
Whole Cohort Abnormal Oscillometry






ΔR5 (kPa/L/s/year) −0.001 ± 0.002 −0.006 ± 0.003 * 0.002 ± 0.003 * −0.027 ± 0.006 **
ΔR5–20 (kPa/L/s/year) 0.001 ± 0.001 −0.001 ± 0.001 0.002 ± 0.001 −0.012 ± 0.004 *
* p < 0.001; ** p < 0.05.
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The predictive value of a (+) BD response on FOT at baseline was evaluated in the cohort of 527
individuals with abnormal oscillometry testing at baseline. Demographic characteristics did not differ
between the group with (−) or (+) BD response at baseline. Although oscillometry was abnormal
in all of these patients, more abnormal pre BD values for R5 and R5–20 were detected at the initial
visit in individuals with a (+) BD response compared with those with a (−) BD response (R5: 0.685
[IQR 0.573–0.816] vs 0.509 [IQR 0.441–0.597] kPa/L/s; R5–20: 0.210 [IQR 0.123–0.302] vs 0.109 [IQR
0.068–0.165 kPa/L/s]. Table 4 and Figure 1 illustrate that while oscillometry variables remained stable
in the group with (−) BD response at baseline, the group with (+) BD response at baseline showed
significant longitudinal improvement over time (ΔR5 = −0.027 ± 0.006 kPa/L/s/year, p < 0.001; ΔR5–20
= 0.012 ± 0.004 kPa/L/s/year, p = 0.002). Additional analysis demonstrated that the post-BD FOT
values in these patients remained stable over time indicating that the residual abnormality noted post
bronchodilator at baseline remained unchanged over time despite standard medical therapy.
Figure 1. Panel (a) Longitudinal values and confidence interval for R5 derived from mixed-effects
modelling for the (−) BD and (+) BD groups. Panel (b) Longitudinal values and confidence interval for
R5–20 derived from mixed-effects modelling for the (−) BD and (+) BD groups.
4. Discussion
The present study addressed the evolution of lung function including assessment of small airways
in a cohort of community members enrolled in the WTC EHC with new onset lower respiratory
symptoms following exposure to WTC dust. Improvement in respiratory function was demonstrated
by parallel improvement in airflow and volume measured by spirometry as well as resistance (R5) and
FDR (R5–20) measured by oscillometry. Moreover, the magnitude of improvement that occurred with
therapy over time was tightly linked to a BD response at the initial visit. Lastly, the longitudinal values
for small airway function observed on oscillometry were similar to the residual abnormality observed
post BD at initial visit. These findings suggest the presence of reversible and irreversible components
of small airway injury that are identifiable at initial presentation.
Data collected in numerous populations exposed to the WTC disaster demonstrate that in many the
predominant site of injury is to the small airways. The most common abnormality noted on spirometry
in exposed firefighters, workers at the WTC site, and community members was parallel reduction in
both FVC and FEV1 (i.e., without change in FEV1/FVC) [1,2,4,6,8]. Small airway injury was implicated
in these populations based on evidence for air trapping on plethysmography and/or computed
tomography [1,6,33,34]. In accord with these findings, recent data show that exposure to inhaled
ambient particulate matter at sizes below 2.5 μm and occupational toxins are also associated with
small airway dysfunction as evidenced by parallel reduction in FVC and FEV1 [35–40]. Furthermore,
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studies in WTC exposed populations using oscillometry demonstrate presence of FDR in accord
with non-uniform distribution of airflow within small airways [4,11,41,42]. The presence of FDR
is tightly correlated with presence of frequency dependence of compliance detected by esophageal
manometry, an established marker of small airway dysfunction [11,28,29,43,44]. The clinical relevance
of FDR in WTC dust exposed patients has been highlighted by association with magnitude of dust
exposure, presence of wheeze and presence of systemic inflammation as assessed by serum C-reactive
protein levels [4,17,18].
Longitudinal data from the present study indicate improvement in small airway function assessed
by both spirometry and oscillometry. Spirometry assessments demonstrated parallel improvement
of FVC and FEV1 without change in FEV1/FVC. This pattern is in accord with prior descriptions of a
“volume response” following bronchodilator inhalation in patients with asthma and COPD, which has
been attributed to improvement in small airway function with relief of air trapping [45–49]. In the
present study, FOT was added to routine assessment of lung function by spirometry to directly assess
the role and evolution of small airway function in WTC dust exposed individuals. Longitudinal
assessment using FOT demonstrated improvement in FDR, in accord with improved small airway
function over time. Of note, this improvement in small airway function was evident only in those
individuals who had abnormal respiratory function at baseline with a reversible component, as evident
by testing post administration of bronchodilator.
Prior studies in WTC dust exposed populations have indicated presence of both reversible
and irreversible airways injury over time. Registry based longitudinal studies have indicated that
resolution of lower respiratory symptoms over time is associated with improvement in measures of
small airway function and conversely, persistence of LRS is associated with persistent small airway
dysfunction [3,5]. In contrast, persistence of severe LRS has been documented despite a high level of
respiratory medication use, including inhaled corticosteroid and long acting β-agonist [3]. Similarly,
high rates of poorly or very poorly controlled asthma has been documented in numerous cohorts of
individuals that were exposed to WTC dust [50–54]. We have previously demonstrated presence of
sustained inflammation in WTC dust exposed community members based on peripheral eosinophilia
and increased C-reactive protein levels, findings that were associated with persistent abnormality
in small airway function [17,55]. Objective evidence for inhalation of particles to the distal lung
and structural airway abnormalities has been demonstrated using analysis of induced sputum and
by histologic assessment of lung tissue which showed peribronchiolar fibrosis and emphysematous
changes [16,56,57]. Taken together these findings are consistent with a chronic disease syndrome due
to disease in the small airways. Lack of complete improvement in small airway function may be
due to chronic inflammation that is either not fully corrected by the current medical therapy and/or
is located beyond the delivery range of conventional inhaled corticosteroid therapy. Alternatively,
given the structural changes in the distal lung noted on histology, the residual small airway dysfunction
observed over time could reflect irreversible structural damage that occurred prior to initial evaluation,
presumably at time of injury.
There are some factors to consider when interpreting the data in the present study. First,
there is significant heterogeneity within this population regarding amount and duration of WTC dust
exposures, as well as other potential environmental exposures. However, data remained significant
after adjustment for exposure categories, dust cloud exposure and smoking. Second, although medical
therapy was prescribed by a standardized clinical algorithm, adherence to therapy was not documented.
Of note, medications and provider visits were provided free-of-charge, theoretically minimizing
financial and access to care issues as barriers to adherence. Despite these limitations, improvements
in spirometry and FOT measures of small airway function were documented and were associated
with presence of acute reversibility at baseline. Nevertheless, a contribution from non-adherence to
medical therapy to the residual abnormality in both spirometry and FOT cannot be excluded. Third,
modeling was performed with a linear time trend for changes in spirometry. These improvements
would eventually be counterbalanced by normal age-related decline in spirometry, but analysis over a
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longer follow-up duration would be needed. In contrast, there are no data demonstrating age-related
change in oscillometry in adult populations. Fourth, there is potential for bias as all patients were
self-referred to the EHC with potential for follow-up bias as only 83% of patients with valid spirometry
and oscillometry measurements at initial visit had subsequent valid spirometry and oscillometry
measurements. Finally, this study was not designed to examine the association of longitudinal change
in lung function with change in lower respiratory symptoms over time.
An additional limitation of this study relates to lack of interpretation of FOT data with respect to
lung volume; change in values for resistance over time would occur if functional residual capacity
(FRC) varied at each study visit. Although FRC was not measured in this study, the most likely
explanation for variability over time would related to changing body weight. However, significant
changes in body weight has not been evident in patients that have returned for routine monitoring
within our WTC EHC population.
5. Conclusions
Inhalation of WTC dust was associated with small airway abnormalities in a cohort of exposed
community members which showed incomplete improvement over time. Positive bronchodilator
response in the small airways at presentation identified individuals with significant ability for
improvement in lung function over time; however, residual abnormality noted post-BD at baseline
identified an irreversible component of small airway injury. These results have implications for the
treatment of isolated small airway abnormalities that can be readily identified by non-invasive effort
independent FOT particularly in individuals who are symptomatic with normal spirometry indices.
Finally, this study also underscores the need to study small airway function to understand physiologic
changes over time for this and other environmental and occupational lung injuries.
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Abstract: We examined whether time to onset of paresthesia was associated with indicators of severity
of World Trade Center (WTC) exposure. We analyzed data from 3411 patients from the Bellevue
Hospital—WTC Environmental Health Center. Paresthesia was defined as present if the symptom
occurred in the lower extremities with frequency “often” or “almost continuous.” We plotted hazard
functions and used the log-rank test to compare time to onset of paresthesia between different
exposure groups. We also used Cox regression analysis to examine risk factors for time-to-paresthesia
after 9/11/2001 and calculate hazard ratios adjusted for potential confounders. We found significantly
elevated hazard ratios for paresthesia for (a) working in a job that required cleaning of WTC dust in
the workplace; and (b) being heavily exposed to WTC dust on September 11, 2001, after adjusting for
age, race/ethnicity, depression, anxiety, post-traumatic stress disorder, and body mass index. These
observational data are consistent with the hypothesis that exposure to WTC dust or some other aspect
of cleaning WTC dust in the workplace, is associated with neuropathy and paresthesia. Further
neurological evaluations of this and other WTC-exposed populations is warranted.
Keywords: paresthesia; neuropathic symptoms; Cox regression; hazard function; World Trade
Center exposure
1. Introduction
The World Trade Center (WTC) Environmental Health Center (EHC) serves community members
exposed to the World Trade Center disaster of September 11, 2001. These individuals include local
workers and residents, as well as other affected community members with potential exposure to WTC
contaminants who developed physical or mental health symptoms after the event. The most common
presenting complaints are aerodigestive symptoms [1,2]. However, within a few years after 9/11,
patients seeking care at the Bellevue Hospital WTC EHC also reported paresthesias or sensations of
tingling, prickling, or numbness in the extremities. Formal questions about paresthesias thus were
added to the medical evaluation questionnaires around January 1, 2008 to evaluate for the potential for
peripheral neuropathy associated with WTC toxic exposures.
Neuropathic symptoms were associated with sarin exposure that occurred during the terrorist
attacks in Japan in 1994 and 1995 [3]. Of 155 individuals who required medical evaluation, 40 subjects
required hospital admission due to severe exposure. These subjects had more frequent salivation,
rhinorrhea, and diarrhea. 40% (16/40) of these subjects reported distal lower extremity dysesthesias
IJERPH 2019, 16, 1429; doi:10.3390/ijerph16081429 www.mdpi.com/journal/ijerph194
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and were noted to have reduced distal vibration on clinical exam. These signs and symptoms resolved
at 3 months follow-up in the majority of cases.
Components of the WTC toxins provide biologic plausibility for the development of neuropathic
disease. Heavy metals and environmental toxin exposures have been associated with distal symmetric
polyneuropathy [4]. Examination of sciatic nerves from rats exposed to WTC dust also demonstrated
reductions in conduction velocities of nerve action potentials when compared to controls [5]. WTC
dust contained known neurotoxins including lead and complex hydrocarbons [6–9]. Workers involved
in clean-up activities may also have been exposed to organic solvents. Distal sensory motor neuropathy
is associated with lead poisoning, with a motor predominant neuropathy primarily seen following
acute exposure [10]. Industrial exposure to n-hexane, an organic solvent, has been associated with
paresthesia and distal symmetric, primarily axonal, large fiber polyneuropathy [11,12].
An earlier analysis of patients from the WTC EHC found that many reported paresthesias at
enrollment 7–15 years after 9/11 [13]. These symptoms were associated with the severity of exposure to
WTC dust on 9/11 and cleaning of workplaces after adjusting for known risk factors for paresthesia,
including preexisting paresthesias, anxiety, and diagnoses of diabetes and cancer [3,12]. Paresthesias
also were associated with respiratory symptoms and reduced lung function, which may have been
surrogate measures of WTC exposure [4,14]. Paresthesia symptoms were associated with later
(2013–2015) enrollment in the WTC EHC, suggesting a long latency period between exposure and
development of symptoms in some patients. Neuropathic symptoms also were reported in a series
of 16 first responders exposed to the WTC disaster [15]. 56% (9/16) of these patients had neuropathy
that could not be explained by diabetes, B12 deficiency, or Lyme disease suggesting WTC exposure as
a possible etiology. The present analyses aim to describe further paresthesia associated with WTC
exposure by exploring time to paresthesia after the September 11, 2001 disaster and associations of
time to paresthesia with measures of severity of WTC exposure.
2. Materials and Methods
2.1. Study Population
As previously described, we enrolled subjects for the present analysis from the Bellevue Hospital
WTC Environmental Health Center (WTC EHC) [2]. Enrollment into the WTC EHC was open to
individuals who were exposed to the disaster who reported medical or mental health symptoms
certified as potentially due to exposure to the WTC event [2]. Paresthesias were not prerequisite
symptoms for inclusion in the program. Patients of the WTC EHC primarily included individuals
who worked in local businesses, lived in buildings near the WTC towers, or were traveling through
the area of Manhattan south of Canal Street on the day of the disaster. A small proportion of the
WTC EHC patient population were first-responders who were enrolled during the initiation of the
program. Subsequently, separate programs were developed for first responders and community
members [2]. Blood glucose was measured by the Bellevue Hospital Clinical Laboratory. Body
mass index (BMI), post-traumatic stress disorder (PTSD), depression and anxiety were measured as
previously described [16]. We limited the present analyses to subjects who responded to questions
added around January 1, 2008 regarding paresthesia.
The New York University School of Medicine Institutional Review Board approved the research
database used for these analyses. The present analyses used only data from patients who provided
informed consent to allow the use of their data in research analyses.
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2.2. Paresthesia
We investigated the incidence of paresthesia of the lower extremities. We defined paresthesia to be
a positive response to the question, “In the past year, did you experience a prickling or tingling feeling,
with or without an asleep feeling, in your feet or legs?” Moreover, we further limited persons with
paresthesia to those who responded that they experienced this feeling “often” or “almost continuous”.
Persons who said they experienced this feeling “occasionally” or “never” were classified as not
having paresthesia.
2.3. Time to Onset of Paresthesia
We inferred dates of onset of paresthesia after 9/11/2001 by two methods: Among subjects with a
baseline visit only, we used subjects’ self-reports of the number of months post-September 11, 2001
when they recalled first experiencing paresthesia of the lower extremities. For subjects who reported
not having had paresthesia at their baseline enrollment interview but who then reported paresthesia at
their first return visit, we estimated the date of onset of paresthesia as the midpoint between the dates
of the baseline interview and the first return visit. We right-censored dates of onset of paresthesia of
subjects in the following situations: (a) patients were considered as censored at initial baseline visit
time for those who reported no paresthesia at the baseline visit and did not come back for a return
visit; (b) patients who did not report paresthesia at both the baseline visit and return are considered as
censored at return.
2.4. Statistical Analyses
Descriptive statistics were used to summarize the characteristics of the study population.
Categorical variables (or categorized continuous variables) were summarized using counts and
percentages. Initial analyses compared persons with follow-up visits to those without follow-up visits.
We used the chi-squared test to compare categorical variables of subjects with and without follow-up.
We used population hazard functions for paresthesia-free survival and the log-rank test to evaluate
differences in time to onset of paresthesia among subjects with versus those without a job related
to cleaning WTC dust. For multivariable analyses, we used Cox proportional hazards regression
analysis to calculate hazard ratios associated with various risk factors after adjusting for potential
confounders. We performed Cox regression analyses both including and excluding those subjects who
reported “occasional” paresthesia without ever reporting “often” or “almost continuous” paresthesia.
All statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA).
3. Results
4165 subjects enrolled in the WTC EHC after January 1, 2008 when questions about paresthesia
were first routinely included in the WTC EHC enrollment questionnaire. We excluded from our
analyses, 11 subjects who were born after September 11, 2001, 132 subjects who reported paresthesia
before September 11, 2001, and 458 subjects who reported diabetes, leaving 3564 individuals (Figure 1).
After dropping subjects with diabetes, histories of cancer chemotherapy, paresthesia prior to 9/11 and
those in utero on September 11, 2001, there remained for analysis data from 3411 individuals (Figure 1).
The median date of enrollment was January 19, 2010 (interquartile range [IQR] = September 19,
2007–May 1, 2014). Of the 3564, 38.5% (1373/3564) returned for follow-up at a median of 35 months
(IQR = 23–47 months) after enrollment. The proportions returning for return visits were associated
with age, year of enrollment, and race/ethnicity (all p < 0.0001) (Table 1).
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Figure 1. Flowchart of patients included in analyses of time to onset of paresthesia among patients of
the Bellevue Hospital WTC (World Trade Center) EHC (Environmental Health Center).
Table 1. Baseline characteristics associated with returning percentage for a return visit (n = 3564).






Female 1811 711 (39.3) 1100 (60.7)
Male 1753 662 (37.8) 1091 (62.2)
Age on 911 <0.0001
<35 967 302 (31.2) 665 (68.8)
35–44 1155 452 (39.1) 703 (60.9)
45–54 1022 435 (42.6) 587 (57.4)
55–64 356 156 (43.8) 200 (56.2)
≥65 64 28 (43.8) 36 (56.2)
Year of
enrollment <0.0001
2008–2010 1432 746 (52.1) 686 (47.9)
2011–2013 817 381 (46.6) 436 (53.4)
2014–2015 538 197 (36.6) 341 (63.4)
2016–2018 777 49 (6.3) 728 (93.7)
Race/Ethnicity <0.0001
Hispanic 799 382 (47.8) 417 (52.2)
Non-Hispanic Caucasian 1713 566 (33.0) 1147 (67.0)
Non-Hispanic African-American 705 294 (41.7) 411 (58.3)
Asian 263 93 (35.4) 170 (64.6)
Other or Native American 47 16 (34.0) 31 (66.0)
Missing race/ethnicity 37
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Among the 3411 subjects included in the present analyses, 50.7% were female, 48% were
Caucasian, and 78% were non-Hispanic (Table 2). The median age was 53 (IQR = 44–61) years.
At baseline, 605 (17.7%) reported feeling “often” or “almost continuous” symptoms of paresthesia of
the lower extremities and these 605 were regarded as having had paresthesia at the number of months
post-September 11, 2001 that each subject recalled having first noticed the symptom. The remaining
2806 (82.3%) were classified as not having paresthesia at baseline in our analysis. These 2806 subjects
included 1004 (35.7%) who answered “occasionally” at either the baseline or return visit.
Table 2. Characteristics of subjects at the baseline visit (n = 3411).











Median age at enrollment (IQR) 53(44–61)






Non-Hispanic Caucasian 1635 (47.9)
Non-Hispanic African- American 675 (19.8)
Asian 258 (7.6)
Other or Native American 44 (1.3)
Missing 34 (1.0)
Subjects reported paresthesia Yes 605 (17.7)
No 2806 (82.3)
3.1. Time to Onset of Paresthesia: Nonparametric Analysis
To examine potential change in the hazard rate (or incidence rate) of paresthesia, we used
nonparametric estimates of the Kaplan–Meier survival functions and the cumulative hazard functions
for times-to-paresthesia after 9/11 in our study population. As is well known, the Kaplan–Meier
survival functions are nonparametric estimates of the survival probabilities and the cumulative hazard
function (Figure 2) is just the negative logarithm of the estimated survival functions. The nonparametric
analysis is based on the 605 paresthesia cases reported at initial visit and the 159 new cases from M1.
The above nonparametric cumulative hazard function of paresthesia-free survival suggests a long-term
and continuing risk of paresthesia 17 years or more after the WTC disaster. More specifically, the slope
for the cumulative hazard function in Figure 2 suggests a near-constant incidence rate of paresthesia in
this population over the study period.
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Figure 2. Nonparametric hazard function of paresthesia-free survival (n = 3411).
3.2. Time to Onset of Paresthesia: Multivariate Cox Regression
Multivariable Cox proportional hazards regression analysis indicated a significantly elevated
hazard ratio (HR = 1.369, p = 0.003) for paresthesia associated with having worked in a job that required
cleaning of WTC dust after adjusting for age, race-ethnicity, depression, anxiety, post-traumatic stress
disorder, and elevated body mass index (Table 3). These associations remained if we analyzed data
only from the baseline questionnaire without considering data from the return visit. Blood glucose
concentrations were not significant and thus did not enter into the model.
Table 3. Multivariable Cox proportional hazards regression using both Baseline and Return Visit data
(n = 3411).
Variable Hazard Ratio 95% Confidence Interval p-Value
Gender F vs. M 1.14 0.99 1.33 0.08




Hispanic 1.24 1.03 1.50 0.03
Non-Hispanic
African-American 1.12 0.92 1.37 0.2
Asian 0.85 0.61 1.18 0.3
Other or
Native-American 1.83 1.07 3.13 0.03
Cleaning Job Yes vs. No 1.37 1.11 1.69 0.003
Covered in Dust Much vs. Little 1.09 0.94 1.27 0.2
Body mass index (kg/m2) Per unit increase 1.02 1.01 1.03 0.001
Anxiety (vs. <1.75) ≥1.75 1.37 1.10 1.71 0.006
Missing 1.45 0.28 7.58 0.7
Post-Traumatic Stress
Disorder (vs. PCL*- < 44)
PCL ≥ 44 1.29 1.04 1.59 0.02
Missing 0.98 0.19 5.14 0.9
Depression (vs. <1.75) ≥1.75 1.41 1.13 1.76 0.002
Missing 1.45 0.28 7.58 0.7
* PCL is Post-Traumatic Stress Disorder Check List.
Nonparametric hazard functions (Figure 3) comparing the 422 subjects who worked in a job that
required cleaning of WTC dust (red curve) to the 2915 subjects who did not have such jobs (blue curve)
showed a significant difference between the two groups (p < 0.0001, log-rank test).
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Figure 3. Nonparametric hazard functions of paresthesia-free survival stratified by cleaning job.
The nonparametric hazard curves in Figure 3 indicate significantly higher risk in time to onset of
paresthesia among persons who worked in jobs that required cleaning of WTC dust in the workplace
after adjusting for potential confounders.
The Cox model shown in Table 3 categorized as paresthesia-free those subjects who reported
paresthesia with frequencies of “none” or “occasional”. This might have weakened the observed
statistical associations because some persons with “occasional” paresthesia might indeed have had
the same condition as subjects with paresthesia of frequency “often” or “almost continuous”. We
therefore analyzed the data excluding 1004 subjects with one or two reports of paresthesia of frequency
“occasional” but who never reported paresthesia of frequency “often” or “almost continuous”. Cox
regression analysis of the reduced data set (Table 4) showed significant associations of time to paresthesia
with being employed in a job that required cleaning of WTC dust and with being heavily covered with
dust on the day of the WTC disaster, September 11, 2001. The hazard ratio for working in a job that
required cleaning of WTC dust increased from 1.35 (95% confidence interval CI = 1.11–1.69) in the
model that included all subjects to 1.52 (95% CI = 1.24–1.87) in the model that excluded subjects with
“occasional” paresthesia.
Table 4. Multivariable Cox proportional hazards regression using Baseline and Return Visit data,
excluding subjects with “occasional” paresthesia (n = 2407).
Variable Hazard Ratio 95% Confidence Interval p-Value
Gender F vs. M 1.22 1.05 1.41 0.01
Age on 911 (years) Per unit increase 1.01 1.01 1.02 <0.0001
Race-Ethnicity (vs.
Non-Hispanic Caucasian)
Hispanic 0.85 0.61 1.18 0.3
Non-Hispanic
African-American 1.32 1.09 1.59 0.004
Asian 1.29 1.06 1.57 0.0106
Other or
Native-American 1.75 1.02 2.99 0.04
Cleaning Job Yes vs. No 1.52 1.24 1.87 <0.0001
Covered in Dust Much vs. Little 1.19 1.03 1.38 0.02
Body mass index (kg/m2) Per unit increase 1.02 1.01 1.03 0.0007
Anxiety
(vs. <1.75)
≥1.75 1.51 1.21 1.89 0.0002
Missing 1.10 0.25 4.82 0.9
Post-Traumatic Stress
Disorder (vs. PCL < 44)
PCL ≥ 44 1.35 1.09 1.67 0.006
Missing 1.42 0.32 6.27 0.6
Depression
(vs. <1.75)
≥1.75 1.49 1.19 1.85 0.0004
Missing 1.10 0.25 4.82 0.9
200
IJERPH 2019, 16, 1429
4. Discussion
Among WTC survivors from the general community, we found significantly shorter time to
onset of paresthesia among persons who worked in jobs that required cleaning of WTC dust in the
workplace, or who were heavily covered with dust on the day of the disaster, after adjusting for
potential confounders. Paresthesia was a common problem in this population, with 17.7% of subjects
reporting symptoms of paresthesia at initial visit, even after excluding from the case definition those
who reported paresthesias only of the upper extremities, and restricting the case definition to those
who experienced the symptom with a frequency of “often” or “almost continuous”. The slope of
the estimated cumulative hazard function was approximately constant, indicating a long latency
period before onset of paresthesia among many subjects and a flat incidence rate in the WTC affected
populations many years after 9/11.
Results of a previous analysis of risk factors for paresthesia among WTC EHC patients that did
not take into account times to events were similar to those of one of the present models in finding
significant associations of paresthesias with both working in jobs that required cleaning of WTC dust
in the workplace and heavy exposure to WTC dust on September 11, 2001 after adjusting for potential
confounders [13]. Of these two risk factors, only work in a job that required cleaning of WTC dust was
significant in our initial Cox regression model that counted subjects with “occasional” paresthesia as
paresthesia-free. The finding that being heavily covered with dust also was significant in the model that
excluded subjects with “occasional” paresthesia suggests that exposures of some of the “occasional”
paresthesia subjects were similar to those of subjects with “often” or “almost continuous” paresthesia.
Categorization of subjects with “occasional” paresthesia as paresthesia-free during the study period
appears to have reduced the statistical power of the analysis that included these subjects.
The present findings cannot establish a causal relationship between WTC exposure and paresthesia.
The findings are consistent, however, with the hypothesis that exposure to the WTC event during
cleaning of dust in the workplace increased the subsequent risk of paresthesia and that the hazard
continued to be relatively constant over extended times through approximately 17 years.
Our hazard function plots of survival times paresthesia-free suggest a long-term and continuing
risk 17 years or more after the WTC disaster of paresthesia. Few instances of exposure to a time-limited
event, including environmental disasters with neurotoxic consequences, have been reported and most
exposures to neurotoxins result in symptoms within weeks or months [3,17,18]. In some instances, it
is difficult to untangle whether a latency period precedes symptom expression of neuropathy or if a
certain level of dose must be accumulated. Chemotherapy-associated neuropathy, for example, is more
likely to develop in patients who have received larger doses over longer periods [19]. Occupational
exposure to n-hexanes and low boiling point hydrocarbons have been associated with the development
of a sub-acute neuropathy [20,21]. Removal of exposure of the occupational neurotoxins and cancer
chemotherapy has been reported to improve neuropathic symptoms and in some cases also reverse
the neuropathy or improve it [19,22]. The increased occurrence of symptoms over time might be due
to other causes, including the onset of diabetes. Our available serum values did not suggest poor
glycemic control in this population. While most patients fasted before blood donation, we did not
record whose samples were provided after fasting and which were not.
One conceptual model for our finding is that WTC exposure resulted in inhalation or ingestion of
neurotoxins on airborne particulate matter and that these particulates became embedded in lung or
other tissues, with slow leaching of the neurotoxins from these particles into the bloodstream over
years, eventually leading to adequate bioaccumulation to cause expression of neurologic symptoms.
Slow leaching of lead from retained bullet fragments has been associated with elevated blood lead
levels [23]. Perhaps the delayed onset of symptoms in WTC subjects may be mediated by a delay in
cumulative dose since the event, or may be due to a combination of industrial and environmental
toxins related to the WTC disaster.
Symptoms of paresthesia resolved or decreased in a subset of subjects between the enrollment
and first return visits. This finding may be due to removal of the toxic exposure and subsequent
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reduction in symptoms. Another possibility may be due to medication for neuropathic symptoms
with improvement in symptoms. Another consideration is that subjects started treatment for known
etiologies of neuropathy that may have alleviated neuropathic symptoms.
Hispanic ethnicity, older age, active mental health issues, and BMI also were associated with
significantly elevated hazard ratios of paresthesia. Diabetes and pre-diabetes are the most common
etiologies of neuropathy, specifically distal symmetric polyneuropathy of the lower extremities [24,25].
Although elevated BMI is associated with a greater risk of diabetes and pre-diabetes, serum glucose
concentrations were not associated with time to paresthesia, suggesting that neither diabetes nor
pre-diabetes were responsible for the reported paresthesias.
Mood disorders are associated with different variants of neuropathy from diabetic, inflammatory,
and chemotherapy-associated neuropathy [26–28]. The prevalence of depression is also greater
in diabetics who have neuropathy [29,30]. The significant association of time to paresthesia with
WTC exposure variables after controlling for covariates including measures of depression, anxiety,
post-traumatic stress disorder and BMI, suggests a role of WTC-associated exposure.
There are limitations to our study. We used a standard question for paresthesias that may
not be specific for neuropathy and our question was not supplemented with complete neurological
examinations, serum studies to search for etiologies of neuropathy, or additional investigations
such as electromyography and nerve conduction study, or skin biopsy for evaluation of small fiber
polyneuropathy. The questionnaire data also did not specifically address unilateral lower limb from
bilateral limb paresthesia. Paresthesias due to other etiologies that would be considered independent of
WTC exposure, such as unilateral lumbar radiculopathy, may have been included in our case definition.
However, to improve the accuracy of our case definition, we only counted as cases those subjects
who reported frequent symptoms. Counting subjects who reported paresthesia with frequency of
“occasional” as paresthesia-free, however, likely weakened the statistical associations we observed
compared with the model we created that excluded such subjects. We lacked a control group without
exposure to the WTC disaster. Only 36% of subjects had follow-up visits. Whereas some subjects had
two or more return visits during this period, the numbers were too small to warrant inclusion in this
analysis and the subset of patients returning for earlier, follow-up visits might have been over-weighted
with those with more severe symptoms. In addition, dates of onset of paresthesia were inferred from
self-reports among subjects without return visits, and were calculated from the mid-points between
visits for those with incident paresthesia at recall. Another limitation of the current study is that a
portion of the reported paresthesia cases might be symptoms that are transient in nature. The patterns
of symptom persistence and/or recurrence of paresthesia are worthy of further studies using more
comprehensive follow up data.
Paresthesia is a common symptom of neuropathy, but the estimated prevalence of neuropathy in
the general population is only 2.4%–7% [31,32]. The higher prevalence of paresthesia in the present
study sample strongly suggests that something about exposure to the WTC event or employment in
jobs requiring cleaning of WTC dust increased the risk of neuropathy and paresthesia.
5. Conclusions
Reports of paresthesia symptoms are common in the WTC EHC population. We also found
significantly higher risk in time to onset of paresthesia for (a) working in a job that required cleaning of
WTC dust in the workplace; and (b) being heavily exposed to WTC dust on September 11, 2001, after
adjusting for potential confounders. This study suggests that WTC exposure is associated with the
development of paresthesias and underscores the importance of further evaluating this population
clinically to search for a possible mechanism.
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Abstract: Airway hyperreactivity (AHR) related to environmental exposure is a significant public
health risk worldwide. Similarly, metabolic syndrome (MetSyn), a risk factor for obstructive airway
disease (OAD) and systemic inflammation, is a significant contributor to global adverse health. This
prospective cohort study followed N = 7486 World Trade Center (WTC)-exposed male firefighters
from 11 September 2001 (9/11) until 1 August 2017 and investigated N = 539 with newly developed
AHR for clinical biomarkers of MetSyn and compared them to the non-AHR group. Male firefighters
with normal lung function and no AHR pre-9/11 who had blood drawn from 9 September 2001–24
July 2002 were assessed. World Trade Center-Airway Hyperreactivity (WTC-AHR) was defined as
either a positive bronchodilator response (BDR) or methacholine challenge test (MCT). The electronic
medical record (EMR) was queried for their MetSyn characteristics (lipid profile, body mass index
(BMI), glucose), and routine clinical biomarkers (such as complete blood counts). We modeled the
association of MetSyn characteristics at the first post-9/11 exam with AHR. Those with AHR were
significantly more likely to be older, have higher BMIs, have high intensity exposure, and have
MetSyn. Smoking history was not associated with WTC-AHR. Those present on the morning of 9/11
had 224% increased risk of developing AHR, and those who arrived in the afternoon of 9/11 had
a 75.9% increased risk. Having ≥3 MetSyn parameters increased the risk of WTC-AHR by 65.4%.
Co-existing MetSyn and high WTC exposure are predictive of future AHR and suggest that systemic
inflammation may be a contributor.
Keywords: metabolic syndrome; airway hyperreactivity; World Trade Center
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1. Introduction
Metabolic syndrome (MetSyn) is a clinical diagnosis made by fulfilment of at least three of the five
following comorbidity criteria: Abdominal obesity, insulin resistance, hypertriglyceridemia, low high
density lipoproteins (HDL), and hypertension [1,2]. MetSyn and particulate matter (PM) exposure are
known independent risk factors in the development of many diseases including cardiovascular disease
and cancer [3]. MetSyn, classically a risk factor for cardiovascular disease, is now being investigated as
a risk factor for pulmonary disease [4].
Obesity, one component of MetSyn, has been typically linked to restrictive patterns of lung
disease through mechanical stress and mass loading. However, many recent studies have focused
on the systemic effects of MetSyn, through hormonal and immunoinflammatory mediators, and their
association with pollution exposure and subsequent respiratory disease [5–11]. One study suggests that
adipose tissue and adipokines such as C-reactive protein (CRP) and tumor necrosis factor-α (TNF-α)
may contribute to a systemic low-grade inflammatory process leading to airway hyperreactivity
(AHR) [12].
The association between MetSyn and the development of AHR has been seen in several studies [13].
Multiple cross-sectional studies have shown an increased prevalence of MetSyn or its constituents
amongst those with diagnosed asthma or asthma-like symptoms [14–16]. A meta-analysis that
included cohorts in the United States (US), Canada, and Europe reported that odds of incident
asthma are increased by 50% in obese individuals, and that risk increased with body weight [17].
Two prospective studies investigated adults who were asthma-free at baseline and showed that obesity
and insulin resistance were MetSyn risk factors that contributed to eventual asthma or asthma-like
symptoms [17,18]. Murine studies showed that mice that developed insulin resistance from a high
fat diet had increased airway resistance at baseline and after methacholine provocation, indicating
a component of AHR [19].
AHR and PM exposure have also been strongly linked in numerous studies. In a cohort of
asthmatic and non-asthmatic children exposed to freeway and non-freeway air pollution, there was
a positive association between air pollution exposure and asthmatic children [20]. In a cohort study of
40 asthmatic children who attended school in close proximity to expressways, there was an increased
risk of wheezing and shortness of breath [21]. In a cross-sectional study of adults over 50 years of age
in low resource countries, 5.12% of cases were secondary to PM exposure, and the prevalence ratio of
asthma after each 10 μg/m3 increase of PM2.5 was 1.05 [22]. The World Trade Center (WTC) complex
destruction on 11 September 2001 (9/11) led to the release of over 11,000 tons of PM, and exposed over
300,000 local workers, residents, and rescue and recovery workers [23]. An early study monitoring
pulmonary function in firefighters from the Fire Department of the City of New York (FDNY) with
World Trade Center Particulate Matter (WTC-PM) exposure had AHR prevalence of 40%, and over half
of the studied group had persistent AHR in a follow-up exam 10 years later [24,25]. These studies
established a significant association between exposure level and AHR [26].
Our initial work focused on inflammatory biomarkers, such as GM-CSF and MDC, in
WTC-PM-exposed firefighters [27]. We also investigated amylin, leptin, and lipids in a subset
of exposed firefighters with WTC lung injury (WTC-LI) as defined by a loss of forced expiratory volume
in 1 second (FEV1) to less than the lower limit of normal (LLN), and recently validated our findings of
MetSyn associated with WTC-LI in the larger exposed group [4,28]. We now investigate the impact of
MetSyn on the development of WTC-associated AHR.
2. Materials and Methods
Study Design: Demographics, clinical information and serial spirometry obtained as part of the
Fire Department of New York World Trade Center Health Program (FDNY WTC-HP) was extracted
from the FDNY electronic medical record [29]. All WTC-exposed FDNY rescue/recovery workers
(baseline cohort; N = 12,781) were included if they were firefighters, had research consent, FEV1 ≥
lower limits of normal, no AHR on available lung function testing pre-9/11, fasting blood drawn prior
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to WTC site closure on 24 July 2002, and available clinical endpoints, yielding a source cohort of
N = 7486 (Figure 1) [30]. Exposure to WTC-PM, defined per the FDNY WTC-HP, was based on first
arrival at the WTC site and considered the highest if arrived in the morning of 9/11 during the collapse
of the WTC, intermediate arriving the afternoon of 9/11, and lower intensity if arriving on or after
9/12 [31]. All subjects consented to analysis of their information for research at the time of enrolment.
All data was collected in compliance with the Code of Federal Regulations, Title 21, Part 11 and the
Montefiore Medical Center/Albert Einstein College of Medicine (#07-09-320) and New York University
(#16-01412) Institutional Review Boards have approved this study. All participants gave informed
written consent.
 
Figure 1. Study Design. Fire Department of New York (FDNY) rescue workers exposed to World Trade
Center (WTC) particulates and enrolled in the WTC Health Program.
AHR Definition. The cohort was followed longitudinally until 1 August 2017 and N = 1906
had either a pulmonary function test (PFT) with assessment of bronchodilator response (BDR) or
methacholine challenge test (MCT) administered. World Trade Center Airway Hyperreactivity
(WTC-AHR) was defined at the earliest positive BDR or MCT after WTC exposure. In general,
a bronchoprovocation test such as an MCT may be utilized to assess hyperreactivity, whereas
a bronchodilator test may indicate reversibility consistent with asthma. MCTs were positive when the
cumulative methacholine dose that reduced the FEV1 by 20%, (PC20) was equivalent or was less than
16 mg/mL [32]. BD was positive when post-bronchodilator FEV1 change exceeded 12% and at least
200 mL [33]. Those without AHR (N = 6947) were defined as those who either had a negative study or
were presumed negative if they did not have subspecialty testing.
207
IJERPH 2019, 16, 1486
MetSyn Phenotypic Definition. Diagnosis of MetSyn was based on National Cholesterol
Education Program Adult Treatment Panel III (NCEP ATP III) guidelines and optimized for our cohort
by having at least 3 of 5 following criteria: Systolic blood pressure (SBP) ≥130 mmHg or diastolic
blood pressure (DBP) ≥85 mmHg; HDL <40 mg/dL; triglycerides ≥150 mg/dL; insulin resistance, as
glucose ≥100 mg/dL; or body mass index (BMI) ≥30 kg/m2. BMI ≥30 kg/m2 was used as surrogate for
central adiposity as per Word Health Organization (WHO) guidelines [34]. Smoking information and
exposure intensity were self-reported and collected from questionnaires administered during medical
monitoring exams. Clinical parameters including DBP, glucose, and lipid panel were measured at
WTC-HP entry. All of the above criteria were from data points obtained pre-9/11 and prior to any
measurements of post-9/11 AHR.
Additional Clinical Biomarkers. We investigated the correlation between AHR and other clinical
biomarkers. Absolute counts of differentiated white blood cells (WBC) such as neutrophils and
eosinophils present at the first post-9/11 evaluation. A cutoff of at least 500 eosinophils was utilized,
consistent with definition of clinical hyper-eosinophilia. Cholesterol/HDL ratio ≥3.5, a predictor of
ischemic heart disease risk, and its association with AHR was also investigated [35–37].
Statistical Analysis. SPSS-23 (IBM) was used for primary data handling and statistics. Continuous
variables are expressed as mean (standard deviation (SD)), and compared by two-sample t-test.
Categorical data was summarized as count and proportions, and compared using Pearson-χ2.
Smoking data was categorized into a dichotomous variable of ever or never a smoker, as previously
described [38–42]. The primary endpoint of all analyses was development of WTC-AHR based on
a positive BDR or MCT any time after 9/11. Survival interval was determined by time from 9/11 to
positive AHR test or until 1 August 2017, the administrative censoring date of the study closure, if they
did not have AHR. Association of endpoints and MetSyn, smoking, BMI, and exposure level were
analyzed using the Cox proportional hazards regression and are represented as hazard ratio (HR) and
95% confidence interval (CI). We assigned a cut point of ≥500 eosinophils/μL as a marker of clinically
significant eosinophilia for Cox modeling. All models were adjusted for age at 9/11, exposure intensity,
and smoking status, and considered significant if p < 0.05. Omnibus testing was used to assess the
quality of the comparisons. Time-to-event curves were determined by the Kaplan–Meier method and
compared with the log-rank test. There were no dropouts in this study.
3. Results
3.1. WTC-AHR Cohort
Of the N = 1906 individuals with subspecialty pulmonary testing, N = 891 had a MCT while N =
1168 had BDR testing, and 153 individuals had both tests (Figure 1). Of the N = 539 participants that
had WTC-AHR, 303 were positive on MCT only, 184 had a positive BDR only and 52 were positive on
both tests, yielding a total of N = 355 who were MCT positive and N = 236 who were BDR positive
(Figure 1). Demographic and clinical measures were compared between those with and without AHR
(Tables 1 and 2). Years of service information was only available on N = 5029/6947 non-AHR and
N = 418/539 AHR. There was no difference between a positive MCT and a positive BDR in age, BMI,
smoking status, or clinical measures except for total cholesterol. A positive MCT had a slightly higher
cholesterol of mean (SD) of 217.4 (40.1) compared to positive BDR 210.2 (36.0), p = 0.03. AHR and
non-AHR were not significantly different in race or smoking status; those with AHR were significantly
older by a mean of 1 year, had an average of three fewer years of service compared to non-AHR, and
had a higher percentage present in the morning of 9/11 (Table 1).
Spirometry was compared in those with AHR and non-AHR at both the most recent pre-9/11 and
first post-9/11 examination showed significantly lower FEV1% predicted, Forced Vital Capacity (FVC)
% predicted, and FEV1/FVC ratios in AHR, but the differences were clinically insignificant and were
not indicative of OAD (Table 1).
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N = 539 p
Age on 9/11 40.3 (6.3) 40.9 (6.8) 39.5 (7.5) 40.5 (6.5) 0.004
Years of service * 19.3 (7.3) 20.1 (7.2) 22.8 (6.5) 19.7 (7.3) <0.001
Ever smokers 122 (34%) 89 (38%) 2531 (36%) 191 (35%) 0.643
Race
Caucasian 342 (96%) 220 (93%) 6529 (94%) 512 (95%)
0.560
African American 3 (1%) 6 (3%) 183 (3%) 9 (2%)
Hispanic 9 (3%) 10 (4%) 215 (3%) 17 (3%)
Asian/other 1 (.3%) 0 (0%) 20 (0.3%) 1 (0.2%)
Exposure
group
Morning of 9/11 79 (22%) 59 (25%) 1124 (16%) 123 (23%)
<0.001Afternoon of 9/11 211 (59%) 134 (57%) 3749 (54%) 317 (59%)
On or after 9/12 65 (18%) 43 (18%) 2074 (30%) 99 (18%)
Pre-9/11
FEV1% pred. 101.5 (11.6) 101.5 (13.5) 106.3 (13.0) 101.7 (12.4) <0.001
FVC% pred. 97.7 (10.9) 98.4 (12.7) 99.6 (12.1) 98.2 (11.7) 0.017
Ratio 82.9 (5.7) 82.4 (5.4) 85.3 (4.9) 82.7 (5.6) <0.001
WTC-HP
entry
FEV% pred. 91.8 (13.4) 90.7 (14.8) 98.1 (13.1) 91.6 (13.9) <0.001
FVC% pred. 89.6 (12.0) 89.3 (21.1) 92.4 (11.8) 89.6 (12.2) <0.001
Ratio 82.0 (6.0) 81.2 (6.6) 84.6 (4.9) 81.7 (6.3) <0.001
Values are in mean (SD) or N (%) as indicated. p calculated by t-test or Chi-square as appropriate, comparing airway
hyperreactivity (AHR) and non-AHR. * Data available on N = 5029/6947 non-AHR, N = 418/539 AHR.









N = 539 p
Systolic BP, mmHg 118.0 (12.5) 118.3 (12.6) 117.1 (12.5) 118.0 (12.7) 0.092
Diastolic BP, mmHg 73.4 (8.0) 74.3 (8.3) 73.4 (8.4) 73.6 (8.2) 0.598
BMI at WTC-HP entry, kg/m2 29.2 (3.2) 28.9 (3.0) 28.6 (3.3) 29.1 (3.2) 0.001
White blood cells × 109 cells/L * 6.5 (1.9) 6.5 (1.8) 6.3 (1.6) 6.5 (1.9) 0.021
Neutrophils (ANC) 3809.8 (1654.5) 3697.7 (1400.1) 3664.6 (1290.1) 3758.1 (1524.8) 0.113
Lymphocytes (ALC) 1818.9 (534.4) 1861.8 (590.2) 1830.9 (540.3) 1843.4 (561.2) 0.608
Eosinophils (AEC) 227.8 (149.9) 227.2 (160.3) 187.1 (130.9) 229.3 (156.6) <0.001
Monocytes (AMC) 579.4 (194.3) 605.7 (216.2) 581.3 (193.2) 591.1 (204.8) 0.263
Glucose 92.9 (18.8) 91.7 (10.4) 91.6 (13.9) 92.5 (16.4) 0.177
Triglyceride 195.7 (139.1) 190.7 (126.0) 185.1 (136.6) 197.4 (137.9) 0.046
HDL 48.0 (12.6) 47.1 (12.1) 48.1 (11.7) 47.6 (12.4) 0.351
LDL 133.1 (34.5) 128.3 (32.4) 128.3 (33.5) 131.6 (33.7) 0.028
Cholesterol 217.4 (40.1) 210.2 (36.0) 210.8 (38.7) 216.3 (38.5) 0.009
Cholesterol/HDL ratio 4.8 (1.5) 4.7 (1.3) 4.6 (1.4) 4.8 (1.4) 0.007
MetSyn definition 82 (23%) 54 (23%) 1329 (19%) 123 (23%) <0.001
SBP ≥ 130 and/or DBP ≥ 85 mmHg 78 (22%) 56 (24%) 1384 (20%) 119 (22%) 0.229
HDL < 40 mg/dL 94 (27%) 72 (31%) 1667 (24%) 151(28%) 0.036
Triglycerides ≥ 150 mg/dL 194 (55%) 123 (52%) 3428 (49%) 294 (55%) 0.020
Glucose ≥ 100 mg/dL 72 (20%) 45 (19%) 1269 (18%) 106 (20%) 0.419
BMI ≥ 30 kg/m2 130 (30%) 78 (33%) 2040 (29%) 193 (36%) 0.002
Values are in mean (SD) or N (%) as indicated; p calculated by t-test or Chi-square as appropriate, comparing AHR
and non-AHR; * Data available on N = 6896/6947 non-AHR, N = 532/537 AHR, differentials expressed as absolute
counts, cells/μL.
Participants with a positive MCT had a PC20 mean (SD) of 5.6 (4.7) mg/mL. Participants with
a positive BDR had a mean (SD) gain of FEV1 % predicted of 18.6% (9.9%), and 661.0 (274.0) mL.
Participants with AHR also had a slightly higher average BMI (29.1 vs. 28.6 kg/m2; p = 0.001),
triglycerides (p = 0.046), low-density lipoprotein (p = 0.028), and cholesterol (p = 0.009) compared to
non-AHR (Table 2). A higher proportion of subjects with AHR also had MetSyn; subgroup analyses
by Maentel–Haenszel odds ratio estimates shows that triglyceride ≥150 mg/dL (OR 21.6, 95% CI of
17.5–26.76, p < 0.001), obesity defined as BMI ≥30kg/m2 (OR 13.07, 95% CI 11.41–14.97, p < 0.001), and
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HDL <40 had OR of 12.25 (10.75–13.97), p < 0.001, were the most likely to meet the definition of MetSyn.
SBP/DBP ≥130/85 had OR of 6.85 (6.03–7.79), p < 0.001, and glucose ≥ 100 OR 5.96 (5.24–6.78), p < 0.001.
Complete blood count and differentials were also compared on available samples between 532/537
AHR and 6896/6947 non-AHR (Table 2). AHR displayed higher WBC count and absolute eosinophil
counts (AEC) compared to non-AHR. Of the N = 196 subjects with AEC > 500 cells/μL, N = 26 had
AHR whereas N = 154 had at least one MetSyn risk factor.
3.2. Model Development
Cox proportional hazard models were used to estimate univariate hazard ratio of individual
clinical biomarkers on developing WTC-AHR, with the adjustment of age, smoking, and WTC-exposure
intensity (Table 3). AEC ≥500 cells/μL increased the risk of development of AHR by 94% (CI 1.31–2.88).
The clinically utilized ratio of cholesterol/HDL ratio ≥3.5 was similarly correlated with a 33% increased
risk of development of AHR. Similar to what was originally identified by t-test, dyslipidemia and
obesity were significant risk factors for development of AHR, whereas hypertension or insulin resistance
were not significant. This also mirrors the subgroup analyses where the most significant contributors
to MetSyn definition were from dyslipidemia and obesity.
Table 3. Cox proportional hazards of univariate metabolic risk factors of AHR.
Measure Hazards (95% CI)
Cholesterol/HDL ratio ≥ 3.5 1.332 (1.057–1.679)
BMI ≥ 30 kg/m2 1.329 (1.114–1.585)
Glucose ≥ 100 mg/dL 1.062 (0.857–1.315)
Lipids
mg/dL
HDL < 40 1.237 (1.025–1.492)
Triglycerides ≥ 150 1.204 (1.016–1.427)
Blood pressure mmHg Systolic ≥ 130 1.079 (0.872–1.335)
Diastolic ≥ 85 0.970 (0.718–1.309)





Morning of 9/11 2.240 (1.719–2.919)
Afternoon of 9/11 1.759 (1.403–2.205)
After 9/12 Reference
Ever smoker 1.759 (1.403–2.205)
Age (per year) 1..017 (1.005–1.029)
All models were adjusted for age, smoking, and exposure intensity. Exposure, age, and smoking RR refer to RR in
final model of combined MetSyn risk factors.
The final MetSyn model, adjusted for age, smoking, and exposure intensity, assessed the total
number of MetSyn risk factors predicting AHR. Having at least two or three MetSyn risk factors had
69% and 65% increased risk of developing AHR, respectively (Table 3). Having high exposure, being
present in the morning of 9/11, increased odds of developing AHR by 2.24 times, whereas being present
in the afternoon increased odds by 1.76 times. Age also had an associated risk of development of AHR
by 1.7% for every increasing year. Smoking was not significantly associated with AHR (Table 3).
Survival curves were plotted and time to divergence calculations from having no MetSyn risk
factors showed that having one MetSyn risk factor diverged three years post-9/11, compared to having
two risk factors, and divergence occurred within the first year post-9/11 (Figure 2). Kaplan–Meier curves
were also assessed for subgroups of each MetSyn factors. BMI ≥30 kg/m2, triglycerides ≥150 mg/dL,
HDL <40 mg/dL, and having the highest exposure to WTC-PM by being present at the site on the
morning of 9/11 carried significantly higher risk of developing of AHR (Figure 3A–D).
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Figure 2. Cumulative AHR survival curves by total number of MetSyn biomarkers. Cumulative
disease-free survival is expressed on the y-axis and time in years from their WTC exposure is on the
x-axis. Life table expresses the number of individuals at risk in 2-year intervals.
Figure 3. Kaplan–Meier survival curves stratified by (A). BMI ≥30 kg/m2 (p = 0.001 by log rank), (B).
Triglycerides ≥150 mg/dL (p = 0.019), (C). HDL <40 mg/dL (p = 0.038), and (D). Exposure intensity
(p < 0.001). Cumulative disease-free survival is expressed on the y-axis and time in years from their
WTC exposure is on the x-axis. Log rank was not significant for SBP, DBP, and glucose, and were not
included in this graph.
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We examined the reproducibility of the model in the cohort of N = 1906 who had MCT/BD testing.
Even in this restricted cohort we found that having two or three MetSyn risk factors also yielded an
increased risk of developing AHR by 54.4% and 39.6% (p = 0.001 and 0.014) respectively. Having one
MetSyn risk factor had 25% increased risk but was not statistically significant (p = 0.08), and exposure
was not a significant risk factor in the smaller cohort.
4. Discussion
The WTC-exposed FDNY rescue/recovery workers represent the largest longitudinally assessed
first responder cohort with pre and post lung function assessments following a high PM exposure.
They continue to have their health adversely impacted even after 18 years [26–28,43–54]. Our previous
work focused on the contribution of MetSyn in the development of WTC-LI [4,28]. We now show that
metabolically active biomarkers and markers of inflammation (such as eosinophils) predict AHR in the
WTC-exposed firefighter cohort [55–57].
This study represents the only longitudinal study to our knowledge investigating the temporal
relationship of MetSyn, PM exposure, and AHR. We demonstrate that MetSyn is an independent risk
factor for the development of AHR, as all study participants were categorized as having or not having
MetSyn prior to the development of AHR. A prior cross-sectional study investigating MetSyn, PM
exposure, and cardiovascular risk found no significant associations with inflammatory markers of CRP
or WBC [3].
Our earlier model showed that dyslipidemia and heart rate independently increased the odds of
developing WTC-LI [4,28]. While WTC-LI and AHR both fall under the umbrella of OAD, there is
little overlap in these populations. When examining a subgroup analysis of the WTC-LI cases, only
N = 203/1204 (16.8%) also have AHR. This strongly suggests that MetSyn is implicated in multiple
pathways in the development of OAD. Although MetSyn risk factors and cholesterol/HDL ratios are
classically predictors of cardiovascular disease, their implications in affecting future lung disease are
novel. Moreover, these represent reversible risk factors that may be potential therapeutic targets to
alter the outcome of other obstructive lung disease.
Our current investigation shows the associations of MetSyn biomarkers with the development
of WTC-AHR. We also show obesity having similar ability to predict AHR, an unexpected finding
given the vast literature of restrictive patterns in obesity. However, this fits in the growing body of
literature showing that obesity has hormonal pathways that influence the pulmonary environment.
Another unexpected finding, but similar to our prior investigation of MetSyn predictor of WTC-LI,
was that glucose was not a significant predictor of WTC-AHR [28]. Specifically, in our current study
with cut-points of 100 and 126 mg/dL, there was no significantly increased risk of lung injury in our
cohort. Studies in non-exposed individuals have shown an association between insulin resistance and
OAD [58].
A strength of this study is the rigorously characterized prospective cohort, with a clearly defined
time of exposure (9/11), pre and post exposure lung function measurements, blood drawn soon after
exposure, and MetSyn categorization done prior to AHR measurements. Another strength of this
study is that the development of AHR was post-exposure in that FDNY firefighters are excluded at
hire and during annual medical monitoring if they have signs or symptoms of airways obstruction
or AHR [59]. A key strength of this study is in the study design that allowed us to explore multiple
aspects of WTC-AHR. Since the decision to administer BDR or MCT tests to determine disease is often
a clinician’s judgement, it was reassuring to have found little difference between the two groups, those
with only a positive BDR and those with only a positive MCT. This suggests that our findings are
plausible and potentially reproducible in other cohorts. Examining the model for reproducibility in the
smaller cohort of N = 1906 also bolsters our findings that MetSyn is an independent risk factor for
development of future AHR.
Using the clinical markers of MetSyn as predictors of AHR is advantageous in several ways. These
biomarkers are easily attainable, cost effective, and can be replicated in many cohorts. Dyslipidemia,
212
IJERPH 2019, 16, 1486
insulin resistance, obesity, and hypertension are also all potentially reversible causes of end-organ
disease. Extending statin therapy, for example, and increasing glycemic control can be the target
of future studies focused on their mitigating effects in progressive lung disease. Furthermore, our
group is currently studying dietary effects on pulmonary function and biomarker profile of the FDNY
exposed cohort. MetSyn also has global reach and can be investigated in other cohorts with similar
pollutant or PM exposure.
Eosinophilia, while a significant risk factor of AHR, did not augment the predictive model
investigating MetSyn. Subgroup analysis shows that although only 13% of the hyper-eosinophilia
group had overlap with the AHR population, 78.5% (N = 154/196) had at least one MetSyn risk factor.
This was somewhat surprising because the literature reflects that obesity-related lung dysfunction
is often a neutrophil-mediated process [60]. This may indicate the need for further studies in
eosinophilia-mediated pathways in MetSyn.
There are several limitations to this study. We focus on a male-only cohort. Interestingly, MetSyn
and asthma have been shown to have stronger associations in female-only cohorts [18,61]. An additional
limitation is that we classified participants as not having AHR if they had negative tests or even if
they had no testing of AHR. The presumption of negative AHR in the absence of direct measurement,
while a limitation, biased our results towards the null. We also used a broad definition of AHR by
requiring either a positive BDR or a positive MCT. This combined definition could have biased our
results away from the null and towards a positive finding but we believe this combined definition is
the most clinically relevant, and also accounts for those that may have only had one type of test due to
clinical contraindications [32].
We also caution on over-interpretation of the results of individual components of MetSyn. We use
a one-time fasting blood level at the earliest time point after exposure to 9/11 to make predictions of
future lung injury. Future studies can focus on repeated measures of MetSyn, dyslipidemia, fasting
blood glucose, and AHR to control for other possible confounders and aid in understanding the
associations of individual components of MetSyn and AHR and their temporal relationships. The lack
of medication history could also cause under-identification of those with MetSyn risk factors. Having
this information could improve the sensitivity of those at risk of AHR and specificity of the model.
Alternatively, it can help to determine if attenuation of MetSyn risk factors through pharmacologic
methods impacted pulmonary health.
5. Conclusions
In summary, MetSyn biomarkers are predictors of future WTC-AHR in a large cohort of
WTC-exposed FDNY firefighters followed over 16 years. These metabolically active biomarkers
are associated with dyslipidemia, insulin resistance, and cardiovascular disease, and suggest that
MetSyn may contribute to systemic inflammation that leads to future development of AHR. Our data
supports the hypothesis and contributes to the growing body of literature investigating the complex
associations between potentially reversible MetSyn risk factors and lung injury. We are strongly
encouraged by our results indicating that pathways involved in metabolism have broad impacts on
the immune and hormonal environment in the lung.
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Abbreviations
AHR Airway hyperreactivity
ATP III Adult treatment panel III
BDR Bronchodilator response
BMI Body mass index
CRP C-reactive protein
CI Confidence interval
DBP Diastolic blood pressure
EMR Electronic medical record
FDNY Fire Department of City of New York
FEV1 Forced expiratory volume over 1 second
FVC Forced vital capacity
HDL High density lipoprotein
HR Hazards ratio
LDL Low density lipoprotein
LLN Lower limit of normal
MCT Methacholine test
MetSyn Metabolic syndrome
NCEP National Cholesterol Education Program
OAD Obstructive Airways Disease
PC20 Methacholine dose required to reduce FEV1 by 20%.
PFT Pulmonary function test
PM Particulate matter
SBP Systolic blood pressure
SD Standard deviation
TNF Tumor necrosis factor
US United States
WBC White blood cell
WHO World Health Organization
WTC World Trade Center
WTC-AHR World Trade Center-airway hyperreactivity
WTC-HP World Trade Center-health program
WTC-LI WTC-lung injury
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Abstract: The World Trade Center Health Program (WTCHP) provides mental health services through
diverse service delivery mechanisms, however there are no current benchmarks to evaluate utilization
or quality. This quality improvement (QI) initiative sought to examine the delivery and effectiveness
of WTCHP mental health services for World Trade Center (WTC) responders who receive care
through the Northwell Health Clinical Center of Excellence (CCE), and to characterize the delivery of
evidence-based treatments (EBT) for mental health (MH) difficulties in this population. Methods
include an analysis of QI data from the Northwell CCE, and annual WTCHP monitoring data for
all responders certified for mental health treatment. Nearly 48.9% of enrolled responders with a
WTC-certified diagnosis utilized treatment. The majority of treatment delivered was focused on
WTC-related conditions. There was significant disagreement between provider-reported EBT use and
independently-evaluated delivery of EBT (95.6% vs. 54.8%, p ≤ 0.001). EBT delivery was associated
with a small decrease in Posttraumatic Stress Disorder (PTSD) symptoms over time. Providers
engaged in the process of data collection, but there were challenges with adherence to outcome
monitoring and goal setting. Data from this report can inform continued QI efforts in the WTCHP,
as well as the implementation and evaluation of EBT.
Keywords: disaster mental health; evidence-based treatment; mental health service utilization;
quality improvement
1. Introduction
1.1. WTC Responders’ Mental Health
Following the September 11, 2001 attacks on the World Trade Center (WTC), an estimated 90,000
World Trade Center responders (WTC responders) provided emergency services at Ground Zero,
where they were exposed to unprecedented traumatic events [1] while providing rescue, recovery,
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demolition, debris removal, and related support services in the aftermath of the attack. Symptoms of
PTSD, depression, panic disorder, and anxiety have been observed in WTC responders over 10 years
after the events of 9/11 [2–14].
The rate of PTSD among WTC responders continues to be significantly higher than in the general
population, and is the most prevalent mental health (MH) diagnosis for responders and clean-up
workers at Ground Zero [2]. One study found that 9.7% of WTC responders interviewed 11–13 years
after 9/11 met the criteria for current PTSD [7], compared to the estimated lifetime PTSD prevalence in
the general United States population of 6.4% [15]. Furthermore, a study of over 10,000 WTC responders
found that nearly 7% experienced a delayed onset of symptoms up to 8 years after 9/11, and the risk of
stable or worsening PTSD among first responders is supported in the literature [16].
Limited research has been conducted on treatment for PTSD in a first responder population [17].
Three studies have examined the efficacy of specific treatment modalities among WTC responders,
including combined prolonged exposure and paroxetine [18], cognitive behavioral treatment [19],
and virtual reality exposure therapy [20]. These studies have been limited in several important ways
including the use of diverse exposure assessment tools limiting comparability and small sample
sizes [21]. The generalizability of these studies to clinical settings is somewhat limited, in that these
studies examine treatment outcomes within a clinical trial, and can speak to treatment efficacy. However,
they do not necessarily reflect MH utilization and treatment outcomes among WTC responders obtaining
routine treatment for PTSD, thereby hindering conclusions regarding clinical effectiveness. In addition,
the studies were university-based, and not reflective of care provided in the community. To our
knowledge, no studies have focused on the evaluation of treatments for other mental health difficulties
(besides PTSD), specifically among WTC responders, including depression and anxiety [21]. Little is
also known as to the extent to which WTC responders are obtaining recommended evidence-based
treatments (EBTs) for their mental health diagnoses, including PTSD, or the impact of treatment upon
their symptoms.
1.2. Mental Health Service Provision for WTC Responders
The WTC Health Program (WTCHP) (previously known as the Medical Monitoring and Treatment
Program) was established in 2002 to address the physical and mental health needs of WTC responders
through annual medical monitoring, and then through the delivery of no-cost medical services [1].
WTC responders treated through the WTCHP (WTCHP responders) include traditional first responder
professionals, such as police, paramedics and non-FDNY firefighters, as well as non-traditional
responders like construction workers and vehicle maintenance workers. To date, an estimated
45,894 WTC responders have had at least one monitoring visit as part of the WTCHP. The structure of
the program’s service delivery efforts rests on partnerships between hospital systems and community
practitioners to meet the needs of the population. Clinical Centers of Excellence (CCE) are responsible
for monitoring the well-being of participants, and then authorizing physical and mental health treatment
in the community. Mental health services coordinated by CCEs are delivered through a provider
network that is comprised of health system-attached clinics and private practice-based clinicians
enrolled by the CCE. A recent report [22] indicated that in 2017, about 5% of continuously-enrolled
WTCHP responders utilized MH services (excluding pharmacy), and 99% of these services were
delivered in an outpatient setting. However, utilization rates varied among sub-groups of members
and by each individual CCE, and little is known about the quality and effectiveness of the treatment
provided. This gap warrants attention, given the high prevalence of PTSD, depression, and anxiety in
this population.
Mental health programs and systems of care that have focused on improving the quality of
services and effectiveness of treatment have broadly targeted two areas for intervention: Supporting
evidence-based practice implementation (EBPI), and measurement-based quality improvement
(MBQI) [23,24]. Treatment recommendations for PTSD include first-line recommendation on the
delivery of trauma-focused EBTs (TF-EBTs), such as Prolonged Exposure therapy and Cognitive
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Processing Therapy [25,26]. Despite these recommendations, it is known that, in general, providers do
not sufficiently use research to inform practice [27].
Prior to a heavy investment by the Veterans Administration (VA) to support implementation of
EBTs for PTSD, one survey showed that as few as 10% of PTSD specialists and general MH providers
utilized evidence-based treatments for PTSD [28]. Since the VA investment in implementation of
TF-EBTs in 2006, progress has been made, yet penetration of these treatments is highly variable,
and challenges remain [29,30].
1.3. Quality Improvement Initiative
The provision of no-cost MH services to a large cohort of responders and the longitudinal,
standardized monitoring of a large cohort of WTC responders through the WTCHP presents a unique
opportunity to better understand the delivery and effectiveness of mental health care services for
this population. The current analysis aims to characterize the provision of mental health services
to WTC responders within the Northwell Health Queens World Trade Center Health Program, also
referred to as the Northwell Clinical Center of Excellence (CCE). Data for this analysis relies on a
quality improvement project that was initiated in late 2017. It entails modification of treatment plan
data collected in the course of administering the program to obtain information on the interventions
being utilized, and to require greater movement towards measurement-based care. In addition,
WTCHP annual monitoring and claims data can be used to verify the information and findings
from the treatment plan data. The goal of the quality improvement project is to characterize the
mental health services delivered to clients, to begin implementing an MBQI process, and to explore
delivery of recommended EBT for PTSD and other WTC-certified mental health diagnoses to WTCHP
responders being treated for mental health difficulties by community providers. Upon characterizing
the population and understanding baseline data, program interventions can be designed to promote
engagement in care, as well as enhanced services and outcomes for the population.
2. Materials and Methods
2.1. Data Sources
This is a quality improvement initiative, focused on a subset of community mental health providers
who provide psychotherapy to World Trade Center Health Program (WTCHP) responders (i.e., WTC
responders to 9/11, excluding FDNY firefighters) served by the Northwell Center of Excellence (CCE).
The Northwell CCE Treatment Plan Database was started in December 2017 to monitor mental health
treatment delivery and outcomes, and consider targets for quality improvement. Community mental
health providers for the Northwell CCE include psychiatrists, psychologists, and clinical social workers
spread across the community, some of whom are attached to a Northwell Health ambulatory program.
Due to logistical challenges, such as administrative burden, and the fact that the ambulatory programs
have their own processes for QI, efforts were initiated with just psychotherapists located in private
practices in the community. Within this group, 100% of providers were able to provide treatment plan
data. The project was submitted to the Northwell Health IRB for evaluation as research, and deemed as
non-human subjects research, due to its quality improvement (QI) focus. Providers had already been
completing treatment plans regarding the mental health treatment of WTCHP responders, but these
were not developed or analyzed in a systematic manner. Members of this team modified the plans to
ensure that they include items to assess modality of treatment, descriptions of treatment, including
whether or not the provider believed that the treatment was evidence based, goals for treatment,
scores on standardized measures of symptoms, expected duration of treatment, and explanation of the
connection between treatment and 9/11 exposure. Providers were engaged prior to the modifications
of the treatment plans, and then again after the plans were modified, to inform them of changes to the
treatment plans, and to answer questions. The Northwell CCE team was also available for questions as
they arose. Follow-up treatment plans are completed every four months, and the data is inputted into
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the database by a Northwell CCE staffmember. For the current analysis, data from baseline (Review 1)
and the first four month follow-up time point (Review 2) were used.
Data from annual monitoring visits collected for the WTCHP General Responder Cohort for all
Northwell CCE responders certified for mental health treatment were also obtained and linked to the
Treatment Plan Database, to provide annual survey and administrative claims data, which included
demographics, mental health diagnoses, standardized scores of mental health symptoms, and mental
healthcare utilization data.
2.2. Treatment Plan Data
Data reported from the Northwell CCE community provider network included provider-reported
used of evidence-based treatments (EBT) (yes/no), goals requested in a specific (or simple), measureable,
achievable, relevant, and time-framed (SMART) format, treatment modality (i.e., individual weekly,
family, group, medication management) type of therapy used, whether treatment was WTC-focused,
and the expected length of further treatment. Mental health symptom scores were also reported.
Primary variables of interest: To evaluate whether recommended EBT was delivered to the WTCHP
responder, treatment plans were reviewed by two independent psychologists with backgrounds in EBT
for mental health (MH) disorders, with particular expertise in working with responders. A standardized
decision process was formulated to make this decision. This included alignment between diagnosis and
indicated EBT, that the provider was utilizing as per the American Psychological Association (APA),
Veterans Administration/Department Of Defense (VA/DOD), and National Institute for Health and Care
Excellence treatment recommendations, where available [31–33]. Information from other sections of
the treatment plan was also utilized. For example, reference to exposure-based goals (for Posttraumatic
Stress Disorder (PTSD)) was indicative of some EBT use. Therapy was categorized by reviewers as:
Cognitive Behavioral Therapy (CBT), Trauma-Focused Evidence-Based Therapies (e.g., Prolonged
Exposure, Cognitive Processing Therapy etc.), non-trauma focused evidence-based therapies for
PTSD (e.g., Interpersonal Psychotherapy, Stress Inoculation Therapy, etc.), eclectic/supportive therapy,
mindfulness/relaxation therapy, psychodynamic therapy, and non-recommended therapies for PTSD
(e.g., “Emotional Freedom Technique”). The determinations for which therapies are considered
recommended for PTSD, were those based on the treatment guidelines noted above. Therapies which
did not meet any criteria for a recommendation based on these guidelines may still have an evidence
base, but it was categorized as non-recommended. The variable (i.e., independent reviewer assessment
of recommended EBT delivery) was labeled EBT Delivered and categorized as: Yes, No, Elements
of EBT-Delivered, and Cannot Interpret from Clinician’s Report. For analysis, EBT-Delivered was
dichotomized as Yes (Yes or Elements of EBT-Delivered), or No. Cases where EBT-Delivered could not
be interpreted from the clinician’s report (n = 4), were excluded for analysis for this variable.
Reviewers also independently evaluated provider-reported therapy, use of SMART goals,
and whether or not treatment had a WTC focus. Providers were expected to list goals in SMART
format, which is frequently used as a frame for goal setting across disciplines. This format facilitates the
reporting of measurable progress for WTCHP responders, even in the absence of EBT and standardized
symptom measurement. Providers were also asked to elaborate on whether or not their treatment had
a WTC focus, which was then reviewed.
Lastly, providers were asked to include symptom severity scores by utilizing self-report instruments
with clients, summing the items to calculate symptom scores, and then including the final score in
their treatment plans. For PTSD symptom severity, providers used the Posttraumatic Stress Disorder
Checklist-5 (PCL-5)—a 20 item measure of PTSD (range = 0–80) [34]. For depression symptom severity,
providers used the Patient Health Questionnaire-9 (PHQ-9)—a nine item measure of depressive
symptoms (range = 0–27) [35]. For anxiety symptom severity, providers utilized the General Anxiety
Disorder-7 Item (GAD-7)—a seven item measure of anxiety symptoms [36].
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2.3. WTCHP Annual Medical-Monitoring Data
Mental healthcare utilization was extracted from administrative claims out of the WTC annual
monitoring data for all Northwell CCE responders certified for MH (N = 477). Utilization during 2018
was defined as having at least one claim for psychotherapeutic services, diagnostic evaluation, or
medication management. Psychotherapy treatment modality (individual, family), length of treatment
session (20–30 min, 45–60 min), and number of medication management appointments, were also
tabulated. The number of sessions per WTCHP responder within each year was also determined.
The WTCHP Annual Medical-Monitoring data also provided demographics including age, sex
(male/female), race, ethnicity, and education (<high school (HS), ≥HS). ICD-9 and ICD-10 codes were
extracted to define WTC-related certified mental health diagnoses of PTSD, anxiety and depression.
PTSD, anxiety and depression symptom scores were measured annually, using the PCL-S (specific
to the WTC terrorist attacks on 9/11), PHQ-9, and GAD-7 scales, respectively. For each instrument
separately, items were summed to create symptom severity scores for PTSD (range = 17–85) [37],
depression (range = 0–27) [35], and anxiety (range = 0–21) [36]. In our sample, the reliability of these
instruments was high (Cronbach’s alpha: PCL-S = 0.949, GAD-7 = 0.914, PHQ-9 = 0.921).
2.4. Statistical Analysis
From the WTCHP Annual medical-monitoring data, mental healthcare utilization rates and
number of sessions per WTCHP responder were described for 2018 overall, and for the responders
treated by the Northwell CCE community provider network. In the Treatment Plan Database, WTCHP
responder characteristics at first review were compared by EBT-Delivered, using the Mann-Whitney
Rank Sum test for continuous variables, and Fisher’s exact test for categorical variables. McNemar’s
test and the Kappa statistic were used to evaluate any agreement between provider-reported EBT
and EBT-Delivered.
For WTCHP responders where MH symptom scores at both review 1 and 2 were available,
the change in mental health symptom scores between the reviews were described using mean
differences overall, and were stratified by EBT-Delivered. To assess the sensitivity of the Treatment Plan
Database results, the change between MH symptom scores between the last two annual monitoring
visits from the WTC-data monitoring data, was also analyzed. For this analysis, WTCHP responders
from the Treatment Plan Database were linked to their annual monitoring visit data, and included if
they had two annual visits from 2016 to 2018 (N = 86). Analyses were conducted using SAS software,
version 9.4 (SAS Institute, Cary, NC, USA).
3. Results
Of the 477 WTCHP responders certified for MH, 48.9% utilized mental healthcare in 2018 (Table 1).
WTCHP responders utilized: Diagnostic evaluation (14.9%), psychotherapeutic services (41.3%), and/or
medication management (8.2%). Of WTCHP responders who utilized psychotherapeutic services
(n = 197), all had individual sessions, and 92.4% of them lasted between 45–60 min. Only 3% also had
a family session. About one third of WTCHP responders (35.5%) also had diagnostic evaluation or
medication management. WTCHP responders had a median number of 17 (IQR = 5–34) individual
therapy sessions in 2018. As expected, utilization rates were high among WTCHP responders captured
through the Treatment Plan Database.
From the Northwell Treatment Plan Database, data were collected from 16 providers on 129 WTCHP
responders at the first review, and of those, 103 had a second review. During the four month review
period, providers conducted a median of 11 sessions (IQR = 2–37, range = 1–64), and saw a median of
5.6 (range = 1–29) WTCHP responders. WTCHP responders were 55.3 (SD = 9.6) years old on average,
32.8% female, and 40.2% white (Table 2). Most were diagnosed with PTSD (74.4%) and some had
anxiety (24.8%) and depression (34.1%) diagnoses. The majority underwent weekly individual therapy
223
IJERPH 2019, 16, 1536
(72.1%), and the estimated length of further treatment was 12 months for 61.7% of WTCHP responders.
Two WTCHP responders were indicated to have group therapy as well.
Providers reported that nearly 94% of services delivered were evidence-based treatments with the
majority of providers reporting delivering CBT (74.4%), and mindfulness or relaxation therapy (19.4%).
Notably, despite reporting delivery of EBTs, providers also reported delivering eclectic/supportive
therapy (which are not categorized as EBTs) 23.3% of the time. Based on the independent QI review,
treatment was determined to be largely WTC-focused (85.3%). However, some of the provider
responses were characterized as “unclear” (14%).
Table 1. Mental healthcare utilization by service type from January 2018–December 2018.
Type
Northwell Health CCE Responders
(N = 477)
Community Provider Network
(N = 124 a)





Overall MH Utilization 233 48.9 13 (3–30) 118 95.2 27 (15–43)
Diagnostic Evaluation 71 14.9 1 (1–2) 7 5.7 2 (1–2)
Medication Management 39 8.2 4 (2–8) 19 15.3 6 (2–8)
Psychotherapeutic Services 197 41.3 17 (5–34) 117 94.4 27 (16–40)
Family 6 1.3 1 (1–2) 6 4.8 1 (1–2)
Individual 197 41.3 15 (5–34) 117 94.4 26 (13–40)
20–30 min TX 37 7.8 2 (1–4) 15 12.1 3 (1–4)
45–60 min TX 182 38.2 18.5 (6–35) 114 91.9 27 (15–40)
MH =mental health. TX = treatment. No. = number. WTCHPR =World Trade Center Health Program Responder.
Med =median. IQR = Interquartile range. a Of the 129 WTCHP responders in the Treatment Database, those who
were transferred out of the Northwell CCE were not included in the WTCHP Annual Monitoring data (n = 5).
b Mental healthcare utilization was not 100% for WTCHP responders in the Treatment Database. This may be due to
the lag time in processing claims in the annual monitoring data.
Almost all providers in the community provider network (96.0) reported using EBT. For those
providers that indicated the use of EBT, treatment plans were reviewed by independent Northwell
CCE reviewers to determine EBT-Delivered status. Sixteen WTCHP responders (12.4%) were assessed
to have likely received EBT, and 52 (40.3%) were assessed to have likely received elements of EBT
at baseline. There was also a significant disagreement between provider-reported EBT use and an
independently-evaluated delivery of EBT (95.6% vs. 54.8%, McNemar’s test p < 0.001, Kappa coefficient
= 0.097 (95% CI = 0.015–0.179)). Demographics and WTC-certified diagnoses were similar across
WTCHP responders, with EBT-Delivered compared to not (Table 2). Use of SMART goals (70.6% vs.
24.6%) and number of SMART goals ≥3 (89.71% vs. 59.7%), were more frequent with patients who had
EBT delivery. Additionally, when EBT was not delivered, WTCHP responders had higher levels of
missing documentation of goal progress (35.1% vs. 14.7%), and a longer length of further treatment
(80.7% vs. 43.9%).
Among all WTCHP responders where MH symptom scores at both review 1 and 2 were available,
PTSD anxiety, and depression symptom scores improved by 1.81, 0.46, and 0.03 points, respectively.
When compared by EBT Delivered, similar changes were noted. PTSD symptom scores decreased
2.29 points in the four month period for those with EBT-Delivered. There was also a weaker mean
decrease of 1.42 points among the group without EBP delivery. WTCHP responders with and without
EBT-Delivered also had small decreases from review 1 to review 2 in mean anxiety and depression
symptom scores (Table 3). The analysis of the WTC annual monitoring data also indicated small
symptom changes over time by EBT provision (Table 3).
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4. Discussion
This project has yielded numerous findings and considerations for future efforts. Consistent with
a recent HRA report on service utilization, our team found that among WTCHP responders with
a WTC-certified mental health diagnosis, nearly 49% utilized mental health care [22]. That report
found the Northwell CCE had service utilization of 55%, but their analysis included the removal of
responders that may have unenrolled in the program, or were deceased. This information was not
available to us for this project, and it is likely that if this information were accounted for, the overall
cohort would shrink, and the utilization rate would further rise. This level of service utilization meets
the national average [22] for access indicated in the HRA report, and speaks to the value of using a
community provider network to ensure access for WTCHP responders.
It was also meaningful that most providers (85%) were providing treatment that was deemed as
targeted towards the WTC-attributed diagnosis. Consistent with the literature, the most prominent
MH diagnosis for the overall cohort at the Northwell CCE was PTSD. Most providers indicated that
they were working on goals that were related to the sequelae of 9/11, such as PTSD and its associated
impact on interpersonal functioning. This is a difficult variable to assess, as treatment is not being
directly observed, but these findings are promising for adherence to WTCHP objectives.
This QI project was also notable for the high rate of participation by providers in the process.
The providers were familiar with completing some information for treatment plans as part of past
program expectations, but this project included a more robust overhaul of the treatment plan process.
There were challenges with framing goals in a SMART format, and with ensuring the collection of
all outcome data, but most providers completed numerous data elements for the treatment plans,
despite the extra reporting requirements. For example, almost no providers submitted treatment
plans without goals, and the majority of providers documented progress on at least one goal. Even
among providers who had missing outcome measures, many of these providers completed some data
points. Importantly, the providers whose treatment plans were evaluated, were also engaged in the
development of the plans. Quality improvement is seen as a bottom up process, and stakeholder
engagement is therefore critical to implementing systems change, which likely contributed to this high
participation [24].
The finding that there was an association among providers between delivering EBT services
and a greater use of SMART goals was interesting. Without further exploration into this association,
it is difficult to say why this occurred, but it may reflect some underlying shared attribute among
those providers towards utilization of measurable objectives and provision of EBT services. Frequent
utilization of measurement tools is consistent with expectations of EBTs, and may help explain this
association. Informal conversations with providers who had difficulty around both the SMART goal
format and reporting on outcome measures, indicated numerous challenges, such as confusion about
what SMART formats entailed, and challenges obtaining measures from WTCHP responders. Future
efforts of this QI project should include further education of providers on how to meet these types of
objectives and engage with providers on problem solving challenges to obtain outcome measurements.
Interestingly, nearly all providers in this project claimed to be providing EBT to the majority of their
clients. This is a higher number than expected, and was unforeseen for numerous reasons. As noted
earlier, even when providers are trained in EBTs, and are provided institutional support to execute
these treatments, penetration is challenging [29]. Furthermore, it has been often reported that there is a
gap between clinical research and practice [27]. Additionally, while providers endorsed utilizing an
EBT, a significant number of them endorsed utilizing eclectic/supportive therapies, and many indicated
utilizing therapies for PTSD that are not recommended as EBTs for PTSD. It is therefore not surprising
that upon independent review by Northwell CCE psychologists, there was significant disagreement
with the provider report. Only about 12% of WTCHP responders were deemed to have likely been in
receipt of a recommended EBT, and an additional 40% were considered to have likely received some
elements of an EBT, such as cognitive restructuring or exposure therapy. Notably, even these numbers
227
IJERPH 2019, 16, 1536
may be an over-representation of true EBT delivery, as treatment was not observed directly, and no
treatment fidelity checks were in place.
Additionally, many of the clients were deemed by providers to require an additional 12 months
of treatment, and the median number of sessions per WTCHP annual monitoring data for 2018 was
27 sessions. This would be inconsistent with expectations of many EBTs that typically range from 8
to 20 sessions. Accurate assessment of EBT delivery is a challenging endeavor that will continue to
require attention if this is an area of priority for the WTCHP.
When recommended EBT or components of EBT were deemed to have been delivered, the WTCHP
responders demonstrated small improvements in measures of PTSD symptoms. This was notable
for PCL-5 scores that were attained using the Treatment Plan Database, however, these changes
were below the 10 point change that is considered a clinically significant change [38]. Additionally,
no significant changes in PTSD symptoms were observed with the data collected from the annual
monitoring exam. While the time between measurements on the annual monitoring exam is about one
year, as compared to the four months in the Treatment Plan Database, the overall negligible movement
in the measurement of symptoms warrants further exploration. It may be that even in cases of clients
deemed to be receiving recommended EBTs, they are not receiving them with great fidelity, which
speaks to program effectiveness, as opposed to efficacy. If this is the case, greater investment on the
part of WTCHP in supporting the dissemination of EBTs for this cohort may lead to an improved
delivery of these treatments.
The findings from this report suggest that future QI projects within the Northwell CCE should
explore mechanisms for increasing engagement in outcome monitoring and support of EBT interventions.
Additionally, future research among the Northwell CCE clients, and in the larger WTCHP mental health
cohort, is needed to explore patterns of change in outcomes for those engaged in treatment. While
those in treatment may not be demonstrating substantial improvements in symptoms on self-report
measures, those who are being seen for an extended duration may be obtaining maintenance treatment
that could be preventing any exacerbation of symptoms. It may also be the case that treatment is not
being delivered as effectively as desired, or that there are unique challenges to understand with this
responder cohort, which explain the lack of demonstrable progress on these measures. For instance,
this population may have a high degree of medical co-morbidity, as well as exposure to multiple and
severe traumas, that may be hindering the treatment progress [7,13].
Several limitations should be noted. Firstly, this is a quality improvement project that included
an analysis of our institution’s administrative data, and should be interpreted as such. We did not
formally adjust significance values for multiple comparisons. Secondly, not all providers overseen by
the Northwell CCE were included at this step of the QI process, and may not be accessible without
further administrative mandates, given that the providers who did not participate were also part of
other systems of care with a high level of administrative burden. This made it difficult to obtain the
necessary information without adding to the administrative burden of those providers. Accordingly,
the data obtained could reflect a potential response bias. Thirdly, even among those who did complete
treatment plan data, the information provided was the report of the provider, and not from direct
observation. Specifically, outcome data were self-report measures that providers collected, scored, and
then reported on, as opposed to data to which the team had direct access. Furthermore, EBT delivery
was captured through an analysis of treatment plans, as opposed to fidelity checks of treatment which
would have been prohibitive. These issues were compensated for by evaluating data from the annual
monitoring report, where feasible. Finally, a high level of missing data was present for mental health
outcomes, and we were not able to model changes in outcomes. Instead, unadjusted analyses were
used to compare differences in symptom scores across time, and whether those changes were different
by use of EBT Delivered. This hampered our ability to adjust for potential confounding variables as
well. Therefore, the results from the analysis represent a signal to be explored further to determine if it
reflects the larger treatment plan population, or the WTC responder population more broadly.
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Many of the limitations listed above are to be expected in a QI project that does not allow for
rigorous controls of treatment setting and delivery. Instead, this project reflects a real-world delivery
setting for services, and offers meaningful first steps towards assuring quality of treatment in a WTCHP
CCE, that could have implications for other CCEs and the larger MH treatment population. Untreated
PTSD and other mental health conditions can have a debilitating impact on functioning, and come
at a significant cost to society [39]. It is therefore important that the CCEs consider opportunities for
improving services among their providers. These services are often delivered in very different contexts,
such as in ambulatory programs of hospital systems, and in private practices of community providers.
Systems of care and individuals can vary widely in the quality and consistency of the services delivered.
This poses a challenge in assuring the quality of services for enrollees in the WTCHP both across and
within CCEs.
The Substance Abuse and Mental Health Services Administration (SAMHSA) has directed
significant attention towards supporting the adoption of evidence-based practices and collecting
and utilizing data to inform policy and practice [40]. Progress has also been made towards a broad
standardization of outcome measures, such as those undertaken in collaboration with the National
Quality Forum [41] and the National Committee for Quality Assurance [42]. The WTC programs, given
their unique funding structure, allow for greater flexibility and oversight to develop QI initiatives and
encourage provision of EBTs by community providers, who provide the care, with the assurance that
they will be paid for their clinical service.
Should the WTCHP move towards more standardized metrics for MH, and/or support for any
implementation of evidence-based therapies, QI processes are an ideal mechanism for measurement
and intervention [23,24]. Unfortunately, it is unclear as to what would constitute ideal targets for an
improvement of program performance. As noted, mental health utilization in the Northwell CCE meets
the national average target, but it is not clear as to what would be the ideal performance measures
for outcome monitoring or EBT delivery. In addition, demands and priorities should be sensitive
to the contexts in which they are implemented. It is important to bear in mind that even robust
implementation programs have had significant challenges. Furthermore, EBT implementation and
quality assurance processes have greater chances of success when the stakeholders’ voices and the
contexts of implementation are factored into the process of change [43,44]. Due to the various demands
imposed on providers, and the diverse contexts within which the WTCHP operates, modifications
should be selective in targeting particular outcomes that will have the greatest value to the WTC MH
cohort. Given the high proportion of responders with PTSD, this will likely require consideration of
interventions that enhance services and outcomes for that population.
5. Conclusions
This project has leveraged the usage of quality improvement mechanisms to characterize service
delivery, evaluate both EBT provision and the implementation of outcome monitoring in a community
provider network for the WTCHP. The initial findings include: Robust access to psychotherapeutic
services, adherence to program objectives of treating WTC-related conditions, and an engagement of
providers in the process. However, the findings also point towards areas for improvement in both
EBT delivery and measurement based care, with implications for the well-being of members served.
Priorities for program performance need to be set by the WTCHP, but information gleaned from this
project in the Northwell CCE provide some areas for consideration. Providers could be engaged in
more outcome-based measurement, and could be given more support for EBT training and delivery.
Close coordination of these changes with relevant stakeholders (i.e., CCEs, providers, and clients)
could ensure effective implementation of any desired objectives.
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Abstract: Thyroid cancer incidence is higher in World Trade Center (WTC) responders compared
with the general population. It is unclear whether this excess in thyroid cancer is associated with
WTC-related exposures or if instead there is an over-diagnosis of malignant thyroid cancer among
WTC first responders due to enhanced surveillance and physician bias. To maximize diagnostic yield
and determine the false positive rate for malignancy, the histological diagnoses of thyroid cancer
tumors from WTC responders and age, gender, and histology matched non-WTC thyroid cancer cases
were evaluated using biomarkers of malignancy. Using a highly accurate panel of four biomarkers that
are able to distinguish benign from malignant thyroid cancer, our results suggest that over-diagnosis
by virtue of misdiagnosis of a benign tumor as malignant does not explain the increased incidence of
thyroid cancer observed in WTC responders. Therefore, rather than over-diagnosis due to physician
bias, the yearly screening visits by the World Trade Center Health Program are identifying true cases
of thyroid cancer. Continuing regular screening of this cohort is thus warranted.
Keywords: 9/11; screening; thyroid cancer; biomarkers
1. Introduction
A significantly increased risk of thyroid cancer has been reported in the Mount Sinai Health
Program of World Trade Center (WTC) responders [1], WTC-exposed firefighters [2], and the New York
City Department of Health exposed residents [3], with an excess risk in the range of 2–3 times the
incidence reported by cancer registries.
The etiology behind this increased incidence of thyroid cancer remains unclear. Though multiple
carcinogens were identified at Ground Zero, including soot, benzene, and other volatile organic
compounds from the burning of the jet fuel, in addition to the asbestos, silica, and other fibers that
IJERPH 2019, 16, 1600; doi:10.3390/ijerph16091600 www.mdpi.com/journal/ijerph233
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were in the dust caused by the towers collapse, none are known to act as carcinogens on the thyroid [4].
Established risk factors for thyroid cancer, such as exposure to radiation or iodine-131, have not been
reported in connection to Ground Zero [5].
Instead, overdiagnosis as a consequence of surveillance and physician biases has been suggested as
a possible explanation of the excess risk of thyroid cancer in the WTC cohort [1]. Enhanced surveillance
leading to heightened diagnosis is a well-recognized phenomenon in heavily screened populations [6].
This phenomenon has been suggested as an explanation for other cancers for which WTC responders
have been observed to be at increased risk, such as prostate cancer [7]. Funded under the James
Zadroga 9/11 Health and Compensation Act of 2010, the World Trade Center Health Program (WTCHP)
monitors the health of WTC responders with yearly visits, including a physical examination, laboratory
testing, spirometry, and chest radiography. Chest imaging is known to increase detection of incidental
thyroid nodules [8], and WTC responders, many of whom report respiratory health problems [9], are
referred for imaging at higher rates, thus making the chance of discovery of a thyroid nodule more
likely. It is possible that some of these nodules would never have become clinically evident, and so
would have never been discovered, if not for this heightened screening [7].
Physician’s cognitive biases are known to lead to diagnostic inaccuracies [10]. Physicians treating
WTC responders, including pathologists, may suspect a worse diagnosis for these patients compared
with non-WTC responders due to implicit biases associated with knowledge of the patient’s past WTC
exposure. In addition, they may prefer risk aversion by a defensive diagnosing strategy to avoid
missing any malignancies and classify a suspicious nodule as cancerous [10]. This, along with the
increase in nodule detection due to enhanced screening through the WTCHP, may be leading to an
over-diagnosis of malignant thyroid cancer among WTC first responders.
The goal of this study is to analyze pathologists’ histological diagnosis of thyroid cancer in WTC
first responders and, by doing so, determine the false positive rate for malignancy. We will examine
the clinical characteristics and results of a cancer-detection four-biomarker panel of WTC tumors
compared with non-WTC exposed age-, gender-, and histology-matched cases.
2. Methods
2.1. Selection and Enrollment of Study Participants
Eligible WTC responders who participated (as employees or volunteers) in rescue, recovery,
and cleanup efforts at the WTC sites and who met established eligibility criteria [11] have been enrolled
in the WTCHP at Mount Sinai. Over 27,000 responders have had at least one monitoring visit in the
WTCHP and have consented to the aggregation of their data;20,984 of which have consented to have
their records used for medical research [12].
Cancer cases are identified through periodical linkage with the cancer registries of New York,
New Jersey, Pennsylvania, and Connecticut, as these states account for 98% of the responders’ residencies
at time of WTCHP enrollment. The full linkage methodology has been described elsewhere [1,12].
Only thyroid cancer cases validated by a cancer registry were eligible to participate in this study.
Additionally, WTC responders were only eligible if their enrollment in the WTCHP predated their
cancer diagnosis.
The full methodology used for patient recruitment and consent has been previously described [12].
In brief, eligible participants were contacted by phone, and those interested in participating were
mailed a consent form. After a patient’s consent, a cancer tissue sample was obtained from the
hospital where the patient’s thyroid surgery had taken place and clinical information related to their
cancer was abstracted from the pathology reports. For each patient, a pathologist reviewed the
tissue blocks to assure that cancer tissue was present, and 5 unstained slides of 4 μm thickness, in
addition to 1 hematoxylin and eosin (H/E) stained slide, were cut from the chosen formalin-fixed
paraffin-embedded (FFPE) tumor block. WTC cases were one-to-one matched by gender, histology,
and age (+/- 5 years) to thyroid cancer samples obtained from the Mount Sinai Biorepository, with
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no known WTC exposure. For cases with rare histology (n = 3), such as columnar cell papillary
carcinoma, it was not possible to match by histology, and matching was limited to age and gender.
After de-identification, all samples were sent to John Hopkins University for analysis. This study
protocol was approved by the Icahn School of Medicine at Mount Sinai’s Institutional Review Board
(IRB-17-01323).
2.2. Assessment of Clinical Characteristics
Pathology reports relating to the thyroid cancer surgeries of the WTC cases and Mount Sinai
non-WTC exposed controls were obtained, and data pertaining to the patient’s age, gender, tumor
histology, and size was abstracted into an excel database. To ensure that the WTC thyroid cancer cases
included in this study represented a random subset of the overall sample, characteristics of the study
sample were compared with the overall WTCHP thyroid cancer cohort using clinical data provided by
the WTCHP (Table 1).
Table 1. Characteristics of the study sample.
Clinical–Pathological Features




(n = 30) p Value
a Included
(n = 30) p Value
b
Age at Diagnosis (years) 48.5 (SD 7.7) 49.3 (SD 8.6) 0.65 47.8 (SD 11.3) 0.5652
Gender 0.16 1.00
Male 36 (83.7%) 21 (70%) 21 (70%)
Female 7 (16.3%) 9 (30%) 9 (30%)
Histology 0.74 1.00
Papillary thyroid carcinoma 27 (62.8%) 21 (70%) 21 (70%)
Papillary thyroid carcinoma,
follicular variant 12 (27.9%) 6 (20%) 6 (20%)
Other 4 (9.3%) 3 (10%) 3 (10%)
Tumor Size c (cm) 1.38 (SD 1.16) 1.46 (SD 0.93) 0.78
Microcarcinoma
Yes c 14 (51.85%) 12 (40.0%) 0.37
a Eligible versus included WTC thyroid cancer cases; b Included WTC versus non-WTC thyroid cancer cases; c Tumor
size unknown for 3 WTC cases; WTC: World Trade Center.
2.3. Immunohistochemistry Analysis
While diagnosis of papillary thyroid carcinoma (PTC), the most common subtype, can usually
be achieved through cytology, diagnosis of other thyroid cancer histologies can prove to be more
difficult [13], resulting in benign thyroid lesions being incorrectly classified as malignant. We have
previously developed a panel of molecular markers to distinguish benign from malignant thyroid
cancer, which can be used to cost-effectively identify the presence of over-diagnosis [14–16]. As seen
in Figure 1, the panel of molecular markers includes DDIT3, ITM1, C1orf24, and PVALB antibodies,
the utility of which has been described elsewhere [14–16], which can accurately discriminate between
malignant and benign tumors with a sensitivity and specificity close to 100% (Figure 1).
FFPE WTC and non-WTC thyroid tumor tissues were analyzed using these carcinoma markers.
Briefly, the FFPE sections (4 μm) were deparaffinized in xylene and rehydrated through a series
of graded alcohols. The endogenous alkaline phosphatase activity was blocked with 15% (vol/vol)
hydrogen peroxide in deionized water for 10 minutes. To expose the PVALB protein, permeabilization
was performed with 0.5% Tween in phosphate-buffered saline (PBS: 10 mM phosphate buffer, pH 7.2,
containing 0.15 M NaCl) at room temperature for 20 min. For PVALB and DDIT3, antigen retrieval was
performed using 0.1 M Tris-HCl for 15 min in a steamer. For C1orf24, antigen retrieval was performed
in a Tris-based solution pH 7.4 (AR-10; Biogenex Laboratories, San Ramon, CA) for 15 min in a pressure
cooker. For ITM1, antigen retrieval was performed using 0.1 M Tris-HCl pH 7.4 for 5 min in a pressure
cooker. After antigen retrieval, the slides were allowed to cool down for 30 min. Non-specific binding
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sites were blocked with 5% (C1orf24) or 10% (ITM1) normal goat serum 1 h or 5% bovine serum
albumin (BSA) (DDIT3 and PVALB) for 30 min prior to incubation with primary antibodies. Polyclonal
anti-C1orf24 and anti-ITM1 (custom produced) were used at 1:200 dilution. Monoclonal anti DDIT3
(Cat. 179823; Abcam, Cambridge) was used at 1:200 dilution, and anti-parvalbumin (clone PARV-19;
Cat. P3088, Sigma-Aldrich, St. Louis, MO) was used at 1:1000 dilution. For all antibodies, incubation
with primary antibodies was performed overnight in a moist chamber. Immunostaining was performed
using the EnVisionTM Dual Link (Cat. K4061; Dako, Hamburg, Germany). The samples were stained


















Figure 1. Antibody Assessment. WTC: World trade center.
2.4. Statistical Analysis
Continuous variables were summarized using mean ± standard deviation, whereas categorical
variables were summarized as frequency (%). Bivariate hypothesis tests were conducted using
two-sided t-tests or Wilcoxon Rank Sum tests for continuous variables and chi-square or Fisher’s Exact
tests for categorical variables. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc.,
Cary, NC).
3. Results
There were 73 participants in the WTC cohort of responders who were eligible to be included in
this study, four of whom had to be excluded as they did not speak English or because they had no viable
contact information. Of the remaining 69 WTC thyroid cancer patients, 37 patients (54%) consented
to participate. We were able to obtain FFPE thyroid tumor tissue samples for 30 WTC participants.
The comparison of the 30 WTC thyroid cancer patients who consented and the 43 remaining WTC
thyroid cancer patients showed that the groups were not significantly different for age at diagnosis,
gender, and histology (Table 1).
After matching, the WTC- and the non-WTC thyroid patient groups were well balanced in terms
of age at diagnosis (p = 0.57), gender (p = 1.00), and histology (p = 1.00) (Table 1). Evaluation of clinical
and pathological characteristics showed that there was no statistically significant difference in terms of
tumor size (p = 0.77). Microcarcinomas, defined as thyroid cancer ≤1cm, were found in 52% of the
WTC thyroid cancer patients compared with 40% in the non-WTC thyroid cancer patients (Table 1).
Antibody assessment correctly classified thyroid nodules in either group (Figure 2, Supplementary
Table S1).
Except for three thyroid samples, all thyroid tumor tissue samples from thyroid tissue from the two
groups and all histology types tested positive for malignancy with antibodies C1orf24, ITM1, and DDIT3
and negative PVALB (Supplementary Table S1). For the other three samples (two WTC cases and one
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control), it was not possible to detect actual tumor tissue in the slides used for immunohistochemistry,
and therefore, these samples could not be confirmed as malignant in the antibody-based test; all three
samples were taken from tumors originally less than 0.3 cm in size. Most of the tumors had a strong
brown staining for three markers (DDIT3, ITM1, and C1orf24) and no staining for the benign Hurthle
adenoma marker (PVALB) (Figure 2; Supplementary Table S1).
 
Figure 2. Representative results of molecular markers in WTC and non-WTC thyroid carcinomas
(original magnification of ×40).
4. Discussion
The findings of the present study suggest that overdiagnosis by virtue of misdiagnosis of a benign
tumor as malignant does not explain the increased incidence of thyroid cancer observed in WTC
responders. If overdiagnosis were occurring, we would expect an excess of false-positive malignancies
among WTC thyroid cancer cases; benign tumors would be detected because of enhanced screening
efforts and diagnosed as malignant because of physician bias associated with knowing that the patient
has a history of WTC exposure. However, there was not an excess of false-positive thyroid cancer
diagnoses found among the WTC thyroid cancer cases. In fact, none of the WTC thyroid cancer
tumors assessed were false-positives; instead, all samples tested using the antibody-based cancer panel
were determined to be true malignant disease. Although it may still be that physicians treating WTC
responders may have biases that make them more likely to defensively diagnose nodules as thyroid
cancer to avoid missing malignancies, our results suggest that screening of WTC responders, at least in
the case of thyroid cancer, may not be unwarranted.
It is important to note that surveillance bias may still be occurring in this cohort. Surveillance
bias occurs when increased screening efforts result in nodules being detected that would otherwise
have gone unnoticed given routine surveillance, thus inflating the actual incidence of disease in a
heavily screened population. Smaller tumor size and younger age at diagnosis in the WTC cohort
would generally be suggestive of surveillance bias, but the design of the present study does not allow
any such conclusions to be drawn. For this study, WTC and non-WTC cases were matched by age,
gender, and histology; thus, it is expected that age and tumor size are similar between the two groups.
However, a descriptive study of the WTC thyroid cancer cases showed that these cases had similar
clinical characteristics as thyroid cancer cases in the Mount Sinai registry in terms of age at diagnosis
and tumor size, suggesting that surveillance bias alone cannot explain the excess risk of thyroid cancer
in WTC responders [17].
Being that the increased risk of thyroid cancer in WTC responders does not appear to be an
artifact due to physician bias, the results of this study leave open the possibility of an as-yet unknown
carcinogenic mechanism through which WTC exposure is acting on thyroid cancer carcinogenesis.
The biological basis of the tumors of WTC responders, including thyroid cancer tumors, warrants
further research.
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This is the first study to investigate the possible reasons for the increased incidence of thyroid
cancer in the WTC population and the first to show that over-diagnosis due to physician bias does not
appear to adequately explain the observed excess risk. The study is also novel in that it is the first to
utilize biomarkers of malignancy in a WTC cohort. A further strength of this study is the high rate of
compliance, with 54% of eligible WTC thyroid cancer patients agreeing to have their tumor sample
molecularly analyzed.
This study is limited in that not all tumor samples could be retrieved from the institutions where
the thyroid cancer surgery was performed and that, for a few samples, there was no tissue sample in
the slides provided. However, this was a small portion of the samples (5%). In addition, a comparison
of the characteristics of those patients for which we obtained a sample to the characteristics of the
eligible patients does not show any difference in personal or tumor characteristics, thus reducing the
possibility of selection bias.
Further analysis is needed to investigate a causal link between thyroid cancer in WTC-responders
and high levels of exposure to potentially carcinogenic agents at Ground Zero, which may result in
cancers with a shorter latency period, similar to that observed in individuals exposed to iodine-131
after the Chernobyl accident. It is well known that patients exposed to Chernobyl fallout demonstrated
a linear dose–response association. Therefore, to define whether there is a correlation between the
levels of exposure to the debris cloud and thyroid cancer, diagnosis is needed, as well as a longer
follow-up. [18]
Additionally, the investigation of somatic events that drive thyroid cancer pathogenesis in this
cohort, concomitant to longer follow-up and correlation with clinical-pathological features, will increase
our knowledge of whether the molecular events in WTC responders differ from those not exposed to
the dust cloud, as well as better define tumor aggressiveness [19,20].
5. Conclusions
In conclusion, rather than overdiagnosis of false-positives due to physician bias, it might instead
be the case that the yearly screening visits by the WTCHP are identifying true cases of thyroid
cancer earlier, increasing the possibility of a favorable prognosis, which warrants regular screening of
this cohort.
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Abstract: Fire Department of the City of New York (FDNY) firefighters experienced intense dust
exposure working at the World Trade Center (WTC) site on and after 11/9/2001 (9/11). We hypothesized
that high-intensity WTC exposure caused abnormalities found on chest computed tomography (CT).
Between 11/9/2001–10/9/2018, 4277 firefighters underwent a clinically-indicated chest CT. Spirometric
measurements and symptoms were recorded during routine medical examinations. High-intensity
exposure, defined as initial arrival at the WTC on the morning of 9/11, increased the risk of bronchial
wall thickening, emphysema, and air trapping. Early post-9/11 symptoms of wheeze and shortness of
breath were associated with bronchial wall thickening, emphysema, and air trapping. The risk of
accelerated forced expiratory volume at one second (FEV1) decline (>64 mL/year decline) increased
with bronchial wall thickening and emphysema, but decreased with air trapping. The risk of airflow
obstruction also increased with bronchial wall thickening and emphysema but decreased with air
trapping. In a previously healthy occupational cohort, high-intensity WTC exposure increased the
risk for CT abnormalities. Bronchial wall thickening and emphysema were associated with respiratory
symptoms, accelerated FEV1 decline, and airflow obstruction. Air trapping was associated with
respiratory symptoms, although lung function was preserved. Physiologic differences between CT
abnormalities suggest that distinct types of airway injury may result from a common exposure.
Keywords: medical imaging; pulmonary function tests; lung injury; occupational exposure;
epidemiological studies
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1. Introduction
The collapse of the World Trade Center (WTC) on the morning of 11 September 2001 (9/11)
produced a caustic dust plume containing more than 10,000,000 tons of irritating alkaline dust with pH
> 10 [1]. Fire Department of the City of New York (FDNY) rescue and recovery workers who arrived at
the site the morning of 9/11, were exposed to an extremely high concentration of dust that produced
airway injury. Those who arrived in the afternoon and following days received a lower intensity, but
substantial exposure, as rescue and recovery work resuspended the dust. WTC exposure produced
an acute drop in forced expiratory volume at one second (FEV1) and forced vital capacity (FVC) in
FDNY workers present at the site prior to 24/9/2001 [2–4]. In the years following 9/11, WTC-exposed
rescue/recovery workers had high rates of airway injury, including excessive loss of lung function [2],
airflow obstruction [3], and airway hyper-reactivity [4]. A significant portion of the cohort experienced
accelerated FEV1 decline, defined as greater than 64 mL/year FEV1 decline, a risk factor for chronic
obstructive pulmonary disease (COPD) [5] and asthma/COPD overlap [6].
Computed tomography (CT) can detect structural lung abnormalities in individuals with
respiratory symptoms and normal spirometry [7]. Self-report of exposure to vapors, gas, dust,
or fumes was associated with an increase in emphysema, bronchial wall thickening, and air trapping
on quantitative CT imaging in cohorts of smokers without WTC exposure [8,9]. Bronchial wall
thickening was associated with FEV1 decline in WTC-exposed cohorts [3,10,11]. Air trapping on
expiratory CT imaging is a manifestation of small airway disease [12,13] and has been observed in a
number of WTC-exposed cohorts [10,14]. The relationship between WTC dust exposure and these CT
abnormalities, however, is still poorly defined.
The aim of this study was to determine predictors of WTC-related airway CT abnormalities on
clinically-indicated chest CT (N = 4277). The main predictor of interest was high-intensity WTC dust
exposure, defined as initial arrival at the WTC site during the morning of 9/11. We also examined
the associations of emphysema, bronchial wall thickening and air trapping with early respiratory
symptoms and longitudinal lung function in order to understand the clinical correlates of radiographic
airway abnormalities in this population.
2. Methods
2.1. Study Population
The source population consisted of 9638 male firefighters who were actively employed by the
FDNY on 9/11, first arrived at the WTC site between 11/9–24/9/2001, and had ≥3 post-9/11 routine
medical monitoring spirometries taken at FDNY [5]. A subset of this population received at least one
clinically-indicated chest CT at a hospital-based radiology facility between 11/9/2001 and 10/9/2018.
The final study population included 4277 firefighters (Figure 1). Participants provided written informed
consent. The Montefiore Medical Center (FWA #00002558)/Albert Einstein College of Medicine (FWA
#00023382) Institutional Review Board approved this study.
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Figure 1. Firefighters who participated in the chest computed tomography (CT) study. Shown is the
source population of male firefighters who were employed by the Fire Department of the City of New
York (FDNY) on 11/9/2001, present at the World Trade Center (WTC) site between 11/9/2001 and 24/9/2001,
and had at least three monitoring pulmonary function tests (PFTs) between 11/9/2001–10/9/2018 to assess
longitudinal forced expiratory volume at one second (FEV1) and FEV1/FVC (forced vital capacity).
The final study population included those who had received a clinically-indicated chest CT scan
between 11/9/2001 and 10/9/2018. A subgroup had a clinically-indicated bronchodilator PFT within one
year of the chest CT.
2.2. CT Scans
Inspiratory and expiratory noncontrast chest CTs were performed at a hospital-based radiology
facility. Clinical indications for chest CT included symptoms or reductions in spirometry. All CT scans
received standard radiologic evaluation. Radiologists were unaware of intensity of WTC exposure,
and radiologist reports were entered into the FDNY medical record in real-time. The findings of
emphysema, bronchial wall thickening, and air trapping were abstracted and entered into the FDNY
medical record. The first post-9/11 CT scan report was used for analysis.
2.3. Participant Characteristics
Demographic data (age and race) were obtained from the FDNY employee database.
Participants’ height, weight, and self-reported smoking status (ever or never-smoker) were assessed
during routine medical monitoring examinations at FDNY, scheduled once every 12–18 months.
Those who consistently self-reported no cigarette smoking were classified as never-smokers. Those who
ever reported current or former smoking on medical monitoring exams were defined as ever-smokers.
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2.4. World Trade Center Dust Exposure
Participants’ time of initial arrival at the WTC site was determined during the first medical
monitoring examination. We classified individuals who arrived at the site on the morning of 9/11 as
having high-intensity WTC exposure [4].
2.5. Longitudinal Respiratory Symptoms
A total of 44,832 medical monitoring exams, which included administration of health questionnaires
and spirometry, were performed in the study population between 2/10/2001 and 10/9/2018 (median
per individual: 11, interquartile range: 9–12). Reports of lower respiratory symptoms were collected
via the self-administered physical health questionnaires [15]. For the respiratory symptoms within
6 months post 9/11, the first monitoring exam was used.
2.6. Longitudinal Screening Spirometry
FEV1 and FVC measurements were obtained from spirometry performed during the monitoring
examinations. Spirometry was carried out as described in our previous studies [2,4]. Post-9/11 rates of
FEV1 decline (FEV1 slopes) were estimated for each participant using the first post-9/11 FEV1 and all
subsequent FEV1 measurements in linear regression analyses that modeled FEV1 as a linear function
of time since 9/11. An FEV1 slope of more than 64 mL/year was defined as accelerated FEV1 decline.
Airflow obstruction was defined as two consecutive FEV1/FVC ratios less than 0.70; we required that
measurements be at least one year apart [5].
2.7. Complete Pulmonary Function Testing
A subset of participants underwent complete pulmonary function tests (PFTs), which were
performed according to American Thoracic Society standards [16] at a hospital-based pulmonary
function laboratory. Because the Global Initiative for Chronic Obstructive Lung Disease definition
of airflow limitation requires a postbronchodilator FEV1/FVC ratio < 0.70, we conducted a
sensitivity analysis within the participants who had had a complete PFT, which included pre- and
postbronchodilator flow rates [17]. Total lung capacity, functional residual capacity (FRC) and residual
volume (RV) measurements were also available from the complete PFT data; these were measured
prior to bronchodilator administration and were used to calculate expiratory reserve volume (FRC
minus RV).
2.8. Statistical Analyses
Demographic and other characteristics of the study population were assessed as n (%) and
means (±SD). Chi-square tests were used to evaluate associations between bronchial wall-thickening,
emphysema, and air-trapping. Hierarchic cluster analysis of the CT abnormalities was performed
and a dendrogram was generated using SAS proc varclus with centroid method. We performed
log-rank Mantel–Cox tests to examine the univariable associations of WTC exposure with the CT
diagnoses of air trapping, emphysema, and bronchial wall thickening. Three separate multivariable
Cox regression models assessed the associations of WTC exposure intensity with the outcomes
emphysema, bronchial wall thickening, and air trapping. These analyses were repeated in the
subset of the cohort that underwent medical monitoring in the first six months after 9/11 in order
to investigate the relationship between early post-9/11 respiratory symptoms and abnormalities on
chest CT (N = 3610). Follow-up time for these Cox models started at 9/11 and ended at the date
of the CT scan. Parametric interval-censored survival models were used as sensitivity analyses,
as the date of incidence of abnormalities would necessarily be prior to the CT on which they are
identified. As a secondary analysis we performed a logistic regression to estimate associations between
CT abnormalities and respiratory symptoms throughout the follow-up period, adjusting confidence
intervals and p-values for potential overdispersion using the Pearson goodness-of-fit statistic. We then
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used logistic regression models to estimate associations of CT abnormalities with accelerated FEV1
decline and airflow obstruction. We first used minimally-adjusted models, with age on 9/11 and race
as the only covariates, and later added the covariates smoking status at the end of follow-up, first
post-9/11 FEV1, first post-9/11 BMI, and WTC exposure level. Covariates were selected based on
previously known factors that affect lung physiology.
Linear mixed models with random intercepts were used to examine longitudinal FEV1 % predicted
and FEV1/FVC ratio trajectories in those who had CT abnormalities. Participants’ age on 9/11, height,
and race were included as fixed effects in the models with FEV1/FVC ratio as the outcome. Mean FEV1 %
predicted and FEV1/FVC ratio were estimated for each 1-year period between 11/9/2000 and 10/9/2018
for four separate groups based on the following CT outcomes: no CT diagnosis, isolated air trapping,
isolated emphysema, and isolated bronchial wall thickening. For these analyses, we excluded 403
participants with more than one CT abnormality.
Two analyses were performed in the subset of study participants with complete PFTs (N = 1226).
A multivariable logistic regression model assessed the associations between the CT abnormalities and
airflow obstruction (post-bronchodilator FEV1/FVC ratio < 0.70), and multivariable linear regression
models were used to assess the associations between CT abnormalities and prebronchodilator lung
volumes. Age on 9/11, race, BMI, smoking status at the end of follow-up, WTC exposure level and
first post-9/11 FEV1 were included as covariates. As stated above, covariates were selected based on
previously known factors that affect lung physiology.
Reported p-values are two-sided and considered significant at the < 0.05 level. Data analyses and
dendrogram were performed using SAS version 9.4 (SAS Institute, Inc., Cary, NC, USA). Cumulative
incidence curves and lung function figures were created with Prism 8 (GraphPad Software, Inc.,
San Diego, CA, USA).
3. Results
3.1. Population Characteristics
The final study population, with clinically-indicated inspiratory and expiratory chest CT, was
37% of the source population. The CT scans were performed throughout the entire follow-up period,
with a peak at year six post-9/11; this was due to increased outreach to recently retired WTC-exposed
firefighters at that time (Figure S1 in Supplementary Materials). Demographic and other characteristics
of the 4277 firefighters in the final study population (Figure 1) and those without chest CT scans are
presented in Table 1. Fewer than 1% of study participants had missing covariate data. Compared with
WTC-exposed firefighters who did not have a clinically indicated chest CT, the study population with
a clinically indicated chest CT was slightly different in that it was older, had a greater proportion of
ever-smokers, higher intensity WTC exposure (arrival at the WTC site on the morning of 9/11), lower
postexposure lung function, and had a higher proportion of reports of shortness of breath and wheeze
within six months of 9/11.
Table 1. Population characteristics *.
Variable Population without Chest CT N = 5361 Chest CT Study Population N = 4277
Age on 9/11 39.4 ± 7.5 41.2 ± 7.2
BMI ‡ 28.7 ± 3.4 29.0 ± 3.5
Smoking Status, N (%)
Never 3804 (71.0) 2653 (62.0)
Ever 1557 (29.0) 1624 (38.0)
Race, N (%)
White 5026 (93.8) 4053 (94.8)
Black 139 (2.6) 86 (2.0)
Hispanic 180 (3.4) 128 (3.0)
Other 16 (0.3) 10 (0.2)
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Table 1. Cont.
Variable Population without Chest CT N = 5361 Chest CT Study Population N = 4277
World Trade Center exposure, N (%)
Morning of 9/11 463 (8.6) 1113 (26.0)
Afternoon on 9/11–9/12 4125 (76.9) 2781 (65.0)
9/13–9/24 773 (14.4) 383 (9.0)
First Post-9/11 Spirometry
FEV1 % predicted 98.3 ± 13.1 95.4 ± 14.2
FVC % predicted 93.4 ± 11.8 91.1± 12.3
FEV1/FVC 0.84 ± 0.05 0.83 ± 0.06
Post-9/11: FEV1 slope (mL/year) −34.6 ± 25.6 −38.9 ± 30.5
Report of respiratory symptoms within 6 months of 9/11
Shortness of breath 1004 (22.3) § 1289 (35.7) ‖
Wheeze 797 (17.7) § 989 (27.4) ‖
* All values are mean ± standard deviation unless otherwise stated. ‡ Body Mass Index. § N = 4500. ‖ N = 3610.
3.2. CT Abnormalities and WTC Exposure
Inspiratory and expiratory chest CTs diagnosed bronchial wall thickening in 837 individuals (20%)
and air trapping in 894 (21%). Nodules greater than or equal to 5 mm and ground glass opacities were
less common but present in over 10% of participants (Table 2). Emphysema, pleural thickening, and
bronchiectasis were present in between 3% and 6% of participants. Pulmonary fibrosis was rare, present
in just 0.6% of individuals with a CT. Bronchial wall thickening was correlated with air trapping and
emphysema (p< 0.001 and p< 0.001, respectively), but air trapping and emphysema were not correlated
with one another (p = 0.72). Hierarchical clustering demonstrated that bronchial wall thickening
clustered with air trapping (Figure 2). Bronchiectasis and emphysema clustered but were distantly
related to bronchial wall thickening and air trapping. The parenchymal abnormalities of pleural
thickening and pulmonary nodules clustered as did ground glass opacities and pulmonary fibrosis.
Table 2. Prevalence of CT abnormality.
CT Abnormality Percentage of Chest CT Scans with Abnormality
Air Trapping 20.9
Bronchial Wall Thickening 19.6
Nodules ≥ 5 mm 14.6





Note: abnormalities are not mutually exclusive.
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Figure 2. Chest CT abnormalities in WTC-exposed firefighters. The dendrogram demonstrates
clustering of abnormalities on chest CTs.
Univariable analyses showed that high-intensity WTC exposure is associated with a 2.2-fold
increased risk of air trapping, a 1.6-fold increased risk of emphysema, and a 2.2-fold increase in the risk
of bronchial wall thickening Figure 3. The associations between high-intensity WTC exposure and chest
CT diagnoses persisted in a multivariable Cox regression model (Table 3). Emphysema was strongly
associated with ever-smoking. Bronchial wall thickening was also associated with ever-smoking,
though the magnitude of association was lower.
Figure 3. Cumulative incidence of chest CT diagnosis according to WTC exposure intensity. (A) shows
the cumulative incidence of emphysema in participants who arrived morning of 9/11 at the WTC site
(red line) compared with those who arrived between the afternoon of 9/11 and 24/9/2001 (blue line).
(B) shows the cumulative incidence of bronchial wall thickening in those who arrived morning of
9/11 (red) and those who arrived later (blue). (C) shows the cumulative incidence of air trapping in
participants who arrived morning of 9/11 (red) and those who arrived later (blue).
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Table 3. Cox regression models predicting three Chest CT abnormalities a,b.
Variables
Emphysema Bronchial Wall Thickening Air Trapping
HR 95% CI p HR 95% CI p HR 95% CI p
WTC exposure
morning of 9/11 1.83 1.36–2.45 <0.001 2.33 2.00–2.72 <0.001 2.34 1.95–2.80 <0.001
Ever-smoker c 7.04 4.94–10.04 <0.001 1.25 1.08–1.44 0.003 0.73 0.61–0.88 0.001
a N = 4277. b Adjusted for age, race, BMI and first post-9/11 FEV1. c Reference is never-smoker.
3.3. CT Abnormalities and Respiratory Symptoms
Respiratory symptoms of shortness of breath and wheezing were common during the first six
months after 9/11; 28.2% (1,018/3,610) reported a single symptom of either shortness of breath or
wheezing, and 17.5% (630/3,610) reported both shortness of breath and wheezing. Early respiratory
symptoms increased the risk of air trapping, emphysema, and bronchial wall thickening according to a
Cox model adjusted for age, race, BMI, smoking status, WTC exposure and first post-9/11 FEV1. Having
both shortness of breath and wheezing was a greater risk factor for each of the CT abnormalities than
having either symptom by itself (Table 4). We also assessed persistence of symptoms in longitudinal
follow-up. Participants with air trapping, emphysema, or bronchial wall thickening on chest CT
reported shortness of breath and/or wheeze more frequently during medical monitoring exams between
11/9/2001 and 10/9/2018 than those without one of those abnormalities on chest CT. (data not shown).
Table 4. Subpopulation with respiratory symptoms reported within six months of exposure a,b.
Variables
Emphysema Bronchial Wall Thickening Air Trapping
HR 95% CI p HR 95% CI p HR 95% CI p
Either shortness of breath or wheeze 1.43 1.04–1.97 0.03 1.38 1.16–1.63 <0.001 1.27 1.08–1.49 0.005
Both shortness of breath and wheeze 1.62 1.12–2.33 0.01 1.49 1.22–1.83 <0.001 1.41 1.16–1.70 <0.001
a N = 3610. b Adjusted for age, race, BMI, smoking status, WTC exposure and first post-9/11 FEV1.
3.4. CT Abnormalities and Longitudinal Spirometry
To assess spirometric correlates of CT abnormalities, we tested the associations of emphysema,
bronchial wall thickening, and air trapping with accelerated FEV1 decline. A minimally-adjusted
logistic regression model, adjusted for only age and race, showed similar results as Table 5 (data not
shown). Emphysema and bronchial wall thickening were associated with increased risk of accelerated
FEV1 decline in a multivariable-adjusted logistic model (Table 5), and air trapping was associated with
reduced odds of accelerated FEV1 decline.
Table 5. Multivariable logistic regression model assessing associations of CT diagnoses with accelerated
FEV1 decline *,†.
CT Diagnosis OR 95% CI
Emphysema 1.89 1.37–2.60
Bronchial Wall Thickening 1.55 1.25–1.92
Air Trapping 0.77 0.61–0.97
* N = 4277; † Adjusted for age, race, BMI, smoking status, WTC exposure and first post 9/11 FEV1.
We then examined how airway abnormalities on CT were associated with longitudinal FEV1
and FEV1/FVC ratio using stratified mixed effect linear models (Figure 4). Isolated emphysema
was associated with the most rapid longitudinal FEV1 decline, while FEV1 decline in those with
isolated bronchial wall thickening was intermediate between the isolated emphysema and air trapping
subgroups (Figure 4A).
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A different pattern emerged when examining longitudinal FEV1/FVC ratio (Figure 4B).
When compared with individuals with no airway abnormalities on CT, isolated air trapping was
associated with increased FEV1/FVC ratio both before and after 9/11. FEV1/ FVC ratio was lowest in
the isolated emphysema subgroup, and intermediate in those with isolated bronchial wall thickening.
Figure 4. Longitudinal lung function according to CT abnormality. (A) shows mean FEV1 % predicted
(± SEM) in each year between 11/9/2000 and 10/9/2018 in the no chest CT diagnosis (black circles),
isolated air trapping (blue triangles), isolated bronchial wall thickening (brown squares), and isolated
emphysema (red inverted triangle) groups. (B) shows mean (± SEM) FEV1/FVC ratio in each year in the
aforementioned groups, adjusted for age, race and height. Number of subjects in each nonoverlapping
group is shown. The vertical line at 0 represents 11/9/2001.
We then tested whether having airway abnormalities on CT was associated with airflow obstruction,
defined as either two consecutive FEV1/FVC ratios < 0.70 on screening spirometry (N = 4277)
or as postbronchodilator FEV1/FVC ratio <0.70 in the subgroup with complete PFTs (N = 1226).
Minimally-adjusted logistic regression, adjusting for age and race only, showed that both emphysema
and bronchial wall thickening increased the odds of airflow obstruction (OR: 3.34, 95% CI: 2.47–4.51
and OR: 2.19, 95% CI: 1.04–1.07), but air trapping was associated with a reduced odds of this outcome
(OR: 0.46, 95% CI: 0.34–0.62). Emphysema and bronchial wall thickening were also associated with an
elevated odds of airflow obstruction in multivariable logistic regression analyses that included age,
race, BMI, smoking status, first post-9/11 FEV1, and WTC exposure level (Table 6). Air rapping was
still associated with a lower odds of airflow obstruction after adjusting for these additional covariates.
Analyses performed in the subpopulation with complete PFTs showed similar results.
Table 6. Multivariable logistic regression models assessing association of CT diagnosis with two









OR 95% CI OR 95% CI
Emphysema 2.03 1.44–2.88 2.63 1.56–4.42
Bronchial Wall Thickening 2.25 1.77–2.87 2.67 1.84–3.88
Air Trapping 0.40 0.29–0.55 0.36 0.22–0.58
* Adjusted for age, race, BMI, smoking status, WTC exposure and first post-9/11 FEV1. $ Post-bronchodilator.
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3.5. CT Abnormalities and Lung Volumes
We evaluated the associations of emphysema, bronchial wall thickening, and air trapping with
lung volumes in the subgroup with complete PFTs. In multivariable linear regression analyses,
emphysema, bronchial wall thickening, and air trapping were associated with greater total lung
capacity. Emphysema and bronchial wall thickening were also associated with increased functional
residual capacity, while air trapping was associated with reduced expiratory reserve volume (Table 7).
Table 7. Multivariable linear models assessing the association of CT abnormalities with lung volumes a,b.
CT Abnormality
Total Lung Capacity c Functional Residual Capacity c Expiratory Reserve Volume c
Beta 95% CI p Beta 95% CI p Beta 95% CI p
Air Trapping 57 −76, 189 0.40 −71 −169, 27 0.16 −205 −281,−129 <0.001
Emphysema 571 357, 786 <0.001 478 319, 637 <0.001 161 38, 285 0.01
Bronchial Wall
Thickening 300 169, 432 <0.001 236 139, 334 <0.001 −46 −122, 30 0.23
a Adjusted for age, race, BMI, smoking status, WTC exposure and first post-9/11 FEV1. b mL. c N = 1226 due to
missing covariates. d N = 1224 due to missing covariates.
4. Discussion
This study documented that firefighters who arrived at the WTC site on the morning of 9/11
(high-intensity exposure) had a higher risk of subsequent airway abnormalities on chest CT than
those with lesser WTC exposure. This supports the hypothesis that WTC exposure contributed to the
development of these airway abnormalities. Those with the highest dust exposure had an increased
odds of subsequent emphysema, bronchial wall thickening and air trapping after controlling for
potential confounders. The increased risk of CT abnormalities following high-intensity WTC exposure
suggests that a massive but brief irritant contact is a risk factor for radiographic abnormalities even
years after the exposure. Because both the high and low WTC exposure groups share the non-WTC
occupational exposure of firefighting, the increased risk of CT abnormalities in the high exposure
group is therefore attributable to WTC exposure. These data are consistent with prior case-control
studies in WTC-exposed cohorts [10] and in occupational cohorts with high smoking prevalence [8,9].
The airway abnormalities on CT were associated with early respiratory symptoms in this
cohort. Large cohort studies in the general population have demonstrated associations between
respiratory symptoms and CT abnormalities including emphysema, bronchial wall thickening, and air
trapping [7,18–20]. In our population, those with CT abnormalities had elevated functional residual
capacity. Similar elevated lung volumes have been observed in other WTC cohorts [14], suggesting that
dynamic hyperinflation could contribute to respiratory symptoms even in individuals with normal
FEV1 and FEV1/FVC ratio [21].
Unlike other dust-exposed occupational cohorts, WTC exposed firefighters were a health
occupational cohort prior to WTC exposure with normal lung function [2]. This could be a reason
why certain CT abnormalities were rare. Pulmonary fibrosis was present in only 0.6% of the first
post-9/11 clinically indicated chest CTs. Similarly, ground glass opacities, pulmonary nodules, and
pleural thickening were uncommon present in only 3 to 15%.
Only 6% of the study population had emphysema, likely due to the healthy worker effect of a
physically demanding occupation, and the fact that there were fewer smokers than in the general
population. As expected, emphysema was strongly associated with cigarette smoking, accelerated
FEV1 decline, and airflow obstruction. Importantly, those with the most intense dust exposure had an
increased risk of emphysema when compared with those with less intense exposure after adjusting
for potential confounders. This suggests that those caught in the dust cloud on the morning of 9/11,
especially ever-smokers, will continue to be at a higher risk for developing emphysema than those
with less intense WTC dust exposure.
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While bronchial wall thickening and air trapping cluster closely together, air trapping is a
physiologically distinct manifestation of dust-induced small airway injury. Unlike bronchial wall
thickening, small airways disease leading to air trapping was associated with reduced odds of airflow
obstruction in this cohort. Reduction of expiratory reserve volume associated with air trapping
likely contributes to the observed reduction of FVC. This could account for the elevated longitudinal
FEV1/FVC ratio. The preservation of FEV1 in those with air trapping suggests the disease process
spares the larger airways that limit forced expiratory airflow. In our cohort, the impact of high-intensity
exposure on subsequent air trapping was stronger in never-smokers than ever-smokers. In non-WTC
cohorts, excessive FEV1 decline was observed in those with smoking-associated and age-related air
trapping [12,13,22]. Furthermore, in smokers, air trapping may be a transition state to emphysema [23].
In our cohort with preserved lung function and low smoking prevalence, air trapping was not associated
with smoking or emphysema, suggesting that the mechanism of small airway injury or stage of disease
may influence the relationships between CT abnormalities and FEV1 decline. This highlights the
need to use different measures of distal airway function, such as impulse oscillometry, to assess
and follow the physiology of small airway abnormalities associated with air trapping on CT [24–26].
Further research is needed to define effective treatments in those who have air trapping-associated
symptoms, but preserved FEV1 and FEV1/FVC ratio.
Firefighters with bronchial wall thickening had greater longitudinal FEV1 decline and airflow
obstruction when compared with those having no airway abnormalities or air trapping. Bronchial wall
thickening had a phenotype that was similar to but less severe than emphysema, with increased total
lung capacity, functional residual capacity, and increased risk of accelerated FEV1 decline and airflow
obstruction. Greater FEV1 decline observed on serial spirometry is a strong risk factor for airflow
obstruction [5]. The increased risk of airflow obstruction associated with bronchial wall thickening was
similar regardless of whether obstruction was determined by FEV1/FVC < 0.70 in the entire study group
(serial spirometry) or in the subgroup with postbronchodilator measurements. This suggests that
misclassification or selection bias associated with the different definitions of obstruction did not change
the associations with CT abnormalities. The association of bronchial wall thickening with accelerated
FEV1 decline highlights the utility of CT in risk assessment of symptomatic patients with preserved
lung function [7]. Future investigation of longitudinal CT scans is needed to assess if bronchial wall
thickening is a risk factor for developing emphysema, especially in never-smokers.
There are several limitations to this investigation. FDNY firefighters are overwhelmingly white,
male, and previously healthy workers, potentially limiting generalizability of these findings; however,
most findings from the FDNY cohort have been replicated in other WTC-exposed cohorts [10,11,14].
The reported CT abnormalities were real world data defined by clinical radiologists without quantitative
image analysis or inter-reader reliability measures. Nonetheless, there were strong correlations
between CT abnormalities and exposure intensity. CT airway abnormalities also correlated with
PFT measurements, including lung volumes, suggesting validity of the clinical CT interpretation.
Lastly, since the CT scans were clinically indicated, this study was vulnerable to selection bias.
The study population differed from those without chest CTs, with more intense WTC exposure, more
respiratory symptoms and worse postexposure lung function. This precludes assessment of the
incidence of abnormal CTs in the entire cohort, since undiagnosed cases are likely. Nevertheless,
analyses within the CT population provide a valid assessment of risk factors for specific diagnoses
within a symptomatic subgroup.
5. Conclusions
In WTC-exposed firefighters, high-intensity dust exposure was associated with subsequent
bronchial wall thickening, air trapping, and emphysema, a causal link between WTC exposure and
these CT abnormalities. Emphysema and bronchial wall thickening were associated with airflow
obstruction and an accelerated rate of longitudinal FEV1 loss. Isolated air trapping identifies a
symptomatic subgroup without excessive FEV1 decline or airflow obstruction.
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The findings from this study are a valuable resource for understanding irritant-induced airways
disease in a previously healthy population. In those with radiographic abnormalities, the 17-year
decline in lung function is still mild enough that the potential exists for interventions, such as tobacco
cessation or pharmacologic targeting of specific inflammatory pathways, to improve lung function
trajectory and respiratory symptoms.
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Figure S1: Distribution of the timing of chest CT. The histogram is showing the number of chest CT scans used
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performed that year.
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Abstract: Peripheral neuropathy can result from numerous conditions including metabolic disorders,
inflammatory disease, or exposure to environmental or biological toxins. We analyzed questionnaire
data from 9239 Fire Department of the City of New York (FDNY) World Trade Center (WTC)-exposed
firefighters and emergency medical service workers (EMS) to evaluate the association between work
at the WTC site and subsequent peripheral neuropathy symptoms using the validated Diabetic
Neuropathy Symptom (DNS) score. We grouped the population into an “Indicated” group with
conditions known to be associated with paresthesia (N = 2059) and a “Non-Indicated” group without
conditions known to be associated (N = 7180). The level of WTC exposure was categorized by time
of arrival to the WTC. Overall, 25% of workers aged 40 and older reported peripheral neuropathy
symptoms: 30.6% in the Indicated and 23.8% in the Non-Indicated groups, respectively. Multivariable
logistic models performed on the Non-Indicated group, and on the Non-Indicated in comparison
with non-WTC exposed National Health and Nutrition Examination Survey (NHANES), found that
the highest level of WTC-exposure was significantly associated with DNS positive outcomes, after
controlling for potential confounders. In conclusion, this study suggests that symptoms of peripheral
neuropathy and paresthesias are common and are associated with WTC-exposure intensity.
Keywords: peripheral neuropathy; prevalence; World Trade Center; rescue/recovery workers;
occupational exposure
1. Introduction
The collapse of the World Trade Center (WTC) buildings in New York City after the terrorist
attacks on 11 September, 2001 (9/11) resulted in high volumes of aerosolized dust and gases
including neurotoxins such as lead, aluminum, cadmium, manganese, tin, and complex hydrocarbons,
specifically polychlorinated biphenyl (PCB), dioxins, and polycyclic aromatic hydrocarbons (PAHs) [1,2].
Additionally, the 10-month rescue/recovery effort may have exposed workers to organic solvents [3] and
pesticides [4], which are known causes of peripheral neuropathy and neurodegenerative diseases [1].
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The peripheral nervous system may be particularly vulnerable to environmental and metabolic
insult that can result in peripheral neuropathy (PN), which can take axonal, demyelinating, or
mixed forms [5]. Diabetic neuropathy is most common [6,7], but there are other types, such as
inflammatory and toxic. Inflammatory neuropathies include those that are infectious, for example,
those of autoimmune origin like sarcoidosis and Gullian–Barré syndrome [5,8]. Toxic neuropathies are
often related to chemotherapeutic agents (chemotherapy-induced toxic peripheral neuropathy) [9,10],
chronic alcohol abuse [11,12], or exposure to heavy metals and other environmental toxins [13], which
result in primary axonal damage. Toxins may also include industrial solvents due to their use of
hexacarbons [14], a group of chemical compounds shown to cause length-dependent distal sensory
loss, weakness, atrophy, reduced distal reflexes, and autonomic dysfunction.
To date, three previous questionnaire-based studies have investigated the prevalence and risk
factors for peripheral neuropathy in smaller WTC-exposed populations and reported that neuropathy
symptoms were commonly associated with WTC-related exposure or WTC cleaning work [15–17].
The purpose of the current study is to investigate the prevalence of self-reported peripheral neuropathic
symptoms and paresthesias among more than 9000 WTC-exposed Fire Department of the City of
New York (FDNY) firefighters and emergency medical workers (EMS) between 7 June 2017, when
the Diabetic Neuropathy Symptom (DNS) score was added to FDNY monitoring questionnaires, and
6 April 2019. The DNS score was developed by an expert panel consisting of a diabetologist, a vascular
internist, a neurologist, and a physician for rehabilitation medicine seeking a validated, rapid, and easy
to preform screening tool. The score demonstrates good inter-rater agreement (Cohen’s weighted κ for
both raters was 0.89 and 0.78), reliability (0.64) and sound screening properties due, in particular, to its
high sensitivity (79%) and specificity (78%) [18]. We hypothesized that WTC exposure, overall, and
specifically, arrival time to the disaster site would be associated with a higher prevalence of neuropathic
symptoms both as measured by the DNS and by paresthesias of the lower and upper extremities.
Further, we included as a comparison population, data from non-WTC individuals who participated
in the 2003–2004 National Health and Nutrition Examination Survey (NHANES) survey [19].
2. Materials and Methods
2.1. Data Collection
The FDNY WTC Health Program performs periodic health evaluations on all active FDNY
members, and on WTC-exposed retired members, both firefighters and EMS, every 12–18 months.
Since 2001, self-administered health questionnaires have been used to collect information about WTC
exposure, health behaviors such as smoking history, and physician diagnoses.
2.2. Description of the Study Population
The source population consisted of 14,185 WTC-exposed firefighters and EMS enrolled in FDNY
WTC Health Program (WTCHP) who provided written consent for research. The inclusion criteria
for this study were: (1) having arrived at the disaster site between the morning of 11 September, 2001
(9/11) and 24 September, 2001; (2) being an active FDNY firefighter or EMS on 9/11; (3) having taken at
least one post-9/11 health questionnaire within the study period; and, (4) being 40 years or older at the
time of their most recent questionnaire. The final study population included 9239 firefighters and EMS;
this population was separated into two groups. The first, hereafter called the ‘Indicated’ group, was
comprised of those with conditions that are known to be linked to peripheral neuropathy (N = 2059),
which include those with: diabetes (glucose ≥140 mg/dL on the most recent FDNY blood test), a
history of confirmed cancer (not including in situ cancers or non-melanoma skin cancers) [20–22],
or a history of a confirmed autoimmune disease (including phospholipid, aplastic, myositis, lupus,
sclerosis, myasthenia, psoria, rheum, sarcoidosis, Sjögren’s, thrombocytopenia, and Wegener’s) [23,24].
The second, hereafter called the ‘Non-Indicated’ group, was comprised of those without such conditions
(N = 7180). These groups are mutually exclusive.
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The Montefiore Medical Center/Albert Einstein College of Medicine’s Institutional Review Board
approved this study (IRB: 07-09-320).
2.3. Defining WTC Exposure Intensity
WTC exposure is defined from the earliest post-9/11 health questionnaire. We categorized exposure
based on the FDNY-WTC exposure intensity index [25] as being high (arrived on the morning of
9/11), moderate (arrived afternoon of 9/11 or on 9/12/2001), or low (arrived between 9/13/2001 and
9/24/2001) [25,26].
2.4. Defining FDNY Peripheral Neuropathy Symptoms
Self-administered health questionnaires completed by all FDNY firefighters and EMS at their
monitoring exams captured self-reported, physician-diagnosed peripheral neuropathy, and beginning
in 2017, the validated four-item DNS score was used for diagnosing distal diabetic polyneuropathy [18].
Each DNS item scores one point, a score of 1 or greater signals the presence of polyneuropathy.
Additionally, FDNY added the following two questions: “Considering any time in the last two
weeks (excluding during exercise), do you have prickling, pins and needles, burning, aching pain or
tenderness in your legs or feet?” followed by the same question regarding the arms or hands. Answer
choices were “never, occasional, often, or almost continuously”. All analyses used information from
each participant’s most recent questionnaire within the study period.
2.5. Defining NHANES Peripheral Neuropathy Symptoms
The 2003–2004 National Health and Nutrition Examination Survey (NHANES) [19] (N = 3299)
asked participants 40 years and older about numbness, loss of feeling, painful sensation, or tingling in
the hands or feet, other than from the hands or feet falling asleep, in the past three months. Survey
participants who confirmed such experiences in their feet or both their hands and feet were identified as
having symptoms of peripheral neuropathy. We excluded 519 who reported that a health professional
had ever diagnosed them with “diabetes” or “sugar diabetes”, and 62 who reported either “borderline”
or “don’t know” for diagnosed diabetes. The final population consisted of 2718 non-diabetic NHANES
survey participants.
2.6. Statistical Methods
First, prevalences of self-reported peripheral neuropathy and symptoms were calculated among
the Indicated and Non-Indicated groups, and a weighted prevalence was calculated for NHANES
(via SAS PROC SURVEYMEANS) using the two-year interviewed sample weights provided in the
NHANES data file.
Then we conducted two phases of analyses exclusively on the Non-Indicated group: (1) the
association of WTC exposure and peripheral neuropathy and (2) the estimation of the likelihood of
symptoms in the FDNY cohort relative to NHANES.
(1) Odds ratios (ORs) and 95% confidence intervals (CIs) were used to explore associations
between peripheral neuropathic symptoms and various risk factors. Multivariable logistic regression
was used to analyze the association between the level of WTC exposure and peripheral neuropathy
as defined by the DNS. Further, we investigated the association with the frequency of paresthesia
(often or almost continuously vs never or occasional) separately in the lower and upper extremities,
and in the extremities compiled. Additionally, we tested linear trends in the exposure–response
relationship of each model by including WTC exposure as an ordinal predictor. All multivariable
models controlled for work assignment on 9/11 (EMS, firefighter), sex, race (non-Hispanic white,
non-white (non-Hispanic black, Hispanic, other)), smoking history at the time of the questionnaire
(ever, never), chronic alcohol abuse (yes, no), and age at exam. Chronic alcohol abuse, based on the
Alcohol Use Disorders Identification Test (AUDIT) [27], was defined as positive for alcohol abuse on
every questionnaire after the first ever indication.
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(2) Using the analytic technique employed by Myers et al. [28], we created a combined analytic file
for multivariable logistic regression estimation by normalizing variable names and variable coding for
the NHANES and FDNY Non-Indicated datasets and appending the two data files. In the combined
file, two-year interviewed sample weights formed the frequency weights for NHANES records, and
FDNY records received a frequency weight of one. An indicator variable identified records that were
NHANES or FDNY. In this way, the NHANES cohort is used as a national reference population to
standardize the FDNY Non-Indicated group. Our models compared the association of peripheral
neuropathic symptoms with the FDNY cohort overall and to each level of WTC exposure (via SAS
PROC SURVEYLOGISTIC), adjusting for sex, race (non-Hispanic white, non-white (non-Hispanic
black, Hispanic, other)), and age at exam. As a secondary analysis, a WTC exposure test for trend
was conducted. In order to compare the DNS questions to NHANES, we removed the first DNS item
which asks if a person is suffering from unsteadiness in walking; thus, a positive score on the DNS was
restricted to a score of 1 or higher using only the other three items.
All analyses were conducted using SAS 9.4 (SAS Institute, Inc., Cary, NC, USA).
3. Results
3.1. Baseline Characteristics
The study cohort (N = 9239) was 97.6% male, 89.7% non-Hispanic white, and 88.2% were
firefighters on 9/11. Most of the cohort (69.3%) was moderately-exposed to the WTC disaster. The mean
(SD) age on 9/11 was 39.7 (7.5) years, and 25.3% (N = 2341) of the study cohort scored positive on
the DNS. These demographic characteristics are reflected in the Indicated and Non-Indicated groups
presented in Table 1. Compared with the Indicated, the Non-Indicated group was younger, on average,
included a slightly higher percentage of non-Hispanic whites and firefighters, and had a greater
proportion of never smokers.
Table 1. Demographic characteristics among individuals 40 years and older (7 June, 2017–6 April, 2019).
Variable Indicated † (N = 2059) Non-Indicated (N = 7180)
Age on 9/11, y a 42.1 ± 7.6 39.0 ± 7.3
Age at exam, y a 59.0 ± 7.6 56.0 ± 7.3
Sex, N (%)
Male 1997 (97.0) 7022 (97.8)
Female 62 (3.0) 158 (2.2)
Race, N (%)
Non-Hispanic white 1778 (86.4) 6512 (90.7)
Non-Hispanic black 120 (5.8) 264 (3.7)
Hispanic 141 (6.9) 372 (5.2)
Other 20 (1.0) 32 (0.5)
Work assignment on 9/11, N (%)
Firefighter 1666 (80.9) 6484 (90.3)
EMS 393 (19.1) 696 (9.7)
Smoking status, N (%) b
Never 1453 (70.6) 5625 (78.3)
Former 519 (25.2) 1342 (18.7)
Current 87 (4.2) 213 (3.0)
WTC exposure level, N (%)
High 383 (18.6) 1155 (16.1)
Moderate 1356 (65.9) 5047 (70.3)
Low 320 (15.5) 978 (13.6)
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Table 1. Cont.
Variable Indicated † (N = 2059) Non-Indicated (N = 7180)
Chronic Alcohol Abuse c
Yes 0 (0.0) 107 (1.5)
No 2059 (100.0) 7073 (98.5)
PN Risk Factor
Diabetes (glucose ≥ 140 mg/dL) 1147 (55.7) -
Cancer (not ‘in situ’) 886 (43.0) -
Autoimmune Disease 184 (8.9) -
PN = peripheral neuropathic symptoms; 9/11 = 11 September, 2001; WTC =World Trade Center. † Rescue/recovery
workers with any of the following conditions: diabetes, cancer (not including in situ cancers or non-melanoma skin
cancers), or an autoimmune disease. a Mean ± SD. b Value at the time of the physical health questionnaire. c Scored
positive on the Alcohol Use Disorders Identification Test (AUDIT) on all questionnaires after the first indication.
3.2. Prevalence of Neuropathic Symptoms
The prevalence of scoring positive on the DNS among the Indicated group was 30.6% while
the Non-Indicated group scored 23.8% (Table 2). Both groups, with 20.2% of the Indicated group
and 15.2% of the Non-Indicated group, commonly reported symptoms of burning, aching pain or
tenderness in the legs or feet. The greatest proportion of overlap between items in the Indicated
group and Non-Indicated group, respectively, was by those who answered positively to questions 2–4
(19.8%; 16.1%); additionally, 72 (11.4%) of the Indicated group and 146 (8.5%) of the Non-Indicated
group answered positively to all four questions. The Indicated group reported a greater prevalence of
paresthesia in the legs or feet (11.7%, N = 240) than in the arms or hands (8.1%, N = 167), as did the
Non-Indicated group (8.5%, N = 613; 7.1%, N = 509). Physician-diagnosed peripheral neuropathy was
very rare: approximately 2% of the Indicated group and 1% of the Non-Indicated group.
Table 2. The Diabetic Neuropathy Symptom (DNS) score prevalence among the Indicated and
Non-Indicated peripheral neuropathy groups.
DNS Item
Indicated †,
N = 2059 (%)
Non-Indicated,
N = 7180 (%)
1. Considering any time in the last two weeks (excluding during exercise),
are you suffering of unsteadiness in walking? 184 (8.9) 419 (5.8)
2. Considering any time in the last two weeks (excluding during exercise),
do you have a burning, aching pain or tenderness at your legs or feet? 416 (20.2) 1091 (15.2)
3. Considering any time in the last two weeks (excluding during exercise),
do you have prickling sensations at your legs and feet? 344 (16.7) 817 (11.4)
4. Considering any time in the last two weeks (excluding during exercise),
do you have places of numbness on your legs or feet? 372 (18.1) 954 (13.3)
5. Any of the Above 630 (30.6) 1711 (23.8)
† Rescue/recovery workers with any of the following conditions: diabetes, cancer (not including in situ cancers or
non-melanoma skin cancers), or an autoimmune disease.
3.3. Associations of 9/11-Related Exposures with Peripheral Neuropathy Symptoms
Final logistic regression models used the following outcomes: positive on the DNS; and
often/almost continuously experiencing paresthesias in the legs or feet, in the arms or hands, or
in both (Table 3). Those with the highest exposure to the WTC disaster (arriving the morning of 9/11)
were more likely to score positive on the DNS (OR 1.35, 95% CI 1.10–1.65) than those in the lowest
exposure group (P test for trend P = 0.004). This signal became stronger when assessing paresthesias,
except for paresthesias of the legs or feet where the association was not significant. Trend tests
between WTC exposure level and paresthesias of the arms and the extremities compiled, respectively,
were significant (P test for trend P = 0.036; 0.006). There were no significant associations with work
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assignment on 9/11 (EMS vs Fire). Sex, older age, a history of smoking, and chronic alcohol abuse were
associated with almost every outcome.
Table 3. Reports of DNS positive scores and paresthesias of the upper and lower extremities in World














High 1.35 (1.10, 1.65) 1.36 (0.99, 1.87) 1.47 (1.04, 2.08) 2.47 (1.35, 4.53)
Moderate 1.17 (0.99, 1.38) 1.30 (1.00, 1.70) 1.33 (0.99, 1.78) 2.18 (1.27, 3.75)
Low Ref. Ref. Ref. Ref.
Age at exam 1.04 (1.03, 1.04) 1.03 (1.02, 1.04) 1.02 (1.00, 1.03) 1.03 (1.01, 1.05)
Race
Non-Hispanic
white 0.97 (0.78, 1.19) 1.03 (0.74, 1.42) 0.93 (0.66, 1.32) 0.77 (0.47, 1.26)
Non-white Ref. Ref. Ref. Ref.
Sex
Male 0.64 (0.44, 0.95) 0.41 (0.24, 0.70) 0.46 (0.26, 0.84) 0.36 (0.17, 0.77)
Female Ref. Ref. Ref. Ref.
Work assignment
on 9/11
EMS 1.05 (0.84, 1.33) 0.91 (0.63, 1.33) 0.81 (0.54, 1.22) 1.14 (0.63, 2.03)
Firefighter Ref. Ref. Ref. Ref.
Smoking status a
Ever 1.22 (1.07, 1.39) 1.20 (0.99, 1.46) 1.02 (0.82, 1.28) 1.16 (0.83, 1.61)
Never Ref. Ref. Ref. Ref.
Chronic Alcohol
Abuse b
Yes 2.32 (1.57, 3.42) 1.48 (0.84, 2.63) 1.43 (0.76, 2.69) 1.99 (0.86, 4.62)
No Ref. Ref. Ref. Ref.
OR = odds ratio; CI = confidence interval; EMS = emergency medical service worker; Ref. = reference group;
DNS = Diabetic Neuropathy Symptom score; 9/11 = 11 September, 2001. † Often/almost continuously experiencing
prickling, pins and needles, burning, aching pain or tenderness in the area defined. a At the time the questionnaire
was taken. b Scored positive on the Alcohol Use Disorders Identification Test (AUDIT) on all questionnaires after
the first indication.
3.4. U.S. Population Prevalence and Comparison to FDNY Cohort
Among the 2003–2004 non-diabetic NHANES population, a weighted estimate of 13% (95% CI
11.2–15.1) reported experiencing symptoms of peripheral neuropathy, as compared with the estimated
23% (95% CI 19.0–27.1%) of the 519 diabetic survey participants. Our restricted DNS definition (DNS
scored excluding the first question) reduced the prevalence of reported symptoms to 22.3% among
the Non-Indicated group. The multivariable logistic regressions (Table 4) found that any exposure
to the WTC increased the odds of reporting symptoms (OR 2.06, 95% CI 1.65–2.57). An exposure
response gradient became apparent when each level of WTC exposure was compared to the NHANES
population (P test for trend P < 0.0001) (Table 4).
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Table 4. Multivariable logistic regression using the NHANES 2003–2004 non-diabetic cohort as a
national referent population.
Title OR (95% CI) †
Model 1: WTC exposure overall
Exposed 2.06 (1.65, 2.57)
Unexposed NHANES Ref.
Model 2: WTC exposure level
High 2.36 (1.84, 3.04)
Moderate 2.04 (1.62, 2.56)
Low 1.82 (1.41, 2.35)
Unexposed NHANES Ref.
NHANES = National Health and Nutrition Examination Survey; WTC =World Trade Center; 9/11 = 11 September,
2001; Ref. = reference. † Exposure measurements adjusted for age at exam, sex, and race (non-Hispanic white, other).
4. Discussion
Our study uniquely examines peripheral neuropathy symptoms reported about 15 years after the
inhalation and dermal absorption of WTC particulates and gases in a cohort of exposed firefighters and
EMS. Nearly one-quarter of the Non-Indicated group reported one or more symptoms of peripheral
neuropathy, compared with 31% of those with a comorbid condition known to be associated with
paresthesias, specifically diabetes, cancer, or autoimmune disease. The prevalence of reported DNS
symptoms was lower in the Non-Indicated than in the Indicated group, but not by half, a prevalence
difference that has been demonstrated between non-diabetic and diabetic groups in the general
population [19,29,30]. Not only does this result demonstrate the applicability of the DNS in our
cohort, it also indicates a potential for WTC-exposed workers, other than those typically at risk, to
be experiencing peripheral nerve damage. Our findings illustrated moderate associations between
the most highly exposed workers (rescue/recovery workers most exposed to massive volumes of
aerosolized particulates and pulverized building materials) and a positive DNS score and with
paresthesias of the upper extremities. As expected, we found stronger associations with those who
reported paresthesias of both the upper and lower extremities.
Unlike the previous two WTC-associated studies of paresthesia, we used peripheral neuropathic
symptom data from the 2003–2004 NHANES non-exposed, non-diabetic population as a comparison.
NHANES prevalence data from this period suggested that any WTC exposure, whether the most
or the least exposed, increased by two-fold the likelihood of reporting neuropathic symptoms. This
standardization to NHANES bolsters the connection between WTC exposure and paresthesia symptoms
also found in previous neuropathy symptom studies [15–17]. Moreover, we used a validated screening
questionnaire, the DNS, in addition to questions on paresthesias of the upper and lower extremities,
similar to the questions used by Marmor et al. [16], to examine prevalence in our population using
multiple measures; therefore, giving our findings a more robust framework. Further support for
our findings can also be found in a 2016 study of 16 WTC-exposed responders and survivors, which
concluded that there was a higher probability of a neuropathy diagnosis in patients who were
WTC-exposed as compared with others referred for electromyography (EMG) testing [31].
Our study has some limitations. Since the FDNY WTCHP did not add questions about peripheral
neuropathy symptoms to the monitoring questionnaires until 2017, we are not yet able to assess
longitudinal persistence of paresthesias, which could help elucidate the long-term effects of the WTC
on neurodegeneration in the peripheral nervous system. And, while we adjusted for work assignment
on 9/11, sex, race, smoking history, chronic alcohol abuse, and age, our logistic models may not have
fully controlled for unmeasured confounding. Additionally, during the second phase of analysis, we
were unable to remove those who had a history of cancer or autoimmune disease from the NHANES
dataset. We can assume, therefore, that the already strong association between WTC exposure and
peripheral neuropathy symptoms was biased toward the null. We acknowledge that NHANES does
not represent an exact counterfactual for our WTC-exposed cohort and, instead, a comparison group
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comprised exclusively of firefighters with no exposure to the disaster or a truly random sample of the
U.S. population would be most desirable; nevertheless, no such cohort data were available at this time.
Finally, the use of cross-sectional questionnaire data cannot establish causality, we cannot account for
the specific impacts of career firefighting versus WTC-specific particulate exposures, and very few
rescue/recovery workers reported a physician diagnosis of peripheral neuropathy. However, the high
prevalence of symptoms in the Non-Indicated group and significant associations with WTC exposure
intensity and as compared to the general population underscore the need for further investigation.
5. Conclusions
EMG, skin punch biopsy, and nerve conduction velocity testing will provide confirmation of
neuropathies and determine the specific types of nerve injuries that may be associated with WTC
exposure. The mechanism by which WTC exposure results in neuropathy will require further
investigation by others. Such research has been started by Stecker et al.’s 2014 study on rat sciatic
nerves [32], which provided biological plausibility for the effect of WTC exposure mediated by a
methanol-soluble element in WTC dust, leading to an increased risk of neuropathy. Furthermore,
recent studies of neurodegeneration, in the military and populations exposed to terrorist attacks
other than the WTC, have begun to stress the relevance of toxic neuropathy [33–35]. In conclusion,
our study suggests that WTC exposure may result in an increased risk of peripheral neuropathy in
rescue/recovery workers, especially those who were most highly exposed to the dust cloud. This risk
appears to be independent of the illnesses and conditions generally related to neuropathic symptoms.
Treatment for peripheral neuropathy is not currently covered under the James Zadroga 9/11 Health
and Compensation Act. Therefore, if confirmed by future studies, our research may have policy
implications for consideration of neuropathy as an addition to the list of covered conditions.
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Abstract: Sarcoidosis is a systemic granulomatous disease of unknown etiology. It may develop in
response to an exposure or inflammatory trigger in the background of a genetically primed abnormal
immune response. Thus, genetic studies are potentially important to our understanding of the
pathogenesis of sarcoidosis. We developed a case-control study which explored the genetic variations
between firefighters in the Fire Department of the City of New York (FDNY) with World Trade
Center (WTC)-related sarcoidosis and those with WTC exposure, but without sarcoidosis. The loci of
fifty-one candidate genes related to granuloma formation, inflammation, immune response, and/or
sarcoidosis were sequenced at high density in enhancer/promoter, exonic, and 5’ untranslated regions.
Seventeen allele variants of human leukocyte antigen (HLA) and non-HLA genes were found to be
associated with sarcoidosis, and all were within chromosomes 1 and 6. Our results also suggest an
association between extrathoracic involvement and allele variants of HLA and non-HLA genes found
not only on chromosomes 1 and 6, but also on chromosomes 16 and 17. We found similarities between
genetic variants with WTC-related sarcoidosis and those reported previously in sporadic sarcoidosis
cases within the general population. In addition, we identified several allele variants never previously
reported in association with sarcoidosis. If confirmed in larger studies with known environmental
exposures, these novel findings may provide insight into the gene-environment interactions key to
the development of sarcoidosis.
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1. Introduction
Sarcoidosis is a multisystem granulomatous disease that presents with pulmonary involvement
in 90% of cases and extrapulmonary manifestations, mostly skin, in 10% of patients [1]. The annual
age-adjusted incidence in the United States (U.S.) between 1946–2013, in a mostly Caucasian cohort,
was 10 per 100,000 (9.4 in males and 10.5 in females) [2]. Between 1985 and 1998, firefighters in the Fire
Department of the City of New York (FDNY) had an annual incidence of sarcoidosis somewhat higher
than the white male general population at 12.9 per 100,000 and many-fold higher than an internal
control group of emergency service workers [3]. The incidence doubled following the World Trade
Center (WTC) attacks on September 11, 2001 (9/11), giving an age-adjusted incidence rate of 25 per
100,000 in mostly Caucasian male WTC-exposed FDNY firefighters between 2002–2015 [4].
Since the disorder clusters in families, genetic factors are thought to play an important role in
sarcoidosis pathogenesis, presumably through mechanisms of immunologic response to antigenic
or other triggering exposures. A recent population-based study suggests a genetic risk factor for
sarcoidosis in a large Swedish cohort, where a 3.7-fold increase in risk of sarcoidosis was observed in
those with first-degree relatives with the disease. The risk further increased in those with relatives
with Lofgren’s syndrome or with ≥1 relative with sarcoidosis [5]. A case-control etiologic study of
sarcoidosis (ACCESS) found a five-fold increase in siblings of those with sarcoidosis [6].
We selected several candidate genes for genetic analysis based on their function encoding
proteins involved in granuloma formation, innate and immune recognition, and inflammation.
Several have been implicated in genetic studies of sarcoidosis such as the highly polymorphic human
leukocyte antigen (HLA) genes. HLA genes encode the major histocompatibility complex (MHC)
in humans and are involved in immunologic recognition and regulation. Within various racial
groups, allele variations within HLA genes are associated with sarcoidosis. Examples include the
HLA-DRB1*1101 allele in both Caucasians and African Americans [7], HLA-DRB1*1501, -*03 and -*0402
specifically in European Americans [7–9], HLA-DRB1*1201 and -*0302 in African-Americans [7,10].
The HLA-DQB1 alleles HLA-DQB1-*0402, and -*0503 are associated in Asian Indians [7] and
HLA-DQB1-*0602 in a Dutch cohort [8]. Several other non-HLA genes have been associated with
sarcoidosis, such as prostaglandin G/H synthase/cyclooxygenase (PTGS2/COX2), neurogenic locus
notch homolog 4 (NOTCH4), nucleotide-binding oligomerization domain-containing protein 2 (NOD2),
and Butyrophilin-like 2 (BTNL2) [11–15].
The current case-control study is the first to examine genetic features associated with WTC-related
sarcoidosis. Compared to other genetics studies of sarcoidosis, our study uniquely includes a baseline
sarcoidosis rate, a known time point of exposure (9/11), and extensive, systematized clinical follow-up
for over 14 years. The objective of this study is to explore the genetic characteristics of WTC-associated
sarcoidosis and understand its similarities to and differences from sporadic sarcoidosis cases without a
clear environmental exposure.
2. Materials and Methods
2.1. Study Population
The source population for the cases and controls was WTC-exposed firefighters. Recruitment of
sarcoidosis cases for this study was part of a larger study that explored the clinical course of firefighters
with post-9/11 sarcoidosis between the time of diagnosis and 14 years after 9/11 [16]. As outlined in
Hena, et al (2018), cases were identified as WTC-exposed firefighters with WTC-related sarcoidosis
if they had normal chest imaging prior to 9/11 and then post-9/11 radiographic findings consistent
with sarcoidosis [16]. Extra-pulmonary organ involvement was determined from study questionnaires
and medical records and was defined according to the World Association of Sarcoidosis and Other
Granulomatous Diseases (WASOG) criteria [17].
Controls were randomly selected from the source population and were matched to cases based on
race, age on 9/11, smoking history, and WTC-exposure history. WTC-exposure history was determined
265
IJERPH 2019, 16, 1830
by arrival time to the WTC site: arrival group 1 (arriving the morning of 9/11) being the group with the
highest dust cloud exposure and arrival group 4 (arriving between 9/13–9/24) having the least dust
cloud exposure [18]. Controls also had normal chest radiographs at the time of the study.
The final study population included 55 cases and 100 controls. All cases and controls had
peripheral blood drawn in 2015–2016 and completed a questionnaire at the time of blood draw to
aid with matching on clinical characteristics and WTC-exposure history. The study was approved
by the Montefiore Medical Center/Albert Einstein Institutional Review Board (2014-4291). All study
participants provided written informed consent.
2.2. Genotyping
Peripheral blood mononuclear cells were obtained from cases and controls for sequencing analysis.
A panel of 51 candidate genes were pre-selected based on their function encoding proteins involved
in granuloma formation, innate and immune recognition, inflammation, and sarcoidosis. The loci of
targeted candidate genes were sequenced using a custom designed sequencing panel for IonTorrent
Ampliseq technology. The custom sequencing panel contained 1193 amplicons spanning all known
exons, splice junctions and promoter regions of the genes. Promoter regions were defined as 2 kb
upstream from the transcriptional start site. The panel overall coverage was over 90% for 422 exons
(Supplementary Table S1). One exception was HLA-A, which had 41% coverage, but is known to be
associated with low coverage in prior design assays as well. The sequencing panel was designed
for the analysis of amplicons of 125–375 bp using the Ion AmpliSeq technology and was suitable for
sequencing using the Ion Proton Sequencer as previously reported [19].
DNA was extracted using the QuickGene 610 system and the whole blood kit (Kurabo #DB-L),
and quality verified and quantitated by the NanoDropTM 1000 Spectrophotometer (Thermo Fischer
Scientific, Waltham, MA, USA). The Qubit® dsDNA HS Assay Kit (Life Technologies, Carlsbad, CA,
USA) was used to determine the concentration of each sample. Approximately 20 ng of DNA was used
to generate libraries for sequencing. When not in use, samples were stored at −20 ◦C. For each sample,
a PCR reaction was set up according to the manufacturer’s protocol using 20 ng of genomic DNA,
two separate primer pools, and 16 amplification cycles. Following amplification, each sample was
treated with FuPa reagent and ligated to a uniquely barcoded adapter to enable sample multiplexing.
Libraries were then purified using the 1.5X Agencourt AMPure XP (Beckman Coulter Inc, Brea, CA,
USA) kit. Amplification products from each primer pool were quantified individually using the KAPA
Library Quantitation kit (Roche, Mannheim, Germany) and then pooled together. Template preparation
was performed using the Ion OneTouch 2 system and the Ion PI Template OT2 200 kit v2 (Thermo Fisher
Scientific, Waltham, MA, USA), according to the manufacturer’s protocol. All libraries were sequenced
on the Ion Proton sequencer using the Ion PI chip and the Ion PI Sequencing 200 kit v2 (Thermo Fisher
Scientific, Waltham, MA, USA) to generate 200bp single ended sequencing.
For the identification and reporting of germline variants, we used a custom validated bioinformatic
pipeline for the identification of SNPs as well as insertions and deletions (INDELs) included in the
target panels [20–22]. The sequence reads obtained from the samples were aligned to the human
reference genome (hg19-Genome Reference Consortium GRCh37) using the Ion Torrent Suite and
then processed by the Torrent Variant Caller for variant calling. The generated BAM files were next




We identified 909 variants (SNPs or INDELs) with minor allele frequency (MAF) ≥0.05 and p-value
for Hardy-Weinberg Equilibrium Test > 0.0001. The variants were classified by their genomic locations
to four categories: exon, intron (likely intron/exon boundaries), upstream, and 5’untranslated region
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(5’UTR). For those in an exonic region, they were further classified by their function as synonymous,
nonsense, missense, or frameshift (Supplementary Tables S2 and S3). For each of these common
variants, Pearson Chi-square test was used to compare the genotype frequencies between the 55 cases
and 100 controls that were successfully sequenced (see Supplementary Table S4). To verify the
robustness of our results, Fisher’s Exact Tests were also performed. For each of the variants, odds ratios
were estimated using unconditional logistic regression under the co-dominant model.
We conducted two secondary analyses. First, we explored the interaction between each common
variant and degree of WTC exposure, measured as arrival time to the WTC site. For each variant,
we applied unconditional logistic regression under the co-dominant model with sarcoidosis as the
outcome and the genotypes, WTC exposure group and their interaction term, as the explanatory
variables. Likelihood ratio tests are applied to compare two models with and without the interaction
term between the genotype and degree of WTC exposure. We also conducted a secondary analysis
in which we associate the genetic variants with extrathoracic sarcoidosis. In these analyses, for each
variant we applied unconditional logistic regression under the co-dominant model with extrathoracic
sarcoidosis as the outcome and the genotypes as the explanatory variable.
2.3.2. Rare Variants
For variants whose MAF < 0.05, for each individual, the total number of rare alleles located in each
gene were counted. We then compared the number of rare alleles between the cases and controls for
each gene by each genomic location category (exon, intron, upstream, or 5’untranslated region) using
two-sample T-tests. Furthermore, we counted rare variants with MAF < 0.01 across all target genes by
the above-mentioned categories by genomic location and function, and then performed two-sample
t-tests comparing the cases and controls for each of the categories.
3. Results
Final genetics analyses were completed on 55 cases and 100 controls. All but one case (54/55) and
one control (99/100) self-identified as Caucasian, the remaining one case and one control self-identified
as African American. The cases and controls were well matched, with at least one control for each case
(Table 1).
Table 1. Demographics of WTC Study Population.
Demographics
Case Characteristics Control Characteristics p-Value
N % N %
Total 55 100 100 100
Arrival group 0.99
Morning of 9/11 12 21.8 22 22
Afternoon of 9/11 24 43.6 46 46
Day 9/12 15 27.3 25 25
Day 9/13–9/24 4 7.3 7 7
Race 1.00
White 54 98.2 99 99
African-American 1 1.8 1 1
Smoking status at time of blood draw 0.66
Never 40 72.7 72 72
Former 14 25.5 23 23
Current 1 1.8 5 5
Age on 9/11, years, median [IQR] 36.8 [32.7–39.0] 35.4 [30.2–39.3] 0.29
Age at sarcoidosis diagnosis, median [IQR] 43.0 [38.2–46.6] –
Time to diagnosis post 9/11, median [IQR] 6.7 [3.3–9.6] –
IQR: interquartile range.
Organ involvement for the 55 cases included 47/55 (85.5%) with biopsy proven sarcoidosis.
The 8/55 (14.5%) without biopsy results had their imaging and organ involvement reviewed by two
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pulmonologists to confirm consistency with sarcoidosis [16]. As outlined in Table 2, there was a decrease
in intrathoracic involvement from the time of diagnosis to the time of the blood draw (mean eight-years
post diagnosis) from 95% to 47% and an increase in extrathoracic involvement, especially cardiac
and joint.
Table 2. Sarcoidosis organ involvement in WTC genetics study population.
Organ Involvement
Study Cases (N = 55)
At Diagnosis Time of Blood Draw a





Extrathoracic lymph nodes 0 0
Eyes 3 3




Nervous system 0 1




a All cases had complete data regarding organ involvement at diagnosis and blood draw with the following
exceptions: chest CT scan at diagnosis (N = 52), and at blood draw (N = 53); muscle at diagnosis (N = 54), and at
blood draw (N = 54); spleen at diagnosis (N = 54), and at blood draw (N = 53); cardiac at blood draw (N = 53);
and ear/nose/throat at diagnosis (N = 51), and at blood draw (N = 53).
Within the 51 candidate genes analyzed, we identified 3619 total number of variants. A total
of seventeen common variants were found to be associated with sarcoidosis with Chi-Squared
p-value < 0.01 (Table 3). All of the 17 variants were within chromosomes 1 and 6. Multiple variants
were in HLA genes such as HLA-C, HLA-DRB1, HLA-DQB1, HLA-DPA1, and HLA-DPB1. There was
a strong association with sarcoidosis within exonic regions of the HLA-DQB1 gene, represented by
rs1049133 and rs1049130, two SNPs 12bp apart (ORs = 2.56 and 1.90, respectively). Two variants
upstream from an intronic/exonic border region of HLA-DQB1 were also significantly associated with
sarcoidosis, rs4516985 and rs9274614 (ORs = 1.74 and 2.49, respectively). In addition, several genetic
variants within or near non-HLA genes were also significantly associated with sarcoidosis: BTNL2,
PTGS2/COX2, and PACERR (PTGS2 Antisense NFKB1 Complex-Mediated Expression Regulator RNA).
SNPs in a non-coding region of BTNL2, rs2076525 and rs2076524, were significantly associated with
sarcoidosis (OR = 1.71). In addition, rs2076523, representing a missense mutation within a BTNL2
coding region was associated (OR = 1.97). Upstream from PTGS2/COX2 gene, rs20417 was also
associated with sarcoidosis cases in our cohort (OR = 1.79).
In our secondary analysis, we did not find statistical evidence of an interaction between common
variants and the degree of WTC exposure. We also found no statistical significance when we compared
the number of rare variants between the cases and controls.
Our results also suggest an association between extrathoracic involvement and genetic variants
within several HLA and non-HLA genes: HLA-B, PTGS2/COX2, PACERR, NOTCH4, NOD2, and ITGAE
(Integrin Subunit Alpha E) (Table 4). Genetic variants associated with extrathoracic cases were found
on chromosomes 1 and 6, similar to the loci associated with all sarcoidosis cases, and were also found
on chromosomes 16 and 17. On chromosome 1, rs2066826 represents an intronic region/exonic border
of PTGS2/COX2 associated with sarcoidosis, and specifically, extrathoracic disease in this cohort (OR
1.88 and 1.45, respectively). As seen in all sarcoidosis cases with rs20417, another variant only a few
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hundred base pairs away and downstream from PACERR, is rs689466, for which the allele C was
more common in those with extrathoracic disease. A genetic variant within an HLA-B, rs2276448,
was also associated with extrathoracic sarcoidosis. In addition, on chromosome 6, a locus upstream
from NOTCH4, rs3134929, was associated with extrathoracic disease. And in chromosome 16 and
17, three variants were associated with extrathoracic involvement: two SNPs within chromosome
16, rs2066843 and rs2066842, both within exonic regions of NOD2; and one within chromosome 17,
rs220465, representing a genetic variant within the intronic region/exonic border of ITGAE. As shown
in Table 2, cardiac and joint involvement were common, but our cohort size was too small to identify
genetic variants associated with any specific extrathoracic organ manifestation. We also found no
association between the degree of exposure and extrathoracic organ involvement.
Table 3. Genetic variants most associated with sarcoidosis.







PTGS2/COX2 chr1:186645927 rs2066826 T/C C 0.002 0.001 1.88
PTGS2|PACERR chr1:186650321 rs20417 G/C C 0.003 0.001 1.79
HLA-C chr6:31239681 rs9264669 T/A A 0.004 0.003 1.75
BTNL2 chr6:32370616 rs2076525 C/T T 0.006 0.003 1.71
BTNL2 chr6:32370684 rs2076524 G/A A 0.006 0.003 1.71
BTNL2 chr6:32370835 rs2076523 C/T T 0.005 0.002 1.97
HLA-DRB1 chr6:32549424 rs112116022 T/C C 0.003 0.002 5.21
HLA-DQB1 chr6:32629847 rs1049133 G/A A 0.004 0.003 2.56
HLA-DQB1 chr6:32629859 rs1049130 G/A A 0.006 0.004 1.90
HLA-DQB1 chr6:32635632 rs4516985 G/A A 0.004 0.005 1.74
HLA-DQB1 chr6:32635846 rs9274614 G/C C 0.005 0.004 2.49
HLA-DPA1|HLA-DPB1 chr6:33048457
rs386699868






TT/GG TT 0.007 0.007 1.66 †
HLA-DPA1|HLA-DPB1 chr6:33049211 rs928976 T/C T 0.007 0.008 1.74 †
indicates that SNP overlaps part of both genes; * listed as alternative allele/reference allele; ** ORs are calculated
under the co-dominant model and are relative to the alternative allele unless specified with † which is in relation to
the reference allele. This was done to maintain the OR as a comparison between the risk allele and non-risk allele.
Table 4. Genetic variants associated with extrathoracic organ involvement.







PTGS2 chr1:186645927 rs2066826 T/C C 0.009 0.012 1.45
PACERR chr1:186650751 rs689466 C/T C 0.006 0.016 2.33 †
HLA-B chr6:31323020 rs2276448 C/T T 0.008 0.003 2.13
NOTCH4 chr6:32192107 rs3134929 G/C G 0.009 0.012 2.39 †
NOD2 chr16:50744624 rs2066842 T/C T 0.010 0.019 2.00 †
NOD2 chr16:50745199 rs2066843 T/C T 0.010 0.019 2.21 †
ITGAE chr17:3637915 rs220465 T/C T 0.005 0.006 1.08 †
* listed as alternative allele/reference allele; ** ORs are calculated under the co-dominant model and are relative to
the alternative allele unless specified with †which is in relation to the reference allele. This was done to maintain
the OR as a comparison between the risk allele and non-risk allele.
4. Discussion
Sarcoidosis has been identified in all WTC cohorts (FDNY, general responders other than FDNY,
the survivor population and the WTC Registry), the most extensively described being that from
FDNY [4,16,23–26]. In our current FDNY case-control study, we examine genetic characteristics in our
cases as compared with our WTC-exposed controls without sarcoidosis. Seventeen allele variants
of HLA and non-HLA genes were found to be associated with sarcoidosis with p-value < 0.01 and
all were within chromosomes 1 and 6. Our results also suggest an association between extrathoracic
involvement and allele variants of HLA and non-HLA genes found not only on chromosomes 1 and
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6, but also on chromosomes 16 and 17. Comparing our findings to published studies of sporadic
sarcoidosis, we found similarities between genetic variants with WTC-related sarcoidosis and those
reported in studies of sarcoidosis without known environmental exposures. In addition, we identified
several allele variants not previously reported to be in association with sarcoidosis. If confirmed in
larger studies with known environmental exposures, these novel findings may provide insight into the
gene-environment interactions key to the development of sarcoidosis.
For example, our data are consistent with a prior study showing an association between SNP
rs20417, in a non-coding region of the PTGS2/COX2 gene on chromosome 1, and sarcoidosis in a
UK and Austrian Caucasian cohort without known environmental exposure [11]. This allele variant,
described using prior nomenclature -765C (-765 is the nucleotide base pair position and C is the base
pair), was found to be more often present in sarcoidosis subjects with severe pulmonary disease
(poor lung function or extensive fibrosis). The authors also created lung fibroblast cell lines that were
stimulated by transforming growth factor (TGF)-β1. They found that the cell lines with the -765C
(currently named rs20147) produced little to no prostaglandin E2 (PGE2), an important inhibitor of the
proliferation of fibroblasts. The loss of this lung protective inflammatory mediator could explain its
relationship to more severe forms of pulmonary sarcoidosis. As eloquently described by Valentonyte
and colleagues (2005), allele variations in BTNL2 impact the negative T-cell regulation function of
BTNL2 [14]. Thus, the dysregulation of T-cell function from some BTNL2 mutations may explain its
relationship to sarcoidosis. Interestingly, Akers and colleagues (2011) determined there was strong
linkage disequilibrium between rs9274614, an allele significantly associated with sarcoidosis in our
cohort, and several HLA-DQB1*06 alleles [27]. Another study found an association between the
HLA-DQB1*0601 allele and cardiac sarcoidosis in a Japanese cohort [28]. Although our sample size
was too small to identify specific alleles associated with cardiac sarcoidosis, the known association
between the SNP rs9274614 and an allele associated with cardiac sarcoidosis, HLA-DQB1*0601, is one
of interest in this cohort given the significant number of participants with cardiac sarcoidosis.
Except as noted above, the genetic variants associated with sarcoidosis in our WTC-exposed
cohort have not previously been reported. Several of the SNPs identified in our cohort as associated
with WTC-related sarcoidosis have been associated with other diseases in cohorts without known
environmental exposures. Perhaps the most frequently investigated is rs20417 in PTGS2/COX2.
Studies have identified its association with carotid-calcified plaque in those with diabetes [29],
protection against myocardial infarction and stroke [30], as well as asthma [31]. In addition,
SNP rs1126513, significantly associated with WTC-related sarcoidosis in our cohort, was found
to be associated with ankylosing spondylitis [32].
The main strength of this study was its reliance on a rigorously characterized prospective cohort,
with a clearly defined time of exposure (9/11). One limitation of this study is that it was focused on
candidate genes already identified in sarcoidosis studies from the general population without WTC
exposure. Additionally, the identification of novel SNPs may be partially due to our high-density
sequencing which evaluated almost every base pair of these candidate genes. The main limitation,
however, is that this study includes a relatively small sample size. Our statistical power was limited
to detect only sizable effects. At significance level 0.01, we had 0.8 power to detect an odds ratio
of 2.3 at variants with MAF = 0.5 and an odds ratio of 4 at variants with MAF = 0.05; we had 0.2
power to detect an odds ratio of 1.5 at variants with MAF = 0.5 and an odds ratio of 2 at variants with
MAF = 0.05. Additional power would be obtained if this study was expanded to include all of the
various WTC health program cohorts to allow for both replication of the main effects observed, and to
allow for gene-environment analyses. This could potentially allow for more robust causal inferences to
be made regarding the etiology of sarcoidosis, and whether there are unique differences in those with
extrathoracic disease, particularly cardiac and joint involvement.
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5. Conclusions
The incidence of sarcoidosis was increased after the collapse of the WTC towers and this is best
demonstrated in the FDNY cohort where there was clear evidence that these cases were new in onset
after 9/11 [4,16]. Our findings suggest that the genetic characteristics of WTC-related sarcoidosis are
similar to the sporadic cases found in the general population without known environmental exposures.
These data suggest the granulomatous disease observed post-9/11 and originally termed “Sarcoid-Like”
Granulomatous Disease (SLGD) is better described as WTC-related Sarcoidosis. Our findings, however,
suggest that there are several novel allele variants (SNPs) which may be uniquely associated with
WTC-related sarcoidosis and with extrathoracic disease. These novel findings may provide some
insights into the unique gene-environment interactions key to the development of sarcoidosis in this
population, among others. Future studies should focus on increasing the power of our findings by
combining sarcoidosis cases from all WTC health program cohorts and comparing them to matched
controls with non-WTC associated sarcoidosis.
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Abstract: Asthma control is suboptimal among World Trade Center Health Registry (WTCHR)
enrollees. Air pollution/irritants have been reported as the most prevalent trigger among World Trade
Center responders. We examined the relationship between air pollution/irritants and asthma control.
We also evaluated the association of asthma control with health-related quality of life (HRQoL).
We included 6202 enrollees age≥18 with a history of asthma who completed the WTCHR asthma survey
between 2015 and 2016. Based on modified National Asthma Education and Prevention Program
criteria, asthma was categorized as controlled, poorly-controlled, or very poorly-controlled. HRQoL
indicators include ≥14 unhealthy days, ≥14 activity limitation days, and self-rated general health.
We used multinomial logistic regression for asthma control, and unconditional logistic regression
for HRQoL, adjusting for covariates. Overall, 27.1% had poorly-controlled and 32.2% had very
poorly-controlled asthma. Air pollution/irritants were associated with poorly-controlled (adjusted
odds ratio (AOR) = 1.70; 95% CI = 1.45–1.99) and very poorly-controlled asthma (AOR = 2.15;
95% CI = 1.83–2.53). Poor asthma control in turn worsened the HRQoL of asthmatic patients.
Very poorly-controlled asthma was significantly associated with ≥14 unhealthy days (AOR = 3.60;
95% CI = 3.02–4.30), ≥14 activity limitation days (AOR = 4.37; 95% CI = 3.48–5.50), and poor/fair
general health status (AOR = 4.92; 95% CI = 4.11–5.89). Minimizing World Trade Center (WTC)
asthmatic patients’ exposure to air pollution/irritants may improve their disease management and
overall well-being.
Keywords: 9/11 disaster; asthma; trigger(s); air pollution; irritant(s); health-related quality of life
1. Introduction
The prevalence of asthma has increased in the last decade and placed a significant economic
burden on the United States and globally. Asthma is a chronic disease characterized by inflammation
of the airways, reversible airflow obstruction, and bronchial hyper-responsiveness, with symptoms
including wheezing, coughing, tightness of the chest, shortness of breath, and sleep awakening. These
symptoms can greatly affect daily activities and quality of life. In the United States, asthma was
responsible for $3 billion in losses due to missed work and school days, $29 billion due to asthma-related
mortality, and $50.3 billion in medical costs during 2008–2013 [1]. A previous World Trade Center
(WTC) study reported that asthma control was poor or very poor in over 68% of World Trade Center
Health Registry (WTCHR) enrollees diagnosed after 9/11 [2], likely affecting their quality of life.
The presence of asthma triggers that are difficult to avoid may be responsible for some of this lack
of asthma control in many patients. Part of the difficulty in asthma medical management is explicitly
defining triggers that contribute to exacerbations [3,4]. A higher number of triggers experienced [3]
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and a wide array of asthma triggers have been identified and perceived by patients as contributing to
the severity and frequency of asthma exacerbations [3,5,6].
Air pollution/irritants are materials in the indoor or outdoor air that can have adverse effects
on humans and the ecosystem. These substances can be in the form of particulates, liquid droplets,
or gases, and can be of natural origin or man-made. They induce airway inflammation or an
allergen-induced response by causing direct cellular injury or by inducing intracellular signaling
pathways and transcription factors that are known to be sensitive to oxidative stress [6]. The subsequent
mucosal damage and impaired mucociliary clearance may facilitate access of inhaled allergens to
the cells of the immune system [6]. Air pollutants/irritants were the most prevalent type of asthma
triggers reported in previous studies [7,8]. The most abundant components of air pollution in urban
areas are particulate matter (PM), nitrogen dioxide (NO2), and ozone (O3). PM is a mixture of organic
and inorganic solid and liquid particles of different origin and size. NO2 can enhance the allergic
response to inhaled allergens, and its concentration in ambient air is reportedly associated with cough,
wheezing, and shortness of breath in atopic patients. O3 is thought to increase asthma morbidity by
enhancing airway inflammation and epithelial permeability [6]. High ambient concentrations of these
materials are associated with an increased rate of asthma exacerbations [6,9], and were associated with
increased post-9/11 asthma-related hospital admissions [9].
Health-related quality of life (HRQoL) has been increasingly recognized as an important endpoint
and measure for interventions [10–12]. It is regarded as a measure of the effect of the disease on a
patient’s life. A previous study reported that greater severity and frequency of exacerbations were
significantly associated with decreases in asthma-related quality of life [13]. Poorly-controlled asthma
were also found to be related to poorer HRQoL in the United Kingdom [14]. Moreover, asthmatic
patients had worse indicators of quality of life compared to the general population regardless of
whether symptoms were clinically controlled [15].
To better understand the relationship between asthma triggers, asthma control, and HRQoL
among asthmatic enrollees who were exposed to the WTC disaster, the current study consists of two
parts. The first part aims to supplement existing knowledge regarding the various triggers in an
effort to determine whether air pollution/irritants are an important trigger reported by individuals
exposed to 9/11. The second part of this study assesses two objectives: (1) to examine the association
of self-reported air pollution/irritants trigger with asthma control among all asthmatic enrollees
who were exposed to WTC disaster; and (2) to examine the association of different level of asthma
control with three domains of impaired HRQoL: self-reported mental or physical unhealthy days,
self-reported activity limitation days, and self-reported general health. We hypothesized that reporting
air pollution/irritants as an asthma trigger is associated with poorer asthma control, and that poorer
asthma control is associated with lower HRQoL among 9/11-exposed individuals with asthma.
2. Materials and Methods
The WTCHR has been described in detail elsewhere [16,17]. Briefly, this is a longitudinal cohort
study including rescue/recovery workers and volunteers (RRW) and community members not involved
in rescue/recovery (lower Manhattan area residents, students, and workers; passersby and commuters
on 9/11). Participants were recruited through Lower Manhattan area building or employer lists,
or encouraged to enroll via a toll-free telephone number or website [17]. Between 12 September
2003 and 24 November 2004, 71,431 people completed a computer-assisted (95%) or in-person (5%)
enrollment interview on demographics, exposures incurred during and after the WTC disaster and
health information. Since that baseline enrollment (Wave 1), the Registry has conducted three follow-up
surveys (Waves 2 to 4) via mail, website, or telephone interview to collect updated health information.
The response rates for Wave 2 (2006–2007), Wave 3 (2011–2012), and Wave 4 (2015–2016) were 65.2%,
60.4%, and 51.6%, respectively. All surveys inquired about enrollees’ medical history and physical and
mental health status. The Wave 4 asthma survey began on 3 September 2015 and continued through
20 March 2016, and was administered as a supplement to the Wave 4 Core (Wave 4) survey. We sent out
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the Wave 4 asthma survey to 14,983 eligible enrollees age ≥18 who reported ever being diagnosed with
asthma in any of the three prior wave surveys, either before or after 9/11/2001. Asthma survey data
were collected via the internet or through paper mailings and entailed disease management questions,
including triggers, asthma control and exacerbation. The Registry’s protocol was approved by the
institutional review boards of the US Centers for Disease Control and Prevention and the New York
City Department of Health and Mental Hygiene (#02-058).
2.1. Study Sample
Of the 14,983 eligible enrollees who were sent the Wave 4 asthma survey, 8482 responded to the
survey either fully or partially. Of these, 4653 (55%) were completed by web and 3829 (45%) were
completed by paper. In our study, we only included those who reported “yes” to the gate question of
“Have you ever been told by a doctor or other health professional that you had asthma?” on the Wave
4 asthma survey (N = 7129), though we only mailed the Wave 4 asthma survey to enrollees who had
reported an asthma diagnosis on at least one of the three prior Registry surveys (Waves 1 through 3).
We excluded enrollees who had missing age (N = 3), and those who did not respond to the Wave 4
survey (N = 830) since we used the sociodemographic and health variables from Wave 4. We also
excluded additional persons who had missing value for the asthma control variable (N = 94). The final
study sample was 6202 for data analyses.
2.2. Study Outcomes and Variables
2.2.1. Determining Air Pollution/Irritants as Trigger
We derived this variable by analyzing asthma triggers following the method of Ritz [4]. Briefly,
open-ended responses to the asthma triggers question “Please list up to six of the strongest triggers
of your asthma” were grouped into 11 main categories: air pollution/irritants, exercise, infection,
allergens (pollen), allergens (animal), allergens (general), air temperature, psychological, allergens
(food), medications, and other. Similar to findings in previous studies [7,8], air pollution/irritants was
the most prevalent type of trigger, reported by over 50% of the participants. We therefore derived a
dichotomous variable of air pollution/irritants.
2.2.2. Asthma Control and HRQoL
We focused on two main outcomes in the second part of the study. The first outcome was asthma
control and the second outcome was HRQoL. We categorized asthma control for study participants as
having controlled, poorly-controlled, or very poorly-controlled asthma reported in the Wave 4 asthma
survey, based on criteria modified from the National Asthma Education and Prevention Program’s
Third Expert Panel Report 3 (EPR 3). Briefly, the criteria consist of four components: shortness of
breath, wheezing, and/or cough; nighttime awakenings; interference with normal activity; and use of
a rescue inhaler or nebulizer. The level of asthma control category was determined by frequency of
experience on each component. Participants were assigned to the most severe category in which any
component was reported. In our slightly modified criteria, for interference with normal activity, we
specified none/a little of the time to well-controlled, some/most of the time to poorly-controlled, all of
the time to very poorly-controlled asthma, versus no interference with normal activity, some limitation,
and extreme limitation for well-controlled, poorly-controlled, and very poorly-controlled asthma,
respectively, based on EPR 3 definition. We also slightly modified use of a rescue inhaler or nebulizer.
We specified inhaler use of <3 times/week to well-controlled, 1–2 times/d to poorly-controlled, and >2
times/d to very poorly-controlled asthma, versus ≤2 days/week, >2 days/week, and several times per
day for well-controlled, poorly-controlled, and very poorly-controlled asthma, respectively, based on
EPR 3 definition [2,18]. In the second analysis, asthma control was treated as predictor variable, and
we assessed three dichotomous outcome variables for HRQoL: ≥14 physically or mentally unhealthy
days; ≥14 days of poor physical or mental health that keep you from doing your usual activities
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(activity limitation); and self-rated general health status (excellent, very good, or good versus fair or
poor) [19,20].
2.3. Covariates
In both analyses, we adjusted for age, gender, race/ethnicity, marital status, education,
social integration, smoking status, depression, probable post-traumatic stress disorder (PTSD),
gastroesophageal reflux symptoms (GERS), obstructive sleep apnea (OSA), body mass index (BMI),
having at least one regular healthcare provider, and WTC dust/debris cloud exposure. WTC dust/debris
exposure was a dichotomous variable obtained from the Wave 1 survey. Those who reported having
been caught in the dust and debris cloud on 9/11/2001 were considered to have had dust cloud exposure.
Comorbid conditions were assessed at Wave 4 survey. The Wave 4 survey began in 20 March 2015 and
continued through 31 January 2016, while the Wave 4 asthma survey began on 3 September 2015 and
continued through 20 March 2016. The mean time interval between the Wave 4 and Wave 4 asthma
surveys was 132 days, with a range from 0 to 323 days. Probable PTSD, depression, and generalized
anxiety disorder (GAD) were defined using validated scales. Participants with a score ≥44 on the PTSD
Checklist, Stressor-Specific Version, a 17-item scale that inquired about 9/11-related psychological
symptoms during the 30 day before Wave 4, were considered to have probable PTSD [21,22]. Depression
within the two weeks before completion of Wave 4 was defined as a score ≥10 on the 8-item Patient
Health Questionnaire depression scale [23]. Probable GAD during the two weeks before Wave 4 was
defined as a score ≥10 on the 7-item GAD scale [24]. Self-reported GERS and history of OSA were also
obtained from Wave 4 questionnaire responses. Participants who reported having heartburn at least
once a week during the 12 months preceding Wave 4 were considered to have GERS. Smoking history
was taken from the most recent questionnaire where smoking data were available. Social integration
was defined as either low or high based on participants’ responses to the four questions that assess
the components of social integration construct [25]: “In the last 30 days, have you visited, talked, or
e-mailed with friends at least twice?”, “In the last 30 days, have you attended a religious service at least
twice?”, “In the last 30 days, have you been actively involved in a volunteer organization or club?”,
and “About how many close friends or relatives do you have now? Include people you feel at ease
with and can talk with about what is on your mind.” Each of these questions received a score of 1 if the
response was yes or more than zero. Participants were considered as having lower social integration if
the total score was less than two, higher social integration if the total score was two or higher. BMI at
Wave 4 was calculated from self-reported height and weight data; a BMI <25 was considered under or
normal weight, 25–29.9 was considered overweight and ≥30 was obese.
2.4. Statistical Analyses
We used a multinomial logistic regression model to examine the association of self-reported
air pollution/irritants as trigger with poor and very poor asthma control, adjusting for covariates.
We also used multiple logistic regression model to examine the association between asthma control
and three health-related quality of life indicators: ≥14 days of poor physical or mental health, ≥14
days of activity limitation, and self-rated general health, adjusting for the same covariates as analysis 1.
In both analyses, we used two-sided tests of significance and assumed a type 1 error of 5%. We used
SAS software (Version 9.4, SAS Institute Inc., Cary, NC, USA) for all analyses.
3. Results
3.1. Asthma Trigger
The frequencies of different self-reported asthma triggers are shown in Figure 1. Half of the
WTCHR enrollees with asthma reported air pollution/irritants as their asthma trigger. It was the most
prevalent trigger, followed by physical activity and general allergens.
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Figure 1. Percentage of each self-reported asthma trigger among World Trade Center Health Registry
enrollees with asthma (not mutually exclusive).
Asthma control status by sociodemographic characteristics, comorbid conditions, reporting air
pollution/irritants as an asthma trigger, and WTC dust exposure are shown in Table 1. The overall
prevalence of poorly-controlled and very poorly-controlled asthma were 27.1% and 32.2%, respectively.
We also observed an increase in prevalence of very poorly-controlled asthma among those with
self-reported air pollution/irritants trigger (39.8%), depression (55.8%), and probable PTSD (58.1%).
Table 1. Prevalence of asthma control by sociodemographic, air pollution/irritants, and World Trade
Center (WTC) dust cloud exposure among 9/11-exposed individuals with asthma (N = 6202).




Male 3357 38.2 26.2 35.6
Female 2845 43.6 28.2 28.2
Age
<45 1026 59.2 22.2 18.6
45–64 3897 38.0 27.8 34.2
≥65 1279 33.9 29.2 36.9
Race/Ethnicity
White non-Hispanic 4109 44.3 25.0 30.7
Black non-Hispanic 622 31.4 33.6 35.1
Hispanic 938 29.5 33.5 37.0
Asian 286 46.9 25.9 27.3
Other 247 38.5 24.3 37.3
Marital Status
Never married 961 44.8 27.4 27.9
Married/living with a partner 3978 42.6 26.6 30.8
Widowed, divorced, or separated 1163 32.0 28.1 39.9
Education
College/post-graduate 3194 52.5 24.1 23.5
Some college 1964 31.7 29.7 38.7
High school or less 970 20.3 31.4 48.3
Smoking Status
Never smoker 3832 44.0 26.3 29.7
Previous smoker 1791 39.1 26.8 34.1
Current smoker 438 24.2 31.3 44.5
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Table 1. Cont.




Normal (<25) 1450 54.6 22.7 22.8
Overweight (25–29) 2111 41.8 27.5 30.7
Obese (>30) 2436 31.7 29.2 39.2
Social Integration
High 5587 42.8 26.9 30.3
Low 411 16.8 28.7 54.5
Depression
No 4384 50.2 25.9 23.9
Yes 1452 15.8 28.4 55.8
Probable PTSD
No 4632 50.0 25.9 24.1
Yes 1452 12.4 29.5 58.1
GERS
No 3450 50.7 25.1 24.2
Yes 2344 27.8 29.0 43.2
Sleep Apnea
No 4081 49.7 25.6 24.7
Yes 1647 21.9 28.5 49.5
Had at least one regular healthcare provider
No 415 42.4 28.2 29.4
Yes 5681 40.7 26.9 32.4
Air pollution/irritants as an important trigger
No 2777 49.2 24.8 26.0
Yes 2926 30.3 29.9 39.8
Dust cloud exposure at 9/11
No 2587 46.9 25.3 27.8
Yes 3592 36.1 28.5 35.4
* Variable may not add up to total due to missing category. BMI: body mass index; PTSD: post-traumatic stress
disorder. GERS: gastroesophageal reflux symptoms.
3.2. Self-Reported Air Pollution/Irritants as Trigger and Asthma Control
Enrollees who reported air pollution/irritants as triggers had elevated odds ratios for
poorly-controlled ((adjusted odds ratio (AOR): 1.70, 95% CI: 1.45–1.99) and very poorly-controlled
asthma (AOR: 2.15, 95% CI: 1.83–2.53), after adjusting for covariates (Table 2).
Table 2. Multivariable odds ratios for association of level of asthma control with air pollution/irritants,
controlling for selected sociodemographic factors, WTC dust cloud exposure, physical and mental
health co-morbidities among 9/11-exposed individuals with asthma, 2015–2016.
Characteristics at Wave 4 *
Poorly-Controlled Very Poorly-Controlled
Adjusted OR (95% CI) Adjusted OR (95% CI)
Gender
Female referent referent
Male 1.08 (0.91–1.28) 1.52 (1.27–1.82)
Age
<45 referent referent
45–64 1.41 (1.13–1.75) 1.53 (1.21–1.94)
≥65 1.78 (1.36–2.33) 2.13 (1.60–2.83)
Education
College/post-graduate referent referent
Some college 1.44 (1.20–1.71) 1.79 (1.50–2.15)
High school or less 1.80 (1.39–2.33) 2.76 (2.14–3.55)
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Table 2. Cont.
Characteristics at Wave 4 *
Poorly-Controlled Very Poorly-Controlled
Adjusted OR (95% CI) Adjusted OR (95% CI)
Smoking Status
Never smoker referent referent
Former smoker 1.07 (0.90–1.27) 1.19 (1.00–1.42)
Current smoker 2.11 (1.50–2.97) 2.61 (1.86–3.67)
BMI
Normal (<25) referent referent
Overweight (25–29) 1.32 (1.08–1.63) 1.22 (0.98–1.52)
Obese (>30) 1.58 (1.28–1.95) 1.68 (1.35–2.10)
Social Integration
High referent referent
Low 1.60 (1.09–2.37) 1.77 (1.21–2.60)
Depression
No referent referent
Yes 1.46 (1.14–1.87) 2.32 (1.83–2.94)
Probable PTSD
No referent referent
Yes 2.64 (2.04–3.43) 3.39 (2.63–4.37)
GERS
No referent referent
Yes 1.47 (1.24–1.73) 1.72 (1.45–2.03)
Sleep Apnea
No referent referent
Yes 1.38 (1.13–1.68) 1.78 (1.46–2.16)
Dust cloud exposure at 9/11
No referent referent
Yes 1.22 (1.05–1.43) 1.36 (1.16–1.59)
Air pollution/irritants
No referent referent
Yes 1.70 (1.45–1.99) 2.15 (1.83–2.53)
* Non-significant covariates were not reported in the table.
3.3. Asthma Control and HRQoL
All three HRQoL indicators were strongly associated with asthma control level (Table 3). Enrollees
with poorly-controlled asthma had higher odds ratios for ≥14 physically or mentally unhealthy days
(AOR: 2.12, 95% CI: 1.78–2.52), ≥14 days of activity limitation (AOR: 2.17, 95% CI: 1.70–2.77), and
self-rated poor general heath (AOR: 2.66, 95% CI: 2.22–3.18), compared to those with well-controlled
asthma. Stronger associations were observed for very poorly-controlled asthma.
3.4. Mental Health, Asthma Control and HRQoL
Consistent with previous WTCHR findings, both depression and PTSD were associated with
asthma control level [2]. Enrollees who reported depression or PTSD had higher odds ratios
for poorly-controlled (AOR: 1.46, 95% CI: 1.14–1.87; AOR: 2.64, 95% CI: 2.04–3.43) and very
poorly-controlled asthma (AOR: 2.32, 95% CI: 1.83–2.94; AOR 3.39, 95% CI: 2.63–4.37), respectively.
Moreover, both mental illnesses were associated with ≥14 physically or mentally unhealthy days
(AOR: 5.24, 95% CI: 4.22–6.51; AOR 3.08, 95% CI: 2.46–3.86); ≥14 days of activity limitation (AOR: 3.18,
95% CI: 2.58–3.92; AOR: 2.13, 95% CI: 1.72–2.64); and self-rated poor general heath (AOR: 2.65,
95% CI: 2.17–3.24; AOR: 2.04, 95% CI: 1.66–2.51) for depression and PTSD, respectively.
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Table 3. Multivariable odds ratios for association of three health-related quality of life indicators with
asthma control, controlling for selected sociodemographic factors, WTC dust cloud exposure, physical
and mental health co-morbidities among 9/11-exposed individuals with asthma, 2015–2016.
Characteristics at Wave 4 *
≥14 Days of Poor
Physical or Mental
Health




Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
Sex
Female referent referent referent
Male 0.81 (0.70–0.95) 1.12 (0.92–1.35) 1.16 (0.99–1.37)
Age
<45 referent referent referent
45–64 1.26 (1.03–1.55) 1.35 (1.03–1.77) 1.58 (1.28–1.97)
≥65 1.33 (1.03–1.71) 1.92 (1.40–2.63) 1.76 (1.36–2.29)
Race/ethnicity
White non-Hispanic referent referent referent
Black non-Hispanic 1.05 (0.81–1.35) 1.37 (1.03–1.81) 1.32 (1.03–1.70)
Hispanic 1.13 (0.91–1.40) 1.05 (0.83–1.33) 1.40 (1.13–1.73)
Asian 1.10 (0.77–1.59) 0.76 (0.46–1.25) 2.46 (1.72–3.52)
Other 1.11 (0.76–1.63) 1.32 (0.87–2.01) 1.48 (1.01–2.17)
Marital Status
Never married referent referent referent
Married/living with a partner 0.87 (0.71–1.07) 0.71 (0.55–0.90) 0.78 (0.64–0.97)
Widowed, divorced, or separated 1.11 (0.87–1.43) 0.93 (0.71–1.23) 0.91 (0.71–1.17)
Highest Education Attainment
College/post-graduate referent referent referent
Some college 1.29 (1.09–1.51) 1.47 (1.22–1.78) 1.40 (1.19–1.65)
High school or less 1.47 (1.18–1.84) 1.94 (1.53–2.46) 1.90 (1.53–2.37)
BMI
Normal (<25) referent referent referent
Overweight (25–29) 1.09 (0.90–1.32) 0.98 (0.77–1.25) 1.29 (1.05–1.58)
Obese (>30) 1.17 (0.96–1.42) 1.11 (0.87–1.41) 1.50 (1.22–1.83)
Social Integration
High referent referent referent
Low 1.80 (1.25–2.59) 1.51 (1.12–2.04) 1.95 (1.40–2.70)
Depression
No referent referent referent
Yes 5.24 (4.22–6.51) 3.18 (2.58–3.92) 2.65 (2.17–3.24)
Probable PTSD
No referent referent referent
Yes 3.08 (2.46–3.86) 2.13 (1.72–2.64) 2.04 (1.66–2.51)
GERS
No referent referent referent
Yes 1.46 (1.25–1.70) 1.57 (1.32–1.87) 1.72 (1.48–2.00)
Sleep Apnea
No referent referent referent
Yes 1.55 (1.30–1.85) 1.52 (1.25–1.83) 1.81 (1.53–2.14)
Asthma Control
Controlled referent referent referent
Poorly-controlled 2.12 (1.78–2.52) 2.17 (1.70–2.77) 2.66 (2.22–3.18)
Very poorly-controlled 3.60 (3.02–4.30) 4.37 (3.48–5.50) 4.92 (4.11–5.89)
* Non-significant covariates were not reported in the table.
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4. Discussion
4.1. Main Findings
More than half of WTC Health Registry enrollees who have asthma had poorly- or very
poorly-controlled symptoms. Consistent with other studies in various populations [7,8], our study
found that air pollution/irritants were the most prevalent asthma trigger, and poor asthma control
worsened the HRQoL of asthmatic patients. Additionally, our study found that those who identified
air pollution/irritants as their asthma trigger were more likely to have poorly- or very poorly-controlled
asthma than those who did not report air pollution/irritants as their trigger. Our findings underscore
the importance of reduction in indoor and outdoor air pollution exposure, in combination with optimal
asthma control, to improve HRQoL among those who were exposed to 9/11 disaster.
4.2. Air Pollution/Irritants and Asthma Control
Consistent with existing knowledge, our study supports the premise that air pollution/irritants
are significantly associated with poorer asthma control [5,7,9]. This relationship persists independent
of other possible and known risk factors, including 9/11 dust cloud exposure. Higher pollutant levels
such as increased daily NO2 and O3 have been associated with increased asthma-related emergency
department visits after the WTC attacks [9]. Air pollutants may not only increase the frequency and
intensity of symptoms but may also promote airway sensitization to airborne allergens in predisposed
persons [6]. WTC-dust exposed asthmatic patients may be likely to have poorer asthma control when
exposed to certain environmental triggers that recall the WTC attack, such as air pollution/irritants.
Measures reducing indoor and outdoor air pollution/irritants exposure, such as high-efficiency
particulate air filtration system, can improve indoor air quality by reducing levels of PM2.5 and particle
count [26,27]. In addition, educating enrollees about trigger identification and avoidance may prevent
exacerbations and help to improve overall asthma management [13,28–30]. Other sociodemographic
factors, including older age, lower education level, and higher BMI also contributed to poorer asthma
control, consistent with existing literature [2,10,30–32]. This highlights the possible prevention of
asthma exacerbation through lifestyle modification focusing on maintaining normal BMI among
asthmatic persons.
4.3. Asthma Control and HRQoL
Our findings are also congruent with the existing literature that poorer asthma control is associated
with worse HRQoL [10,14,33]. This association continued to be significant after adjusting for known
covariates, suggesting that perceived well-being is a complex interplay between the pathophysiological
manifestations of asthma, socio-demographic factors, and physical and mental health comorbidities.
A previous study also suggested that increased severity of asthma was linked to lower HRQoL among
the poorly controlled [33]. In addition, people with poorly controlled asthma and poor HRQoL are
more likely to have an asthma attack or been admitted to hospital more than once in the previous
12 month [14]. Since the frequency of asthma attack and asthma-related hospitalization are long-term
outcome indicators for asthma [34,35], future studies looking at these outcomes may be helpful to
understand how different level of asthma control affects the overall disease outcome.
4.4. Mental Health, Air Pollution/Irritants, and Asthma Control
Our study also supported previous findings that mental health is an important factor for asthma
severity, exacerbation and HRQoL [7,15,30,36]. A previous study showed that the effect of air
pollution/irritants on asthma control was heightened among WTC workers with panic disorder and
PTSD [8]. The air pollution trigger was also found to be associated with anxiety in another study [36],
suggesting those with comorbid anxiety might be more susceptible to exacerbation when exposed to
air pollution/irritants. Moreover, anxiety and depression were reported to be associated with lower
HRQoL among asthmatic patients [15,30,32,36]. Mental illness constitutes a substantial component of
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asthma disease manifestation. It is necessary to include mental health management in any control
measures targeted to improve disease outcome and HRQoL among asthmatic patients.
4.5. Strength and Limitations
The data in this study were self-reported, and we did not have quantitative assessment of asthma
control, which requires clinical measurement of pulmonary function such as peak expiratory flow (PEF)
and forced expiratory volume (FEV). However, such data may not be essential to our analysis since
spirometric lung function may be largely unrelated to perceived asthma triggers [36], though it might
support the reliability of our asthma control outcome. A strength of this study was that it included a
large sample size and data were available on a wide range of comorbid health conditions. There is
a high level of agreement on risk factors of asthma control with previous studies of WTC-exposed
populations [2,8], supporting the reliability of our findings.
The asthma triggers information in this study was also self-reported. Given the subjectivity
of trigger perception and one’s physiological response to it, the validity of self-reported air
pollution/irritants was in question. There are publicly available data on air quality from the air
monitoring stations, such as the air quality index from the Environment Protection Agency, which
provides information on level of specific pollutants such as O3, sulfur dioxide or NO2 by geographic area.
Future studies integrating such local monitoring environmental data [37,38] with patients’ geospatial
information such as residential address, may be helpful to validate the accuracy of self-reported air
pollution/irritants as trigger.
Given the complexity of treatment regimens and our lack of clinical information on enrollees, we
did not account for medication use and treatment adherence, which are both known to play an important
role in asthma severity and control [39]. Since self-rated severity of disease has been associated with
HRQoL or asthma-related quality of life [10,13,30,33,35,36], future studies that consolidate medication
and treatment adherence information to assess asthma severity maybe useful to better understand their
role in the relationship of asthma triggers, severity and control, as well as between asthma triggers
and HRQoL.
5. Conclusions
Asthma control is closely associated with the perception of asthma trigger exposure, especially to
air pollution. Awareness of appropriate preventive measures against air pollution/irritants exposure,
and ensuring compliance with these measures may improve asthma control. Asthma control is also
closely associated with HRQoL. Optimal asthma control, in combination with treatment for mental
health conditions and lifestyle modification advice such as maintaining healthy weight by encouraging
diet modification and physical activity, may subsequently lead to improved HRQoL for asthmatic
persons exposed to the WTC disaster.
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